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Summary 
 
During the process of protein synthesis, the ribosome translates mRNA-encoded 
nucleotide triplets (codons) into a polypeptide sequence using tRNA molecules as 
adapters. Starting with translation initiation, which comprises the placement of the 70S 
ribosome on the AUG start codon, protein synthesis further passes through the stages 
of translation elongation and translation termination. Each of these steps utilizes 
additional translation factors, which greatly increase translation fidelity and speed. The 
process of translation termination involves release factors RF1, RF2 and RF3. While 
RF1 and RF2 mediate the release of a nascent polypeptide from the 70S ribosome 
upon stop codon selection, RF3 facilitates the recycling of RF1 and RF2 after 
polypeptide release. We obtained cryo-EM structures of intermediate states of RF3-
mediated recycling of RF1 and show that RF3 binding induces SSU rotation. RF3-
induced SSU rotation ultimately leads to formation of rotated state ribosomes with P/E 
hybrid state tRNAs. RF3 moves as rigid-body with the SSU. RF3-induced SSU rotation 
fulfills a dual function. First, SSU rotation mediates accommodation of the G-domain 
of RF3 on the LSU and second, leads to destabilization of RF1 on the 70S ribosome. 
With regard to the recruitment of termination factors, our study shows that RF1 is 
recruited by L7/L12 to the ribosome. Consistently, we observe in one intermediate 
state density next to domain I of RF1, which can be assigned to one CTD of L7/L12. 
Knowing the exact mechanism of RF3 action may help in future to develop new 
antimicrobial agents that can be used in a clinical context.  
 Generally, various clinically relevant antibiotics target bacterial translation and 
thus allow infections to be fought without resulting in toxicity to the human body. 
However, the continuous rise in bacterial resistance highlights the need for new 
antibiotics that can be used to treat bacterial infections. Pro-rich antimicrobial peptides 
(PrAMPs) are a new promising source of antimicrobial agents, which show high 
potency against Gram-negative bacteria by interfering with protein synthesis, while 
exhibiting low toxicity in eukaryotes. PrAMPs are produced by the innate immune 
system of higher eukaryotes and are secreted in response to a bacterial infection. We 
report structural and biochemical data on PrAMP binding, as well as the exact 
mechanism of action. The binding site of all investigated PrAMPs is situated within 
nascent polypeptide exit tunnel. The mechanism of action allows class I PrAMPs to be 
distinguished from class II PrAMPs. Consistently, we show that class I PrAMPs, such 
Summary XVII 
as Bac7, Onc112, pyrrhocoricin and metalnikowin block delivery of aa-tRNA by EF-Tu, 
whereas the class II PrAMP Api137 acts during translation termination and inhibits 
protein synthesis by trapping of RF1 on the 70S ribosome after the nascent chains 
have been released. 
Introduction 1 
1 Introduction  
 
Biochemistry embraces chemical reactions within living cells/organisms. As such, DNA 
replication, RNA transcription and protein synthesis (translation) constitute the three 
crucial chemical processes which are common in all living organisms and defined in 
the central dogma of molecular biology (Crick, 1958). Translation represents the last 
step of the central dogma in which the genetic information encoded in DNA is turned 
into a functional macromolecule, called protein. Although the genetic information is 
encoded in DNA, proteins are not decoded directly from DNA, but rather from 
messenger molecules which consist of RNA. These messenger ribonucleic acid 
(mRNA) molecules are generated during the process of transcription. DNA constitutes 
the template for the generation of mRNA. mRNA on the other hand functions as the 
template during translation in which nucleotide triplets (codons) are consecutively read 
from the 5’ to 3’ end, thereby dictating the exact sequence of the polymerized amino 
acids (primary sequence) (Crick et al., 1961). The nucleotide (nt) triplets are read from 
the mRNA by decoding factors, or transfer RNAs (tRNAs) that act as adaptors and 
carry the incorporated amino acid. In general, tRNAs exhibit a cloverleaf secondary 
structure with an acceptor stem, a T-arm, a D-arm and an anticodon stem (Holley et 
al., 1965; Kim et al., 1973). The amino acid is attached at the 3’ acceptor end (CCA-
end). Polymerization of a polypeptide is a unidirectional chemical process, which is 
characterized by the covalent linkage of an incoming amino-group to the carboxyl end 
(C-terminus) of a growing peptidyl moiety. The opposing end of a nascent polypeptide 
chain, which carries the first incorporated residue with a free amino-group, constitutes 
the N-terminus. 
 
1.1 Bacterial translation machinery 
 
The elongation of the liberated protein macromolecule is catalyzed by a large 
ribonucleoprotein complex, called a ribosome, which can be found in all kingdoms of 
life (McQuillen et al., 1959). The ribosome is the result of billions of years of evolution 
and consists of ribosomal RNA (rRNA) and ribosomal proteins. The ribosomal RNA 
(rRNA) builds up the catalytically active core of the machine, which is per definition a 
ribozyme (Ban et al., 2000; Cech, 2000; Hansen et al., 2002; Harms et al., 2001; 
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Nissen et al., 2000; Noller, 2012; Schlünzen et al., 2001). Ribosomal proteins are 
mostly bound to the surface with extensions reaching deeper into the translation 
machine. The catalytic core of the ribosome that possesses the activity for peptide 
bond formation, called the peptidyl transferase center (PTC), is especially highly 
conserved in all living organisms (Melnikov et al., 2012).  
Overall, the eubacterial ribosome is a large (2.5 MDa) ribonucleoprotein particle 
consisting of a large ribosomal subunit (LSU, 50S) and a small ribosomal subunit 
(SSU, 30S) (Figure 1A) (Wilson and Nierhaus, 2005). The LSU and SSU come 
together to form a 70S ribosome (Figure 1A). The LSU consists of ~30 ribosomal 
proteins (33 proteins in Escherichia coli), one 23S and one 5S rRNA molecule 
(Nierhaus, 1991). The SSU contains ~20 ribosomal proteins (21 proteins in E. coli) and 
a single 16S rRNA molecule. LSU and SSU proteins are from here on designated with 
an ‘L’ or an ‘S’, respectively (e.g. SSU protein S5). Ribosomal proteins are synthetized 
by the classical translation pathway and ribosomal RNAs are transcribed directly from 
DNA (encoded in seven rRNA operons in E. coli) by RNA polymerases as one long 
immature RNA precursor. The immature precursors get post-transcriptionally 
processed by cleavage (Mathy et al., 2007; Nierhaus, 1991; Srivastava and 
Schlessinger, 1990) and modification (Chow et al., 2007), leading to the three different 
rRNAs. The mature rRNAs exhibit a complex three-dimensional structure which is 
characterized by distinct secondary structures, such as helices, and tertiary structures, 
such as domains. The LSU can be divided into six domains (I-VI) and the SSU can be 
divided into four domains, namely, the 5’ domain (body), the central domain (platform), 
the 3’ major domain (head) and the 3’ minor domain (helix 44-45). 
Figure 1 - Bacterial translation machinery. (A) Overview of the bacterial 70S ribosome consisting of a 
small 30S subunit (yellow) and a large 50S subunit (grey). (B) Transverse section of the 70S ribosome 
harboring an A-site tRNA (blue), a P-site tRNA (green) and an E-site tRNA (red). The catalytic centers 
on the LSU (grey) and the SSU (yellow) are highlighted by black contoured grey circles. The LSU 
harbors the peptidyl transferase center (PTC) and the SSU harbors the decoding center (DC). (C) 
Transverse section of the SSU (yellow) showing the path of the mRNA (cyan) and the mRNA-tRNA 
contact sites of A-site tRNA (blue), P-site tRNA (green), and E-site tRNA (red). (D) Overview of the LSU 
(grey) polypeptide exit tunnel (NPET) containing a nascent chain (MifM staller) attached to P-site tRNA 
(green). A-site (blue) and E-site tRNA (red) are shown for reference. 
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The LSU contains the catalytic activity for peptide bond formation in the PTC. 
The SSU facilitates decoding in the decoding center (DC) (Figure 1B) and plays a 
crucial role for the accuracy of the translation process. Just like the PTC, the key 
residues in the DC are formed by rRNA residues. The interactions between both 
subunits are maintained by eight major intersubunit bridges which involve RNA-RNA, 
protein-protein and RNA-protein interactions (Cate et al., 1999). Intersubunit bridges 
ensure the stability of the 70S ribosome and allow the coupling of the decoding 
capacities of the SSU on the one hand and the peptide transferase activity of the LSU 
on the other hand. Furthermore, the intersubunit bridges allow large conformational 
changes during the process of translation which are important for movement of tRNAs 
through the ribosome during translocation.  
During protein synthesis adapter tRNAs bind to three distinct tRNA binding 
sites, called the aminoacyl (A) site, the peptidyl (P) site and the exit (E) site (Figure 
1B), and establish codon-anticodon interactions with the protein encoding mRNA 
located on the SSU (Figure 1C). The tRNA binding-sites are located within the 
intersubunit space embraced by the LSU and the SSU. The protein encoding mRNA 
becomes inserted into the SSU through the mRNA channel (Figure 1C). The channel 
is located along the neck of the SSU at the interface of the head and body (Yusupova 
et al., 2001). The entry of the mRNA channel is formed by proteins S3, S4 and S5 
(Yusupova et al., 2001). The mRNA channel exit site is surrounded by proteins S1, S7, 
S11, S18 and S21, as well as the 3’ end of the 16S rRNA (Loveland and Korostelev, 
2017; Yusupova et al., 2001). The anticodon, which distinguishes the incorporated 
amino acid, is located within the anticodon stem loop (ASL) of a tRNA (Figure 1C). An 
aminoacylated tRNA (aa-tRNA) generally enters the 70S ribosome via the ribosomal 
A-site and is subsequently handed over to the P-site after peptide bond formation as 
so called peptidyl-tRNA. After deacylation, which is the result of another round of 
peptide bond formation, tRNAs are passed to the E-site where they depart from the 
ribosome. Irrespective of the binding site, the tRNA 3’-end always interacts with the 
LSU. On the LSU the 3’-end of the A-site and P-site tRNA is stabilized by 23S rRNA 
loops termed A-loop (nts 2547-2561) and P-loop (nts 2246-2259) (E. coli numbering is 
used exclusively in this thesis). C75 within the 3’-end of the A-site tRNA basepairs with 
G2553 and C74 and C75 within the 3’-end of the P-site tRNA basepair with G2252 and 
G2251, respectively (Kim and Green, 1999; Moazed and Noller, 1989a; Nissen et al., 
2000; Samaha et al., 1995).  Besides the stabilization of the aminoacyl acceptor stem, 
Introduction 4 
this also allows the proper placement of the attached amino acids inside the PTC that 
is indispensable for efficient peptide bond formation.   
The growing polypeptide chain stays always attached to tRNAs bound in the 
ribosomal A- or P-site. The tRNAs bound in the ribosomal E-site are deacylated. 
Peptide bond formation takes place within the LSU of the 70S ribosome, the nascent 
chain has to exit the translation machinery through an exit tunnel located on the back 
of the LSU (Figure 1D) (Nissen et al., 2000). Starting at the PTC, the polypeptide exit 
tunnel has a total length of ~100 Å (Figure 1D), is 10-30 Å wide and covers ~30 amino 
acids of a growing protein (Nissen et al., 2000). While the tunnel is primarily build from 
rRNA, the narrowest section of the tunnel, that is 15 Å wide, is constricted by LSU 
proteins (L4 and L22) (Nissen et al., 2000). The very end of the polypeptide exit tunnel 
is build up from ribosomal RNA and proteins L23, L24 and L29 (Nissen et al., 2000).  
 
1.2 Bacterial translation 
 
The successful synthesis of a protein requires the exact definition of an open reading 
frame (ORF) in order to produce a functional product. The most crucial information for 
the establishment of an ORF is provided by an mRNA molecule itself. Accordingly, the 
minimal requirements for a normal bacterial mRNA are a start codon (mostly an AUG 
codon) and a stop codon (UAA, UAG or UGA). In addition, many prokaryotic mRNAs 
(~39% in E. coli) harbor a Shine-Dalgarno (SD) sequence seven to eight nucleotides 
upstream of the start codon (Chen et al., 1994). The start and the stop codon pre-
define the ORF and the nucleotide triplets that are read consecutively from the 5’ 
towards the 3’ end of the mRNA. The SD sequence promotes the correct placement 
of the ribosome with the start codon placed within the P-site. The placement of the 70S 
ribosome on the start codon and the recruitment of the first fMet-tRNAfMet to the P-site 
occurs during translation initiation (Figure 2A). Protein synthesis in general, passes 
through four major steps: Translation initiation, translation elongation, translation 
termination and subsequent ribosome recycling (Figure 2). The polymerization of the 
nascent chain takes place during translation elongation (Figure 2B). The starting point 
for translation elongation represents a fMet-tRNAfMet placed in the P-site of the 70S 
ribosome during initiation (Figure 2A). In bacteria, this first incorporated methionine is 
formylated, thereby distinguishing it from canonical methionine used during later steps 
of translation elongation (Guillon et al., 1992; Lee et al., 1991; Seong and 
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RajBhandary, 1987).  Starting with formylated methionine attached to the tRNA in the 
P-site, the peptide chain becomes polymerized in a cyclic manner. Each translation 
elongation cycle results in the extension of the polypeptide chain by one amino acid 
(Figure 2B). The ribosome repetitively passes through steps of polypeptide 
polymerization and translocation of 3 nts of the mRNA per cycle and thereby manages 
to incorporate ~15-50 aa per second (Katunin et al., 2002). The repetitive cycling 
through the elongation steps stops as soon as the ribosome encounters a stop codon 
(Figure 2C). Once the stop codon is selected, the peptide chain is released from the 
tRNA and the 70S complex becomes recycled (Figure 2C). 
Figure 2 -  Bacterial translation cycle. (A-C) Simplified scheme showing the steps of protein synthesis 
and important factors, which facilitate the polymerization process. Protein synthesis can be divided into 
steps of (A) translation initiation, (B) translation elongation and (C) translation termination/recycling. (A) 
Placement of fMet-tRNAtRNA (red) in the ribosomal P-site is achieved during translation initiation. 
Translation initiation leads to the formation of a translation competent 70S initiation complex. Translation 
initiation is facilitated by initiation factors 1 to 3 (IF1-IF3) that bind to the SSU (yellow) and facilitate 
fMet-tRNAtRNA recruitment, as well as LSU (grey) joining. IF1 is colored green, IF2 is colored blue and 
IF3 is colored magenta. (B) Translation elongation comprises the steps of aa-tRNA (pale green) delivery 
by EF-Tu (brown) to the ribosomal A-site, peptide bond formation and subsequent ribosome 
translocation facilitated by EF-G (salmon). Translocation of tRNAs to the consecutive tRNA binding site 
coincides with SSU (yellow) rotation relatively to the LSU (grey). Each round of translation elongation 
leads to the extension of the polymerized nascent chain by one amino acid (+1). (C) Termination takes 
place upon stop codon selection. Release of the nascent chain (harboring +n amino acids) is achieved 
by class I release factor RF1/2 (orange). RF1/2 becomes released from the 70S ribosome by class II 
release factor RF3 (cyan). After termination, splitting of the 70S ribosome into LSU (grey) and SSU 
(yellow) is carried out by RRF (light blue), as well as EF-G (salmon). Figure adapted from (Sohmen et 
al., 2009). 
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All translation steps involve - besides the 70S ribosome as translational 
platform, tRNAs and mRNAs - other translation factors for each translation step. The 
additional translation factors greatly increase translational fidelity and speed. The 
different steps of protein synthesis and the involved factors will be treated in more 
detail in the following sections. 
 
1.2.1 Translation initiation 
 
Translation initiation is defined by the recruitment of fMet-tRNAfMet to the P-site of the 
70S ribosome (Allen et al., 2005; Hussain et al., 2016; Julian et al., 2011; Simonetti et 
al., 2008). Bound to the ribosome the fMet-tRNAfMet is placed at the AUG start codon 
encoded within the mRNA (Allen et al., 2005; Hussain et al., 2016; Julian et al., 2011; 
Simonetti et al., 2008). Initiation involves three initiation factors (IFs), namely IF1, IF2 
and IF3 (Figures 2A and 3A). Furthermore, the placement of the ribosome is often 
stabilized by interactions of the mRNA-encoded Shine-Dalgarno (SD) sequence with 
an anti-Shine-Dalgarno (ASD) sequence encoded within the 3’ end of the 16S rRNA 
(Shine and Dalgarno, 1974; Steitz and Jakes, 1975). The formation of a translation-
competent 70S initiation complex (70S-IC) proceeds via a 30S pre-initiation complex 
intermediate (30S-PIC) and a 30S initiation complex (30S-IC) intermediate 
(Grigoriadou et al., 2007a; Milon and Rodnina, 2012; Tomsic et al., 2000). The 
transition from a 30S-PIC to a 30S-IC occurs upon codon-anticodon recognition 
between mRNA and fMet-tRNAfMet (Milon and Rodnina, 2012). Both 30S initiation 
complexes are characterized by the presence of all three initiation factors (Milon and 
Rodnina, 2012). To obtain the 30S-IC, the SSU undergoes a series of conformational 
changes which coincide with fMet-tRNAfMet accommodation and distinct rotational 
movements of the SSU head (Gualerzi et al., 2001; Hussain et al., 2016; Julian et al., 
2011; Lopez-Alonso et al., 2017). Rotational movements within the SSU, as well as 
the accommodation of the fMet-tRNAfMet are mandatory to prevent steric clashes 
during subunit joining caused by H69 and L5 of the LSU (Hussain et al., 2016; 
Simonetti et al., 2008; Sprink et al., 2016). Initiation factors mediate these 
conformational changes and prevent premature joining of the LSU. The sequential 
order of initiation factor binding seems to be irrelevant, however, mRNA is likely to bind 
prior to fMet-tRNAfMet (Hussain et al., 2016). Binding of the mRNA is possibly promoted 
through A-site latch opening and mRNA tunnel entry widening induced by the presence 
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of initiation factors IF1 and IF3 (Hussain et al., 2016). fMet-tRNAfMet has been proposed 
to bind to the SSU, which exhibits a swiveled head domain, and harbors at least IF1, 
IF3, as well as mRNA (Hussain et al., 2016).  
IF1 is a compact single domain protein with an OB-fold (Sette et al., 1997). It 
binds to the SSU A-site next to S12, the G530 loop and 16S helix 44 (Figures 3A and 
3B) (Carter et al., 2001; Dahlquist and Puglisi, 2000; Hussain et al., 2016; Simonetti et 
al., 2008). Bound to the SSU, IF1 enhances the binding activities of IF2 and IF3 
(Hussain et al., 2016; Milon et al., 2012).  
IF2, a translational GTPase with a five-domain structure (Figure 3C) (Simonetti 
et al., 2013; Simonetti et al., 2008), promotes recruitment of fMet-tRNAfMet to the SSU 
and is involved in LSU joining (Allen et al., 2005; Marshall et al., 2009; Simonetti et al., 
2008; Sprink et al., 2016). The GTPase activity resides within domain I (Figure 3C) 
(Simonetti et al., 2013). Recruitment of fMet-tRNAfMet is mediated via interactions of 
IF2 domain IV (Figure 3C) (Hussain et al., 2016; Julian et al., 2011; Laursen et al., 
2005; Simonetti et al., 2008; Sprink et al., 2016; Spurio et al., 2000). Domain IV directly 
interacts with the N-formylmethionine moiety of the fMet-tRNA. This allows IF2 to 
distinguish fMet-tRNAfMet from an elongator Met-tRNA and protects fMet-tRNAfMet from 
Figure 3 - Binding of initiation factors to the SSU. (A) Overview of the binding positions of IF1 (green), 
IF2 (blue), IF3 (magenta) and fMet-tRNAfMet on the SSU (yellow spheres). (B) Interactions of IF1 with 
SSU h44 and h18, S12 and the C-terminal domain of IF3. (C) Model of IF2 with fMet-tRNAfMet attached 
to domain IV. The SSU (yellow) is shown for reference. (D) Zoom of (C) showing interactions of IF2 
domain IV with the fMet-moiety attached to the CCA-end of fMet-tRNA. (E) Contacts of the IF3 N-
terminal domain (NTD) with the elbow of fMet-tRNAfMet and protein S11. (F) Interactions of the CTD of 
IF3 with h24, h44, h45 and IF1. (G) Superimposition of 70S-IC and 30S-IC. The CTD of IF3 is 
incompatible with intersubunit bridge B2a/d. The intersubunit bridge is formed by LSU H69 and SSU 
helices h24, h44 and h44 during LSU joining. (H) Movement of the NTD and CTD of IF3 during 
translation initiation. The SSU (yellow) head and platform is indicated for reference. Figure based on 
(Hussain et al., 2016). 
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premature deacylation (Figure 3D) (Guenneugues et al., 2000). Binding to the SSU is 
promoted by IF2 domains II and III (Hussain et al., 2016; Julian et al., 2011; Simonetti 
et al., 2013; Simonetti et al., 2008; Sprink et al., 2016). The ternary complex, consisting 
of IF2, GTP and fMet-tRNAfMet, creates a scaffold which greatly increases the 
interaction surface for LSU joining (Simonetti et al., 2013; Simonetti et al., 2009; 
Simonetti et al., 2008).  
IF2 and IF3 seem to have antagonistic activities (Milon and Rodnina, 2012). 
While IF2 promotes LSU joining, IF3 has anti-association activity that prevents 
premature subunit joining (Grigoriadou et al., 2007b; Grunberg-Manago et al., 1975). 
IF3 exhibits a two-domain dumbbell structure and binds to the platform at the SSU E-
site (Figure 3A) (Biou et al., 1995; Garcia et al., 1995; Hussain et al., 2016; Julian et 
al., 2011; McCutcheon et al., 1999). The N-terminal domain (NTD) and the C-terminal 
domain (CTD) are connected via a flexible linker (Biou et al., 1995; Garcia et al., 1995; 
Hussain et al., 2016; Julian et al., 2011). The NTD is critical for initiation fidelity and 
recruitment of the correct fMet-tRNAfMet (Hartz et al., 1990; Hartz et al., 1989). It binds 
near the SSU platform (Figure 3B) (Dallas and Noller, 2001; Fabbretti et al., 2007; 
Hussain et al., 2016; McCutcheon et al., 1999) and potentially establishes interactions 
with S11 (Figure 3E) (Hussain et al., 2016). Recruitment of the correct initiator tRNA 
is promoted through interactions of the NTD of IF3 with the elbow region of the fMet-
tRNAfMet, which are maintained throughout initiation (Figure 3E) (Hussain et al., 2016; 
Julian et al., 2011). Furthermore, IF3 monitors three G:C basepairs within the 
anticodon stem (G29-G31 and C39-C41) that are specific for tRNAfMet (Hartz et al., 
1990; Hartz et al., 1989; O'Connor et al., 2001; Risuleo et al., 1976; Sussman et al., 
1996), as well as correct codon-anticodon interaction of fMet-tRNAfMet and mRNA 
(Milon et al., 2008). The CTD binds next to the P-site on top of h44, establishing 
interactions with h24 and h45 (Figure 3F) (Hussain et al., 2016). Both IF3 domains 
undergo large conformational changes during initiation (Elvekrog and Gonzalez, 2013; 
Fabbretti et al., 2007; Hussain et al., 2016; Takahashi et al., 2013). The conformational 
changes allow fMet-tRNAfMet accommodation and LSU joining (Hussain et al., 2016). 
Premature subunit joining is prevented by a steric clash of the CTD of IF3 with H69 of 
the LSU (Figure 3G) (Garcia et al., 1995; Hussain et al., 2016; McCutcheon et al., 
1999). As the fMet-tRNAfMet accommodates, the steric hindrance becomes resolved by 
CTD movement and the anti-association activity of IF3, preventing LSU subunit joining, 
is abolished (Hussain et al., 2016). The IF3 CTD moves from its binding position near 
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the P-site to a more distal position from the SSU neck (Figure 3H) (Hussain et al., 
2016). H69 can then form an intersubunit bridge together with h44 of the SSU (Figure 
3G).  
Successful subunit joining leads to placement of the G-domain of IF2 next to 
the sarcin-ricin loop (SRL) of the LSU (La Teana et al., 2001; Qin et al., 2009; Sprink 
et al., 2016). The SRL rearranges a catalytic histidine (His448) within the G-domain 
(Sprink et al., 2016) which triggers GTP hydrolysis to GDP and Pi. Pi dissociates and 
IF2 releases fMet-tRNAfMet, which accommodates in the ribosomal P-site (La Teana et 
al., 1996; Myasnikov et al., 2005). IF2-GDP constitutes the low affinity form that rapidly 
dissociates from the 70S ribosome together with IF1. Although it was shown that the 
release of IF3 is independent of GTP-hydrolysis (Goyal et al., 2015), IF3 dissociates 
after IF1 and IF2 as the 70S-IC matures (Milon et al., 2008). After dissociation of IF1 
to IF3 the translation-competent 70S-IC enters the translation elongation cycle 
(Figures 2A and 2B). 
 
1.2.2 Translation elongation 
 
The term “translation elongation” refers to a repetitive sequence of events that lead to 
the successive extension of a nascent polypeptide chain (Figure 2B). The respective 
events include decoding, peptide bond formation and translocation (Figure 2B). Like 
translation initiation, elongation involves a set of factors binding to the ribosome that 
guarantee the translation fidelity and rapid protein synthesis progress. Generally, 
translation elongation requires a translation competent 70S ribosome with an empty 
A-site and an fMet-tRNAfMet or a peptidyl-tRNA in the P-site. As described in section 
1.2.1, the translation competent ribosome for the very first cycle of translation 
elongation is generated during initiation (Figure 2A). In contrast to initiation, elongation 
utilizes aa-tRNAs coding for all 20 amino acids instead of fMet-tRNAfMet. The aa-tRNAs 
are delivered to the ribosome by a ternary complex consisting of the translational 
GTPase elongation factor thermounstable (EF-Tu), GTP and an aa-tRNA. Delivery of 
tRNAs by EF-Tu and subsequent accommodation in the ribosomal A-site requires 
accurate decoding within the DC of the SSU (Figure 2B). Delivery of aa-tRNA is 
followed by peptide bond formation, taking place on the LSU within the PTC. The 
peptide attached to the P-site tRNA is transferred to the aminoacyl moiety attached to 
the A-site tRNA (Figure 2B). During the very first elongation cycle just a single amino 
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acid (N-formylmethionine) is transferred from the P- to the A-site tRNA. Afterwards, the 
translocation of the ribosome along the mRNA is necessary. Ribosome translocation 
is achieved by movement of the ribosome bound tRNAs through the ribosome together 
with the base-paired mRNA. This leads to the freeing of the ribosomal A-site and the 
exposure of the next consecutive codon of the translated ORF. Translocation of the 
tRNAs together with the mRNA is facilitated by elongation factor GTPase (EF-G) 
(Figure 2B). Similar to initiation and translation elongation, especially translocation 
requires conformational changes within the 70S ribosome and bound factors. 
Conformational changes include rotations of the SSU body/platform and swiveling of 
the head as well as alternative conformations of tRNAs bound to the A- and P-sites. 
The latter changes facilitate the movement of the ribosome along the mRNA. 
 
The process of translational decoding  
 
As previously mentioned, amino acids are encoded within the mRNA as nucleotide 
triplets (codons). The mRNA runs through the neck of the SSU between the head and 
the platform (Yusupova et al., 2001). The mRNA codons exposed in the tRNA binding 
sites are decoded to an amino acid using tRNAs as adaptors (Figure 4A). On a 
structural level, this decoding is achieved by classical Watson-Crick base-pairing and 
involves the critical residues (DC nucleotides) A1492 and A1493 within h44 and G530 
within h18 (530 loop) (Demeshkina et al., 2012; Jenner et al., 2010; Loveland et al., 
2017; Ogle et al., 2001; Selmer et al., 2006). It has been suggested that these highly 
conserved nucleotides discriminate cognate codon-anticodon interactions from non-
cognate interactions by monitoring the Watson-Crick basepair geometry between 
mRNA and tRNA (Ogle et al., 2001).  
The decoding aa-tRNA is delivered to the SSU A-site by the EF-Tu ternary 
complex (Figure 4A) (Nissen et al., 1995). EF-Tu binds to non-rotated 70S ribosomes 
that adopt an open SSU conformation and bear an empty A-site (Loveland et al., 2017). 
The aa-tRNA stays attached to EF-Tu until decoding is accomplished (Figure 4B) 
(Loveland et al., 2017; Ogle and Ramakrishnan, 2005). EF-Tu interacts with h5 and 
h15 of the SSU shoulder and protein S12 (Figure 4A) (Loveland et al., 2017). Upon 
initial EF-Tu binding the aa-tRNA adopts a relaxed conformation and no interactions 
are established with the mRNA codon (Figure 4C) (Loveland et al., 2017; Nissen et al., 
1995). The DC nucleotides A1492 and G530 adopt an “inactive” conformation (Figure 
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4C) (Loveland et al., 2017). Accordingly, while A1492 stays within h44 and stacks on 
A1913 from H69 of the 23S rRNA, G530 is located distal from the codon (Figure 4C). 
The DC nucleotide A1493 loosely interacts with the nucleotides exposed in the A-site 
(Figure 4C). As the ASL enters the A-site the anticodon of the aa-tRNA starts probing 
for Watson-Crick base-pairs with the exposed mRNA codon. The anticodon 
nucleotides flip out and the aa-tRNA ASL acquires a kinked conformation resulting in 
an A/T tRNA state (Figure 4D). G530 and A1493 start monitoring codon-anticodon 
base-pairing geometry (Figure 4D). G530 adopts an intermediate state and initially 
interacts with the codon-anticodon helix by hydrogen-bonding with the second 
Figure 4 - Delivery of aa-tRNA by EF-Tu and subsequent decoding on the SSU. (A) Overview showing 
aa-tRNA (blue) delivery by EF-Tu (brown) to the A-site of the bacterial 70S ribosome harboring P-tRNA 
(green), E-tRNA (red) and mRNA (cyan) (Loveland et al., 2017). Binding of EF-Tu to the ribosome 
involves interactions with the SRL (grey), h5 (yellow), h15 (yellow) and SSU protein S12 (dark salmon). 
(B) Interactions of the CCA-end of unaccommodated tRNA (blue) with EF-Tu domain II (brown) 
(Loveland et al., 2017). (C-E) Conformational changes of 16S DC nucleotides (yellow) during decoding 
(Loveland et al., 2017). (C) Conformation of DC nucleotides before establishment of codon-anticodon 
interactions. A1492 and G530 adopt an inactive conformation. The tRNA ASL adopts a relaxed 
conformation. (D) Conformation of DC nucleotides upon establishment of codon-anticodon interactions 
between mRNA (cyan) and A-tRNA (blue). The ASL adopts a kinked conformation. G530 and A1493 
start monitoring codon-interactions. (E) Active conformation of all DC nucleotides. A-minor interactions 
are monitored of the codon-anticodon helix. The kinked conformation of the A-tRNA ASL (blue) is 
maintained. (C-E) Hydrogen bonds between the nucleotide pairs are indicated by black dashed lines. 
Polar contacts between DC nucleotides and mRNA, as well as DC and tRNA are indicated by yellow 
dashed lines. (F) Accommodation of the G-domain of EF-Tu upon domain closure (Loveland et al., 
2017). The G-domain approaches the SRL (grey), which arranges a catalytic histidine (His84) for GTP 
hydrolysis. The position of the G-domain upon initial binding is shown in yellow. The position of the G-
domain after domain closure is shown in brown.  
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nucleotide of the anticodon and the third (3’-) nucleotide of the mRNA codon (Figure 
4D). A1493 establishes interactions with the minor groove of the codon-anticodon helix 
(first base-pair) (Figure 4D) (Loveland et al., 2017; Nissen et al., 2001; Ogle et al., 
2001). During the final stage G530 establishes an additional hydrogen-bond (Figure 
4E). Decoding interactions now involve the first and second codon-anticodon base-
pair as well (Figure 4E) (Loveland et al., 2017).  
In general, the DC nucleotides act like a latch that closes upon successful 
establishment of cognate codon-anticodon interactions (Figure 4E) (Loveland et al., 
2017). A1492 and A1493 form A-minor interactions and monitor the geometry of the 
first and second base-pair within the codon-anticodon interaction (Figure 4E) 
(Loveland et al., 2017; Nissen et al., 2001; Ogle et al., 2001). SSU-domain closure is 
induced by correct Watson-Crick base-pairing in the DC and leads to the 
accommodation of the EF-Tu G-domain (Figure 4F) (Loveland et al., 2017; Ogle et al., 
2002; Schmeing et al., 2011; Voorhees et al., 2010). The G-domain approaches the 
sarcin-ricin loop (SRL) localized on the LSU (Figure 4F) (Loveland et al., 2017; Villa et 
al., 2009; Voorhees et al., 2010). The SRL is crucial for translational GTPases, since 
binding of the G-domain leads to the rearrangement of a catalytic histidine (His84 for 
EF-Tu) (Figure 4F) (Loveland et al., 2017; Villa et al., 2009; Voorhees et al., 2010). 
EF-Tu becomes activated and hydrolysis of GTP to GDP + Pi takes place (Loveland et 
al., 2017; Villa et al., 2009; Voorhees et al., 2010). As consequence, the aa-tRNA 
attached is released from EF-Tu and changes from an A/T state to a fully 
accommodated A/A state in the ribosomal A-site (Blanchard et al., 2004a; Douthwaite 
et al., 1983; Sanbonmatsu et al., 2005). EF-Tu departs from the ribosome and is free 
to form a ternary complex with another aa-tRNA for a subsequent round of the 
translation elongation cycle. The presence of a near-cognate ternary complex leads to 
perturbed latching of G530 and hence no SSU-domain closure occurs (Loveland et al., 
2017). Accordingly, the lack of SSU-domain closure results in dissociation of the non-
cognate tRNA from the ribosome. Noteworthy, A1492, A1493, as well as G530, 
generally neglect the third position of the codon-anticodon interaction, allowing 
unusual base-pairs, called wobble base-pairs (Figures 4C-E). Wobble base-pairs 
enable different codons to code for the same amino acid decoded by a single tRNA 
(Crick, 1966). 
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Peptide bond formation 
 
After full accommodation of the aa-tRNA into the A-site, the extension of the nascent 
chain takes place in the PTC. As described before, the CCA-ends of the 
accommodated tRNAs in the A- and P-site are positioned and stabilized in the PTC by 
the A- and P-loop nucleotides (Moazed and Noller, 1989a). The alignment of the 3’ 
ends and the respective attached moieties promotes peptide bond formation. During 
peptide bond formation the peptidyl chain attached to the CCA-end of the P-site tRNA 
is transferred to the aminoacyl moiety of the A-site tRNA. The whole reaction is driven 
by the energy stored in the ester linkage connecting the nascent chain to the P-site. 
The transfer of the peptide chain from the P- to the A-site requires a nucleophilic attack 
of the a-amine of the A-site aminoacyl moiety on the peptidyl ester of the P-tRNA. The 
LSU PTC provides the environment for successful transfer of the peptidyl moiety and 
ensures translation fidelity. Like decoding, peptide bond formation also involves 
conserved residues that facilitate the reaction. The most critical residues are G2583, 
U2584, U2585 and U2506 located within the central loop of the 23S rRNA domain V 
(Polacek and Mankin, 2005; Polikanov et al., 2014; Schmeing et al., 2005b; Voorhees 
et al., 2009), which upon full accommodation of the CCA-end of the aa-tRNA into the 
A-site of the PTC, adopt a specific conformation characterized by shifting of G2583, 
U2584 and U2585 and rotation of U2506 (Figure 5A) (Polikanov et al., 2014; Schmeing 
et al., 2005b; Voorhees et al., 2009). This conformation of the ribosome and its PTC 
residues is called the induced state (Figure 5A) (Polikanov et al., 2014; Schmeing et 
al., 2005b; Voorhees et al., 2009). U2585 is critical for peptide bond formation and 
protects the peptidyl-ester of the P-tRNA from premature hydrolysis in the uninduced 
state (Schmeing et al., 2005a; Schmeing et al., 2005b).  
The need for deprotonation and the transfer of hydrogens has led to different 
concepts explaining the actual process of peptide bond formation. These primarily 
differ as to how the nucleophilic a-NH2 group is generated and the path the described 
protons take. The older concept termed the ‘proton shuttle’ postulates that the 2’OH 
group of the peptidyl-tRNA  functions like a shuttle by providing a hydrogen to the 3’ 
oxygen of the released peptidyl moiety, while deprotonating the a-amine of the 
aminoacyl residue attached to the A-site tRNA (Schmeing et al., 2005a; Schmeing et 
al., 2005b; Schmeing et al., 2002; Trobro and Aqvist, 2005; Zaher et al., 2011). 
Problematic here is that many of the corresponding structural studies, which were used 
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to infer a ‘proton-shuttle’, involved solely the LSU in complex with reduced substrates, 
intermediate states or product analogs (Schmeing et al., 2005a; Schmeing et al., 
2005b; Schmeing et al., 2002), thus preventing the observation of a fully native PTC in 
action. In contrast, a more recent concept based on structural studies with highly 
resolved (2.5 Å and 2.6 Å) T. thermophilus 70S ribosomes, called the ‘proton wire’, 
suggests the binding of three water molecules that facilitate successful peptide bond 
formation by serial transfer of protons (Figures 5B-D) (Polikanov et al., 2014). In 
addition to the mentioned rRNA residues, this model involves the N-terminus of L27. 
Generally, a proton-wire describes the translocation of protons utilizing a chain of 
coordinated water molecules (Nagle and Morowitz, 1978; Polikanov et al., 2014). The 
‘proton-wire’ model for peptide bind formation was based on observations with 70S 
ribosomes containing complete tRNA molecules representing pre- and post-attack 
states (Figure 5A) (Polikanov et al., 2014). The pre-attack state contained non-
hydrolysable fMet-NH-tRNAfMet in the P-site and non-hydrolysable Phe-NH-tRNAPhe in 
the A-site (Figure 5A). The post-attack state contained deacylated tRNA in the P-site 
and non-hydrolysable fMet-Phe-NH-tRNAPhe in the A-site. In both pre- and post-attack 
structures the key residues that form the framework for peptide bond formation, namely 
U2506, G2583, U2584 and U2585, adopt almost exactly the same induced/rearranged 
conformation (Figure 5A) (Polikanov et al., 2014). The three water molecules, crucial 
for the proton-wire, become coordinated at three distinct spots inside the PTC (Figure 
5B) (Polikanov et al., 2014). Water 1 is coordinated between the CCA-end of the A-
tRNA, the N-terminal residue of L27, A2602 (H93) and A2451 (Figures 5B-D) 
Figure 5 - The process of peptide bond formation. (A) Position of aminoacylated pre-attack A-tRNA 
(blue),  peptidyl-P-tRNA (green) and 23S nucleotides A2506, U2584 and U2585 in the PTC (Polikanov 
et al., 2014). The conformation of PTC nucleotides in the uninduced state is shown in orange (Schmeing 
et al., 2005a; Schmeing et al., 2005b). The conformation of the 23S nucleotides after aa-A-tRNA 
accommodation (induced state) is shown in grey. (B-D) The chemical process of peptide bond formation 
(Polikanov et al., 2014). (B) Deprotonation of the a-amine of the A-site aminoacyl moiety and 
nucleophilic attack on the carbonyl carbon. (C) Formation of a tetrahedral intermediate. The critical water 
molecules (cyan) involved in this process are indicated with red numbers. (D) Breakdown of the 
tetrahedral intermediate leads to formation of the post-attack state. The polypeptide chain is finally 
attached to the A-tRNA and deacyl-tRNA is bound in the P-site of the ribosome. 
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(Polikanov et al., 2014). The second water (water 2) is placed between the 2’-OH group 
of U2584 and A2602 (Figures 5B-D) (Polikanov et al., 2014). Additionally, in the pre-
attack state water 2 establishes a contact with the carbonyl oxygen of the peptidyl 
moiety of the P-tRNA (Polikanov et al., 2014). Water molecule 3 shows the most 
dynamic interactions within pre- and post-attack states. While in the pre-attack state 
water 3 interacts with P-tRNA A76 by contacting N3, the 2’-OH group, as well as the 
3’-O group (non-hydrolysable 3’-N group in this study), in the post-attack state water 3 
interacts with the 2’-OH groups of C2063 and P-site A76, as well as the 3’-OH group 
of P-site A76 (Figures 5B-D) (Polikanov et al., 2014). During peptide bond formation it 
is hypothesized that the possibly deprotonated N-terminus of L27 together with a 
negatively charged oxygen of the A-site A76 5’-phosphate may lead to a partial 
negative charge of the oxygen of water 1 (Figure 5B) (Polikanov et al., 2014). As 
consequence, protonation of water 1 can occur which in turn leads to the deprotonation 
of the 2’-OH group of P-site A76 and subsequently to the deprotonation of the a-amine 
of aminoacyl moiety attached to the A-site tRNA (Figures 5B and 5C) (Polikanov et al., 
2014). The created nucleophile a-NH2 can attack the ester bond of the peptidyl moiety 
of the P-site tRNA, resulting in a tetrahedral intermediate (Figure 5C) (Polikanov et al., 
2014). The hydrogen bond established by water 2 leads to an electrophilic carbonyl 
group that promotes the nucleophilic attack of the a-amine (Figures 5B and 5C) 
(Polikanov et al., 2014). Water 3 stabilizes the tetrahedral intermediate and facilitates 
the reversal of the deprotonation, which results in the release of the peptidyl moiety 
from the P-site tRNA and full attachment to the aminoacyl moiety attached to A76 of 
the A-site tRNA (Figures 5C and 5D) (Polikanov et al., 2014). The 70S ribosome with 
its deacylated tRNA in the P-site acquires a post-attack state (Figure 5D). The 
previously described data obtained from T. thermophilus ribosomes confirm for the first 
time the possible chemical importance of the L27 N-terminus (Polikanov et al., 2014), 
as suggested in earlier studies (Maguire et al., 2005; Wower et al., 1998). Structure-
wise the close proximity of the NTD of L27 implicated a possible role in peptide bond 
formation (Voorhees et al., 2009). However, it is still unclear whether L27 is crucial for 
peptide bond formation in general (or just specific amino acids), since more recent 
studies indicated a rather less important role during peptide bond formation (Maracci 
et al., 2015).  Nonetheless, the proton-wire model seems to fill gaps or correct 
uncertainties of the proton-shuttle model. Both described models of peptide bond 
formation are based on the results of at least partially artificial systems. Therefore, 
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peptide bond formation is likely to be a combination of both models involving the 
concept of wiring and shuttling.  
 
Ribosome translocation 
 
Peptide bond formation results in deacyl-tRNA in the P-site and peptidyl-tRNA in the 
A-site (Figure 2B). To allow another round of peptide bond formation translocation 
must take place to free the A-site for exposure of the next consecutive mRNA codon 
and aa-tRNA binding. Peptidyl-tRNA previously bound to the A-site is moved to the P-
site and deacyl-tRNA previously bound to the P-site is moved to the E-site (Figure 2B). 
The mRNA is translocated indirectly due to established codon-anticodon interactions 
with the tRNAs. Ribosomes harboring deacyl-tRNA in the A-site and peptidyl-tRNA in 
the A-site are termed pre-translocation (PRE) state. Ribosomes after translocation of 
tRNAs from the A- to the P-site and from the P- to the E-site are in a post-translocation 
(POST) state. Translocation, as well as translation in general, can take place without 
additional factors (Pestka, 1968, 1969), since the ribosome itself provides all the 
necessary activities to carry out protein synthesis. Nonetheless, in absence of 
additional translation factors the translocation of tRNAs is rather slow. Therefore, the 
translation elongation cycle utilizes the translational GTPase EF-G to promote 
translocation (Figures 6A-D). The exact role of GTP hydrolysis for EF-G function is still 
not entirely clear. One possibility is that EF-G utilizes GTP for a power-stroke to 
facilitate movement of tRNAs through the translation machinery (Chen et al., 2016). 
Alternatively, translocation possibly involves a Brownian ratchet mechanism, which is 
temperature driven (Astumian, 1997; Cordova et al., 1992; Fischer et al., 2010; Frank 
and Gonzalez, 2010; Spirin, 2009; Wintermeyer et al., 2004). Regardless, the process 
of translocation requires large scale movements of both ribosomes and tRNAs. The 
movement of the tRNAs through the ribosomes is carried out in two steps (Agrawal et 
al., 1999; Bulkley et al., 2014; Munro et al., 2010; Noller, 1991; Salsi et al., 2014; Stark 
et al., 2000; Wang et al., 2007). First, the 3’-end of the tRNAs bound to the A- and P-
site becomes dislocated on the LSU to the P- and E-sites, respectively (Figure 6B). 
Second, the ASL base-pairing with the mRNA sense codon is moved to subsequent 
tRNA binding site on the SSU (Figures 6C and 6D). Dislocation of the CCA-end of 
tRNAs can occur spontaneously and is indirectly driven by successful peptide bond 
formation and SSU rotation (Ermolenko et al., 2007; Noller, 1991). Accordingly, in the 
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absence of a nascent chain attached to the P-site tRNA the 70S ribosome is no longer 
restricted to the classical state. Therefore, the ribosome starts to fluctuate between an 
intermediate rotated (R) and a non-rotated (N) state by a ~6° rotational movement of 
the complete SSU relative to the LSU (Blanchard et al., 2004b; Cornish et al., 2008; 
Munro et al., 2007). This rotation of the SSU was initially described as ratchet-like 
movement (Agrawal et al., 2000; Frank and Agrawal, 2000). In addition to SSU 
rotation, the SSU head was observed to undergo ~5° swiveling in rotated 70S 
ribosomes (Dunkle et al., 2011). Both, SSU rotation and head swiveling, coincide with 
movement of the 3’-end of A- and P-site tRNA on the LSU (Figure 6E). Consistently, 
the CCA-end of the P-tRNA moves from the PTC to the LSU E-site that is only available 
for deacylated tRNAs (Figure 6F) (Agirrezabala et al., 2008; Brilot et al., 2013; Dunkle 
et al., 2011). In this binding position C75 stacks upon A2432 and A76 is inserted 
between 23S rRNA nucleotides G2421 and C2422 (Figure 6F) (Agirrezabala et al., 
Figure 6 - EF-G promoted translocation. (A-D) Overview of obtained structures of EF-G (salmon) bound 
to 70S ribosomes. The LSU is shown in grey and the SSU is shown in yellow. The degree of head swivel 
observed for each complex is indicated at the bottom right of the panels. (A) PRE state ribosomes bound 
with EF-G (salmon) adopting a compact form and A-tRNA (blue), P-tRNA (green) and E-tRNA (red) in 
a classical state. (B-D) Ribosomal complexes with EF-G (salmon) bound in an elongated conformation 
(Lin et al., 2015). (B) Intermediate state 70S ribosome with hybrid state A/P-tRNA (blue) and P/E-tRNA 
(green) (Brilot et al., 2013). (C) Intermediate state 70S ribosome with chimeric state ap/ap-tRNA (blue) 
and pe/E-tRNA (green) (Ramrath et al., 2013). (D) POST state ribosome with translocated tRNA in the 
P-site (blue) (Lin et al., 2015). (E) Relocation of the CCA-ends of A-tRNA (faint blue) and P-tRNA (faint 
green) , which leads to hybrid state formation (Lin et al., 2015). The relocated A-tRNA CCA-end (blue) 
basepairs with the P-loop nucleotides G2251 and G2252 upon hybrid state formation (Brilot et al., 2013). 
(F) Interactions of the relocated CCA-end of hybrid state P/E-tRNA (green) with LSU 23S nucleotides 
(grey). (G) Interactions of EF-G domain IV (salmon) with ap/P chimeric state tRNA (blue) (Ramrath et 
al., 2013). Movement of the tRNAs requires ‘unlocking’. The lock is formed between the 16S rRNA 
(yellow) nucleotides G1338-U1341 and h24, which harbors nucleotides A790. The locked position of 
the nucleotides G1338-U1341 is shown in faint yellow. Chimeric state pe/E-tRNA is shown in green. 
The position of the maintained codon-anticodon interactions with mRNA (cyan) and the position of DC 
nucleotides A1493 and A1493 within h44 are shown for reference.  
Introduction 18 
2008; Brilot et al., 2013; Dunkle et al., 2011). Because the previous interactions of the 
P-tRNA with P-loop are resolved (Figure 6E), now the 3’-end of the peptidyl-tRNA in 
the A-site can establish interactions with the P-loop (Figure 6E) (Agirrezabala et al., 
2008; Julian et al., 2008). The resulting relocated states of the tRNAs were termed 
hybrid A/P and P/E states (Figure 6B) (Agirrezabala et al., 2008; Julian et al., 2008; 
Moazed and Noller, 1989b). Although EF-G preferentially binds to rotated ribosomes 
containing hybrid state tRNAs, it can in principle bind to non-rotated ribosomes (Dorner 
et al., 2006), but immediately drives them into a rotated state  (Adio et al., 2015; Chen 
et al., 2011; Chen et al., 2013; Cornish et al., 2008; Holtkamp et al., 2014; Spiegel et 
al., 2007). It is not entirely clear in which conformational form EF-G binds to the non-
rotated PRE state without creating a steric clash with an A/A or A/P state tRNA. 
Accordingly, most of the structural studies present data of rotated or non-rotated POST 
state 70S ribosomes (Figures 6B-D) (Agrawal et al., 1998; Connell et al., 2007; Frank 
and Agrawal, 2000; Gao et al., 2009; Ramrath et al., 2013; Ratje et al., 2010; Valle et 
al., 2003; Zhou et al., 2013, 2014). In these structures EF-G adopts an open/elongated 
conformation, binding 70S ribosomes primarily via its G-domain (domain I) in the 
intersubunit space between S12 and L14 (Gao et al., 2009; Lin et al., 2015; Pulk and 
Cate, 2013; Zhou et al., 2013). Domain IV mimics the ASL of a tRNA reaching to the 
DC on the SSU and is thought to perform the most crucial tasks (Figures 6B-D) 
(Agrawal et al., 1998; Nissen et al., 1995). As observed in viomycin bound PRE 
complexes, simultaneous placement of elongated EF-G and A/P-tRNA requires an 
additional swivel of the head by +7° (12° total) to avoid steric hindrance caused by the 
A-tRNA ASL (Figure 6B) (Brilot et al., 2013). However, the presence of viomycin leaves 
the physiological relevance of this complex questionable. Presumably, other 
conformational states exist that are in better agreement with binding to the PRE state. 
The existence of other EF-G forms is also supported by biochemical studies (Salsi et 
al., 2015). A recent higher resolution study suggests that EF-G can possibly adopt a 
compact form on PRE state ribosomes (Figure 6A) (Lin et al., 2015). While domain I 
and II were observed in a position similar to previous structural studies (Figures 6A-
D), domain III and IV showed a previously unobserved conformation (Figure 6A) (Lin 
et al., 2015). Domain IV did not reach into the DC of the SSU, but instead is rotated 
backwards next to domain I and II (Figure 6A) (Lin et al., 2015). This movement is 
facilitated by domain V, which undergoes a simultaneous ~180° flipping and a ~90° 
rotational movement, while the overall position of this domain is not altered (Lin et al., 
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2015). Problematic in the respective study is the approach used to form the complex, 
which makes the observations potentially artificial. First, EF-G binding to the ribosome 
was forced by fusion of the NTD of L9 to the N-terminus of EF-G (Lin et al., 2015). 
Second, the presence of dityromycin sterically clashes with EF-G domain III in the 
elongated form. Thus EF-G is forced into a compact form, which indirectly prevents 
movement of EF-G domain IV into close proximity to the ASL of an A-site tRNA. 
Nonetheless, the compact conformation of EF-G is a possible explanation for the 
previously observed binding of EF-G to N-state ribosomes in biochemical studies (Salsi 
et al., 2014; Salsi et al., 2015). The elongated EF-G most likely represents the active 
conformation.  
Stabilization of R-state ribosomes through EF-G binding marks the first phase 
of translocation. Bound to R-state ribosomes, containing A/P- and P/E-tRNAs (Figure 
6B), the task of elongated EF-G is to supervise and facilitate the complex movements 
of the ASLs on the SSU. Movement of the ASL of tRNAs requires the elimination of 
several energetic barriers (Noller et al., 2017). In the A-site, previously established 
decoding contacts with peptidyl-tRNA involving G530, A1492 and A1493 need to be 
disrupted (Figure 4E) (Noller et al., 2017). In the P-site, stabilization contacts of the 
SSU body involving C1400 and A790 have to be resolved (Noller et al., 2017). 
Furthermore, the movement of P-tRNA requires ‘unlocking’ (Savelsbergh et al., 2003; 
Spirin, 1968) of G1338-U1341 and A790 of the 16S rRNA. G1338-U1341 and A790 
form a 13 Å constriction between P-site and E-site, which prevents the ASL from 
moving to the P-site (Figure 6G) (Noller et al., 2017). Elimination of all energetic 
barriers without actually impacting the stability of the codon-anticodon interactions is 
challenging, since the destabilization of codon-anticodon interactions possibly leads to 
the loss of the translational reading frame. EF-G is thought to overcome these 
problems and promote the maintenance of the reading frame by preventing mRNA 
slippage of the ribosome during translocation.  
Stabilization of the A-site tRNA codon-anticodon helix during translocation is 
mediated by loops I and II at the tip of (elongated) EF-G domain IV (Figure 6G) 
(Ramrath et al., 2013; Zhou et al., 2014). These conserved loops establish interactions 
with the codon-anticodon helix of the A-site tRNA and replace the A-minor stabilization 
interactions of decoding nucleotides A1492 and A1493 (Figure 6G) (Gao et al., 2009; 
Khade and Joseph, 2011; Liu et al., 2014; Ramrath et al., 2013). Furthermore, loop I 
and loop II seem to act like a pawl that prevents the backward movement of the A-
Introduction 20 
tRNA to its previous binding position (Noller et al., 2017). Notably, movement of the P-
site tRNA is not directly stabilized by EF-G (Figure 6G). Instead, the ASL of deacyl-P-
tRNA is stabilized by the SSU head during translocation (Noller et al., 2017; Zhou et 
al., 2013). The respective contacts, which are maintained from N-state 70S ribosomes, 
involve the nucleotides G1338, A1339 and G966, as well as the CTD of proteins S9 
and S13 (Noller et al., 2017; Zhou et al., 2013).  
The steric block created by A790 and G1338-U1341, as well as contacts 
between the SSU body and P-site elements, are resolved during the second phase of 
translocation through head swiveling by 21° (Figures 6C and 6G) (+9° compared to 
initial binding) (Ramrath et al., 2013; Zhou et al., 2013, 2014). It is induced by 
interactions of EF-G domain IV with h34 of the 16S rRNA (Ratje et al., 2010) and 
coincides with backward rotation of the SSU (body/platform) (Ramrath et al., 2013; 
Zhou et al., 2013, 2014). Backward rotation mediates accommodation of the G-domain 
of EF-G on the LSU (Belardinelli et al., 2016; Ramrath et al., 2013; Zhou et al., 2013, 
2014) and induces hydrolysis of GTP to GDP and Pi (Belardinelli et al., 2016).  
However, after ‘unlocking’ of the constriction took place (Savelsbergh et al., 
2003; Spirin, 1968) and contacts of the tip of EF-G domain IV with the codon-anticodon 
helix have been established, the ASL of the tRNAs move forward towards the next 
consecutive tRNA binding site on the SSU (Noller et al., 2017). The tRNAs adopt 
chimeric states termed ap/P-tRNA state and pe/E-tRNA state (Figures 6C and 6G) 
(Noller et al., 2017; Ramrath et al., 2013; Zhou et al., 2014). The lowercase letters 
indicate the position of the tRNA ASLs with elements of the head (a or p) and elements 
of the body (p or e) (Ramrath et al., 2012). Accordingly, ap/P-tRNA establishes 
simultaneous contacts with A-site elements of the head, as well as P-site elements of 
the body and the pe/E-tRNA establishes simultaneous contacts with P-site elements 
of the head, as well as E-site elements of the body. Chimeric states become resolved 
by a final clockwise movement of the SSU head that occurs together with release of Pi 
(Belardinelli et al., 2016; Noller et al., 2017; Savelsbergh et al., 2003; Savelsbergh et 
al., 2005). Clockwise (backward) swiveling of the SSU head results in N-state 70S and 
the full translocation of deacyl-tRNA to the E-site and peptidyl-tRNA to the P-site, 
adopting an E/E and a P/P state, respectively (Figure 6D) (Noller et al., 2017). GDP-
bound EF-G departs from the POST state 70S ribosome and leaves a vacant A-site. 
The deacyl-tRNA bound to the E-site is released and the ribosome can enter the next 
translation elongation cycle. 
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1.2.3 Translation termination 
 
When the translating ribosome encounters one of the three stop codons, namely UAA, 
UAG or UGA, the translation elongation cycle comes to an end and the polypeptide 
chain is released from the 70S ribosome during the termination process (Figure 2C) 
(Brenner et al., 1965; Capecchi, 1967; Weigert and Garen, 1965). Termination involves 
binding of class I peptide chain release factors RF1 or RF2 to the A-site of POST state 
70S ribosomes (Figure 2C) (Capecchi, 1967). RF1 and RF2 have a four-domain 
structure and couple the termination signal exposed in the A-site of the DC to release 
of the polypeptide chain at the PTC (Figure 7A) (Zhou et al., 2012a). Domains II and 
IV form a super-domain responsible for decoding of the mRNA stop codon exposed in 
the DC (Figure 7A). Domain III reaches into the PTC and thereby facilitates the 
liberation of the polypeptide chain (Figure 7A). Importantly, the domains crucial for 
successful termination, namely super-domain II/IV and domain III, harbor specialized 
motifs that allow accurate stop codon recognition and efficient release of the peptide 
in the PTC, respectively. Similar to canonical decoding, termination involves the DC 
nucleotides G530, A1492 and A1493 (Korostelev et al., 2008; Laurberg et al., 2008; 
Weixlbaumer et al., 2008), which together with a ß-sheet provided by domain II 
recognize the exposed stop signal in the DC. Upon stop codon selection and RF 
binding, A1492 moves outward from h44 (Korostelev et al., 2008; Laurberg et al., 2008; 
Ogle et al., 2001; Selmer et al., 2006; Weixlbaumer et al., 2008). A1493 stays in a 
‘flipped-in’ conformation and stacks upon 23S nucleotide A1913, which occupies the 
space of non-flipped A1492 (Korostelev et al., 2008; Laurberg et al., 2008; 
Weixlbaumer et al., 2008). G530 establishes a stacking interaction with nucleotide in 
the third position of the stop codon (Korostelev et al., 2008; Laurberg et al., 2008; 
Weixlbaumer et al., 2008). The motif within the ß-sheet of domain II involved in stop 
codon recognition differs between RF1 and RF2. RF1 harbors the tripeptide Pro-Val-
Thr (PVT) sequence (Figure 7B) whereas RF2 has instead the Ser-Pro-Phe (SPF) 
motif (Figure 7C) (Ito et al., 2000). The sequence motifs allow both factors to recognize 
UAA yet distinguish between UAG and UGA codons. Consistently, decoding of the 
very first position of a stop codon is carried out by both factors similarly (Figures 7B 
and 7C): The N-terminal part of a-helix 5, present in both class I release factors, 
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contributes two hydrogen bonds and allows RFs to validate the presence of a uridine 
in the first position (Figures 7B and 7C) (Korostelev et al., 2008; Laurberg et al., 2008; 
Petry et al., 2005; Weixlbaumer et al., 2008). The second codon position, crucial for 
RFs to distinguish between UAG and UGA codons, is the only position that involves 
direct interactions with the PVT or SPF motifs of RF1/2 (Figures 7B and 7C) (Zhou et 
al., 2012a). The Thr of the PVT motif (RF1) (Figure 7B) (Korostelev et al., 2010; 
Laurberg et al., 2008) and the Ser (Korostelev et al., 2008; Weixlbaumer et al., 2008) 
of the SPF motif (RF2) (Figure 7C) directly contact the second position by establishing 
hydrogen bonds (Zhou et al., 2012a). In this way, RF1 forms one hydrogen bond in the 
presence of adenine in the second position (Figure 7B) (Korostelev et al., 2010; 
Laurberg et al., 2008) and RF2 makes two hydrogen bonds with a purine nucleotide, 
guanine and adenine, in the second position (Figure 7C) (Korostelev et al., 2008; 
Weixlbaumer et al., 2008). The determination of the third position of the stop codon 
involves a Thr and a Gln residue in RF1 (Figure 7B) (Korostelev et al., 2010; Laurberg 
et al., 2008) and a Thr, as well as a Val residue in RF2 (Figure 7C) (Korostelev et al., 
2008; Weixlbaumer et al., 2008). These residues monitor the Hoogsteen edges of the 
base in the third position (Figures 7B and 7C) (Zhou et al., 2012a). In addition to the 
described discrimination activities of domain II of the RFs, stop codon recognition is 
further stabilized by other amino acids to ensure termination fidelity. For example, 
His197 in RF1 (Figure 7B) (Laurberg et al., 2008) and His214 in RF2 (Figure 7C) 
(Weixlbaumer et al., 2008) stack upon the purine base of the nucleotide in the second 
position of the stop codon.  
Figure 7 – Class I peptide chain release factor binding. (A) Overview of a 70S ribosome with RF1 
(orange) and P-tRNA (green). The P-tRNA carries the MifM staller nascent chain at the CCA-end 
(Sohmen et al., 2015). The nascent chain reaches down the polypeptide exit tunnel (NPET), which is 
located on the LSU (grey). The position of the domains of RF1 is indicated in black. (B-C) Interactions 
of domain II/IV of RF1 and RF2 with the stop codon nucleotides encoded by an mRNA (cyan). (B) 
Interactions of RF1 (orange) with a UAG stop codon (cyan) (Laurberg et al., 2008; Pierson et al., 2016). 
(C) Interactions of RF2 (wheat) with a UAA stop codon (cyan) (Pierson et al., 2016; Weixlbaumer et al., 
2008). (D) Zoom of (A) showing the relative position of the mehtylated GGQ motif (red) to the nascent 
chain that is attached to P-tRNA (green) (Pierson et al., 2016). The GGQ motif is situated within domain 
III of RF1 (orange).  
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The successful decoding of the stop codon leads to conformational changes 
within the switch loop of RF1/2 (Youngman et al., 2008; Zhou et al., 2012a). As a 
consequence of switch loop rearrangements, RF1/2 domain III accommodates into the 
PTC of the LSU (Figure 7D) (Youngman et al., 2008; Zhou et al., 2012a). Domain III 
harbors a tripeptide Gly-Gly-Gln (GGQ) motif that facilitates the release of the nascent 
chain (Figure 7D) that is conserved between RF1 and RF2 (as well as the evolutionarily 
unrelated eukaryotic termination release factor eRF1) (Frolova et al., 1999; Mora et 
al., 2003; Seit-Nebi et al., 2001; Shaw and Green, 2007; Zavialov et al., 2002). 
Therefore, RF1 and RF2 utilize the same mechanism for polypeptide chain release. 
As part of this mechanism, a water molecule is utilized as an acceptor for the nascent 
peptide to release it from the ribosome (Tate and Brown, 1992). The water molecule 
fulfils the same function during termination as the deprotonated a-amine during 
transpeptidation (Kuhlenkoetter et al., 2011; Trobro and Aqvist, 2009) by attacking the 
carbonyl linking the peptidyl moiety to the P-site tRNA (Kuhlenkoetter et al., 2011; 
Trobro and Aqvist, 2009). Molecular dynamic simulations suggest that the conserved 
GGQ motif positions the crucial water molecule in the PTC next to nucleotide A76 of 
the P-tRNA that carries the peptidyl moiety (Trobro and Aqvist, 2009). It presumably 
involves the 23S rRNA residue A2451, the 2’-hydroxyl of A76 and the backbone NH-
group of the glutamine residue (Trobro and Aqvist, 2009). Strikingly, glycine residues 
in the first two positions of the GGQ motif are more critical for placement of the water 
molecule than glutamine in the third (Mora et al., 2003; Shaw and Green, 2007; 
Zavialov et al., 2002). Mutagenesis of either glycine leads to strong effects on 
translation termination (Mora et al., 2003; Shaw and Green, 2007; Zavialov et al., 
2002). This is caused by the unique conformation of the GGQ motif, which is 
constrained by the achiral nature of glycine residues and their dedicated torsion angles 
(Zhou et al., 2012a). In absence of the glycine residues, the placement of the GGQ, 
as well as the water molecule inside the PTC is perturbed (Mora et al., 2003; Shaw 
and Green, 2007; Zavialov et al., 2002). This contrasts with alterations of the Gln which 
were observed to have only rather mild effects (Shaw and Green, 2007; Zavialov et 
al., 2002). Instead, the glutamine (E. coli Gln235) has been suggested to be crucial for 
the nucleophile specificity (Shaw and Green, 2007). In any case, the backbone NH-
group is involved in the coordination of the water molecule and seems to be important 
for stabilization of a tetrahedral intermediate and the final product (Laurberg et al., 
2008). The tetrahedral intermediate results from the nucleophilic attack of the 
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coordinated water, possibly carrying an oxyanion stabilized by the NH-group (Laurberg 
et al., 2008). After successful cleavage, the peptidyl moiety is released from the 
ribosome and the deacyl-tRNA stays bound to the ribosome. The deacyl-tRNA is 
stabilized by the backbone NH-group through hydrogen bonding with 3’-hydroxyl of 
A76 (Laurberg et al., 2008). Due to the minor relevance of the side chain, replacement 
of Gln by other amino acids, like alanine, is acceptable and primarily affects the rate of 
release (Mora et al., 2003; Seit-Nebi et al., 2001; Shaw and Green, 2007; Zavialov et 
al., 2002), since the presence of the amino-group is not altered (Laurberg et al., 2008). 
However, under natural conditions RF1 and RF2 carry a post-translational modified 
GGQ motif. N5 of the Gln side chain becomes methylated by the methyltransferase 
HemK (Dincbas-Renqvist et al., 2000; Heurgue-Hamard et al., 2002; Pierson et al., 
2016; Zeng and Jin, 2018). Methylation of the Gln side chain possibly plays a more 
crucial role in coordination of water together with the backbone NH-group of the 
glutamine residue (Shaw and Green, 2007). This concept is supported by a recent X-
ray crystallography study, which resolved the exact conformation of the methylated Gln 
side chain (Zeng and Jin, 2018). The authors describe that in presence of the Gln 
methylation the side chain adopts a conformation which allows the exact positioning of 
the carbonyl carbon for coordination of the nucleophilic water molecule (Zeng and Jin, 
2018).   
After nascent peptide release, RF1/2 and deacyl-tRNA stay bound to the 
ribosome (Figure 2C). The termination release factor 3 (RF3), a class II RF, dissociates 
ribosome-bound RF1/2 and returns them to the pool of translation factors available for 
protein synthesis (Figure 2C) (Freistroffer et al., 1997; Goldstein and Caskey, 1970). 
RF3 is a three-domain protein and shows high structural similarity to other translational 
GTPases like EF-G, EF-Tu and IF2 (Gao et al., 2007; Jin et al., 2011; Kihira et al., 
2012; Zhou et al., 2012b). Domain I (G-domain) harbors the GTPase activity and is 
activated by contacting the SRL (Lin et al., 2015; Loveland et al., 2017; Zhou et al., 
2012b). Domain II and III are linked via a flexible linker and establish contacts with the 
SSU that allow RF3 binding (Gao et al., 2007; Zhou et al., 2012b), in particular with 
S12 and 16S rRNA helices h5 and h15 (Jin et al., 2011; Zhou et al., 2012a; Zhou et 
al., 2012b). However, in contrast to the previous termination step, binding of RF3 does 
not require an mRNA signal exposed in the A-site. Possibly facilitated by L7/L12 
(Carlson et al., 2017; Pallesen et al., 2013), RF3 binds most likely in its GTP-bound 
form to 70S ribosomes irrespective of the presence of termination factors and deacyl- 
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or peptidyl-tRNA (Adio et al., 2018; Koutmou et al., 2014; Peske et al., 2014). 
Furthermore, RF3 binding can occur even before release of the nascent chain from the 
ribosomes (Pre-hydrolysis 70S ribosome) (Adio et al., 2018). RF3 binding in complex 
with GDP has been discussed as well (Zavialov et al., 2001; Zavialov et al., 2002) but 
seems to be unlikely due to the presence of large excess of GTP over GDP inside the 
eubacterial cell under native conditions (Adio et al., 2018; Bennett et al., 2009). 
Nonetheless, the actual substrate for RF3-GTP action is a post-hydrolysis 70S 
ribosome harboring deacyl-tRNA in the P-site and RF1/2 in the A-site. The mechanism 
of factor dissociation was investigated in the last 15 years utilizing biochemistry, as 
well as cryo-EM and X-ray crystallography. Biochemical studies implied a mechanism 
driven by RF3 that leads to the formation of R-state ribosomes by SSU rotation (Adio 
et al., 2018; Ermolenko et al., 2007; Koutmou et al., 2014). Factor induced SSU rotation 
most likely leads to disengagement of RF1/2 domain III and superdomain II/IV from the 
ribosome. This view is supported by structural studies investigating RF3-GDP((C/N)P) 
bound to different ribosomal complexes (Gao et al., 2007; Jin et al., 2011; Kihira et al., 
2012; Pallesen et al., 2013; Zhou et al., 2012b). In the presence of deacyl-tRNA, as 
well as in absence of other ligands/factors, all 70S-RF3 complexes showed rotational 
movement of the SSU by up to 9° and SSU head swiveling of 4-14° (Jin et al., 2011; 
Zhou et al., 2012b). Independent of the rotational state of the ribosome, 
superimpositions of RF1/2 in its binding site and corresponding RF3 structures show 
no steric hindrance for simultaneous binding of class I and class II release factors. 
Thus, rotation-driven dissociation of RF1/2 seems to be the most likely concept of RF3 
mediated RF1/2 dissociation (Gao et al., 2007; Jin et al., 2011; Kihira et al., 2012; 
Pallesen et al., 2013; Zhou et al., 2012b). What remained unclear from previous 
studies is the underlying mechanism inducing subunit rotation and whether RF3 
undergoes large conformational changes prior to GTPase activation. Furthermore, it 
has been discussed that GTP hydrolysis is not necessary for the actual process of 
RF1/2 recycling, but rather for dissociation of RF3 from the ribosome (Adio et al., 2018; 
Peske et al., 2014). This contrasts with EF-Tu and EF-G, which hydrolyze GTP 
before/during their action on the ribosome. 
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1.2.4 Ribosome recycling 
 
Ribosomes and factors involved in protein synthesis are not single-use instruments. 
Therefore, mRNA has to be released and post-termination ribosomes have to be 
recovered after successful translation in a process called ‘ribosome recycling’ (Janosi 
et al., 1994; Karimi et al., 1999). While ribosome recycling itself is not crucial for protein 
synthesis per se, it is crucial to prevent depletion of the pool of ribosomal subunits 
ready for recruitment to mRNA. The process of ribosome recycling involves previously 
described translation elongation factor EF-G and an additional factor called ribosome 
recycling factor (RRF) (Figure 2C). Both factors are compulsory for recycling, since 
they act in concert in a GTP-dependent fashion (Hirokawa et al., 2006; Hirokawa et 
al., 2005; Peske et al., 2005; Zavialov et al., 2005). Successful recycling requires 
binding of RRF to post-termination complex (PoTC) in the intersubunit space prior to 
EF-G association (Borg et al., 2016; Dunkle et al., 2011; Prabhakar et al., 2017). There 
are numerous structures showing RRF bound to 70S ribosomes (Fu et al., 2016; Kim 
et al., 2000; Nakano et al., 2003; Saikrishnan et al., 2005; Selmer et al., 1999; Toyoda 
et al., 2000; Yokoyama et al., 2012; Yoshida et al., 2001). Two of these available 
structures are complexes showing RRF and EF-G simultaneously bound to 70S-PoTC 
(Fu et al., 2016; Yokoyama et al., 2012). RRF consists of two domains that are linked 
via a flexible linker that allows domain movement (Fu et al., 2016; Weixlbaumer et al., 
2007). Characteristic for the structure of RRF is a three-helix bundle (domain I) that 
reaches up to the PTC (Dunkle et al., 2011). The loop at the tip of the bundle contacts 
the LSU P-loop (Dunkle et al., 2011). a-Helix 3 of the bundle is involved in ribosome 
binding by contacting H71 of the 23S rRNA (Dunkle et al., 2011). Domain II of RRF 
contacts the SSU via protein S12 (Dunkle et al., 2011; Fu et al., 2016; Gao et al., 
2005). Binding of RRF to PoTC stabilizes R-states containing P/E hybrid state deacyl-
tRNAs (Dunkle et al., 2011). Accordingly, ~9° SSU body/platform counterclockwise 
rotation and ~4° head swivel was observed upon RRF binding (Dunkle et al., 2011). 
Simultaneous positioning of RRF and either tRNA in a P/P-state (Dunkle et al., 2011), 
or RF1/2 (Pavlov et al., 1997), is not possible due to a steric block created by the three-
helix bundle of RRF, which reaches up to the PTC and blocks the A- and P-site cleft 
on the LSU (Dunkle et al., 2011). Hence, binding is dedicated to complexes after 
peptide chain release and RF1/2 dissociation. However, ribosome splitting is 
presumably facilitated through domain II (Dunkle et al., 2011; Yokoyama et al., 2012), 
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which can adopt at least two different conformations in presence or absence of EF-G. 
Upon binding of EF-G and subsequent GTP hydrolysis RRF domain II rearranges 
towards domain I in close proximity to intersubunit bridge B2a (H69 and h44)(Fu et al., 
2016; Wilson et al., 2005). Interactions between RRF and EF-G are generally different 
compared to EF-G/tRNA interactions (Yokoyama et al., 2012). While the tip of EF-G 
domain IV interacts with the tRNA ASL during translocation, no tRNA contact was 
observed in the RRF-EF-G structure (Yokoyama et al., 2012). Instead interactions 
between the junction of EF-G domain II-III and RRF domain II are present (Yokoyama 
et al., 2012). Problematic is the use of RRF and EF-G from different organisms in the 
respective study which in combination were shown to be inactive (Ito et al., 2002). 
Mechanistically it was suggested that EF-G induced conformational changes in domain 
II distort subunit bridges, such as B2a (Fu et al., 2016; Wilson et al., 2005; Yokoyama 
et al., 2012) and thereby dissociating the 70S ribosome into LSU and SSU. IF3 binding 
to the SSU then occludes interactions with the LSU and acts as starting point for 
another round of translation initiation (Hirokawa et al., 2005; Peske et al., 2005; 
Prabhakar et al., 2017). Furthermore, it was suggested that IF3 binding is also involved 
in dissociation of tRNA and mRNA from the SSU (Karimi et al., 1999; Prabhakar et al., 
2017). Ribosome recycling connects translation termination with translation initiation 
and allows a handover between both steps of the cycle. 
 
1.2.5 Interaction of L7/L12 with translational GTPases 
 
Translational GTPases, such as EF-Tu, EF-G, IF2 and RF3, are indispensable for 
translation speed and fidelity. Binding of translational GTPases to the ribosome and 
subsequent GTPase activation involves the L7/L12 stalk, which is located on the LSU. 
The L7/L12 stalk comprises the 23S helices 42 to 44 (stalk base) and a pentameric (in 
E. coli) protein complex (Diaconu et al., 2005). The 23S rRNA stalk base forms the 
backbone of the L7/L12 stalk (Diaconu et al., 2005). The attached pentameric protein 
complex consists of two L7/L12 dimers, which are linked via their NTD to L10 (Diaconu 
et al., 2005). The L7/L12 NTD and CTD are connected through a flexible linker 
(Diaconu et al., 2005; Liljas and Gudkov, 1987). The CTD was observed to interact 
with the G-domain of translational GTPases, such as EF-Tu (Kothe et al., 2004; Stark 
et al., 1997), EF-G (Gao et al., 2009; Nechifor et al., 2007; Tourigny et al., 2013; Zhou 
et al., 2013, 2014), IF2 (Simonetti et al., 2013) and RF3 (Pallesen et al., 2013). This is 
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consistent with biochemical studies showing that EF-Tu, EF-G, RF3 and IF2 binding 
depends on the presence of L7/L12 (Wahl and Moller, 2002). The L7/L12 CTD can 
presumably ‘fish’ for translation factors in the cytoplasm and hence increase the 
efficiency of translation. Due to the presence of four CTDs in the E. coli L7/L12 stalk 
and six CTDs in the T. thermophilus L7/L12 stalk, several translation factors can 
establish interactions with L7/L12 stalk simultaneously. The importance for translation 
efficiency has been shown in various biochemical experiments. Accordingly, while one 
dimer of L7/L12 leads to basic levels of translation in vitro, the presence of two dimers 
leads to significantly increased translation efficiency (Mandava et al., 2012). The 
complete absence of the L7/L12 protein results in a strongly reduced rate of protein 
synthesis catalyzed by EF-G and EF-Tu (Koteliansky et al., 1977). Nonetheless, 
L7/L12 does not affect the translation efficiency solely by binding to the G-domain of 
translational GTPases. It was observed that interactions with L7/L12 stimulate the 
GTPase activity of translation factors, like EF-G, EF-Tu, IF2 and LepA (Carlson et al., 
2017; Mohr et al., 2002; Savelsbergh et al., 2000). The absence of L7/L12 results in 
reduced GTPase activity and perturbed Pi release (Mohr et al., 2002).  
Noteworthy, until recently there were no indications whether L7/L12 is involved 
in recruitment of non-GTPase translation factors, such as class I release factors. 
However, our studies on 70S ribosomes in complex with Api137, RF1 and RF3 
revealed an unassigned density adjacent to domain I of RF1, which likely constitutes 
one of the four L7/L12 CTDs. Thus, the L7/L12 stalk seems to be involved in class I 
release factor recruitment as well (see discussion). 
1.3 Plastid-derived ribosomes 
 
Considering that living organisms constitute isolated systems with membranes 
shielding them from the environment, it is not surprising that evolution resulted in 
alterations of cellular machineries. Chloroplasts are a good example of isolated 
evolution. Chloroplasts are the result of an endosymbiotic event approximately 1 billion 
years ago that led to engulfment of a photosynthetic cyanobacterium by a eukaryotic 
cell (Price et al., 2012). Chloroplasts as such, are crucial for plants due to their function 
in carbon fixation, which is the result of photosynthesis. Photosynthesis takes place in 
the thylakoid membrane of chloroplasts and requires synthesis of protein components 
of the photosystem I and II complex as well as adenosine triphosphate synthase 
(Schmitz-Linneweber et al., 2001). The majority of the required chloroplast proteins 
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are synthesized outside the plastid and encoded within the eukaryotic host cell 
genome. A minor subset of proteins is encoded by the remaining chloroplast genome 
and synthesized inside the organelle by a specialized ribosome (Yamaguchi and 
Subramanian, 2000, 2003; Yamaguchi et al., 2000).  
Protein synthesis inside chloroplasts is carried out by ribosomes that are similar 
to bacterial 70S ribosomes. Consistently, 70S chlororibosomes harbor a SSU and a 
LSU (Figures 8A-C). Just like ribosomes from other organisms and all kingdoms of life, 
the rRNA core shows high sequence conservation. Thus, it seems plausible that the 
same principles underlay protein synthesis. Nonetheless, despite similarities that 
derive from a common progenitor (Margulis, 1971; Price et al., 2012; Sagan, 1967), 
clear differences in the set of ribosomal proteins (Yamaguchi and Subramanian, 2000, 
2003; Yamaguchi et al., 2000) and rRNA are evident (Schmitz-Linneweber et al., 
2001). The overall tendency is an increase in protein mass (Reyes-Prieto et al., 2007). 
The rRNA nucleotide number stayed approximately the same (+13 nts), although 
chloroplast rRNA harbors numerous insertions and deletions compared to E. coli 
rRNA. Interestingly, the LSU of the chlororibosome harbors 23S, 5S and a 4.8S rRNA 
(Figures 8A-C). The 4.8S rRNA molecule, consisting of 103 nucleotides, is the result 
of a 3’-end fragmentation of the 23S rRNA. As a consequence, the 23S rRNA is 
truncated and consists of a total of 2,810 nucleotides compared to the E. coli 23S rRNA 
with 2,904 nucleotides. The most obvious differences between bacterial and 
chloroplast 70S ribosomes are six additional plastid-specific ribosomal proteins 
(PSRP1-6) (Figures 8A-C) and the lack of LSU proteins L25 and L30 (Yamaguchi and 
Subramanian, 2000, 2003; Yamaguchi et al., 2000). PSRP1-4 associate with the SSU 
(Figures 8A and 8C); PSRP5 and PSRP6 bind to the LSU (Figures 8A and 8B). 
PSRP3-5 were shown to be essential in Arabidopsis thaliana chloroplasts (Tiller et al., 
2012). In addition to PSRP1-6, most of the plastid proteins harbor N- or C-terminal 
extensions (NTE and CTE), which together with PSRPs account for the increased 
rRNA/protein ratio (Yamaguchi and Subramanian, 2000, 2003; Yamaguchi et al., 
2000). NTEs and CTEs compensate for rRNA deletions and allow reshaping of the 
ribosomal features (Ahmed et al., 2017; Ahmed et al., 2016; Bieri et al., 2017; Graf et 
al., 2017a). Reshaping of ribosomal features is especially important considering that 
the translational process in chloroplasts exhibits significant differences. In contrast to 
bacteria, more than 70% of all mRNAs in chloroplasts do not harbor a SD-sequence 
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(Drechsel and Bock, 2011; Hirose et al., 1998; Ruf and Koessel, 1988) and the protein 
targeting signal-recognition particle (SRP) lacks an RNA molecule directly involved in 
Figure 8 Chloroplast ribosome. (A-C) Overview of the structure of the chloroplast ribosome harboring 
PSRP1 (pale green), PSRP2 (orange), PSRP3 (red), PSRP4 (light blue), PSRP5 (dark blue) and PSRP6 
(teal). The LSU is shown in grey and the SSU is shown in yellow. 5S and 4.8S rRNA are shown in dark 
red. (A) Interface view of the 70S ribosome consisting of a LSU (grey) and a SSU (yellow) (Ahmed et 
al., 2017). (B) Crown view of the LSU (Ahmed et al., 2017; Ahmed et al., 2016; Bieri et al., 2017; Graf 
et al., 2017a). (C) Interface view of the SSU (Ahmed et al., 2017). (D) Interactions of PSRP1 (pale green) 
with SSU (yellow) helices h18, h30, h34 and h44. Arg119 and Pro127 of PSRP1 protect C1054 and 
G530, respectively (Bieri et al., 2017). A1492 and A1493 of h44 are stabilized in a partially flipped 
conformation. The model was superimposed with P-tRNA (faint grey) to show the evidence of a steric 
block by PSRP1 that prevents tRNAs from binding. (E) PSRP2 (orange) bound to h6 and h10 (both 
yellow) at the foot of the SSU (Ahmed et al., 2017). (F) PSRP3 (red) binding site at the mRNA tunnel 
entry (grey filling with black contour) at the interface between the SSU (yellow) head and platform in 
close proximity to S7 (purple) and S11 (light blue) (Ahmed et al., 2017). (G) Interactions of PSRP4 (light 
blue) with the SSU head (yellow) and intersubunit bridges B1b and B1a (Ahmed et al., 2017; Bieri et al., 
2017). Intersubunit B1a comprises LSU H38 (grey) and SSU protein S13 (pink). Intersubunit bridge B1b 
comprises S13 (pink), L5 (dark green) and L31 (wheat). (H) Interactions of PSRP5 (dark blue) with 23S 
rRNA helices (grey) H40, H41 and H49 (Bieri et al., 2017; Graf et al., 2017a). (I) Interactions of PSRP6 
(teal) with the LSU (grey) (Ahmed et al., 2017; Bieri et al., 2017; Graf et al., 2017a). The N-terminal part 
of PSRP6 interacts with H40, H41 and H89. The C-terminal part of the proteins provides a β-strand to 
L21 (wheat). (J) Previously unobserved intersubunit bridge between SSU protein S6 (brown) and LSU 
protein L2 (green) (Bieri et al., 2017). The LSU helices (grey) H58 and H76, as well as the SSU helix 
h23 (yellow) are shown for reference. (K) Hypothetical interaction surface of the LSU (grey) with 
bacterial membrane that is created by the N-terminal extension (NTEs) of LSU proteins L13 (slate), L21 
(salmon) and S22 (pale green) (Graf et al., 2017a). The NTEs interact with each other extensively 
(encircled area). The proteins L23 (cyan), L24 (purple) and L29 (brown) are shown for reference. (L) 
Stabilization of the 23S rRNA (grey) 3’-end and the 4.8S rRNA (dark red) 5’-end by the helical NTE of 
L13 (slate) (Bieri et al., 2017; Graf et al., 2017a).  
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localization (Richter et al., 2010).  
However, the structure of chlororibosomes at higher resolution was recently 
presented in five different publications (Ahmed et al., 2017; Ahmed et al., 2016; Bieri 
et al., 2017; Forsberg et al., 2017; Graf et al., 2017a). All publications are in good 
agreement with each other and show just minor differences. The presented structures 
allowed the assignment of many of the protein extensions, the unambiguous 
placement of PSRPs and clarification of aberrations within rRNA and chloroplast 
ribosomal proteins compared to bacteria. All results, taken together with old studies, 
bring us a step closer to understand how translation in chloroplasts works. 
The role of PSRP1, also known as translation factor pY, was clarified previously 
(Sharma et al., 2010). PSRP1 is a homologue of the bacterial stress response factor 
YifA (pY) (Agafonov et al., 2001; Vila-Sanjurjo et al., 2004) and therefore not a 
chlororibosome specific protein per se (Sharma et al., 2010). PSRP1 modulates 
protein synthesis in response to stress, such as lack of light (Sharma et al., 2010). 
Upon stress, PSRP1-mediated modulation of protein synthesis is achieved by binding 
to the mRNA channel on the SSU and contacting DC nucleotides (Figure 8D) (Bieri et 
al., 2017; Sharma et al., 2010). Contacts with the DC are thought to prevent 
degradation of the ribosome. Furthermore, PSRP1 occupies the SSU A- and P-site, 
which sterically occludes binding of tRNAs (Ahmed et al., 2017; Bieri et al., 2017; Graf 
et al., 2017a; Vila-Sanjurjo et al., 2004). As a consequence, translation is inhibited 
under stress conditions (Ahmed et al., 2017; Bieri et al., 2017; Sharma et al., 2010). 
The blockage of the A-/P-site, and hence protein synthesis, involves contacts with 
numerous elements of the SSU. PSRP1 a-helix 1 contacts the backbone of 16S helix 
44 (Figure 8D) (Bieri et al., 2017). Binding to the mRNA channel occurs through a-
helix 2 that is positioned on top and prevents binding of a transcript (Figure 8D) (Bieri 
et al., 2017). In the DC PSRP1 induces partial flipping of DC nucleotides A1492 and 
A1493 (Figure 8D) (E. coli numbering) (Ahmed et al., 2017; Bieri et al., 2017). G530 
and C1054 (E. coli numbering) are protected by interactions with Pro127 and Arg119 
of PSRP1 (Figure 8D) (Bieri et al., 2017). PSRP1 binding is further stabilized by 
interactions of the CTE that harbors two histidine residues (His178 and His181) and 
mimics the mRNA nucleotide base in the ribosomal E-site (Bieri et al., 2017). An 
extended loop between b-strand 2 and 3 establishes interactions with 16S helices 18 
and 34 (Figure 8D) (Bieri et al., 2017).  
Introduction 32 
The exact function of PSRP2 and PSRP3 remains mostly elusive. Biochemical 
assays indicated a chaperone function for PSRP2 under stress conditions (Xu et al., 
2013). Other studies suggest that binding of both factors primarily compensates for the 
deletion of 16S rRNA nucleotides in h6 and h10 at the SSU foot (Sharma et al., 2007). 
However, two recent chlororibosome reconstructions contradict the simultaneous 
binding of PSRP2 and PSRP3 to the foot (Ahmed et al., 2017; Forsberg et al., 2017). 
Although an additional density at the tip of h6 and h10 has been observed (Ahmed et 
al., 2017; Bieri et al., 2017; Forsberg et al., 2017), another spare density is present at 
the mRNA tunnel exit (Ahmed et al., 2017; Forsberg et al., 2017). Using 8 Å filtered 
maps, the density was assigned by Ahmed and colleagues to PSRP3 (Figure 8F) 
(Ahmed et al., 2017).  This allowed the placement of the entire PSRP2 at the tip of h6 
and h10 (Figure 8E) (Ahmed et al., 2017). Thus, PSRP2 alone compensates for rRNA 
truncations.  Structurally, PSRP2 is comprised of two domains connected by a linker 
(Figure 8E) (Ahmed et al., 2017). Nonetheless, the overall density at the respective 
positions is rather poor (Ahmed et al., 2017; Bieri et al., 2017; Forsberg et al., 2017). 
Therefore, none of the recent reconstructions allowed unambiguous placement of 
protein homology models with side chain accuracy. Notably, Bieri and colleagues do 
not see the respective additional density at the mRNA tunnel exit at all (Bieri et al., 
2017). In their model, PSRP2 and PSRP3 were placed at the foot, in accordance to 
the original suggested model (Sharma et al., 2007). This is surprising, since evaluation 
of the deposited map showed no density for PSRP3 at the tip of h6. Furthermore, 
simultaneous placement of PSRP2 and PSRP3 requires significant N-terminal 
truncation of PSRP2 due to the lack of additional unassigned density. Considering 
these differences, it seems unlikely that PSRP2 and PSRP3 bind side by side to the 
spur. 
PRSP4 is a short (46 aa) protein, which has homology to the T. thermophilus 
protein bTHX that binds to the head of the SSU (Wimberly et al., 2000). Consistently, 
PSRP4 is also seen to bind in the analogous position in chlororibosomes (Figure 8G) 
(Ahmed et al., 2017; Bieri et al., 2017). A counterpart in E. coli does not exist. Binding 
to the SSU is thought to stabilize the SSU head, as well as contacts between the LSU 
and the SSU (Ahmed et al., 2017; Bieri et al., 2017). Stabilization is achieved through 
interactions with 16S rRNA and intersubunit bridge B1a (Ahmed et al., 2017) as well 
as B1b (Figure 8G) (Ahmed et al., 2017; Bieri et al., 2017). The respective interactions 
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involve the core of the protein, conserved between T. thermophilus and chloroplasts, 
contacting h41 and h42 of the 16S rRNA (Ahmed et al., 2017; Bieri et al., 2017).  
In recent studies, PSRP5, which is largely enriched in positively charged 
residues, was found to interact with H58 through its N-terminal a-helix (Figure 8H) 
(Bieri et al., 2017; Graf et al., 2017a). This contradicts older low-resolution structures 
where PSRP5 was positioned incorrectly near the L1 stalk (Sharma et al., 2007). A 
shorter a-helical portion at the C-terminus of PSRP5 contacts the minor groove of H49 
(Figure 8H) (Bieri et al., 2017; Graf et al., 2017a). Positioning of the protein most likely 
serves as compensation for H63 that is lacking in chlororibosomes and contacts H58, 
H59 and H60 in E. coli ribosomes (Bieri et al., 2017). Hence, PSRP5 seems to be 
required for stabilization by taking over functions from rRNA residues.  
PSRP6 was identified as a protein with an extended conformation (Figure 8I) 
(Ahmed et al., 2016; Bieri et al., 2017; Graf et al., 2017a). The positively charged N-
terminal portion containing two small a-helices interacts with the negatively charged 
backbone of the 23S rRNA (Figure 8I) (Bieri et al., 2017; Graf et al., 2017a). The 
interactions involve the minor grooves of H40, H42 and H89 (Figure 8I) (Bieri et al., 
2017; Graf et al., 2017a). The C-terminal portion of PSRP6 does not contact rRNA 
(Figure 8I) (Graf et al., 2017a), but instead contributes a b-strand to the b-sheet of L21 
(Figure 8I) (Graf et al., 2017a). Nonetheless, despite identification of the binding 
position of PSRP6, the exact role and function of the protein remains unclear. 
Many of the chloroplast protein extensions replace rRNA residues, stabilize the 
altered rRNA network and introduce new features to the ribosome architecture. Such 
features include intersubunit bridges, reshaping of the mRNA tunnel, restructuring of 
the polypeptide exit tunnel and the formation of an expanded membrane interaction 
surface.  
CTEs of SSU protein cpS6 and LSU protein cpL2 form a previously unobserved 
intersubunit bridge, termed B7c (Figure 8J) (Bieri et al., 2017).  
The SSU proteins cpS1, cpS4 and cpS5 rebuild the chloroplast mRNA tunnel 
entry/exit. Rebuilding of the tunnel entry occurs through cpS3, cpS4 with an internal 
insertion and the NTE of cpS5 (Bieri et al., 2017). All proteins together form a confined 
mRNA tunnel entry (Bieri et al., 2017). In addition, the NTE of cpS5 mediates between 
proteins by interacting with cpS1, cpS3 and cpS4 (Bieri et al., 2017). The SSU protein 
cpS1 reaches from the tunnel entry to the tunnel exit on the solvent side of the SSU. 
The extension of cpS1 is primarily involved in reshaping of the mRNA tunnel exit (Bieri 
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et al., 2017). Reshaping of both tunnel entry and tunnel exit was suggested to be 
required for translation initiation in chloroplasts utilizing cis- and trans-acting elements 
that compensate for altered translation initiation (Ahmed et al., 2017; Bieri et al., 2017; 
Sugiura, 2014; Zerges, 2000).  
The polypeptide tunnel exit becomes restructured by NTEs of cpL23 and cpL24, 
as well as a CTE of cpL29 (Ahmed et al., 2016; Bieri et al., 2017; Graf et al., 2017a). 
The CTE of cpL29 and the NTE of cpL23 contact each other and replace truncated 
23S rRNA helix 9 present in E. coli (Ahmed et al., 2016; Bieri et al., 2017; Graf et al., 
2017a). Reshaping of the polypeptide tunnel exit is thought to be the result of a 
coevolution, which took place together with reduction of cpSRP54 lacking an RNA 
molecule (Bieri et al., 2017; Richter et al., 2010). Consistently, the additional protein 
residues might be required for additional contacts that allow cpSRP54 mediated 
protein localization in chloroplasts (Ahmed et al., 2016; Bieri et al., 2017; Graf et al., 
2017a).  
Targeting to thylakoid membranes is possibly facilitated through protein 
extensions of cpL13, cpL21 and cpL22 (Figure 8K) (Graf et al., 2017a). The NTE of 
cpL13, the NTE of cpL21 and the CTE of cpL22 extensively interact with each other 
and increase the surface of the LSU (Figure 8K) (Graf et al., 2017a). The expanded 
surface constitutes a suitable candidate for membrane interactions (Figure 8K). 
Assuming such interactions, the polypeptide tunnel exit would face the thylakoid 
membrane.  
An example for the stabilization by protein extensions is the fragmented 23S 
rRNA (Figure 8L). Fragmentation of the rRNA into two separate molecules, namely 
4.8S and 23S rRNA, led to the loss of nucleotides in-between (-16 nts) as well as the 
creation of exposed 5’- and 3’-ends. The helical NTE provided by cpL13 contacts the 
5’-end of the 4.8S rRNA and the 3’-end of the 23S rRNA via positively charged residues 
and thereby stabilizes each terminus (Figure 8L) (Bieri et al., 2017; Graf et al., 2017a). 
 
1.4 Antimicrobial peptides  
 
Continuous competition of organisms in a quickly changing environment results in the 
development of a wide range of survival strategies which grant some organisms 
advantages over others - a principal that has been described by Charles Darwin almost 
150 years ago (Darwin, 1869). One strategy of microorganisms is the invasion of 
Introduction 35 
multicellular organisms, such as mammals, that provide a nutritious environment for 
successful bacterial progression and proliferation. Bacterial invasion of an organism 
occurs through lesions and mucosae for example. To prevent the establishment of an 
infection, higher eukaryotes developed an immune system that ideally prevents but at 
least restricts and eliminates further bacterial proliferation. The first line of defense 
represents the innate system. The innate immune system recognizes pathogens by 
specialized receptors and establishes a non-specific immune response by recruitment 
of phagocytic cells, such as macrophages and neutrophils. At the site of infection these 
cells either release a deadly compound cocktail or engulf the foreign organism and 
subsequently kill it inside the cell. The released cocktail contains antimicrobial peptides 
(AMPs) as well as other agents, such as reactive oxygen species. Due to the nearly 
unlimited number of amino acid combinations, AMPs are capable of attacking almost 
every extra-/intra-cellular site and process of a bacterial pathogen (Brogden, 2005). 
Among those extracellular targets is the bacterial cell wall and the bacterial membrane 
(Brogden, 2005). Intracellular targets include fundamental processes like bacterial 
replication, transcription and translation (Brogden, 2005; Graf et al., 2017b). The 
intrinsic diversity of peptides combined with the need for compounds fighting bacterial 
infections, make AMPs a valuable and promising source for future antibiotics that can 
be possibly used in a clinical setting. 
 AMPs can be classified based on their amino acid composition, as well as their 
specific target (Jenssen et al., 2006). One specific group, called Proline-rich AMPs 
(PrAMPs), belongs to the subclass of cationic peptides, which are characterized by a 
high content of proline and arginine residues (Graf et al., 2017b). Starting with the 
identification of the first PrAMP in the late 1980s by HPLC, namely apidaecin from the 
honey bee Apis mellifera (Casteels et al., 1989), more PrAMPs have been identified in 
higher eukaryotes, like mammals and arthropods (Agerberth et al., 1991; Bulet et al., 
1993; Casteels et al., 1990; Chernysh et al., 1996; Cociancich et al., 1994; Gennaro 
et al., 1989; Huttner et al., 1998; Knappe et al., 2010; Mardirossian et al., 2018; 
Schnapp et al., 1996; Schneider and Dorn, 2001; Shamova et al., 1999; Stensvag et 
al., 2008). Among mammals, PrAMPs have been identified in cows (Gennaro et al., 
1989), dolphins (Mardirossian et al., 2018), goats (Shamova et al., 1999), pigs 
(Agerberth et al., 1991), as well as sheep (Huttner et al., 1998; Shamova et al., 1999). 
Arthropod PrAMPs were found in crabs (Stensvag et al., 2008) and numerous insects 
(Bulet et al., 1993; Casteels et al., 1989; Casteels et al., 1990; Chernysh et al., 1996; 
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Cociancich et al., 1994; Knappe et al., 2010; Schneider and Dorn, 2001). Equivalent 
to apidaecin (Casteels et al., 1989), the nomenclature of PrAMPs predominantly 
corresponds to the origin of identification. Accordingly, PrAMPs from Tursiops 
truncates (bottlenose dolphin) are termed Tur1A and Tur1B (Mardirossian et al., 2018), 
peptides from Bos taurus (cattle) are called bactenecins (Gennaro et al., 1989) and 
Oncopeltus fasciatus (milkweed bug) derived PrAMPs are termed oncocins (Knappe 
et al., 2010; Schneider and Dorn, 2001). Noteworthy, peptides with high sequence 
similarity are commonly named after the source in which the PrAMP was first 
discovered. Thus, PrAMPs from Capra hircus (goat) and Ovis aries (sheep) (Huttner 
et al., 1998; Shamova et al., 1999), which show similarity to Bos taurus peptides, are 
called bactenecins as well.  
 
1.4.1 Synthesis of PrAMPs 
 
As mentioned before, PrAMPs are primarily produced upon bacterial infection by cells 
of the innate immune system, called phagocytes (Zasloff, 2002). Phagocyte 
progenitors, immature myeloid cells in mammals, synthesize PrAMPs as inactive 
precursors and store these in granules (Graf et al., 2017b; Zanetti et al., 1990; Zanetti 
et al., 1991). Storage of PrAMPs as inactive precursors in granules serves different 
functions. First, it protects the producing cell from harm by the peptide, and second, it 
allows a fast pathogen response by avoiding time-consuming protein synthesis. 
Activation of the inactive precursors occurs at the target site by proteolytic cleavage 
(Zanetti et al., 1990; Zanetti et al., 1991). The respective proteases are stored 
separately from the inactive precursors in a different set of granules (Zanetti et al., 
1990; Zanetti et al., 1991). In mammals PrAMP-containing granules are called large 
granules, and protease-harboring granules are termed azurophil granules (Zanetti et 
al., 1990; Zanetti et al., 1991). Activation of precursors is induced by simultaneous 
exocytosis into extra-cellular space or bacteria-containing phagosomes (Zanetti et al., 
1990; Zanetti et al., 1991). However, the overall structure of PrAMP precursors, as well 
as the resulting path of activation differs between organisms and PrAMPs (Graf et al., 
2017b). Although not all mechanisms of peptide activation have so far been clarified, 
a single-peptide activation mechanism can be distinguished from a multi-peptide 
activation mechanism (Graf et al., 2017b). All mammalian PrAMPs seem to be 
activated by the single-peptide mechanism. Insect PrAMPs activated through a multi-
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peptide activation mechanism are apidaecin (from Apis mellifera) (Casteels-Josson et 
al., 1993) as well as riptocin (from Riptortus pedestris) (Graf et al., 2017b). The single-
peptide mechanism involves an mRNA coding for a polypeptide sequence harboring a 
preceding pre-sequence (~20-30 aa), a pro-sequence (~20-100 aa) and a Pro-Arg-rich 
sequence (Bulet et al., 1993; Graf et al., 2017b; Storici and Zanetti, 1993; Zanetti et 
al., 1993). The pro-sequence is placed either before (e.g. bactenecin and PR-39) 
(Storici and Zanetti, 1993; Zanetti et al., 1993) or after the PrAMP (e.g. drosocin) (Bulet 
et al., 1993). The multi-peptide mechanism comprises an mRNA coding for multiple 
PrAMPs that are intercepted by an inactivating oligopeptide linker, such as “RR-
EAEPEAEP” from Apis mellifera (Casteels et al., 1989; Casteels-Josson et al., 1993). 
Proteolytic cleavage sites at the N- and C-terminus of the linker liberate the peptide 
(Casteels et al., 1989; Casteels-Josson et al., 1993). Similar to single PrAMP coding 
mRNAs, the multi-coding messages harbor a pre- (~15-20 aa) and pro-sequence (~13-
16 aa) at the very beginning of the polypeptide (Casteels et al., 1989; Casteels-Josson 
et al., 1993). Noteworthy, the amino acid sequences of the PrAMPs encoded by the 
multi-peptide messages can vary significantly. In accordance, the multi-peptide 
activation mechanism leads to the liberation of different isoforms.  
 
1.4.2 Uptake pathway of PrAMPs 
 
The vast majority of antimicrobial peptides utilized by the innate immune system target 
the bacterial membrane and thereby facilitate lysis of the pathogenic cell (Brogden, 
2005). This contrasts with PrAMPs, which were shown to inhibit bacterial growth at low 
concentrations through a non-lytic mechanism (Casteels and Tempst, 1994; Castle et 
al., 1999; Otvos, 2002; Scocchi et al., 2011). At high concentrations, PrAMPs, such as 
Bac7, were reported to have lytic activity as well (Scocchi et al., 2011). Regardless, 
the utilization of a non-lytic mechanism of action initially raised the question of putative 
uptake pathways. Mutagenesis experiments led to the identification of two key players 
responsible for PrAMP uptake, namely SbmA (Mattiuzzo et al., 2007) and more 
recently MdtM (Krizsan et al., 2015b). While SbmA seems to be the major transporter 
for PrAMP uptake, the inner membrane protein MdtM seems to play just a minor role 
in antimicrobial peptide internalization (Krizsan et al., 2015b). The major transporter 
SbmA is a 46.5 kDa protein localized in the inner membrane of Gram-negative bacteria 
(Mattiuzzo et al., 2007). SbmA internalizes PrAMPs, as well as other antimicrobial 
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agents using an electrochemical proton gradient (Runti et al., 2013). Besides peptide 
uptake, the general function of SbmA remains elusive. Among Gram-negative bacteria 
homologs of SbmA can be found in Enterobacteriaceae, like Escherichia species and 
Salmonella species and Pseudomonadales, like Acinetobacter baumannii, as well as 
in a- and ε-proteobacteria, such as Neisseria meningitis and Campylobacter species, 
respectively (Graf et al., 2017b). 
 
1.4.3 Discovery of the intracellular target of PrAMPs 
 
Biochemical studies within the last 50 years led to a controversy about the primary 
intracellular target of PrAMPs. Although at first, translation was suggested as the 
putative target for PrAMP inhibition (Castle et al., 1999), co-immunoprecipitation 
experiments contradicted this theory and resulted in the identification of chaperone 
assisted folding as primary target for PrAMPs (Otvos et al., 2000). In the course of 
these investigations, biotinylated derivatives of pyrrhocoricin (Pyr), drosocin (Dro) and 
apidaecin (Api) analogs were purified with anti-biotin antibodies and observed to co-
purify with the chaperone DnaK (Otvos et al., 2000). In a similar fashion to 
pyrrhocoricin, drosocin and apidaecin, coupling of the N-terminal 35 amino acids of 
bactnecin-7 (Bac7) to 2-chlorotrityl resins also resulted in co-purification of DnaK 
(Scocchi et al., 2009). The direct visualization of PrAMP binding to DnaK was achieved 
using X-ray crystallography (Knappe et al., 2011b; Zahn et al., 2013; Zahn et al., 2014). 
PrAMPs were observed to bind to the cleft of DnaK, which represents the canonical 
binding site of DnaK substrates (Knappe et al., 2011b; Zahn et al., 2013; Zahn et al., 
2014). However, soon after structures of PrAMPs in complex with DnaK had been 
obtained reasonable doubts about the working concept were raised. Experiments with 
E. coli dnaK deletion strains resulted in susceptibilities comparable to wildtype E. coli 
strains (Krizsan et al., 2014; Scocchi et al., 2009). Therefore, co-immunoprecipitation 
experiments with labeled PrAMPs and E. coli lysate were used again to identify an 
alternative target. As result, ribosomes were determined as alternative binding sites 
for PrAMPs (Krizsan et al., 2014; Mardirossian et al., 2014). Subsequent binding 
assays, as well as in-vitro translation experiments, indicated that ribosomal protein 
synthesis is the primary process inhibited by PrAMPs (Krizsan et al., 2014; 
Mardirossian et al., 2014).  
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1.4.4 Determination of the ribosomal binding site of PrAMPs 
 
As consequence of the newly discovered ribosome binding and inhibition capacity of 
PrAMPs, it became interesting to resolve structures of 70S ribosomes in complex with 
different peptides and to determine the mode of action for each peptide. Thus, it 
remained elusive whether all PrAMPs bind in the same position and whether they 
exhibit the same mechanism of inhibition. The first PrAMP to be resolved on the 
bacterial ribosome was an oncocin (Onc) from milkweed bugs (Oncopeltus fasciatus) 
(Roy et al., 2015; Seefeldt et al., 2015), followed by bactenecin-7 (Bac7) from cows 
(Bos taurus), metalnikowin (Met) from the green shield bug (Palomena prasina) and 
pyrrhocoricin (Pyr) from the firebug (Pyrrhocoris apterus) (Gagnon et al., 2016; 
Seefeldt et al., 2016). The latest resolved structures of PrAMPs are Api137 from the 
honey bee (Apis mellifera) (Florin et al., 2017) and Tur1A from bottlenose dolphins 
(Tursiops truncates) (Mardirossian et al., 2018). The only structure resolved by cryo-
EM is a Api137 containing 70S ribosomal complex (Florin et al., 2017).  
All PrAMPs were found to bind to the polypeptide tunnel in an extended 
conformation, which overlaps with the path of a nascent chain (Florin et al., 2017; 
Gagnon et al., 2016; Mardirossian et al., 2018; Roy et al., 2015; Seefeldt et al., 2016; 
Seefeldt et al., 2015). The extended conformation probably results from the high-
content of arginine residues in combination with trans-proline (Graf et al., 2017b). As 
shown by the structural studies, binding of PrAMPs involves a series of polar contacts, 
as well as stacking interactions between the peptide and the ribosome (Graf et al., 
2017b). Interactions of Bac7 and Tur1A with the ribosome predominantly involve 
arginine side chains (Gagnon et al., 2016; Mardirossian et al., 2018; Seefeldt et al., 
2016). Nonetheless, the primary difference between all PrAMPs resides within the 
mode of action, as well as the binding orientation. Accordingly, the N-terminus of class 
I PrAMPs is situated within the A-site binding pocket, whereas the C-terminus reaches 
down the polypeptide exit tunnel. Compared to a nascent chain, class I PrAMPs bind 
with an opposite orientation. This contrasts with the class II PrAMP Api137, which 
binds to the polypeptide exit tunnel with a similar orientation to a nascent chain. The 
N-terminus of Api137 is situated deeper in the tunnel and the C-terminus reaches into 
the PTC but not further into the A-site binding pocket. In general, PrAMP residues 
buried in the polypeptide tunnel are less crucial for antimicrobial activity than the 
residues in the PTC or A-site binding pocket. The termini located in the A-site 
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distinguish the mode of action. Consistently, the N-terminal residues of class I PrAMPs, 
located in the A-site binding pocket, inhibit the transition from translation initiation to 
translation elongation by sterically overlapping with an accommodated A-tRNA. Class 
II PrAMPs specifically inhibit translation termination by establishing interactions with 
deacyl-P-tRNA and RF1 (see discussion).  
Objectives of these studies 41 
2 Objectives of these studies 
 
Class II release factor RF3 (Publication 1) 
The class I release factors RF1 and RF2 mediate the release of a nascent polypeptide 
from the 70S ribosome upon stop codon selection. Recycling of RF1 and RF2 from the 
70S ribosome is mediated by the class II release factor RF3. Dissociation of RF1 or 
RF2 is presumably the result of SSU rotation, which is induced through RF3 binding. 
Although structural data on RF3-bound 70S ribosomes are available, the exact series 
of events and interactions, which ultimately lead to dissociation of RF1 and RF2 from 
the ribosomes, remain partially obscure. Especially intermediate states that harbor 
RF1, RF3 and deacyl-tRNA simultaneously are highly interesting to understand the 
exact mechanism of RF3 action. The aim of this work is to obtain high resolution 
structures of intermediate states of RF3-mediated recycling, which contain (besides 
RF3) RF1 and tRNA. Intermediate states will give insights into the changing 
interactions between the ribosome, tRNA, RF1 and RF3. Further it may become clear 
whether RF3 undergoes conformational changes and how RF3 exactly drives rotation 
of the SSU.  
 
Chloroplast ribosomes (Publication 2) 
Chloroplast 70S ribosomes are characterized by an increased ratio of protein to rRNA 
residues. Consistently, chlororibosomes harbor compared to Escherichia coli 70S 
ribosomes numerous additional protein extension and six plastid specific ribosomal 
proteins (PSRPs). With regard to rRNA residues, although the total number of 
nucleotides stayed approximately the same, chlororibosomes exhibit numerous rRNA 
deletions and insertions. However, older biochemical analysis allowed the rough 
assignment of PSRPs to the LSU (PSRP5 and PSRP6) and the SSU (PSRP1 to 
PSRP4). The precise localization of protein extensions and PSRPs requires structural 
data. While the binding position of PSRP1 has been determined before in a 9.4 Å low 
resolution structure, the exact binding position of PSRP2 to PSRP5 remained partially 
elusive. The aim of this work is the determination of a higher resolution structure of the 
chlororibosome, which allows the unambiguous localization of protein and rRNA 
alterations. Knowing the resulting structural features will help to understand how the 
chlororibosome satisfies special functional requirements within chloroplasts.   
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Proline-rich antimicrobial peptides (Publication 3, 4, 5 and 6) 
The continuously rising numbers of bacterial strains showing resistances towards 
numerous clinically relevant antibiotics, increases the demand for the discovery of new 
potent compounds. Antimicrobial peptides (AMPs) constitute one promising source. 
Antimicrobial peptides are produced by the innate immune system of higher 
eukaryotes in response to a wide range of bacteria to prevent the establishment of an 
infection. Proline-rich antimicrobial peptides represent a subclass of antimicrobial 
peptides, which are enriched in Pro and Arg residues. Despite original description of 
DnaK as major target for PrAMPs, more recently ribosomes were identified as primary 
target for inhibition. The aim of this works is the reconstruction of high-resolution 
complexes of 70S ribosomes together with different PrAMPs. The obtained complexes 
will allow the identification of the ribosomal binding site of PrAMPs and the 
determination of the mechanism of action, which leads to protein synthesis inhibition. 
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3 Cumulative thesis: Summary of publications 
 
3.1 Publication 1 - Visualization of translation termination 
intermediates during RF3-mediated recycling of RF1 
 
Graf, M., Huter, P., Maracci, C., Peterek, M., Rodnina, M.V. and Wilson, D.N. 
 
Nature Communications. (2018) (accepted) 
 
 
When the translation machinery encounters an UAA, UAG or UGA stop codon, the 
polymerized polypeptide chain is released from the 70S ribosome. Decoding of stop 
codons occurs through class I release factors RF1 and RF2. After peptide chain 
release, RF1 and RF2 are dissociated from the ribosome by the action of class II 
release factor RF3. The mechanism by which the decoding factors are recycled from 
the ribosome by RF3 has remained partially elusive. Previous higher resolution 
structural studies reported 70S ribosomes in complex with RF3, but in absence of RF1 
or RF2 (Gao et al., 2007; Jin et al., 2011; Klaholz et al., 2004; Zhou et al., 2012b). The 
authors suggested a rotation-based recycling of RF1 by RF3. Accordingly, RF3 was 
observed to induce SSU body/platform rotation of up to 10° and up to 4° swiveling of 
the SSU head. This ultimately leads to formation of R-state ribosomes with P/E hybrid-
state deacyl-tRNA. 
  We obtained five reconstructions of 70S-bound RF3 using the antimicrobial 
peptide Api137 with resolutions ranging from 3.8 to 4.4 Å. On the basis of four of these 
reconstructions, which presumably represent intermediate states of RF3-mediated 
RF1 recycling, we describe an improved model for the mechanism of RF3 action. The 
four intermediates, which harbor RF1 and RF3, show different degrees of SSU rotation 
and SSU head swivel. Strikingly, this is the first time an R-state 70S ribosome was 
observed in complex with RF1. As suggested by previous studies, ejection of RF1/2 
correlates with the progress of SSU rotational movement. In our obtained structures, 
we observe destabilization of RF1 binding with ribosomes that adopt fully rotated 
states. Moreover, we suggest that RF3 GTPase activation is the result of a previously 
unobserved rotational accommodation of the RF3 G-domain on the sarcin-ricin loop. 
In general, RF3-induced SSU rotation fulfills a dual function. First, SSU rotation leads 
to disengagement of RF1/2 domain II and III from the ribosomal DC and PTC, 
respectively and second, it contributes to GTPase activation of RF3, which is thought 
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to be required for RF3 dissociation. Besides RF3-induced SSU rotation we observe a 
new P-tRNA state. This new tRNA state seems to be a secondary effect of the RF3-
induced movement. The tRNA, termed Pint-tRNA, exhibits an unusual Watson-Crick 
base-pairing with the P-loop of the 23S rRNA. The Pint-tRNA CCA-end is shifted by 10 
Å outward the PTC. C75, as well as A76 are observed to base-pair with G2253 and 
G2252. P-loop interactions normally involve contacts of nucleotides G2252 and G2251 
with tRNA nucleotides C75 and A76, respectively. The relevance of this state is not 
clear, but presumably represents an intermediate tRNA conformation previous to the 
formation of P/E tRNAs. 
In accordance to a previous low-resolution cryo-EM study (Pallesen et al., 2013) 
we observe interactions of one copy of L7/L12 with RF3. Maps filtered to 7 Å allowed 
us the assignment of an ‘arc’-like density to the CTD of L7/L12 next to the G’-domain 
of RF3. Strikingly, we observed another density in our 7 Å filtered maps, which we 
could assign to a second CTD of an L7/L12 dimer. The second CTD seems to facilitate 
recruitment of RF1 via domain I. To our knowledge, this is the first example of the 
recruitment of a translation factor without GTPase activity by L7/L12 to the Escherichia 
coli 70S ribosome.  
 
3.2 Publication 2 - Cryo-EM structure of the spinach chloroplast 
ribosome reveals the location of plastid-specific ribosomal 
proteins and extensions 
 
Graf, M., Arenz, S., Huter, P., Donhofer, A., Novacek, J., and Wilson, D.N. 
 
Nucleic Acids Research. 45, 2887-2896. (2017) 
 
 
Chloroplasts are the result of an endosymbiotic event billion years ago and are crucial 
for carbon fixation in plants. The proteins involved in photosynthesis as well as other 
required proteins inside the organelle are produced by specialized chlororibosomes, 
which are similar to eubacterial 70S ribosomes. As shown by initial biochemical studies 
the major differences between Escherichia coli 70S ribosomes and chlororibosomes is 
an increased ratio of protein to rRNA (Yamaguchi and Subramanian, 2000, 2003; 
Yamaguchi et al., 2000). While the number of rRNA residues stayed approximately the 
same, chloroplast ribosomes acquired plastid-specific ribosomal proteins (PSRPs), as 
well as N- and C-terminal extensions within ribosomal proteins. The only significant 
loss in protein mass represents the absence of ribosomal proteins L25 and L30. With 
Cumulative thesis: Summary of publications 45 
respect to the rRNA, chloroplast ribosomes harbor, compared to E. coli, numerous 
additions and deletions of rRNA residues. The most obvious difference is the existence 
of a 4.8S rRNA that is the result of a 3’ fragmentation of the chloroplast 23S rRNA.   
Although lower resolution structures of these chlororibosomes at 9.4 Å exist 
(Sharma et al., 2007), no higher resolution structures were available that allow 
placement of all plastid-specific ribosomal proteins and the identification of N- and C-
terminal extensions of chloroplast ribosomal proteins. We provide a 3.6 Å 
reconstruction of the large subunit and a 5.4 Å reconstruction of the small subunit. The 
resolution of the LSU allowed us to generate a molecular model that contains 2961 
rRNA residues out of 3035 (98%) and 3422 amino acids of r-proteins out of 5036 
(68%). The LSU model helps to visualize alterations in rRNA and proteins residues. 
We observe the absence of L25 and L30 and the presence of additional densities, 
which account for chlororibosome-specific protein residues. Consistently, we were 
able to unambiguously localize the binding sites for PSRP5 and PSRP6 on the LSU. 
Despite low resolution of the SSU, we were further able to assign densities to PSRP1 
and PSRP4. With respect to other ribosomal proteins, we managed to identify and 
model protein extensions of LSU ribosomal proteins. The extensions are involved in 
reshaping the chlororibosome structure. We suggest that reshaping allows the 
ribosome to cope with the altered functional requirements inside the chloroplast. The 
extensions stabilize the differing rRNA network and provide additional contacts with 
the surrounding. This possibly allows improved interactions with the reduced signal 
recognition particle (SRP), which only harbors the protein component SRP54. 
Furthermore, we suggest that a large conglomerate of NTEs/CTEs of cpL13, cpL21 
and cpL22 provides an extended surface for interactions with the thylakoid membrane.  
 
3.3 Publication 3 - The proline-rich antimicrobial peptide Onc112 
inhibits translation by blocking and destabilizing the initiation 
complex 
 
Seefeldt, A.C.*, Nguyen, F.*, Antunes, S.*, Perebaskine, N., Graf, M., Arenz, 
S., Inampudi, K.K., Douat, C., Guichard, G., Wilson, D.N. 
 
Nature Structural & Molecular Biology. 22, 470-475. (2015) 
 
 
Although PrAMPs, such as oncocins, were initially suggested to inhibit DnaK (Otvos et 
al., 2000), it was shown more recently that Escherichia coli dnaK deletion strains 
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remain susceptible to PrAMPs (Krizsan et al., 2014; Mardirossian et al., 2014). This 
led to the identification of ribosomes as an alternative target for PrAMP action. The 
lack of newly discovered antimicrobials combined with the increasing number of 
bacteria which are resistant to antibiotics, make PrAMPs attractive lead compounds 
for future medicine. To elucidate the actual binding site of PrAMPs, the X-ray structure 
of Onc112, a 19 aa long derivative of oncocin, was resolved in complex with Thermus 
thermophilus 70S ribosomes and an fMet-tRNAfMet at a resolution of 3.1 Å. The 
structure shows that Onc112 binds within the nascent polypeptide exit tunnel (NPET), 
overlapping with the path of a nascent chain. Unlike a nascent chain, PrAMP Onc112 
binds with a reverse orientation to the upper NPET. The N-terminus is located at the 
PTC in the ribosomal A-site and the C-terminal residues reach deeper into the NPET. 
Binding in general is facilitated by an extensive hydrogen bonding network and several 
stacking interactions, which are established with the surrounding rRNA residues of the 
NPET.  With respect to the mechanism of inhibition, we observe that the C-terminal 
residues are predominantly important for stable binding and uptake of Onc112. 
Consistently, our biochemical data show that Onc112 derivatives with C-terminal 
deletions exhibit reduced antimicrobial activity in vitro but no activity in vivo. The N-
terminal residues that reach into the ribosomal A-site are crucial for translation 
inhibition. Superimposition of the N-terminal residues with an accommodated pre-
attack A-site tRNA show a severe steric hindrance, which presumably prevents 
coexistence of Onc112 and A-tRNA on the 70S ribosome. Thus, delivery of an aa-
tRNA by EF-Tu is presumably possible, but the subsequent accommodation into the 
ribosomal A-site is excluded. In contrast, a tRNA bound to the ribosomal P-site, 
carrying a single or no amino acid, does not clash with 70S-bound Onc112. As shown 
by in vitro toe-print assays, the steric clash, generated between the 3’-end of an 
accommodated A-tRNA and the N-terminal residues of Onc112, results in stalling and 
destabilization of the 70S ribosome at the AUG initiation site of an open-reading frame 
(ORF). Because inhibition of protein synthesis requires in vivo import of PrAMPs into 
the cytoplasm of a bacterial cell, we further validated the pathway of Onc112 uptake 
via the transporter SbmA. In accordance, in vivo cell-culture experiments with E. coli 
sbmA deletion strains show that efficient uptake and inhibition of Onc112 is perturbed 
in absence of the transporter SbmA.  
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3.4 Publication 4 - Structure of the mammalian antimicrobial 
peptide Bac7(1-16) bound within the exit tunnel of a bacterial 
ribosome 
 
Seefeldt, A.C.*, Graf, M.*, Perebaskine, N., Nguyen, F., Arenz, S., Mardirossian, 
M., Scocchi, M., Wilson, D.N., and Innis, C.A. 
 
Nucleic Acids Research. 44, 2429-2438. (2016) 
 
 
The proline-rich antimicrobial peptide Onc112 was shown to bind to the nascent 
polypeptide exit tunnel (NPET) (Roy et al., 2015; Seefeldt et al., 2015). For other 
antimicrobial peptides, such as mammalian bactenecins, the ribosomal binding site 
remained obscure. Sequence alignments of Onc112 with mammalian bactenecin-7 
(Bac7) as well as insect metalnikowin and pyrrhocoricin indicate similarities, which 
imply binding at the same location as reported before. To investigate the binding 
location of other PrAMPs, we obtained three X-ray structures of Bac7, metalnikowin 
and pyrrhocoricin in complex with Thermus thermophilus 70S ribosomes and fMet-
tRNAfMet. In general, binding and inhibition of the peptides presented in this study is 
very similar to Onc112. The PrAMPs Bac7, metalnikowin and pyrrhocoricin bind to the 
NPET and overlap with the path of a nascent chain. Binding of PrAMPs involves both 
polar contacts and stacking interactions. Due to the higher content in arginine residues, 
contacts of Bac7 with the surrounding rRNA residues primarily involve the side chains 
of the arginine residues. The N-terminal residues of all peptides are situated within the 
ribosomal A-site and the C-terminal residues reach down the NPET. The N-terminal 
residues are relevant for antimicrobial activity and the C-terminal residues are 
presumably more crucial for uptake. Binding of Bac7 derivatives to the NPET was 
validated in competition assays with the macrolide erythromycin (Ery), which binds to 
the NPET and hence clashes with the path of PrAMPs. Our data show that Bac7 
derivatives compete with Ery present in the NPET for ribosome binding. When 
comparing the structure of all our resolved PrAMPs, the most significant difference is 
observed for the N-terminus. In comparison to Onc112, metalnikowin and 
pyrrhocoricin, Bac7 harbors four additional amino acids at the N-terminus, which form 
a short loop that reaches deeper into the A-site binding pocket. Independent of the 
number of N-terminal residues, all resolved PrAMPs are incompatible with the CCA-
end of an accommodated A-site tRNA but allow binding of tRNA in the P-site. 
Accordingly, toe-print assays show that PrAMPs inhibit 70S initiation complexes at the 
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AUG start site of an open reading frame and do not allow further transition to translation 
elongation. This is consistent with the previously described model of inhibition by 
Onc112. Interestingly, in vitro translation assays with rabbit reticulocyte extract show 
that PrAMPs do not exclusively inhibit bacterial translation. Accordingly, our data 
indicate that Bac7 can inhibit eukaryotic translation as well. Nonetheless, based on the 
model of Bac7 synthesis, targeting and inhibition, we hypothesize that inhibition of 
translation within PrAMP producing cells is not possible because PrAMPs are 
produced by cells of the innate immune system as inactive precursors that are targeted 
to large granules and thus cannot harm ribosomes of the producing cell. Upon bacterial 
infection the inactive precursors are released from the large granules into the extra-
cellular space and activated by protease cleavage. The proteases are stored 
separately in azurophil granules and released together with precursor PrAMPs during 
the establishment of an infection.  
 
3.5 Publication 5 - Proline-rich antimicrobial peptides targeting 
protein synthesis  
 
Graf, M.*, Mardirossian, M.*, Nguyen, F., Seefeldt*, A.C., Guichard, G., Scocchi, 
M., Innis, C.A., and Wilson, D.N. 
 
Natural Product Reports. 34, 702-711. (2017) 
 
 
The innate immune system of higher eukaryotes utilizes a broad spectrum of 
antimicrobial agents to prevent infection by pathogens. One group of agents, identified 
in some mammals and insects, are the proline-rich antimicrobial peptides (PrAMPs). 
As shown by recent biochemical and structural studies, PrAMPs inhibit protein 
synthesis by binding to the nascent polypeptide exit tunnel and obstructing of the A-
site binding pocket. In this review, we compare the recently obtained structures of 
Onc112, Bac7, metalnikowin and pyrrhocoricin in complex with Thermus thermophilus 
70S ribosomes (Gagnon et al., 2016; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt 
et al., 2015) and summarize the current concepts of PrAMP synthesis, targeting and 
inhibition. In general, PrAMPs are synthesized as inactive precursors by cells of the 
innate immune system. In the presence of a pathogen the inactive precursors are 
secreted into extracellular space or pathogen-containing phagosomes and activated 
by protease cleavage. In general, a single-peptide activation mechanism can be 
distinguished from multi-peptide activation mechanism. Import of PrAMPs is 
Cumulative thesis: Summary of publications 49 
predominantly facilitated by the SbmA transporter (Mattiuzzo et al., 2007) and to a 
lesser extent by the MdtM transporter (Krizsan et al., 2015a). Once bound to the 
nascent polypeptide exit tunnel, the path of PrAMPs overlaps with the path of a nascent 
chain. However, in contrast to a nascent chain, PrAMPs bind in an inverted orientation 
to the tunnel. Consistently, the N-terminal residues are located in the A-site binding 
pocket and the C-terminal residues are located in the upper polypeptide exit tunnel. 
Biochemical studies have shown that the N-terminal residues are crucial for protein 
synthesis inhibition and the C-terminal residues are thought to be important for the 
import of PrAMPs. Inhibition of protein synthesis by the N-terminal residues results in 
inhibition of 70S initiation complexes at the AUG start site with fMet-tRNAfMet bound in 
the P-site. 
 
3.6 Publication 6 - An antimicrobial peptide that inhibits translation 
by trapping release factors on the ribosome 
 
Florin, T.*, Maracci, C.*, Graf, M.*, Karki, P., Klepacki, D., Berninghausen, O., 
Beckmann, R., Vazquez-Laslop, N., Wilson, D.N., Rodnina, M.V., Mankin, A.S. 
 
Nature Structural & Molecular Biology. 24, 752-757. (2017) 
 
 
Proline-rich antimicrobial peptides (PrAMPs) constitute tools of the innate immune 
system to fight invading bacteria. Previous structural and biochemical studies showed 
that PrAMPs, such as Onc112, pyrrhocoricin, metalnikowin and Bac7, inhibit protein 
synthesis by binding to the nascent polypeptide exit tunnel (NPET) of eubacterial 70S 
ribosomes and blocking of the transition from translation initiation to translation 
elongation (Gagnon et al., 2016; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et al., 
2015). Contrasting these initial studies, we describe that Api137, a derivate of the 
naturally occurring PrAMP apidaecin, inhibits protein synthesis by an alternative 
mechanism i.e. by trapping RF1 on a terminating 70S ribosome. To our knowledge, 
this is the first description of a compound that specifically inhibits translation 
termination. To determine the exact binding site, we resolved the structure of Api137 
in complex with Escherichia coli 70S ribosomes by cryo-EM and performed 
biochemical protection assays. The reconstruction of the 70S ribosome exhibited an 
average resolution of ~3.4 Å. Like other previously reported PrAMPs, we observe 
binding of Api137 to the NPET. The path of Api137 overlaps with the path of a nascent 
chain. Contrasting Onc112, Bac7, metalnikowin and pyrrhocoricin, Api137 binds in a 
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similar orientation to a nascent polypeptide. The N-terminal residues are situated in 
the upper NPET and the C-terminal residues reach into the PTC, but not further into 
the A-site binding pocket. Binding and inhibition involves hydrogen bonding, as well as 
stacking interactions within the NPET. Trapping of RF1 is the result of specific 
interactions of the C-terminal Arg17 of Api137 with 23S rRNA residues and the 
conserved GGQ-motif of RF1. Furthermore, we observe interactions of Leu18 with the 
deacyl-tRNA present in the P-site of the E. coli 70S ribosome. However, trapping of 
RF1 on the 70S ribosome is only the primary effect of Api137 inhibition. The secondary 
effect, which contributes to the inhibition of bacterial growth in vivo, is the depletion of 
the pool of class I release factors that are available for translation termination. As a 
consequence, we observe in biochemical assays accumulation of 70S ribosomes 
harboring peptidyl-tRNAs and stop codon read-through.  
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4 Discussion 
 
4.1 Chloroplast ribosomes 
 
Our structural studies provide deeper insights into the structure of the chloroplast 
ribosome. In general, the most pronounced differences between bacterial ribosomes 
and chlororibosomes are the absence of L25 and L30, as well as the presence of 
plastid specific ribosomal proteins (PSRPs) 1-6, protein extensions (internal insertions 
and N-/C-terminal extensions) (Yamaguchi and Subramanian, 2000, 2003; Yamaguchi 
et al., 2000) and a 4.8S rRNA, which is the result of a 3’ fragmentation of the chloroplast 
23S rRNA. In our cryo-EM studies the LSU was resolved with resolutions reaching up 
to 3.6 Å and the SSU was resolved with resolutions up to 5.4 Å. The well-resolved LSU 
allowed us to determine the binding site of PSRP5 and PSRP6 with side chain 
accuracy. We identified PSRP5 as an elongated protein with a long N-terminal a-helix 
that contacts H58 and a shorter C-terminal a-helix, which establishes contacts with 
H49. PSRP6 exhibits a long-extended conformation as well and is situated near the 
central protuberance. The N-terminal fraction of PSRP6 exhibits two short a-helices, 
which interact with H40, H41 and H89. The C-terminal fraction provides a b-strand to 
protein L21. In general, the placement of PSRP5 and PSRP6 is in good agreement 
with other reconstructions published around the same time (Ahmed et al., 2017; 
Ahmed et al., 2016; Bieri et al., 2017). One exception was that Ahmed and colleagues 
placed PSRP5 with an inverted orientation (Ahmed et al., 2016) compared to us. 
Nonetheless, sidechain information in our map as well as secondary structure 
predictions and the released chlororibosome model by Bieri and colleagues gave us 
confidence that PSRP5 was modeled correctly in our model and with the correct 
orientation. Secondary structure predictions anticipated the presence of a short helix 
at the C-terminus and a long helix at the N-terminus. PSRP6 was modelled in all 
published models in a similar orientation and with no register shifts (Ahmed et al., 2017; 
Ahmed et al., 2016; Bieri et al., 2017).  
However, in contrast to the other chlororibosome structures (Ahmed et al., 2017; 
Bieri et al., 2017), which provided higher resolutions for the SSU, we were only able to 
roughly assign the locations of PSRP1-4 on the SSU. Consistently, on the SSU 
unassigned densities were identified by us at the head, at the neck of the SSU between 
head and platform and at the spur. At the SSU neck two unassigned densities were 
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identified. The smaller density in this region was not observed in any of the other 
chlororibosome cryo-EM structures (Ahmed et al., 2017; Bieri et al., 2017). Thus, it is 
possible that this density is a map artifact, resulting from the low resolution of the SSU. 
The second bigger density observed in the neck region was assigned to PSRP1. The 
assignment of the density to PSRP1 was based on secondary structure features and 
is in agreement with initial low-resolution cryo-EM reconstructions by Sharma and 
colleagues (Sharma et al., 2007) as well as more recent models by Bieri et al. and 
Ahmed et al. (Ahmed et al., 2017; Bieri et al., 2017). The other two densities observed 
at the SSU head and spur did not show clear secondary structure features. The density 
at the spur reaches from 16S rRNA helix h6 to h10 and exhibits a long dumbbell shape. 
In accordance to Ahmed and colleagues, this density presumably belongs to full-length 
PSRP2 (Ahmed et al., 2017). The density at the SSU head was assigned by us to 
PSRP4 (bTHXc) and is consistent with the position of the T. thermophilus protein bTHX 
(Wimberly et al., 2000), which has high sequence similarity to PSRP4. As described 
by others (Ahmed et al., 2017; Bieri et al., 2017), PSRP4 is presumably responsible 
for stabilization of the head region and the establishment of contacts with intersubunit 
bridges B1a and B1b. However, we did not observe additional densities, which can be 
assigned to PSRP3, neither at the mRNA tunnel entry, nor somewhere else on the 
SSU.  
In addition to PSRP1-6, we managed to model numerous differences in the 
chlororibosome ribosomal proteins compared to E. coli ribosomal proteins (Graf et al., 
2017a). More than five residues of N- and/or C-terminal extensions have been 
modelled for L13, L15, L21, L22, L24, L27, L29 and L34. An insertion was modelled 
for protein L33. Protein deletions were observed and modelled for L2, L19 and L23. 
The alterations of the ribosomal proteins reshape the chlororibosome and presumably 
result in differences in translation activity. The most striking examples for the 
stabilization of the rRNA by protein extensions were observed by us for the NTE of 
LSU protein L13 and the CTE of L27. Consistent with the other reported structures of 
chlororibosomes, the NTE of L13 stabilizes the 5’-end of the 4.8S rRNA and the 3’ of 
the truncated 23S rRNA (Ahmed et al., 2017; Ahmed et al., 2016; Bieri et al., 2017; 
Graf et al., 2017a). Moreover, we report that the CTE of L27 allows stabilization of a 
three-way junction of H38 (Graf et al., 2017a). In general, functional reshaping of the 
chloroplast ribosome was observed especially at the surface of the LSU (Ahmed et al., 
2017; Ahmed et al., 2016; Bieri et al., 2017; Graf et al., 2017a). Accordingly, N-terminal 
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and C-terminal extensions L23, L24 and L29 reshape the ribosomal exit tunnel. 
Reshaping of the polypeptide exit tunnel presumably represents an adaption to the 
structural reduction of chloroplast SRP, which is crucial for targeting of the 70S 
ribosome to the thylakoid membrane. In contrast to E. coli SRP, which consists of a 
4.5S RNA and protein SRP54, chloroplast SRP just exhibits the protein component. 
The protein extension of L23, L24 and L29 presumably provide additional contacts for 
SRP54 that allow targeting of the ribosome to the membrane. Additional contacts with 
the membrane are potentially provided by the NTEs of L13 and L21 as well as the CTE 
of protein L22, which build an extensive conglomerate (Graf et al., 2017a).  
 Overall it was possible for us to model more than 75% of the extensions of LSU 
proteins visible in our structure. Modelling of more residues was not possible due to 
the lack of resolution and intrinsic flexibilities within the extension. The residues, which 
were not modelled, are possibly involved in targeting processes and are just stabilized 
in presence of additional factors.  
 
4.2 Class I release factor recycling by RF3 
 
RF1/2 recycling by RF3 
 
The translational GTPase RF3 recycles class I release factors from post-hydrolysis 
ribosomes. To date, there have been five structural studies published that have 
investigated the mechanism of RF3 action on the bacterial 70S ribosome (Gao et al., 
2007; Jin et al., 2011; Klaholz et al., 2004; Pallesen et al., 2013; Zhou et al., 2012b). 
All of the higher resolution structural studies elucidating the mechanism of class I 
release factor recycling by RF3 do not provide information on simultaneous binding of 
RF1 and RF3 (Jin et al., 2011; Zhou et al., 2012b). The only existing structural study 
on RF1 and (apo-) RF3 is a low-resolution reconstruction and thus does not provide 
much structural as well as mechanistic insight into RF3 action (Pallesen et al., 2013). 
Furthermore, it is not clear how physiologically relevant the binding of apo-RF3 is for 
the process of RF1/2 recycling (Adio et al., 2018; Koutmou et al., 2014). However, 
common to the higher resolution RF3-70S structures is that the SSU is rotated by up 
to 9° and the head is swiveled by up to 14° (Jin et al., 2011; Zhou et al., 2012b). No 
rotation was observed for the low-resolution reconstruction harboring RF1 and RF3 
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(Pallesen et al., 2013). None of the previously reported structures show intermediate 
states of RF3 action and dissociation of class I release factors from the ribosome.  
Utilizing Api137, a termination specific translation inhibitor (see section 4.3) 
(Florin et al., 2017), it was possible for us to in vitro reconstitute a termination complex 
consisting of E. coli 70S ribosome, P-tRNA and RF1-GAQ decoding a UAA stop codon. 
By further addition of RF3-GDPCP to this complex and subsequent cryo-EM analysis 
it was possible for us to obtain five different reconstructions containing RF3. The 
overall resolution reached from 3.8 Å to 4.4 Å. The reconstructions provide new 
insights into the recycling process of RF1 by RF3. Reconstruction I to IV presumably 
represent intermediate states, which harbor RF1, P-tRNA and RF3 simultaneously 
(Figure 9A). These states show different degrees of SSU rotation and head swivel. The 
fifth reconstruction constitutes a rotated 70S complex that solely harbors RF3 and no 
other factor (RF3-only). The latter complex presumably represents empty 70S 
ribosomes, which are suitable for RF3 binding but do not constitute the actual substrate 
for recycling. Release of deacyl-tRNA from the ribosome occurs after RRF and EF-G 
facilitated 70S recycling by IF3 (Prabhakar et al., 2017). Although RF3 shows high 
affinity to 70S ribosomes, independent of the presence of other ligands, it exhibits no 
splitting activity and does not remove tRNAs from the ribosomal complex. Hence, the 
other four complexes are likely to represent more physiological states of RF3-mediated 
recycling.  
  Due to the proposed model of RF3 induced SSU rotation, which leads to RF1/2 
disengagement from the terminating ribosome, we suggest that the degree of head 
swivel and SSU rotation corresponds to the stage of RF3-mediated recycling. 
Accordingly, each state most likely represents snapshots of SSU movement during 
RF3 action. The SSU rotation ranges from 0.8° in the first state and 9.6° in the fourth 
state. The observed head swivel is rather mild and ranges from 1.1° in state I to 3.6° 
in state IV. In the RF3-only state, SSU rotation of 8.2° was observed and head swivel 
of 5.7°. The observed head swivel in state I to IV is limited compared to RF3-only 
ribosomes, because of the presence of tRNA. This is also consistent with the 
previously described X-ray structure of a 70S-RF3 complex containing P/E-tRNA, 
which showed a milder head swivel of 4° (Jin et al., 2011). In contrast, the RF3-only 
structure shows similar to the previously reported 70S-RF3 complex, which is lacking 
tRNA, stronger swiveling (Zhou et al., 2012b). Noteworthy, the head swivel observed 
for our RF3-only state represents an average value of several head conformations. 
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Thus, the maximum degree of head swivel is most likely higher than 5.7° and therefore 
in good agreement with the strong head swivel of up to 14° observed by others in 
absence of tRNA (Zhou et al., 2012b). Regardless, state IV, which shows 9.6° of SSU 
rotation and 3.6° of head swivel, we consider as fully rotated ribosomes.  
As described by previous structural studies, RF3 interacts with h5, h15 and S12 
(Figure 9B) (Jin et al., 2011; Zhou et al., 2012b). The contacts are maintained by RF3 
through-out the recycling process and independent of the degree of SSU rotation. 
Contrasting previously proposed models (Klaholz et al., 2004), RF3 does not undergo 
large conformational changes and rather moves as rigid body with the SSU. Consistent 
with the degree of SSU rotation, RF3 rotates by 9° relatively to the LSU (Figure 9C). 
This equals a movement of 10 to 11 Å (Figure 9C). Interestingly, there seem to be no 
major interactions of RF3 with the LSU. The only direct interaction of RF3 with the LSU 
was observed by us in state I and involves switch I of RF3, which is crucial for GTP 
Figure 9 – Class I release factor recycling by RF3. (A) Overview of the 70S ribosome bound with RF3 
(cyan), RF1 (orange) and deacyl-P-tRNA (pale green). Binding of RF3 to the ribosome involves 
interactions with SSU protein S12 (dark salmon), h5 and h15 (both in yellow). The SRL (grey with black 
outline), which is crucial for GTP hydrolysis of translational GTPases, is shown on the LSU (grey). (B) 
Zoom of (A) showing the interactions of RF3 (cyan) domain II and III with the SSU (yellow) via h5 and 
h15, as well as protein S12 (dark salmon). (C) Movement of RF3, which results from SSU rotation 
relatively to the LSU. RF3 moves as rigid body and approaches the SRL (grey). The position of RF3 
upon initial binding is shown faint. The position of RF3 at later stages is shown in cyan. The position of 
the domains are indicated next to RF3 in black letters. (D) Model of a previously unobserved 
conformation of switch I (dark blue) within the G-domain of RF3 (cyan). Switch I contacts LSU proteins 
L14 (dark green) and L19 (purple). Switch II (teal) within the G-domain of RF3 and the SRL (grey) are 
shown for reference. (E) Model of RF3 action. The LSU is shown in grey and the SSU is show in yellow. 
RF1 (orange) releases the polymerized peptide chain from the P-tRNA (green). RF3 (cyan) binds to 
post-hydrolysis complexes and induces SSU rotation. SSU rotation leads to release of RF1 and 
accommodation of RF3 on the LSU. At a maximum rotation of 9.6° the G-domain of RF3 comes in close 
proximity to the SRL (black contoured helix). This presumably triggers GTP hydrolysis and RF3 release. 
RRF binds after RF1 and RF3 release to rotated 70S ribosomes harboring P/E hybrid state tRNA. 
Together with EF-G RRF splits the ribosome into subunits. 
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hydrolysis (Figure 9D). In this state switch I adopts a previously unobserved extended 
conformation with a short helical section that comes into close proximity of L14 and 
L19 (Figure 9D). This interaction with the LSU is possibly involved in creating a force 
that drives SSU rotation. Furthermore, the extended conformation possibly prevents 
backward rotation of the ribosome to an N-state and premature GTP-hydrolysis, since 
breakdown of GTP to GDP and Pi requires a closed conformation of switch I. The 
closed conformation was previously observed in the 70S-RF3 X-ray structure by Zhou 
and colleagues (Zhou et al., 2012b) but not in any of our states. This possibly indicates 
that further SSU rotation has to be applied to the 70S ribosome in order to adopt a 
closed switch I conformation. Nonetheless, much further movement beyond 10° SSU 
rotation is not possible due to steric constraints created by domain I of RF3 and the 
LSU. This steric block created by the LSU results in ‘wedging’ of RF3 and the SRL. 
Consistently, state IV comes into close proximity of the SRL. Further movement 
towards the SRL presumably leads to switch I closure and rearrangement of the 
catalytic His92 (Zhou et al., 2012b). It is still not entirely clear whether GTP hydrolysis 
precedes RF1 release and whether RF3 can possibly dissociate (prematurely) before 
RF1 recycling took place. Accordingly, biophysical studies by Adio and colleagues 
suggest that dissociation of RF1 and RF3 is rather random (Adio et al., 2018). In our 
studies, the presence of a non-hydrolysable GTP-analog prevents the observation of 
subsequent processes that occur because of GTP hydrolysis. Therefore, we cannot 
exclude the existence of a checkpoint that prevents premature GTP hydrolysis and 
release of RF3 before successful RF1/2 liberation. Regardless, the general 
mechanism leading to GTP hydrolysis, distinguishes the GTPase activation of RF3 
from other translational GTPases. While GTP hydrolysis of EF-Tu and EF-G is 
triggered upon SSU domain closure, hydrolysis of RF3 bound GTP is independent of 
domain closure and results from SSU rotation. A comparable movement of the G-
domain, which leads to accommodation on the SRL, has been described before only 
for IF2 (Sprink et al., 2016). Nonetheless, in contrast to RF3, accommodation of IF2 
involves a counterclockwise movement of the SSU instead of a clockwise movement. 
Therefore, our reported mechanism of accommodation is considerably different from 
all other translational GTPases described so far, showing domain closure or a 
counterclockwise movement that leads to accommodation. Moreover, the movement 
between state I and state II of the G-domain of IF2, which was described by Sprink 
and colleagues, is far smaller when compared to the movement of the G-domain of 
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RF3. While the G-domain of RF3 shows an average movement of ~10 Å, the G-domain 
of IF2 shows only a movement of ~2 Å. Although, the distances between the catalytic 
His448 and the SRL of state I and state II differ only by less than 1 Å, Sprink and 
colleagues suggest that the G-domain shift of ~2 Å ultimately results in GTP hydrolysis 
(Sprink et al., 2016). Regardless, it is unclear whether GTP hydrolysis by IF2 could in 
principle occur before movement into state II. For RF3, biochemical assays show that 
GTP hydrolysis is triggered when the 70S ribosome reaches a fully rotated state (Adio 
et al., 2018; Koutmou et al., 2014). With regard to the two reported 70S-ICs in complex 
with IF2 (Sprink et al., 2016), biochemical assays are lacking that show GTP hydrolysis 
takes place in 70S-IC state II or earlier. Based on the reported states, it is not possible 
to address this issue and to assume that hydrolysis occurs after such small 
counterclockwise movement of the G-domain. The presence of non-hydrolysable GTP-
analog occludes the moment of GTP hydrolysis within the reported complexes and it 
requires the observation of at least one additional intermediate state to anticipate the 
series of events that lead to hydrolysis (including rearrangement of catalytic His448). 
However, with respect to RF3, the distance between the G-domain and the SRL as 
well as the absence of a closed conformation of switch I do not promote earlier GTP 
hydrolysis before the 70S ribosome reaches a fully rotated state. Consequently, RF3-
induced clockwise SSU rotation fulfills a dual function. First, it results in the release of 
RF1 from the ribosome and second, it triggers GTP hydrolysis in a fully rotated 
ribosome. In general, the different activation mechanism of translational GTPases is 
also reflected by the position of the G-domains of EF-Tu, EF-G and IF2 compared to 
RF3. Relative to the SRL, the G-domain of EF-Tu (Loveland et al., 2017), EF-G (Li et 
al., 2015) and IF2 (Sprink et al., 2016) is rotated by 24 to 31° compared to the G-
domain of RF3.  
The general presence of RF1 and RF3 in the fully rotated state, as well as the 
milder rotated states, distinguishes our complex from the previously described higher- 
and low-resolution studies and gives first insights into the departure process of RF1. 
Moreover, binding of RF1 to R-state ribosomes was never described in any other 
publication. Consistent with the existing model for RF3 mediated RF1 recycling (Adio 
et al., 2018; Koutmou et al., 2014; Peske et al., 2014), we see departure of RF1 from 
fully rotated ribosomes where the G-domain of RF3 is in close proximity to the SRL. 
Compared to the intermediate states I-III the density of RF1 in the ribosomal A-site of 
state IV shows higher flexibility. This implies that in fully rotated ribosomes domain II/IV 
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on the SSU and domain III on the LSU become disengaged from the ribosome and 
hence destabilize 70S-bound RF1. Based on the observation of a direct contact 
between RF1 and RF3 in the structural study by Pallesen and colleagues it has been 
suggested that the dissociation of RF1 is the result of SSU rotation and an increasing 
steric clash between domain I of RF1 and domain III of RF3 (Pallesen et al., 2013). In 
none of our complexes we do observe such direct contacts between RF1 and RF3. 
Instead the destabilization of RF1 appears to be solely driven by SSU rotation that 
leads to a shift of ~4 Å of domain II/IV of RF1, when comparing state III and state IV of 
our reconstructions.  
 
Intermediate tRNA conformation induced by SSU rotation 
 
In the absence of RF3, the 70S ribosome adopts an N-state with the deacyl-tRNA in a 
classical P/P state. As RF3 binds, the SSU rotates and the tRNA in the P-site moves 
from a classical P/P state via an intermediate P-tRNA state (Pint) to a P/E hybrid state. 
Pint-tRNA we observe for state I-III of our reconstructions. In state IV, which represents 
a fully rotated ribosome, the tRNA adopts a P/E-hybrid state. The Pint state observed 
for state I to III is different from any other tRNA conformation observed before. The 3’-
end of the P-tRNA is shifted by ~9 Å out of the PTC and exhibits altered P-loop 
interactions. Normally, the CCA-end nucleotides C74 and C75 of a P/P-tRNA Watson-
Crick base-pair with the P-loop nucleotides G2251 and G2252, respectively. By 
contrast, the Pint-tRNA nucleotide C74 and C75 base-pair with G2253 and G2252, 
respectively, of the P-loop. Furthermore, the tRNA elbow region shifts by ~15 Å. The 
altered base-pairing is presumably caused by the rotation of the SSU. Movement of 
the CCA-end out of the PTC is probably necessary to allow further movement of the 
P-tRNA to a P/E hybrid state. It cannot be excluded that the Pint-tRNA is shifted by two 
nucleotides but the observed density does not support interactions between purine-
purine (A76 and G2252) and pyrimidine-pyrimidine (C74 and C2254) nucleotides 
within the first and third position, respectively, of the CCA-end. Placement of A76 
opposing G2252 would result in a steric clash of the nucleobases and does not allow 
(wobble) base-pairing. Moreover, the distance between C74 and C2254 is too far to 
enable base-pairing. Regardless of a one or two nucleotide shift, our observation of 
Pint-tRNAs probably represents a snap-shot of the transition to hybrid tRNA states, 
which has not been described so far.  
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It is not entirely clear whether this intermediate tRNA state represents a 
physiological conformation and why it was not observed so far. One explanation is the 
presence of additional factors, such as EF-G or RRF, in high-resolution cryo-EM and 
X-ray structure studies, which lead to fast accumulation of a single or just a view major 
intermediate states, and hence prevent the observations of Pint -states (Brilot et al., 
2013; Dunkle et al., 2011; Li et al., 2015; Lin et al., 2015). In case of X-ray structures, 
crystal packing prevents the observation of several different 
conformational/intermediate states. Accordingly, the observation of specific states 
primarily depends i.a. on the conditions and the presence of inhibitors. With respect to 
cryo-EM reconstructions, the lack of higher resolution information may play a role as 
well. Consistently, cryo-EM studies investigating different tRNA intermediate states 
exhibited rather low resolution and did not allow the observation of smaller shifts at the 
3’ end of a tRNA (Agirrezabala et al., 2008; Agirrezabala et al., 2012; Fischer et al., 
2010). In other high-resolution cryo-EM studies the presence of additional factors, such 
as EF-G or RRF, leads to fast accumulation of a single or major intermediate states 
and thus prevents the observations of Pint-states (Brilot et al., 2013; Dunkle et al., 2011; 
Li et al., 2015; Lin et al., 2015). With respect to our obtained complexes we cannot 
exclude that Api137 induces the outward movement of the tRNA. Nonetheless, an 
argument that favors a physiological role of the Pint-tRNA derives from the conservation 
of the P-loop. The P-loop nucleotide G2253, which Watson-Crick base-pairs with Pint-
tRNA nucleotide C74, is conserved in all kingdoms and thus generally allows 
alternative base-pairing upon SSU rotation (RNAcentral, 2017). In future studies it will 
be necessary to clarify the role of G2253 and whether it is crucial for the transition of 
a P-tRNA from a P/P state to a P/E hybrid state.  
 
RF1 recruitment by L7/L12 
 
Ribosomal protein L7/L12 was shown to interact with translational GTPases bound to 
the ribosome (Gao et al., 2009; Kothe et al., 2004; Pallesen et al., 2013; Simonetti et 
al., 2013; Stark et al., 1997; Tourigny et al., 2013; Zhou et al., 2013, 2014). It is not 
entirely clear whether L7/L12 is generally involved in the recruitment of translation 
factors. Nonetheless, biochemical studies show that L7/L12 promotes GTP hydrolysis 
and Pi release of translational GTPases (Figures 10A) (Carlson et al., 2017; Mohr et 
al., 2002; Savelsbergh et al., 2000). The first structural evidence for interactions of the 
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translational GTPase RF3 with L7/L12 was provided by Pallesen and colleagues, 
which described an extra ‘arc’-like density next to the G-domain of RF3 (Pallesen et 
al., 2013). Similarly, we observe in all of our reconstructions unassigned density 
adjacent to the G-domain of RF3 (Figure 10B and 10C). Using 7 Å filtered maps and 
the structural model of the L7/L12 CTD from Thermotoga maritima it was possible for 
us to assign this density to one CTD of a L7/L12 (Figure 10C) (Diaconu et al., 2005). 
Strikingly, in state III we observed another additional density with a comparable size 
next to RF1 domain I (Figure 10C). Although the features of both observed densities 
are rather weak, we are confident that both locations represent binding sites for L7/L12 
CTDs. The involvement of L7/L12 in RF1 recruitment was confirmed by biophysical 
assays. In a L7/L12 depleted system the release of a nascent chain from pre-hydrolysis 
70S ribosomes is clearly perturbed. To our knowledge this is the first example of a 
translation factor without GTPase activity that is recruited to the ribosome by L7/L12. 
 In each case, the L7/L12 CTD binds to an a-helix bundle that is provided by 
either the G-domain of RF3 or domain I of RF1 (Figures 10B and 10C). Nonetheless, 
the placement of two independent CTDs of L7/L12 into a rather feature-less density 
represents a vulnerable structural model. To further improve our concept, which shows 
simultaneous interactions of RF1 and RF3 with L7/L12, we tried to generate the 
complete structural model of the 70S ribosome that harbors the pentameric protein 
complex consisting of two L7/L12 dimers and the protein L10 (Figure 10A). In general, 
dimerization of L7/L12 is achieved by the NTD (Figure 10B). The CTD that fishes for 
translation factors is tethered to the NTD via a long flexible linker (Figures 10B and 
10C). Attachment of each L7/L12 dimer to the stalk base occurs through the dimerized 
NTDs, which are located on the a-helical CTD of protein L10 (Figure 10B). Our 
Figure 10 - Interactions of translation factors with L7/L12. (A) Overview of the 70S ribosome with two 
dimers of L7/L12 (purple) (Diaconu et al., 2005), RF1 (orange), RF3 (cyan), L10 (light blue) and L11 
(green). (B) Zoom of (A) showing interactions of two L7/L12 (purple) CTDs (Diaconu et al., 2005) with 
the G’-domain (G’) of RF3 and domain I (d1) of RF1. The CTDs of L7/L12 are connected to the CTD of 
L10 (light blue) via the NTD of L7/L12. LSU protein L11 (green) is shown for reference. (C) Cryo-EM 
density and rigid-body fitted model for the CTD of L7/L12 (purple) (Diaconu et al., 2005), which contacts 
RF3 (cyan) and RF1 (orange). SSU h33 (yellow), L10 (light blue) and L11 (green) are shown for 
reference.  
Discussion 61 
complete model shows that the position of the CTD next to domain I of RF1 and the 
G’-domain of RF3 allows proper attachment to the NTD (Figures 10A and 10B). The 
linker between the NTD and CTD of L7/L12 is long enough to allow simultaneous 
interaction with RF1 as well as RF3 on the ribosome (Figures 10B and 10C). Overall, 
this model shows that the L7/L12 protein is not dedicated to interactions with 
translational GTPases and stimulation of GTP hydrolysis but also allows recruitment 
of RF1.  
 
4.3 Antimicrobial peptides 
 
Our biochemical and structural studies identified the binding site of class I and class II 
PrAMPs as well as the corresponding mode of action. Although class I and class II 
PrAMPs share some basic features, such as Pro- and Arg-richness, the overall binding 
mode is generally different. Common for both classes is the binding site within the 
polypeptide tunnel of the ribosome.  
 
Binding of class I PrAMPs in general 
 
Class I PrAMPs bind to the ribosome with an inverted orientation compared to a 
nascent polypeptide i.e. with the N-terminus located in the A-site and the C-terminus 
extending down the polypeptide exit tunnel (Figure 11A). The PrAMP binding site on 
the ribosome can be divided into sections located within the A-site binding pocket, the 
A-site crevice and the upper region of the polypeptide exit tunnel. The N-terminal 
residues reaching into the ribosomal A-site determine the mechanism of inhibition. The 
C-terminal residues reaching into the polypeptide exit tunnel seem to be less crucial 
for binding and the inhibitory activity of PrAMPs. Accordingly, in none of the present 
structures the residues at the very C-terminus were resolved (Gagnon et al., 2016; 
Mardirossian et al., 2018; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et al., 2015). 
Furthermore, in biochemical studies investigating Bac7 fragments, deletion of up to 19 
amino acids at the C-terminus did not abolish PrAMP activity (Benincasa et al., 2004). 
In contrast, deletion of the amino acids valine and aspartate from the N-terminus of 
oncocins, which are positioned in the A-site binding pocket, leads to strongly reduced 
activity and underlines the crucial function of the N-terminus for antimicrobial activity 
(Gagnon et al., 2016). The most striking similarity between all class I PrAMPs is a 
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conserved core, which harbors a PRP motif. In all our resolved class I PrAMP 70S 
complexes so far, the PRP motif of each PrAMP was located in exactly the same 
position with exactly the same conformation (Gagnon et al., 2016; Mardirossian et al., 
2018; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et al., 2015). However, the amino 
acid composition, the number of residues and the number of established contacts 
within the A-site binding pocket are the most obvious differences among class I 
PrAMPs (Gagnon et al., 2016; Mardirossian et al., 2018; Roy et al., 2015; Seefeldt et 
al., 2016; Seefeldt et al., 2015). Consistently, while just four N-terminal amino acids of 
insect Onc112, metalnikowin and pyrrhocoricin reach into the A-site binding pocket 
(Figure 11B) (Gagnon et al., 2016; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et 
al., 2015), seven additional amino acids are present in mammalian Bac7 and Tur1A 
(Figure 11C) (Gagnon et al., 2016; Mardirossian et al., 2018; Seefeldt et al., 2016). 
The additional residues present in Bac7 and Tur1A form a short loop, which acts like 
an A-site anchor, and seems to be specific for mammalian PrAMPs (Gagnon et al., 
2016; Mardirossian et al., 2018; Seefeldt et al., 2016).  
 
Binding of insect PrAMPs Onc112, metalnikowin and pyrrhocoricin  
 
The amino acid sequence of the shorter N-terminus of insect PrAMPs is conserved 
between Onc112, pyrrhocoricin and metalnikowin (Graf et al., 2017b). Interaction 
within the A-site binding pocket and A-site crevice involves polar contacts as well as 
stacking interactions (Figure 11B) (Gagnon et al., 2016; Roy et al., 2015; Seefeldt et 
al., 2016; Seefeldt et al., 2015). Polar contacts are established by the peptide 
backbone and side chains of the amino acid residues in the second and third position 
(Figure 11B) (Seefeldt et al., 2016; Seefeldt et al., 2015). Consistently, Asp2 of insect 
PrAMPs contacts the 2’-OH group of C2507 and the base of G2553 (Seefeldt et al., 
2016; Seefeldt et al., 2015). The sidechain of Lys3 establishes a hydrogen bond with 
the phosphate-oxygen of the 23S rRNA nucleotide A2453 (Seefeldt et al., 2016; 
Seefeldt et al., 2015). Examples for backbone interactions are provided by Val1 (Figure 
11B). While the a-carbonyl oxygen of Val1 interacts with the nucleobase of C2573, the 
a-amine of Val1 contacts the ribose of C2507 (Seefeldt et al., 2016; Seefeldt et al., 
2015).  
Residues five to seven of insect PrAMPs are located within the A-site crevice 
(Seefeldt et al., 2016; Seefeldt et al., 2015). Among those residues, Tyr6 is the most 
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conserved and therefore present in all insect PrAMPs (Graf et al., 2017b; Seefeldt et 
al., 2016; Seefeldt et al., 2015). Tyr6 contributes to A-site crevice binding, as well as 
antimicrobial activity by establishing a stacking interaction with C2452 (Figure 11B) 
(Seefeldt et al., 2016; Seefeldt et al., 2015). Replacement of Tyr6 by Ala results in a 
32-fold decreased activity (Knappe et al., 2011b). This contrasts with positions 5 and 
7, which seem to be less critical for binding. While Onc112 harbors a proline residue 
in position 5, metalnikowin and pyrrhocoricin have in the same position an aspartate 
and a serine residue, respectively (Seefeldt et al., 2016; Seefeldt et al., 2015). 
Furthermore, the leucine residue in position 7 of Onc112 and pyrrhocoricin is an 
arginine residue in metalnikowin. The alteration of residues 5 and 7 results in different 
hydrogen bonding patterns within the A-site crevice. Asp5 in metalnikowin establishes 
hydrogen bonds with U2584 and U2585. Arg7 of metalnikowin contacts A2503 and the 
backbone phosphate of G2505. Ser5, which is present in pyrrhocoricin, interacts with 
Figure 11 - Binding site of class I PrAMPs. (A) Overview showing the binding site of Tur1A within the 
LSU (grey) polypeptide exit tunnel (NPET) with P-tRNA (green) shown for reference (Mardirossian et 
al., 2018). The N- and C-terminus of Tur1A is indicated by the letters N and C, respectively. (B-C) 
Established interactions of (B) Pyr (Gagnon et al., 2016; Seefeldt et al., 2016) and (C) Tur1A 
(Mardirossian et al., 2018) within the NPET. Hydrogen bonds are indicated by yellow dashed lines. 
Stacking interactions are indicated by black two-headed arrows. (B) Pyr (cyan) establishes interactions 
solely with 23S rRNA residues (grey) (Gagnon et al., 2016; Seefeldt et al., 2016). (C) Tur1A (yellow) 
establishes interactions with 23S rRNA residues (grey), as well as protein L4 (purple) (Mardirossian et 
al., 2018). (D) Superimposition of Tur1A (yellow) (Mardirossian et al., 2018) and accommodated pre-
attack aa-tRNA (blue) (Polikanov et al., 2014).  
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U2584 (Figure 11B). Leu7 does not establish interactions, either in Onc112, nor in 
pyrrhocoricin. Hydrogen bonds in the A-site crevice, which are common for all insect 
PrAMPs involve the peptide backbone. Accordingly, the backbone a-carbonyl oxygen, 
the a-amine of Tyr6 and the a-amine of Leu7/Arg7 contact the U2506 nucleobase 
(Figure 11B).  
As mentioned before, the number of resolved residues at the C-terminus differs 
between PrAMPs. With respect to insect PrAMPs, 6 aa of Onc112, 5 aa of 
metalnikowin and 4 aa of pyrrhocoricin were not resolved in our studies (Seefeldt et 
al., 2016; Seefeldt et al., 2015). However, the visualized residues at the C-terminus of 
insect PrAMPs were observed to establish just a single hydrogen bond and a single 
stacking pair within the upper polypeptide exit tunnel (Figure 11B). Both interactions 
involve Arg9 of the conserved PRP motif (Figure 11B). The hydrogen bond is 
established with 23S nucleotide U2584. The stacking interaction is observed with 
C2610 (Figure 11B). The presence of only two interactions underlines the minor 
importance of the C-terminus of insect PrAMPs in binding.  
 
Binding of mammalian PrAMPs Bac7 and Tur1A 
  
Binding of mammalian Bac7 and Tur1A to the A-site binding pocket and the A-site 
crevice of eubacterial 70S ribosomes also involves polar contacts of the peptide 
backbone and the amino acid side chains (Figure 11C) (Mardirossian et al., 2018; 
Seefeldt et al., 2016). Four of eight positions in Bac7 and Tur1A harbor arginine 
residues in the LSU A-site binding pocket, which establish an extensive hydrogen 
bonding network as well as a single stacking interaction. The stacking interaction is 
observed between Arg2 and C2573 (Figure 11C). Compared to insect PrAMPs, this 
stacking interaction replaces the backbone contact of Val1 with the nucleobase of 
C2573 (Figure 11C) (Mardirossian et al., 2018; Seefeldt et al., 2016; Seefeldt et al., 
2015). Hydrogen bonds are evident for all arginine residues in the A-site binding pocket 
(Figure 11C) (Mardirossian et al., 2018; Seefeldt et al., 2016). The sidechain of Arg1 
interacts with the nucleobase of U2555. Hydrogen bonds with the 23S rRNA backbone 
are established by the sidechains of Arg2 (G2454 and A2453), Arg4 (C2452 and 
G2494) and Arg6 (A2453 and U2493). Interactions of the peptide backbone are 
present for the a-amines of Arg1, Arg2, Ile3 and Arg4, which contact U2491, C2573, 
U2492 and U2493, respectively.  
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The overall contacts of Bac7 and Tur1A with the A-site crevice are comparable 
to insect PrAMPs (Figures 11B and 11C) (Mardirossian et al., 2018; Seefeldt et al., 
2016; Seefeldt et al., 2015). Insect PrAMP residues five to seven correspond to 
mammalian PrAMP residues eight to ten. Backbone interactions involve the a-carbonyl 
oxygen and a-amine of residue 9, as well as the a-amine of residue 10 that contacts 
the U2506 nucleobase (Figure 11C) (Mardirossian et al., 2018; Seefeldt et al., 2016). 
Similar to Onc112, position eight and ten harbor proline and leucine residues 
(Mardirossian et al., 2018; Seefeldt et al., 2016; Seefeldt et al., 2015). Except for the 
described backbone interactions, the side chains of both residues do not establish 
hydrogen bonds with the surrounding tunnel (Figure 11C) (Mardirossian et al., 2018; 
Seefeldt et al., 2016). Nonetheless, similar to Tyr6, which is present in all insect 
PrAMPs, residue nine of Bac7 and Tur1A establishes a stacking interaction with C2452 
(Figure 11C) (Mardirossian et al., 2018; Seefeldt et al., 2016; Seefeldt et al., 2015). As 
observed for insect PrAMPs, Tur1A base stacking involves a Tyr residue as well 
(Figure 11C). Bac7 instead harbors an arginine residue in this position that stacks upon 
C2452 (Seefeldt et al., 2016; Seefeldt et al., 2015).  
Due to the enrichment in arginine residues compared to insect PrAMPs, Bac7 
and Tur1A establish more interactions within the upper polypeptide exit tunnel 
(Mardirossian et al., 2018; Seefeldt et al., 2016). The majority of these contacts involve 
stacking interactions. In the case of Tur1A, two stacking interactions are observed 
(Figure 11C), such that Arg15 and Arg16 stack upon U2586 and His69 of L4, 
respectively (Figure 11C) (Mardirossian et al., 2018). The C-terminus of Bac7 
establishes three stacking interactions with the surrounding tunnel (Seefeldt et al., 
2016). Namely, Arg12, Arg14 and Arg16 form stacking interactions with C2610, U2586 
and A2062, respectively. The stacking interactions of Arg12 with C2610 is analogous 
to the tunnel interaction of Arg9 in insect PrAMPs (Seefeldt et al., 2016; Seefeldt et al., 
2015).  
 
Binding of class II PrAMP Api137  
 
Api137, which is derived from wildtype apidaecin from Apis mellifera, is a class II 
PrAMP. In contrast to other (class I) PrAMPs, Api137 binds to the polypeptide tunnel 
with a similar orientation to a nascent chain (Figures 12A and 12B) (Florin et al., 2017). 
The C-terminal residues Arg17 and Leu18 are located in the A-site crevice but do not 
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reach into the LSU A-site binding pocket. Placement of Arg17 and Leu18 in the A-site 
crevice is crucial for the mechanism of action of Api137. For instance, exchange of 
Arg17 by Ala leads to decreased activity against E. coli ribosomes (Castle et al., 1999). 
The N-terminal residues pass down the polypeptide tunnel (Figures 12A and 12C) 
(Florin et al., 2017). In our structure, the last four residues at the N-terminus are not 
resolved. Nonetheless, compared to class I PrAMPs binding of Api137 to the 
polypeptide tunnel is solely facilitated by stacking interactions (Figure 12C) (Florin et 
al., 2017; Seefeldt et al., 2016; Seefeldt et al., 2015). Stacking interactions are 
observed between Tyr7 and A751, Arg12 and C2611 as well as His15 and the 
nucleobase of G2505 (Figure 12C) (Florin et al., 2017). In addition to stacking 
interactions, polar contacts are established in the PTC with RF1 and the deacylated P-
site tRNA (Figures 12D and 12E). The side chain of the penultimate residue Arg17 is 
coordinated between 23S rRNA residues and Gln235 of the RF1 GGQ-motif (Figure 
Figure 12 - Binding site of class II PrAMP Api137. (A) Overview showing the binding site of Api137 
(slate) within the LSU (grey) polypeptide exit tunnel (NPET) in presence of P-tRNA (green) and RF1 
(orange) (Florin et al., 2017). The GGQ motif is highlighted in red. The N- and C-terminus of Api137 is 
indicated by the letters N and C, respectively. (B) Superimposition of Api137 (slate) and Pyr (left; cyan) 
(Gagnon et al., 2016; Seefeldt et al., 2016) or Tur1A (right; yellow) (Mardirossian et al., 2018). P-tRNA 
(green is shown for reference). (C) Interactions of Api137 (slate) with 23S rRNA nucleotides (grey) 
located in the NPET (Florin et al., 2017). Stacking interactions are indicated by black two-headed arrows. 
(D-E) Interactions of Api137 in presence of (D) RF1 (orange) and (E) PtRNA (green) (Florin et al., 2017). 
(D) Arg17 contacts 23S rRNA nucleotides and Gln235 of RF1. (E) Leu18 of Api137 contacts A76 of the 
deacylated tRNA located in the P-site.  
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12D). The 23S rRNA contacts comprise hydrogen bonds with the nucleobase of 
C2452, the 2’ and the 3’-oxygen of G2505 and the ribose of U2506 (Figure 12D). 
Gln235 interacts with Arg17 through the carbonyl oxygen of the side chain (Figure 
12D). Leu18 appears to establish two interactions via the N-terminal OH-group (Figure 
12E). These interactions include the 2’-OH and the 3’-OH of A76 of deacyl-P-tRNA 
(Figure 12E). The overall altered interaction network compared to class I PrAMPs 
forms the basis for the unique mechanism of action of Api137.  
 
Mechanism of action of class I and class II PrAMPs 
 
Under normal conditions ribosomal protein synthesis passes through the phases of 
translation initiation, translation elongation and translation termination (Figure 2). 
Translation initiation involves the placement of an fMet-tRNAfMet over an AUG start 
codon in the P-site of the 70S ribosome (Figure 2A). The CCA-end that carries the 
fMet-moiety is placed in the PTC and the 3’-end establishes contacts with the P-loop 
of the LSU. Translation elongation comprises the EF-Tu mediated delivery and 
subsequent accommodation of an aa-tRNA to the ribosomal A-site, transpeptidation in 
the PTC and translocation catalyzed by EF-G (Figure 2B). Accommodation coincides 
with the establishment of interactions between the CCA-end of the A-site tRNA and 
the A-loop within the 23S rRNA. During translation termination the nascent chain is 
released from the ribosome with aid of the peptide chain release factor RF1 or RF2 
(Figure 2C). Both classes of PrAMPs inhibit protein synthesis by binding to the 
polypeptide tunnel of bacterial 70S ribosomes, yet binding of each class of PrAMPs 
results in inhibition of different steps of the translation cycle (Florin et al., 2017; Gagnon 
et al., 2016; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et al., 2015). In the case 
of class I PrAMPs, the residues crucial for translation interference are located in the A-
site binding pocket (Seefeldt et al., 2016; Seefeldt et al., 2015). In the case of the class 
II PrAMP Api137, the important residues are located in the PTC (Florin et al., 2017). 
In presence of class I PrAMPs the A-site crevice and the A-site binding pocket 
are blocked by the N-terminal residues of the PrAMP (Figure 11D) (Gagnon et al., 
2016; Mardirossian et al., 2018; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et al., 
2015). This allows placement of an fMet-tRNAfMet during translation initiation but 
perturbs delivery of the first aa-tRNA by EF-Tu (Mardirossian et al., 2018; Seefeldt et 
al., 2016; Seefeldt et al., 2015). Although decoding on the SSU is in principle possible, 
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subsequent accommodation following release from EF-Tu is blocked due to the steric 
hindrance generated by the N-terminal residues of class I PrAMPs. Accordingly, 
superimposition with pre-attack 70S ribosomes carrying an accommodated aa-tRNA 
in the A-site shows incompatibility of the A-tRNA CCA-end and the N-terminal residues 
of PrAMPs (Figure 11D) (Graf et al., 2017b). The same steric clash also prevents 
binding of PrAMPs during translation elongation. To avoid steric clashes with a 
peptidyl-tRNA, binding presumably occurs between translation termination and 
translation initiation. In general, class I PrAMPs inhibit the transition from translation 
initiation to translation elongation as confirmed by biochemical experiments 
(Mardirossian et al., 2018; Seefeldt et al., 2016; Seefeldt et al., 2015). In accordance, 
toe-print assays showed that translation in presence of class I PrAMPs indeed leads 
to ribosomal stalling at the AUG start codon. Further translation elongation is not 
possible.  
Initial biochemical investigations of class II PrAMP Api137 assumed that 
translation inhibition occurs in a similar fashion to the first class of PrAMPs by binding 
to the polypeptide tunnel and inhibition of the transition from translation initiation to 
elongation. The major argument for this theory was the high content in proline and 
arginine residues that is common for all PrAMPs (Florin et al., 2017; Graf et al., 2017b). 
Surprisingly, our biochemical toe-prints assays showed that translation termination 
instead of translation initiation is affected (Florin et al., 2017). An explanation for this 
observation was provided by the previously described structural data and biophysical 
experiments. In contrast to the class I PrAMPs, Api137 binds to polypeptide tunnel 
without blocking the A-site binding pocket (Florin et al., 2017; Graf et al., 2017b). Thus, 
binding of a deacylated tRNA to the ribosomal A- and P-site is in principle possible 
(Florin et al., 2017). However, the C-terminal residues Arg17 and Leu18 establish very 
specific interactions with class I release factor RF1 (Figures 12D and 12E) (Florin et 
al., 2017). The resulting hydrogen bonding network further stabilizes Api137 in the 
tunnel and keeps RF1 bound to the ribosome (Figure 12C). Interestingly, RF1 trapping 
is not the major reason for inhibition of bacterial cell growth in vivo. Biochemical assays 
show that the presence of Api137 leads to stop codon read-through and depletion of 
the endogenous pool of RF1 available for translation termination. Hence, RF1 trapping 
on the ribosome just indirectly inhibits bacterial growth by preventing nascent chain 
release from other ribosomal complexes.  
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Validation of the 70S ribosome as a major PrAMP target 
 
Although our studies show binding and inhibition of PrAMPs to 70S ribosomes, it is 
necessary to confirm that the translation machinery is the only target of PrAMPs. The 
tool of choice for this validation are mutagenesis experiments. In the course of these 
mutagenesis studies, bacterial cells are exposed to sub-inhibitory concentrations of a 
compound in culture, which leads to acquirement of rRNA or protein sequence 
alterations that allow bacteria to escape the inhibitory action. Protein or rRNA 
alterations in general, can affect inhibition either more directly, e.g. by decreasing the 
affinity to the binding site, or more indirectly, e.g. by preventing compound uptake into 
the cell.  
Problematic for the identification of rRNA mutations is the presence of several 
rRNA operons in E. coli. Thus, acquirement of a single mutation within one rRNA 
operon does not affect the complete pool of rRNAs incorporated into ribosomes. To 
avoid this issue, the identification of rRNA mutations, which confer resistance to 
PrAMPs, requires the use of special E. coli strains, called squires (SQ) strains (Asai et 
al., 1999). The SQ strains exhibit a single rRNA allele that is encoded by an extra-
genomic plasmid. The genomically encoded operons, coding for 5S, 16S and 23S 
rRNA, are absent. By exposing a SQ strain in culture to PrAMPs, it was possible to 
identify 23S rRNA mutations conferring resistance against the insect PrAMPs Onc112 
(Gagnon et al., 2016) and Api137 (Florin et al., 2017).  
The identified 23S rRNA residues are A2503 and A2059. Single or double 
mutation of A2503 and/or A2059 was shown to result in a 4- to 16-fold decreased 
susceptibility of E. coli cells against Onc112 and Api137 (Florin et al., 2017; Gagnon 
et al., 2016). Normally, A2503 and A2059 stack upon each other and stabilize adjacent 
nucleotides, such as A2062. The decreased susceptibility against both PrAMPs is 
presumably caused by conformational changes of nucleotides 2503 and 2059 as well 
as neighboring residues, which are crucial for stable binding of PrAMPs. Consistently, 
our structural data show that A2503 and A2059 are situated in close proximity to 
Api137 (Florin et al., 2017). Although no hydrogen bonds are observed for both 
nucleotides, the close proximity to Api137 possibly allows van-der-Waals interactions. 
Upon mutation, these interactions are presumably perturbed and result in a decreased 
binding affinity of Api137 towards the 70S ribosome. This contrasts the effect of A2503 
and A2059 mutation on Onc112 binding (Gagnon et al., 2016). In presence of Onc112, 
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A2503 hydrogen bonds with A2062 and stabilizes the nucleotide in a 90° rotated 
conformation, which is crucial for accommodation of Onc112 in its binding site (Roy et 
al., 2015; Seefeldt et al., 2015). The non-rotated conformation of A2062 represents a 
steric block that prevents binding of Onc112 in the NPET. However, independent of 
the effect of the A2503 and A2059 mutation on neighboring rRNA residues, the 
decreased susceptibility against Onc112 and Api137 is a clear evidence for ribosomes 
as major target for the inhibition by PrAMPs. 
With respect to protein alterations, most of the initially identified mutations, 
conferring resistance to PrAMPs, were dedicated to the coding gene of the SbmA 
transporter. The primary reason for this is possibly the lower cost in fitness for bacteria 
grown under lab conditions. Accordingly, sbmA deficient E. coli cells stay viable and 
exhibit lower susceptibility against PrAMPs, such as Bac7 (Mattiuzzo et al., 2007). In 
contrast, sequence alterations within functionally important regions are not well 
tolerated (Sato et al., 2006). Nonetheless, for Api137 it was possible to identify 
mutations within proteins by culturing E. coli cells that express multiple copies of an 
sbmA coding plasmid (Florin et al., 2017). The presence of multiple copies of the sbmA 
gene makes the acquirement of the same resistance mutation in all plasmids highly 
unlikely and ensures continuous uptake of PrAMPs into the bacterial cell. 
Consequently, the bacterial cell is forced to acquire alternative resistance 
mechanisms, which help to validate the ribosome as primary target for PrAMP action. 
Overall, it was possible to identify Api137 resistance mutations within ribosomal 
proteins as well as RF1 and RF2. Mutations within ribosomal proteins, which confer 
resistance against Api137, result from mutation of L4 residue Lys63 to Glu and from 
deletion of L22 residues 82 to 84 (Florin et al., 2017). Furthermore, decreased 
susceptibility against Api137 is observed for mutation of L16 Arg81 to Cys. 
Ribosomal proteins L4 and L22 harbor each an extended loop that form together 
the central constriction within the polypeptide exit tunnel. The observed mutations 
within L4 and L22 presumably lead to reordering of these loops, which were shown in 
our structure to directly or indirectly stabilize binding of Api137 in the polypeptide tunnel 
(Florin et al., 2017). Thus, Arg61 of L4 provides a putative hydrogen bond to binding 
of Api137. Mutation of Lys63 could reorder the extension, which contains the 
interacting Arg61 and hence possibly destabilize binding of Api137. In contrast, 
deletion of L22 residues 82 to 84 presumably destabilizes Api137 binding more 
indirectly by contraction of the extended loop of L22. The extended loop of L22 
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contacts the 23S rRNA backbone and stabilizes H34. H34 harbors nucleotide A751 
that stacks upon Api137 residue Tyr6 and is crucial for stable binding. The contraction 
of the extended loop of L22 most likely causes reordering of H34 and hence, 
destabilization of Api137 by the lacking stacking interaction between Tyr6 and 23S 
rRNA residue A751.  
Arg81 of L16, which can confer resistance to Api137 upon mutation to Cys, 
stabilizes P-loop nucleotide G2251 via two hydrogen bonds (Florin et al., 2017). One 
hydrogen bond is established with the phosphate-oxygen backbone and one hydrogen 
bond is established with the nucleobase of G2251. As described in section 1.1, P-loop 
nucleotide G2251 Watson-Crick base-pairs with C75 of a P-site tRNA and stabilizes 
the CCA-end in the PTC for peptide bond formation. In presence of Api137, the C-
terminal residue Leu18 contacts A76 of the P-tRNA. The interaction between Leu18 
and the 3’-end of the P-tRNA stabilizes Api137 binding to the ribosome. Upon mutation 
of Arg81 of L16 to Cys, both polar interactions with nucleotide G2251 are resolved and 
possibly lead to higher flexibility within the P-loop and the CCA-end of a P-tRNA. As 
consequence, the binding affinity of Api137 towards the ribosome is reduced.  
In addition to ribosomal protein mutations, more resistance mutations against 
Api137 were identified within RF1 and RF2. In this context, mutation of Arg262 to Cys 
and Gln280 to Leu in RF2 as well as Asp241 to Gly in RF1 leads to significantly 
reduced susceptibility of E. coli cells against Api137 (Florin et al., 2017). The cause of 
the decreased susceptibility is most likely a destabilization of the binding of RF1 and 
RF2, which overcomes the stabilizing interactions of Api137 with the GGQ-motif of RF1 
and RF2. Accordingly, RF1 binding to the 70S ribosome is stabilized by a single polar 
contact of 23S nucleotide C2573 with Asp241. Mutation of Asp241 to Gly prevents an 
interaction with C2573 and hence could promote dissociation of RF1. Similar to RF1, 
mutation of RF2 residues Arg262 to Cys and Gln280 to Leu resolves interactions with 
23S rRNA nucleotides C2556 and U2492, respectively. This could promote 
dissociation of RF2 since the interactions of Arg17 of Api137 are presumably 
insufficient to trap RF2 on the ribosome. 
It is noteworthy that none of the rRNA or protein mutations conferred complete 
resistance against Onc112 and Api137. Nonetheless, all mutations taken together are 
rather strong arguments favoring the ribosome as the major target of these PrAMPs. 
A major problem for identifying more resistance mutations against PrAMPs is the high 
conservation of rRNA residues involved in PrAMP binding (RNAcentral, 2017). As a 
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consequence, mutation of interacting residues would result in dramatically decreased 
PTC activity and therefore in reduced viability of bacterial cells (Sato et al., 2006; 
Thompson et al., 2001). An example is C2452, which is located within the A2451 region 
(23S nts 2448 to 2554). C2452 establishes a stacking interaction with Tur1A 
(Mardirossian et al., 2018) and pyrrhocoricin (Gagnon et al., 2016; Seefeldt et al., 
2016) via a Tyr residue and a polar contact with Arg17 of Api137 (Florin et al., 2017). 
Using an SSER approach, Sato and colleagues showed in 2006 that except for A2448 
and A2453 all nucleotides within the A2451 region are essential for ribosomal function 
(Sato et al., 2006). Consistently, it is not possible to select for viable C2452 mutants. 
With regard to mammalian PrAMPs, such as Bac7 and Tur1A, no rRNA or 
ribosomal protein resistance mutations have been identified so far. In general, the 
identification of mutations conferring resistance to mammalian PrAMPs is more 
difficult. In contrast to insect PrAMPs, mammalian PrAMP Bac7 and Tur1A are 
considerably longer (Graf et al., 2017b). Mammalian PrAMPs show a full-length of 39 
to 60 aa, while insect PrAMPs show a full-length between 15 and 34 amino acids. 
Although both, insect and mammalian PrAMPs, target ribosomes and inhibit 
translation, it was shown for full-length Bac7, which is very similar to Tur1A 
(Mardirossian et al., 2018), that a lytic mode of action is also evident (Podda et al., 
2006). Only truncated derivatives of Bac7, like Bac7(1-16), solely inhibit protein 
synthesis without permeabilizing the bacterial membrane (Podda et al., 2006; Seefeldt 
et al., 2016). Selection for resistance mutations is in principle possible but it is difficult 
for bacteria to acquire mutations that affect both modes of action (lytic and non-lytic) 
of mammalian full-length PrAMPs (Lai and Gallo, 2009; Peschel and Sahl, 2006). As 
a consequence, bacteria remain susceptible against full-length antimicrobial peptides 
in culture. With respect to the previously described rRNA mutations conferring 
resistance to Onc112 and Api137 (A2503C and A2059G), no elevated MIC was 
observed in presence of Tur1A and Bac7 upon mutation of these residues (Gagnon et 
al., 2016; Mardirossian et al., 2018). Regardless, as described before, the selection for 
more rRNA resistance mutations is rather difficult since nucleotide alterations within 
the NPET that are involved in binding of mammalian PrAMPs would lead to strongly 
perturbed PTC activity (Sato et al., 2006). 
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Access of the NPET by Api137 
 
Binding of class I PrAMPs presumably takes place after recycling of the 70S ribosome 
and previous to translation initiation (Graf et al., 2017b). With respect Api137, it 
remains obscure at which stage of translation termination binding occurs and how the 
binding site in the NPET is accessed. Although the 70S ribosome constitutes a porous 
complex, the binding site within the polypeptide tunnel must be accessed either from 
the PTC or from the tunnel exit (Voss et al., 2006). Due to the size of Api137, it is not 
possible to access the NPET by lateral diffusion through the LSU. Regardless, 
considering the length of ~100 Å and the width of the polypeptide tunnel with a 
diameter of less than 15 Å at the narrowest section (Nissen et al., 2000), it seems more 
difficult for a longer peptide to access the binding site from the back of the LSU through 
the tunnel exit. Regardless, a further limitation for the access of the binding site 
constitutes the presence of additional factors in the ribosomal tRNA binding sites. 
Accordingly, the space taken by RF1/2 in the A-site and deacyl-tRNA in the P-site 
during termination limits the access of Api137 to its binding site from the PTC (Florin 
et al., 2017). The only alternative is the access of the binding site via the tunnel exit on 
the back of the LSU. Consequently, Api137 presumably enters the 70S ribosome via 
the exit and diffuses to the binding site, which is located in the upper NPET. 
With respect to the timing of binding, Api137 cannot access the binding site at 
all stages during termination. First, the presence of a nascent chain in the polypeptide 
exit tunnel during translation elongation represents a steric block that is incompatible 
with simultaneous binding of Api137. Second, Api137 action requires 70S-bound RF1 
and P-tRNA, which interact via Gln235 of the GGQ-motif and A76 with Arg17 and 
Leu18, respectively (Florin et al., 2017). As consequence, binding of Api137 has to 
occur after peptide chain release and before RF1/2 departure from the post-hydrolysis 
70S ribosome.  
  However, binding of Api137 can in principle also occur at a later stage of 
termination. Consistently, our recent RF3 cryo-EM study shows that RF1/2 departures 
from R-state 70S ribosomes with the deacyl-tRNA in a P/E hybrid state. The disruption 
of the CCA-end P-loop interactions and subsequent movement of the 3’-end to the E-
site on the LSU, which is necessary for P/E hybrid state formation, leads to liberation 
of space in the PTC. This space most likely allows Api137 to enter the polypeptide exit 
tunnel. It is not clear whether binding at this late stage of termination is sufficient to 
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trap RF1/2 before dissociation or recycling by RF3 can take place. However, despite 
the possibility of binding of Api137 to the ribosome during RF1/2 recycling, this 
scenario seems to play just a minor role for RF1/2 trapping. In any case, it requires 
further biochemical studies to distinguish the time point of Api137 binding as well as 
the access to the NPET.  
  
PrAMPs as novel tools to investigate protein synthesis 
 
Knowing the exact mechanisms of action, PrAMPs represent a useful tool to further 
investigate the process of protein synthesis. One great possibility arises from the fact 
that PrAMPs either inhibit translation initiation or translation termination. Accordingly, 
class I PrAMPs stall 70S ribosomes at the AUG start codon (Gagnon et al., 2016; 
Mardirossian et al., 2018; Roy et al., 2015; Seefeldt et al., 2016; Seefeldt et al., 2015). 
Class II PrAMPs trap 70S ribosomes at stop codons (Florin et al., 2017). By utilizing 
the mechanism of action of each class it is possible to perform ribosomal profiling. 
Ribosomal profiling is based on deep sequencing and allows monitoring of in vivo 
translated mRNAs with codon accuracy (Brar and Weissman, 2015; Ingolia et al., 
2009). In order to gain sequence information of the translated ORFs, ribosome 
protected mRNA fragments are purified. The purification of these protected fragments 
is a multi-step process. First, 70S ribosomes are stalled in vivo by translation inhibitors 
and purified together with the associated mRNA. Second, the fraction of the mRNA, 
which is not protected from the 70S ribosomes, becomes cleaved during RNase 
treatment. Afterwards, the ribosome protected fragments are released from the 70S 
ribosome and become modified with an anchor sequence. The resulting fragments that 
carry an anchor sequence are subjected to deep sequence. Generally, ribosomal 
profiling allowed numerous labs to screen for actively translated ORFs in bacterial as 
well as eukaryotic cells under various conditions (Brar and Weissman, 2015). One of 
the most challenging problems in the field of profiling is the identification of start and 
stop sites. Accordingly, many of the translation inhibitors that are effective against 
eubacteria block more than one stage of protein synthesis (e.g. initiation and 
elongation) (Wilson, 2009). Examples for antibiotics, which inhibit multiple stages of 
protein synthesis, are thiopeptides and ribotoxins. Regardless, no inhibitor is known so 
far that specifically inhibits termination (Svidritskiy et al., 2013; Wilson, 2009). 
Therefore, Api137 represents an opportunity, because it specifically inhibits translation 
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termination by trapping RF1/2 on the ribosome (Florin et al., 2017). Both PrAMP 
classes together allow inhibition of the very first step and the very last step of 
translation without interfering with translation elongation (Florin et al., 2017; 
Mardirossian et al., 2018; Seefeldt et al., 2016; Seefeldt et al., 2015). As consequence, 
inhibition of ribosomal translation in vivo by class I or class II PrAMPs can in principle 
lead to the accumulation of 70S ribosomes at the start and stop codon, respectively, 
and thus possibly allow the identification of new ORFs. Noteworthy, the only limitation 
for the identification of new ORFs in bacteria is the presence of the SbmA transporter 
that ensures uptake of PrAMPs in culture at µM concentrations (Scocchi et al., 2011). 
Accordingly, the determination of ORFs in Gram-positive bacteria, such as Bacillus 
subtilis, would require the introduction of the sbmA gene and successful expression 
and incorporation of the SbmA transporter in the membrane of Gram-positive bacteria. 
 Another possibility is the use of class II PrAMP Api137 as tool to allow 
incorporation of non-canonical amino acids as well as the generation of specific read-
through products. As mentioned above, trapping of RF1 on the ribosomes by Api137 
ultimately leads to depletion of RF1 from the pool of available termination factors 
(Florin et al., 2017). As a consequence, termination in general is perturbed since no 
class I release factor is available for peptide chain release. As shown by our 
biochemical assays, the absence of peptide release events leads to stop codon read-
through and thus to the creation of unintended protein products. The stop codon read-
through can be utilized to generate specific proteins in presence of Api137. 
Furthermore, a vacant A-site potentially allows easier delivery of non-canonical amino-
acids by amber suppressor tRNAs.  
 
Development of PrAMPs (Api137) with improved activities to yield future therapeutics 
 
The continuously rising number of bacterial strains with resistances increases the 
demand for the discovery and the development of new therapeutics to treat infections. 
Consistently, antimicrobial peptides, such as Api137, represent interesting targets for 
future medicine. At this stage there are numerous AMPs under clinical trials. One 
example is pexiganan (LocilexÒ), which is currently in phase III clinical trials and used 
as topical cream to treat infected diabetic foot ulcers (Greber and Dawgul, 2017). In 
general, AMPs have one major advantage over small molecule drugs that are 
commonly used in medicine to treat infections (Mahlapuu et al., 2016). AMPs constitute 
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natural products composed of amino acids, which upon degradation do not result in 
toxic metabolites. Nonetheless, besides this one advantage AMPs face several 
problems, which are necessary to rule out before a clinical application is possible. In 
this context, the composition of AMPs out of amino acids also constitutes the biggest 
disadvantage since the peptides are prone to degradation by proteases. Therefore, the 
high abundance of proteases in the digestive tract results in a low oral bioavailability 
of AMPs (Vlieghe et al., 2010). The term bioavailability refers to the efficiency of uptake 
(e.g. into blood circulation or by a cell), which is crucial for the effectiveness of a drug 
against a specific target, such as pathogenic bacteria. To improve the poor 
bioavailability of AMPs it is possible to employ different approaches (Mahlapuu et al., 
2016). This includes modification of the N- or C-termini and substitution of natural 
amino acids by unnatural amino acids, such as D-amino acid. 
 With respect to PrAMPs Api137 and Onc112, many attempts were made to 
obtain sequences with improved properties such as increased antimicrobial activity, 
solubility and serum stability, which is equivalent to decreased vulnerability against 
proteolytic cleavage (Berthold et al., 2013; Czihal et al., 2012; Knappe et al., 2011a; 
Knappe et al., 2010; Knappe et al., 2011b). In accordance, Api137 (Berthold et al., 
2013) and Onc112 (Knappe et al., 2011a) represent derivatives of apidaecin-1b and 
oncocin with increased serum stability, which are the result of N-terminal and C-
terminal modifications, respectively. Instead of an asparagine residue, Api137 harbors 
an ornithine residue with a tetramethylguanidinyl moiety at the N-terminus (Berthold et 
al., 2013). Onc112 harbors at the C-terminus an amino-group instead of an carboxyl-
group and two D-Arg residues in position 15 and 19 (Knappe et al., 2011a). More 
modifications can be introduced based on our structural data. 
The obtained structures of PrAMPs give direct insight into the interactions of 
Api137 and Onc112 with the 70S ribosome and the mechanism of action (Florin et al., 
2017; Seefeldt et al., 2015). As described before, bacterial resistance against Api137 
and Onc112 arises from rRNA and protein (only Api137) mutations (Florin et al., 2017; 
Gagnon et al., 2016). All of these mutations destabilize binding of Api137 and Onc112. 
Knowing the exact interactions of PrAMPs with the 70S ribosome possibly helps to 
generate second generation PrAMPs that are immune to the acquired bacterial 
resistances. Consistently, destabilization of PrAMPs in the presence of any of these 
mutations can be compensated by additional contacts with the polypeptide exit tunnel. 
In order to establish additional contacts within the NPET it is necessary introduce 
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amino acid substitutions. Important during this process is the maintenance of contacts, 
which are crucial for inhibition and the maintenance of the elongated structure of 
PrAMPs, which is essential for binding to the polypeptide exit tunnel. With regard to 
Api137, contacts important for protein synthesis inhibition are established by Tyr7, 
Arg12, His15, Arg17 and Leu18 (Florin et al., 2017). The other residues mostly 
constitute Pro residues and are presumably important for the elongated conformation 
of Api137. Nonetheless, future studies have to investigate the importance of each Pro 
residue and whether substitution results in an altered activity of the Api137. One 
approach is an alanine-scanning mutagenesis (Cunningham and Wells, 1989). 
Alanine-scanning mutagenesis allows the identification of important residues for 
inhibition by step-wise replacement of each Api137 residue with Ala.  
Regardless, Pro residues 5, 9 and 13 seem to be less suitable for substitutions. 
Pro5 constitutes the last resolved residues of Api137 with no residues in close 
proximity, which allow additional contacts (Florin et al., 2017). Pro9 stacks upon Tyr7, 
and thus stabilizes the stacking interaction between Tyr7 and 23S nucleotide A751. 
Similar to Pro5, Pro13 is situated in a position with no tunnel residues in the vicinity. 
Even substitution by large amino acids, such as Arg and Lys, are not sufficient to reach 
the surrounding rRNA residues. This contrasts with Pro residues 11, 14 and 16, which 
are more suitable for substitutions. Noteworthy, none of these Pro residues is in 
optimal distance to 23S nucleotides, which would allow stacking interactions with 
aromatic amino acid substitutions, even when considering all possible side chain 
conformations. Therefore, possible substitutions primarily rely on the introduction of 
additional polar contacts.   
Pro11 is located close to the tip of the extended loop of L4 and 23S nucleotide 
A2059. Mutagenesis to Asn or Asp would allow an additional hydrogen bond with 
A2059. Larger amino acids, like Arg, in the same position result in a steric clash that 
would presumably destabilize Api137. Nonetheless, substitution of Pro11 with Asn or 
Asp can possibly overcome the A2059C mutation that is thought to abolish stabilizing 
van-der-Waals interactions with Api137.  
The only potential stacking interaction that can be introduced through mutation 
of Pro14 to Arg. Arg instead of Pro14 could lead to stacking upon the nucleobase of 
A2062. Alternatively, mutation of Pro14 to a smaller amino acid, such as Thr, possibly 
allows the establishment of two additional hydrogen bonds of the side chain OH-group 
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with the nucleobases of A2062 and A2503. Similar to mutation of Pro11 to Asn or Asp, 
mutation of Pro14 can potentially overcome the A2503G resistance mutation.  
Pro16 is situated in the vicinity of the PTC nucleotides U2506 and U2585. 
Substitution of Pro16 with the small amino acid Thr presumably leads to an additional 
hydrogen bond between the side chain OH-group and the nucleobase of U2506. 
Replacement with larger amino acids most likely does not lead to additional contacts 
because of the confined space at the position of Pro16.  
 Besides substitution of Pro residues, other substitutions most likely lead to 
reduced or loss of Api137 activity. In accordance, substitution of Arg17, which is crucial 
for RF1 trapping, results in dramatically reduced activity of Api137 (Castle et al., 1999). 
The only substitution at the C-terminus that seems to be possible is the replacement 
of Leu18. Leu18 appears to play a less critical role for Api137 action, since deletion of 
Leu18 shows milder effects than replacement of Arg17 by Ala (Krizsan et al., 2014). 
Nonetheless, Leu18 establishes two hydrogen bonds via the C-terminal OH-group with 
A76 of the deacyl-P-tRNA that contribute to stable binding of Api137. Substitution of 
Leu18 by other amino acid does not resolve the polar contacts of the OH-group but 
can potentially lead to additional contacts through the amino acid side chain. The most 
promising substitution represents an exchange of Leu18 by Arg. An Arg residue in 
position 18 can provide two additional contacts with the ribose of U2585 and U2586.  
Another possibility to improve the properties of AMPs is the fusion of two 
different AMP molecules resulting in a chimeric molecule. An example for such chimera 
AMPs are artilysins, which are the result of coupling of bacteriophage endolysins with 
another AMP (Briers and Lavigne, 2015; Briers et al., 2014a; Briers et al., 2014b; 
Defraine et al., 2016). Endolysins decompose the peptidoglycan of the bacterial cell 
wall. By fusion to other AMPs uptake of endolysins into the cytoplasm of Gram-
negative bacteria is promoted. In the context of PrAMPs, fusion of class I and class II 
PrAMPs can possibly improve the overall binding activities. Although the orientation of 
class I and class II PrAMPs is different (Florin et al., 2017; Graf et al., 2017b), an 
interesting combination would be a chimera consisting of Api137 and pyrrhocoricin. 
Compared to class I PrAMPs (Graf et al., 2017b), Api137 establishes more contacts 
within upper nascent polypeptide exit tunnel (Florin et al., 2017). This contrasts 
pyrrhocoricin, which establishes primarily contacts with the A-site binding pocket and 
the A-site crevice (Gagnon et al., 2016; Seefeldt et al., 2016). Superimposition of 
pyrrhocoricin and Api137 shows that Pro16 of Api137 and Pro8 of pyrrhocoricin are 
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located in the same position within the tunnel (Figure 12B). Using the N-terminal 
residues of pyrrhocoricin with a reversed amino acid sequence, it would be possible to 
fuse the sequence ‘PLYSGKDV’ to a truncated derivate of Api137, which is lacking 
Arg17 and Leu18. The result is a chimeric PrAMP, which reaches into the A-site 
binding pocket while establishing additional interactions within polypeptide tunnel. 
However, it is not clear whether the reversed sequence of pyrrhocoricin still exhibits 
the same contacts within the A-site crevice and A-site binding pocket. Nonetheless, 
this approach is one possible example for the improvement of PrAMPs. 
 
Implications for toxicity of Api137 in eukaryotes 
 
As described before, usage of PrAMPs as therapeutics requires low toxicity in humans. 
Since PrAMPs target the 70S ribosome and inhibit protein synthesis of eubacteria, it 
needs clarification whether PrAMPs inhibit human translation as well. To have an 
inhibitory effect on human cells it requires first, the uptake of PrAMPs into the 
cytoplasm and second, binding to the eukaryotic ribosome. With regard to Bac7, our 
biochemical data show that Bac7 is capable of inhibiting in vitro protein synthesis in a 
rabbit reticulocyte extract (Seefeldt et al., 2016). Similarly, it is necessary to validate 
whether Api137 can bind and inhibit human 80S ribosomes. Our cryo-EM structure of 
70S ribosomes in complex with RF1 and Api137 shows that Api137 binding primarily 
involves interactions with universally conserved rRNA residues (RNAcentral, 2017) 
and the GGQ motif at the tip of RF1 domain III (Florin et al., 2017). The latter GGQ-
motif is conserved within bacteria as well as evolutionary unrelated eukaryotic eRF1 
(Frolova et al., 1999; Mora et al., 2003; Seit-Nebi et al., 2001; Shaw and Green, 2007; 
Zavialov et al., 2002). Assuming that Api137 is taken up by human cells, the 
conservation of both rRNA residues and the GGQ-motif of the class I release factors 
implies that Api137 is active against human 80S ribosomes and hence would be 
unsuitable for use as a therapeutic. Superimposition of a mammalian 80S ribosome in 
complex with eRF1 (Shao et al., 2016) and the 70S E. coli ribosome in complex with 
RF1 and Api137 (Florin et al., 2017) shows that binding of Api137 is in principle 
compatible with binding to both eubacterial and eukaryotic ribosomes. All observed 
contacts between Api137 and the 70S-RF1 complex could be established with an 80S-
eRF1 complex as well. Therefore, inhibition of human translation termination by Api137 
seems to be likely. Nonetheless, inhibition of human 80S ribosomes would still require 
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uptake of Api137 from the extra-cellular space. Gram-negative bacteria, like E. coli, 
actively uptake Api137, even at low concentrations, with the SbmA transporter. This 
transporter is absent from eukaryotic cells. Consistently, uptake of PrAMPs into the 
cytoplasm of human cells would require diffusion through the plasma membrane but 
this is unlikely due to the properties of Api137. Similar to most of the AMPs, Api137 
exhibits a positive net charge that has been suggested to interfere with the lytic action 
or uptake of AMPs into eukaryotic cells (Yeaman and Yount, 2003). Bacterial cells 
exhibit a negatively charged cytoplasmic membrane surface, which promotes 
adsorption of positively charged AMPs and subsequent insertion into the membrane 
or uptake into the cell. Eukaryotic membranes, by contrast, exhibit a more neutral 
surface that do not promote adsorption of AMPs. Future experiments will be required 
to determine in vivo and in vitro whether Api137 is taken up by human cells and 
whether it is toxic or even teratogenic. A possibility to test for toxicity or teratogenicity 
in vivo are studies with mice or zebrafish embryos (Nagel, 2002). Inhibition of protein 
synthesis can be tested in vitro by the previously mentioned rabbit reticulocyte extract 
or, alternatively, using wheat germ extract.  
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ABSTRACT  
During translation termination in prokaryotes, the decoding release factors RF1 and RF2 are recycled 
from the ribosome by the translational GTPase RF3. While high-resolution structures of the 
individual termination factors on the ribosome exist, direct structural insight into how RF3 mediates 
dissociation of the decoding release factors has been lacking. Here we present an ensemble of cryo-
electron microscopy structures of translation termination complexes simultaneously bound with both 
RF1 and RF3. Binding of RF3 to the ribosome induces small subunit (SSU) rotation and swivelling 
of the head, yielding intermediate states with shifted P-site tRNAs and RF1 conformations. RF3 does 
not directly eject RF1 from the ribosome, but rather induces full rotation of the SSU that indirectly 
dislodges RF1 from its binding site. SSU rotation is also coupled to the accommodation of the GTPase 
domain of RF3 on the large subunit (LSU), thereby promoting GTP hydrolysis and dissociation of 
RF3 from the ribosome.  
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The termination phase of translation is signalled by the appearance of a stop codon of the mRNA 
within the A-site of the ribosome. In bacteria, stop codons are recognized by the decoding release 
factors RF1 and RF2, which facilitate release of the nascent polypeptide chain attached to the P-site 
tRNA1-4. RF1 and RF2 display distinct but overlapping stop codon specificities, such that RF1 
decodes UAG and UAA and RF2 decodes UGA and UAA. Both RF1 and RF2 contain a universally 
conserved GGQ motif that is critical for peptide release5-9. Structures of RF1 and RF2 in complex 
with termination state ribosomes have revealed how conserved residues within the superdomain 2/4 
specifically recognize the stop codon on the small subunit (SSU)10-14. On the large subunit (LSU), the 
conserved GGQ motif within domain 3 is located at the peptidyltransferase center (PTC) and 
facilitates peptidyl-tRNA hydrolysis10-14. Following peptidyl-tRNA hydrolysis, the decoding RFs 
dissociate from the ribosome in a process that is stimulated by the action of a third release factor, the 
translational GTPase RF315,16.  
Crystal structures of RF3 confirm structural similarity to other translational GTPases such as 
EF-Tu17,18. Like EF-Tu, RF3 binds to the ribosome with high affinity in the GTP form19-23. GTP 
hydrolysis is not required for the decoding factors to dissociate from the ribosome21,22, but rather 
facilitates dissociation of RF3 from the ribosome22,23. RF3-GTP binds to ribosomes irrespective of 
the presence or absence of the decoding release factors, and also interacts with both pre- and post-
hydrolysis complexes21-23. Biophysical studies indicate that binding of RF3 in the GTP form promotes 
the conversion of non-rotated RF1- or RF2-bound ribosomes into a rotated state22,24,25. Recently, an 
antimicrobial peptide that binds to the post-hydrolysis ribosome and prevents RF1 dissociation has 
been reported (Fig. 1a)22,26. This peptide, named apidaecin137 (API), prevents RF1 dissociation even 
in the presence of RF322. 
Cryo-EM and X-ray structures exist of RF3-GDP(C/N)P (non-hydrolysable GTP analogues) 
bound to rotated ribosomes with P/E-hybrid state tRNAs but without the decoding release factors 
(Fig. 1b)17,27-29. Although the RF3 binding site overlaps with that of other translational GTPases, such 
as EF-Tu and EF-G, the G-domain of RF3 adopts a distinct orientation on the ribosome28,29. 
Superimposition of the RF3 and RF1/RF2 ribosome structures revealed no overlap in the factor 
binding sites, suggesting that RF3 indirectly promotes RF1/RF2 dissociation via inducing ribosomal 
subunit rotation14,17,28-30. A low-resolution (9.7 Å) cryo-EM structure of RF1 and apo-RF3 (no 
nucleotide form) bound to a non-rotated ribosome has been determined30, however, the physiological 
relevance of this complex remains unclear21,23. By contrast, structures of decoding factors on 
termination state ribosomes in the presence of the active GTP-like form of RF3 have so been lacking. 
 Here we present an ensemble of structures of ribosomes with tRNA, RF1 and RF3 bound 
simultaneously. The structures reveal that binding of RF3-GDPCP to the complex induces rotation 
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of the SSU relative to the LSU. RF3 does not interact with RF1 in any of the structures, but rather 
mediates dissociation of RF1 indirectly by inducing SSU rotation. SSU rotation also facilitates 
accommodation of RF3 on the LSU, where the G domain interacts with the sarcin-ricin loop (SRL), 
which is necessary to stimulate GTP hydrolysis. Thus, RF3-mediated subunit rotation plays a dual 
role during termination, namely, to dislodge the decoding release factors from the ribosome, but also 
to facilitate dissociation of RF3 itself. 
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RESULTS 
Cryo-EM structures of termination complexes bearing RF1 and RF3 
In order to visualize both RF1 and RF3 simultaneously on the ribosome, we initially assembled a 
termination complex in vitro with RF1-GAQ mutant decoding a UAA stop codon in the A-site. This 
ribosome-tRNA-RF1 complex was then briefly incubated with RF3-GDPCP before being applied to 
cryo-grids and plunge-frozen. A low-resolution cryo-EM analysis revealed that the termination 
complex could be sorted into 8 classes, the majority of which contained either non-rotated ribosomes 
with RF1 but no RF3 or rotated ribosomes bearing RF3 but no RF1 (Supplementary Fig. 1a). The 
single class that appeared to contain both RF1 and RF3 had strong density for RF3 but poor density 
for RF1. Binding of RF1 and RF3 to the ribosome thus appeared to be nearly mutually exclusive, 
suggesting that RF3-GDPCP could recycle RF1-GAQ from the termination complex ribosomes, 
which is consistent with previous biochemical reports22,24,25. To increase the proportion of termination 
complexes containing both RF1 and RF3 bound simultaneously, we repeated the experiment in the 
presence of API, which was previously shown to prevent RF1 dissociation even in the presence of 
RF3-GTP26. Because API binds to the exit tunnel and replaces the nascent peptide, by addition of 
API we selectively stabilized those complexes where the nascent peptide was released despite the use 
of the RF1 mutant that is slow in catalysing hydrolysis of peptidyl-tRNA7,9. Using this complex, cryo-
EM data was collected on a Titan Krios transmission electron microscope (TEM) with a Falcon II 
direct electron detector (DED) and processed with RELION 2.131. A total of 525,595 ribosomal 
particles were sorted into eight distinct ribosomal subpopulations (Supplementary Fig. 1b). The four 
major subpopulations, states I-IV (15.2-22.4%; 79,975-117,725 particles), all contained P-site tRNA, 
RF1 and RF3 but were conformational distinct from one another (Fig. 1c-f). States I-IV were refined 
to average resolutions of 3.8 Å (State I, II) and 3.9 Å (State III and IV) (Supplementary Fig. 1c-g 
and Table 1). Additionally, four minor subpopulations were present in the dataset, resulting in two 
additional low-resolution 70S-RF1-RF3 populations (see Methods), vacant 50S subunits (10.3%, 
53,850 particles) and RF3 bound to rotated vacant 70S ribosomes (5.8%, 30,535 particles) 
(Supplementary Fig. 1b). Since the latter subpopulation did not contain a P/E-tRNA, we believe it 
represents a state where RF3-GDPCP bound directly to vacant 70S ribosomes, rather than to the 
ribosome-RF1-GAQ complexes. Local resolution calculations of the RF3-70S complex revealed that 
while the core of the ribosomal subunits reaches 4.0 Å (Supplementary Fig. 2a,b), there is high 
conformational flexibility in this state. This is particularly evident in the rotation of SSU relative to 
the LSU and swivelling of the SSU head, but also in the positioning of the L1 stalk and RF3 itself 
(Supplementary Fig. 2a,b). By contrast, states I-IV are more conformationally homogeneous, with 
local resolutions reaching 3.5 Å within the core of both ribosomal subunits. Flexibility is 
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predominantly observed at the periphery of the ribosome, namely, for the L1, L11 and L7/L12 stalks 
where local resolutions exceeded 7.5 Å (Supplementary Fig. 2a,b). Local resolution calculations 
also indicated some conformational flexibility within the ribosome-bound ligands (Supplementary 
Fig. 2c). The resolution of the P-site tRNA and RF1 was highest (3.5-4.0 Å) for the regions that 
interact with the SSU and LSU, whereas the linking regions were significantly worse (>7.5 Å), such 
as the elbow of the tRNA, RF1 domain I and the linker between domains II and III of RF1 
(Supplementary Fig. 2c). In states I-IV, the local resolution of the ligands was significantly better 
than that observed in the RF3-70S complex (Supplementary Fig. 2c). Molecular models of states I-
IV and the RF3-70S complex were initially generated using rigid-body and domain-wise fitting of 
the ribosomal subunits, tRNA, RF1 and RF3 crystal structures to the cryo-EM map density, before 
manual adjustment, refinement and validation (Supplementary Fig. 2d; see Methods; Table 1). All 
states contained API bound within the ribosomal exit tunnel, where the interaction between Arg17 of 
API and the Gln235 (Q235 of the GGQ motif) of RF1 (Supplementary Fig. 3a-e) traps RF1 on the 
ribosome as reported previously26. 
 
Binding of RF3 induces ribosomal subunit rotation and head swivel 
The major global movements distinguishing states I-IV and the RF3-70S complex are the rotation of 
the SSU relative to the LSU as well as swivelling of the SSU head relative to the body (Fig. 2a-e and 
Supplementary Video 1). The previously reported X-ray crystallography structures of RF3-70S 
complexes28,29 revealed SSU rotation of ~10° (clockwise when viewed from the intersubunit 
interface) compared to a classical (non-rotated) ribosome, such as the RF1-API-70S complex26 
(Supplementary Table 1). We also observed a similar degree of subunit rotation in the RF3-70S 
complex (Fig. 2a), whereas states I, II, III and IV displayed a range of intermediate levels of rotation, 
namely, 0.8°, 1.8°, 5.5° and 9.6°, respectively (Fig. 2b-e and Supplementary Video 1). In the X-ray 
crystallography structures of the RF3-70S complexes, the degree of head swivel differed dramatically 
from one another and was suggested to be dependent on the presence or absence of the hybrid P/E-
site tRNA28,29. In the absence of the P/E-site tRNA, the head was swivelled ~14° compared to the 
body29, whereas only ~3-4° head swivelling was observed when the P/E-site tRNA was present28 
(Supplementary Table 1 and Supplementary Video 2). In our RF3-70S complex lacking a tRNA 
(Supplementary Fig. 2), we observed an intermediate level (~6°) of head swivel (Fig. 2a, 
Supplementary Table 1 and Supplementary Video 2). However, as noted above, the head is highly 
dynamic in our RF3-70S complex (Supplementary Fig. 2a,b) and thus the value reflects an average 
of multiple different swivel conformations of the head. This supports the suggestion that the large 
degree of head swivel observed in one of the X-ray crystallography structure of the RF3-70S complex 
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is indeed due to the absence of the P/E-site tRNA29. Consistently, in states I-IV that contain P- or 
P/E-site tRNAs, the maximum head swivel observed was ~3.6° (Fig. 2b-e and Supplementary Table 
1). Moreover, the degree of head swivel appeared to be loosely correlated to that of subunit rotation, 
as the degree of swivelling also increased from state I to IV, namely, 1.1° to 3.6°, respectively (Fig. 
2b-e). The degree of rotation (~10°) and head swivel (~4-6°) observed here in state IV and RF3-70S 
complex is similar to that observed previously for translation elongation states with hybrid A/P- and 
P/E-site tRNAs (Table S1)32-37. 
 
Subunit rotation leads to P-site tRNAs with remodelled P-loop interactions 
The SSU rotation and head swivel observed in states I-IV is also accompanied by a corresponding 
shift of the P-site tRNA (Fig. 3a and Supplementary Video 1). Compared to the classical P-site 
tRNA in the RF1-API-70S complex in the absence of RF3, the tRNA is rotated towards the E-site by 
~13° in state I-III and by ~38° in state IV (Fig. 3a). For state IV, this generates a hybrid P/E-tRNA 
where the CCA-end of the tRNA interacts with the E-site on the LSU, as observed for hybrid P/E-
site tRNA during translation elongation32-37. By contrast, the intermediate P-site tRNA positions 
observed in states I-III still have the CCA-end located at the peptidyl-transferase center (PTC) of the 
LSU. A classical P-site tRNA is positioned at the PTC via base-pairing of the C74 and C75 of the 
CCA-end of the P-site tRNA with nucleotides G2252 and G2251, respectively, of the P-loop (helix 
H80) of the 23S rRNA (Fig. 3b). By contrast, the rotation of the P-site tRNA observed in states I-III 
results in a shift of the CCA-end of the P-site tRNA out of the PTC by ~9 Å (Fig. 3c,d). Surprisingly, 
we observed re-base-pairing of the CCA-end of the P-site tRNA intermediate with the P-loop 
nucleotides, such that C74 and C75 were base-paired with G2253 and G2252, respectively. In 
addition, A73 of the P-site tRNA appeared to flip to establish a non-canonical wobble base-pair with 
C2254 (Fig. 3c,d). In contrast to the canonical P-site tRNA where the electron density was clearly 
resolved for the complete CCA-end, no density was visible for the terminal A76 of the P-site tRNA 
intermediate in states I-III, therefore assignment of the acylation state of the Pint-tRNA was not 
possible (Supplementary Fig. 3f-h). We do not believe that the CCA-end of the Pint-tRNA is shifted 
by two nucleotides, such that A76, C74 and C75 base-pair with G2252, G2253 and C2254, 
respectively, because the density does not support a purine-purine (A76-G2252) interaction in the 
first position, nor a pyrimidine-pyrimidine (C74-C2254) interaction at the third position 
(Supplementary Fig. 3i). Moreover, the density for A73 observed in the P/P-tRNA is not observed 
in the Pint-tRNA (Supplementary Fig. 3j-l), which would be expected if C74 interacts with C2254 
and prevents A73 from establishing this interaction. Regardless of one or two nucleotide shift, to our 
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knowledge, such re-base-pairing of the CCA-end of a P-site tRNA with the P-loop has not been 
observed previously. 
 
Subunit rotation is concomitant with RF3 accommodation on the large subunit 
In the RF3-70S complex and states I-IV, RF3 is observed to rotate as a rigid body together with the 
SSU (Fig. 4a and Supplementary Video 1). The overall conformation of RF3 is the same as observed 
in the previous RF3-70S complexes28,29, differing from the free RF3 form by the shift of domains 2 
and 3 relative to domains 117,18,28,29. Because of the coordinated movement of RF3 with the SSU, the 
interactions between domain 2 and 3 of RF3 with ribosomal protein S12 and helices h5 and h15 of 
the 16S rRNA, as described previously28,29, are maintained in all states. Relative to the LSU, however, 
RF3 moves by up to 10-11 Å when comparing states I to IV, bringing the G-domain of RF3 in state 
IV into closer proximity of the sarcin-ricin loop (SRL, H95 of the 23S rRNA) (Fig. 4b and 
Supplementary Fig. 4a). Because the SRL is critical for stimulating the GTPase activity of 
translation factors38, this suggests that the SSU rotation is necessary for efficient activation of the 
GTPase activity of RF3. Evidence for progressive accommodation of translational GTPases on the 
LSU, as well as GTPase activation by the SRL, has been observed for other translational GTPases, 
such as eEF1A39, SelB32 and EF-Tu40 (Supplementary Fig. 4b). However, in these latter cases, the 
translational GTPases bind to non-rotated ribosomes and accommodation of the GTPase appears to 
be mediated by SSU domain closure32,39-41, rather than by rotation as observed here for RF3. Despite 
the sequence and structural conservation of the G-domain of RF3 with other translation GTPases, the 
G-domain of RF3 adopts a distinct orientation on the ribosome28,29. With respect to the SRL, the G-
domain of RF3 is rotated by 24-31° when compared with other translational GTPases, such as IF2, 
EF-Tu and EF-G (Supplementary Fig. 4c-f). Within the limits of the resolution, the switch II loop 
conformation of the G-domain of RF3 in states I-IV is consistent with that observed in previous 
structures of RF317,18,28,29, where it interacts with the  g-phosphate of the GDPCP (Fig. 4c). While the 
switch I loop is poorly ordered in states II-IV, we observed a well-defined conformation in state I, 
where it interacts with ribosomal proteins L14 and L19, but not with the SRL (Fig. 4c). The switch I 
loop is disordered in many previous structures of RF317,18,28, although ordered conformations were 
previously reported in the E. coli RF3-70S structure29 as well as the Desulfovibrio vulgaris RF3 in 
complex with the alarmone ppGpp18. However, they are significantly different from that observed 
here in state I (Supplementary Fig. 5a-f). The interaction of the switch I loop conformation of RF3 
with L14 and L19 is the only direct contact that RF3 establishes with the LSU in state I, and thus may 
be important for facilitating accommodation of RF3 on the ribosome. 
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A dual role for L7/L12 during translation termination 
The GTPase activity of translational GTPases, such as EF-Tu and EF-G42,43 as well as RF344, is 
stimulated by the ribosomal L7/L12 stalk, a pentameric complex consisting of four copies of L7/L12 
tethered to the ribosomal protein L10. In states I-IV, we observe an additional density that we attribute 
to the C-terminal domain (CTD) of one copy of L7/L12 interacting with the G’ domain of RF3 (Fig. 
5a,b), as observed in previous RF3-70S cryo-EM structures17,30, and consistent with NMR45 and 
mutagenesis studies44. L7/L12 was shown to stimulate Pi release from EF-G following hydrolysis of 
GTP to GDP and Pi, enabling the low affinity GDP conformation of EF-G to be adopted and thereby 
facilitating the dissociation of EF-G from the ribosome46. However, L7/L12 has also been implicated 
in promoting binding of translational GTPases, such as EF-G and EF-Tu, to the ribosome43,47. 
Surprisingly, in state III, an extra density is observed that we attributed to a second CTD of L7/L12, 
which bridges domain I of RF1 with the ribosomal protein L11 (Fig. 5b). This extra density can also 
be seen in the cryo-EM map of the previously reported RF1-API-70S complex (Supplementary Fig. 
5g,h)26, but cannot be seen in states I-II and IV due to the delocalized RF1 domain I. In state III, 
domain I of RF1 is better resolved, compared to states I and II, due to head swivelling on the SSU 
and closure of the L11 stalk base of the LSU (Fig. 5b). By contrast, transition from state III to IV 
involves additional head swivelling and opening of the L11 stalk base, which leads to loss of 
interaction and destabilization of domain I of RF1 (Fig. 5c). Thus, our observations suggest that in 
addition to stimulating the GTPase activity of RF3, L7/L12 may also be involved in facilitating the 
binding of the termination decoding factors to the ribosome. To test this hypothesis we prepared 
ribosome termination complexes using L7/L12-depleted (∆L7/L12) ribosomes42 and determined the 
apparent affinity of RF1 by peptide hydrolysis (Fig. 5d, see Methods). The ∆L7/L12 ribosomes 
showed a markedly decreased affinity for RF1, compared to wildtype (wt) ribosomes bearing L7/L12 
(Fig. 5d). We further confirmed this result by measuring the kinetics of RF1 binding via fluorescence 
resonance energy transfer from a dye-labeled fMet-tRNAfMet and a quencher-labeled RF1-GAQ 
(RF1-GAQQsy9) (Fig. 5e)26. Binding of RF1-GAQ to the ∆L7/L12 ribosomes was 150-fold slower 
than to wt ribosomes, indicating that the contribution of L7/L12 to RF1 recruitment is large. 
	
Subunit rotation leads to destabilization of RF1 on the ribosome 
Unlike the previous low-resolution (9.7 Å) cryo-EM structure of apo-RF3-RF1-70S complex where 
contact was reported between RF1 and RF330, we do not observe interaction between RF1 and RF3 
in any of the structures determined here. The closest distance between the two factors is seen in state 
III where domain I of RF1 becomes ordered such that a-helix 2 of domain 1 of RF1 comes within 
9 Å of RF3 domain 3 (Fig. 5b). Thus, we conclude that RF3 does not use a direct steric overlap in 
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binding site to dissociate RF1 from the ribosome. Instead, our results suggest that RF3 dislodges RF1 
from its binding site, indirectly, by inducing SSU rotation, as postulated previously17,28,29. The density 
for RF1 remains well-resolved through-out states I-III, indicating that RF1 is stably bound to the 
ribosome despite the increase in rotation (0.8-5.5°) of the SSU (Fig. 6a). By contrast, the density for 
RF1 is poorly resolved in state IV, indicating that RF1 becomes destabilized from its binding site on 
the ribosome (Fig. 6a,b). Increased flexibility of RF1 in state IV is also supported by local resolution 
calculations (Supplementary Fig. 2c). Transition from state III to IV involves further clockwise 
rotation of the SSU (from 5.5° to 9.6°), which results in a shift of domain 2/4 of RF1 by 4 Å compared 
to state III (Fig. 6a,c). Because domain 3 of RF1 remains static at the PTC of the LSU, the movement 
can be described by a rotation of 6° that is accommodated by the long flexible linkers connecting 
domain 2/4 with domain 3 of RF1 (Fig. 6c). We believe that it was possible to capture the RF1 
conformation in state IV only because the complex was formed in the presence of API, which 
prevented the complete dissociation of RF1 from the rotated ribosome. We note that transition from 
state III to IV also encompasses additional head swivel (from 1.6° to 3.6°) as well as opening of the 
stalk base (Fig. 5c), both of which destabilize domain 1 of RF1 and may facilitate dissociation of RF1 
from the ribosome. Additionally, the formation of a hybrid P/E-tRNA due to the fully rotated SSU in 
state IV also leads to loss of interaction of RF1 with the P/P-tRNA, which may also contribute to 
destabilization of RF1 binding. Specifically, the interactions between Glu155 and His156 in domain 
2/4 and Arg256 in domain 3 of RF1 with the ASL and CCA-end of a P/P-tRNA, respectively, are lost 
upon P/E-tRNA in state IV (Fig. 6d,e). 
 
CONCLUSION 
Based on our ensemble of termination intermediates (states I-IV), as well as the available literature, 
we present a model for RF3-mediated dissociation of RF1 during translation termination (Fig. 7a-e). 
A stop codon in the A site is recognized by the decoding factors RF1 (or RF2), which catalyse 
hydrolysis of the peptidyl-tRNA (Fig. 7a). The observed interaction between the CTD of one copy 
of L7/L12 and domain 1 of RF1 in the RF1-API-70S complex (Fig. 7a), as well as the RF1-API-RF3-
70S complex (state I), is supported by our experimental findings (Fig. 5d,e) showing that L7/L12 
plays an important role in delivery of RF1 to the ribosome, as reported previously for EF-Tu and EF-
G42,43. To date, all reported structures of decoding factors RF1 (and RF2) were bound to ribosomes 
with non-rotated conformations14, including the apo-RF3-RF1-70S complex30. By contrast, we 
observe that binding of RF3 to the ribosome in states I-IV that contain RF1 induces rotation of the 
SSU relative to the LSU (Fig. 7b-e). While we have ordered states I-IV based on the degree of subunit 
rotation, we acknowledge that the exact biological sequence of states cannot be ascertained from our 
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study. Nevertheless, we believe that this order produces a logical sequence of events that provide a 
working model for decoding factor recycling by RF3. In state I, we observe that even a small degree 
(0.8°) of subunit rotation induced by RF3 results in a shifted position of the P-site tRNA, such that it 
partially rotates out of the PTC in the direction of the E-site (Fig. 7b). The resulting intermediate P-
site tRNA (Pint-tRNA) displays unusual base-pairing between the CCA-end of the tRNA and the P-
loop of the PTC (Fig. 3). Moreover, we observe ordering of the switch I loop in the G domain of RF3 
(Fig. 4c), which establishes the sole interaction with the LSU and maybe therefore be important for 
accommodation of RF3 on the ribosome. Further subunit rotation (+4.7°) as well as the head swivel 
observed in state III leads to a stabilization of domain 1 of RF1 and further accommodation of RF3 
on the LSU (Fig. 7c). In state III, domain I of RF1 comes within 9 Å of RF3 (Fig. 5b), which is the 
closest distance between the two factors in any of the structures reported here. The absence of 
interaction between RF1 and RF3 in states I-IV indicates that RF3 must indirectly induce RF1 
dissociation from the ribosome. Indeed, in state IV, we observe that further rotation (+4.1°) of the 
SSU leads to a destabilization in the binding of RF1 (Fig. 7d). We note that transition from states III 
to IV also encompasses additional head swivelling and movement of the L11 away from RF1, as well 
as loss of interaction with the P/E-tRNA, which may also contribute to the destabilization of RF1 
binding (Fig. 5c). The large degree (9.6°) of SSU rotation observed in state IV brings the G domain 
of RF3 into close proximity of the SRL on the LSU (Fig. 7d). Thus, we predict that subunit rotation 
is necessary to stimulate the GTPase activity of RF3 and thereby facilitate dissociation of the low 
affinity RF3-GDP from the ribosome (Fig. 7d). As reported previously, we also observe interaction 
of the CTD of L7/L12 with the G’ domain of RF3 in states I-IV, suggesting that L7/L12 may also 
play a role in GTPase activation and dissociation of RF3 (Fig. 7d). Because RF1 and RF3 are trapped 
on the ribosome with API and GDPCP in our structures, we cannot distinguish the order of 
dissociation of RF1 and RF3. Nevertheless, our structures suggest that RF1 and RF3 dissociation are 
both coupled to full rotation of the SSU, and are therefore likely to occur within a very similar 
timeframe, as reported recently using biophysical assays22,48. We note the product remaining after the 
action of RF1 and RF3 is a rotated ribosome complex with a hybrid P/E-site tRNA, which is the exact 
substrate for the next phase of translation, namely, ribosome recycling via the binding of RRF and 
EF-G49-53 (Fig. 7e). 
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METHODS 
Preparation of the ribosomal complex  
Ribosomes from the E. coli strain MRE600, initiation factors, fMet-tRNAfMet and its fluorescein-
labeled derivative were prepared as described54,55. L7/L12 depleted ribosomes were prepared by 
NH4Cl and ethanol treatment as described42.  The ribosome complexes were assembled on the 
synthetic ‘start-stop’ mRNA as follows: 70S (1 µM), initiation factors 1, 2 (2 µM) and 3 (1.5 µM), 
start-stop mRNA (3 µM) and f[3H]Met-tRNAfMet (1.5 µM) were incubated in buffer A (30 mM 
HEPES pH 7.4, 70 mM NH4Cl, 5 mM MgCl2, 30 mM KCl) in the presence of GTP (1 mM) for 30 
minutes at 37°C and purified through sucrose cushion as described23. The ribosome pellets were 
resuspended in buffer A, flash frozen in liquid nitrogen, and stored at −80°C.  
 
E. coli strain and growth conditions 
E. coli BL21 strain was used for the expression of RF1-GAQ and RF3. Cells were grown in LB 
medium supplemented with the required antibiotic, and expression was induced by addition of 
0.5 mM IPTG. 
 
Purification of peptide chain release factors 
RF1, RF1-GAQ (RF1-G234A), RF3 and the single-cysteine RF1-GAQ were expressed and purified 
by affinity chromatography as described22,26. RF1-GAQ was labeled with Qsy922. 
 
Cryo-grid preparation for the 70S-tRNA-RF1-RF3 complex 
All following steps were performed in buffer B (30 mM HEPES pH 7.4, 70 mM NH4Cl, 5 mM MgCl2, 
30 mM KCl). For grid preparation, 5 OD A260/ml of ribosomes were used. RF3 was initially incubated 
with 1 mM of GDPCP at 37°C for 15 minutes. Subsequently, the ribosome-tRNA complexes were 
incubated with a 2.5x excess of the RF1-GAQ mutant and with or without 50 µM API (NovoPro 
Biosciences Inc.) for 1 minute at room temperature. Afterwards a 7.5x excess of RF3-GDPCP over 
70S ribosomes was added to the RF1-GAQ containing ribosome complexes and kept on ice for less 
than 5 minutes before cryo-grid preparation. All samples were applied to 2 nm precoated Quantifoil 
R3/3 holey carbon supported grids and vitrified using a Vitrobot Mark IV (FEI company).  
 
Cryo-electron microscopy and single-particle reconstruction.  
The low resolution data collection of the 70S-tRNA-RF1-RF3 complex, which was prepared in the 
absence of API, was conducted using a Tecnai G2 Spirit TEM equipped with a TemCam-F816 camera 
(TVIPS) at 120 kV using a pixel size of 2.85 Å. The high resolution data collection of the 70S-tRNA-
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RF1-RF3 complex, which was prepared in the presence of API, was performed using an FEI Titan 
Krios transmission electron microscope equipped with a Falcon II direct electron detector at 300 kV 
using a pixel size of 1.061 Å and an under-defocus range of -0.8 to -1.6 µm resulting in a total number 
of 5,670 micrographs. Each micrograph was recorded as a series of 16 frames (2.7 e-/Å2 pre-exposure; 
2.7 e-/Å2 dose per frame). All frames (accumulated dose of 45.9 e−/Å2) were aligned using the Unblur 
software56, and power spectra, defocus values, astigmatism and estimation of micrograph resolution 
were determined by GCTF57. Micrographs showing Thon rings beyond 4.0Å resolution were further 
used. Automatic particle picking was performed using Gautomatch (http://www.mrc-
lmb.cam.ac.uk/kzhang/), and single particles were processed using the Relion2.1 software package31. 
Initial 2D classification/alignment was performed with 703,379 particles. Subsequently, promising 
2D classes with a total number of 525,595 ribosomal particles were selected and subjected to 3D 
refinement using an E. coli-70S ribosome as a reference structure. Initial alignment and subsequent 
3D classification was performed using 3-times decimated data. The initially refined particles were 
3D classified into 8 classes. Class 1 to 4 were refined again and subjected to another 3D classification. 
Sorting of class 1-4 resulted in 4, 4, 3 or 3 additional subclasses, respectively. The most stable sub-
class of each 3D classification was then 3D-refined. To further increase the resolution of RF3, we 
applied a focussed mask on RF3. For 3D classification, the same reference was used as for the 3D 
refinement. The maximum resolution was observed for state I and state II, extending to <3.9 Å 
(FSC0.143) (Supplementary Fig. 1). The local resolution of the final maps was computed using 
ResMap58 (Supplementary Fig. 2). The final maps were sharpened by dividing the maps by the 
modulation transfer function of the detector and by applying an automatically determined negative B 
factor to the maps using Relion2.131. For model building the final maps were locally filtered using 
the SPHIRE cryo-EM software suite59. Resolution was estimated using the ‘‘gold standard’’ criterion 
(FSC = 0.143)60,61. 
 
Molecular modelling and map-docking procedures  
The molecular models for the ribosome were based on the E. coli-70S-EF-Tu structure (PDB: 
5AFI)62. The models of RF3 and GDPCP are based on the structure of E. coli RF3-GDPNP bound to 
Thermus thermophilus 70S (PDB: 4V85)29. The structure of RF1-GAQ and API is based on the 
recently published E. coli-70S-API-RF1 structure (PDB: 5O2R)26. The tRNAfMet in the classical state 
is derived from an E. coli 70S initiation complex containing the ribosomal rescue factor ArfA (PDB: 
5U9F)63. The tRNAfMet in the P/E hybrid state is based on the hybrid state tRNAfMet from the T. 
thermophilus RF3-GDPCP-70S structure (PDB: 4V8O)28. The rRNA domains and proteins were 
rigid-body fitted into the respective EM-map using Chimera 64. The models were manually adjusted 
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and refined using Coot65. Due to the lack of density, domain I of RF1-GAQ was not modelled for 
states I-II and IV, whereas it was possible to generate a poly-Ala model of domain I of RF1-GAQ for 
state III. The complete atomic model of the respective complexes were refined into the locally filtered 
maps using phenix.real_space_refine with secondary structure restraints calculated by PHENIX 
1.1366. Cross-validation against over-fitting was performed as described elsewhere67. The statistics 
of the refined model were obtained using MolProbity68 (Table 1). 
 
Calculation of rotation angles  
Rotation angles were calculated using PyMol Molecular Graphics Systems (Version 1.8 Schrödinger) 
(Supplementary Table 1). The body/platform (including h44) rotation was calculated relatively to 
the 50S ribosomal subunit. Accordingly, for body/platform rotations the molecular models were 
aligned based on the 23S rRNA using state I (this study) as reference. The head swivel was calculated 
relatively to the 30S body/platform. In order to get comparable values for head swivelling, the 
compared molecular models were aligned based on the 16S rRNA of the body/platform using state I 
(this study) as reference.  
 
RMSD and vector calculations 
Root mean square deviation (RMSD) values were calculated between related alpha-carbon (protein) 
or phosphate atoms (rRNA) using PyMol Molecular Graphics Systems (Version 1.8 Schrödinger). 
The reported RF1-API-70S structure26 was used as reference. All compared models were aligned to 
the 50S subunit of state I (this study). The 30S protein or rRNA residues of the reference structure 
were colored according to the determined RMSD of each atom. Vectors were calculated between 
shifted alpha-carbon and phosphate atoms using the same reference26. The vectors were colored based 
on their length (distance between atoms).  
 
Peptide hydrolysis 
Ribosome termination complexes (10 nM) prepared with wildtype or ∆L7/L12 ribosomes were mixed 
with increasing concentrations of RF1 for 10 s at 37°C in buffer A. Reactions were quenched with a 
solution containing TCA (10%) and ethanol (50%). After centrifugation (30 min, 16,000 x g) the 
amount of released f[3H]Met in the supernatant was quantified by radioactive counting.  
 
Rapid kinetics 
Rapid kinetic experiments were performed on an SX-20MV stopped-flow apparatus (Applied 
Photophysics, Leatherhead, UK), by rapidly mixing equal volumes (60 µl) of reactants at 37°C in 
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buffer A. Binding of RF1-GAQ was monitored by mixing termination complex labelled with 
fluorescein (50 nM) with RF1-GAQQSY9 (300 nM). Fluorescein was excited at 470 nm and monitored 
after passing a KV500 filter (Schott, Mainz, Germany). 
 
Figure preparation 
All figures showing electron densities and atomic models were generated using UCSF Chimera64 and 
PyMol Molecular Graphics Systems (Version 1.8 Schrödinger).  
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FIGURES 
 
 
Figure 1 Structures of RF1- and RF3-containing termination complexes. (a-f) Schematic 
representation (above) and electron density (below) for termination complexes containing (a) RF1 
(orange) stalled by API on a non-rotated ribosome with a classical P/P-site tRNA (green)26, (b) RF3 
(cyan) trapped by GDPCP on a rotated ribosome with hybrid P/E-site tRNA28, (c-d) state I-IV with 
RF1-GAQ (orange), RF3-GDPCP (cyan) bound to (c-e) partially rotated ribosomes with intermediate 
P-site (Pint) tRNA (green) or (f) a fully rotated ribosome with a hybrid P/E-site tRNA (green). In the 
scheme, the SSU and LSU are colored yellow and grey, respectively, with A, P and E-sites and the 
L1 stalk indicated, whereas flexible regions are indicated by increased transparency. In the map 
overviews, the electron density for the SSU and LSU has been filtered locally and is shown as a grey 
transparency so that the ligands can be easily seen within the ribosome.  
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Figure 2 Subunit rotation and head swivel observed in RF3-70S and termination state I-IV 
complexes. (a-e) Schematic representation (upper row) and SSU structures illustrating the degree of 
rotation relative to non-rotated RF1-API-70S reference structure26 as shown for (a) RF3-70S, (b) state 
I, (c) state II, (d) state III and (e) state IV. The distance each atom shifts relative to the reference 
structure is directly colored on the SSU (second row), shown as colored lines connecting the same 
atoms between the reference and the shifted structure (third row). Superimposition of cryo-EM maps 
(row four) of shifted SSU (yellow) relative to reference SSU (grey) based on LSU alignments, with 
degrees of SSU rotation (clockwise as viewed from intersubunit interface) and head swivel indicated.  
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Figure 3 Small subunit rotation induces P-site tRNA rotation. (a) Comparison of the relative position 
of a classical P/P-tRNA (salmon) from the RF1-API-70S complex26 to Pint tRNA (green) 
conformation observed in state I and the hybrid P/E-site tRNA observed in state IV (slate), with the 
degree of rotation and distance shifted indicated. The P-loop of the 23S rRNA is shown for reference. 
(b) The P/P-site tRNA (salmon) in the RF1-API-70S complex26 and (c) the Pint-tRNA (green) in state 
I interact with nucleotides within the P-loop (H80) of the 23S rRNA. Potential hydrogen bonds are 
indicated with dashed lines. (d) Superimposition of (b) and (c).  
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Figure 4 Small subunit rotation leads to RF3 accommodation on the large subunit. (a) Two views of 
the cryo-EM maps of the 70S ribosome (different shades of blue) and RF3 (different shades of green) 
from states I-IV, illustrating the coupled rotation of the SSU and RF3 relative to the LSU. (b) 
Comparison of the binding site of RF3 in state I (pale cyan, sI:RF3) and state IV (teal, sIV:RF3) 
relative to ribosomal protein L6 (red) and sarcin-ricin loop (SRL, grey). The distance shifted of each 
domain (d1-d3) of RF3 between state I and IV is indicated. (c) View showing the G domain of RF3 
in state I (pale cyan, sI:RF3) with switch I (teal), switch II (slate), GDPCP and proximity to SRL 
(grey), ribosomal proteins L14 (tan) and L19 (green).  
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Figure 5 Interaction of L7/L12 with RF1 and RF3 in state III. (a) Overview showing the relative 
position of RF1 (orange), RF3 (pale cyan), L11 (light blue), 23S rRNA helix h33 (dark grey) and two 
copies of the L7/L12 CTD (purple) on the ribosome (light grey). (b) Comparison of state II position 
for RF3 (pale cyan), L11 and h33 (light blue) with state III positions for RF3 (teal), L11 and helix 
h33 (dark blue). In state III, RF1 domain I (orange) becomes ordered and density (grey mesh, filtered 
to 7 Å) for two copies of L7/L12 CTD (purple) are observed. (c) Comparison of state III positions 
from (b) with state IV positions for RF3 (pale cyan), L11 and h33 (light blue). (d) Peptide hydrolysis 
by RF1 in the presence of wildtype (wt, open circles) or L7/L12-depleted (∆L7/L12, closed circles) 
ribosomes. Pre-hydrolysis (PreHC) complexes (0.01 µM) were incubated with increasing 
concentrations of RF1 for 10 sec at 37°C. Solid lines represent the hyperbolic fit of the experimental 
points. Error bars represent the standard deviation of the mean for four technical replicates from two 
independent biological experiments. The apparent affinities of RF1 for wt and ∆L7/L12 PreHCs are 
9 ± 1 and 210 ± 30 nM, respectively. (e) Time courses of RF1-GAQQsy9 (0.3 µM) binding to PreHCFlu 
(0.05 µM) prepared with wt (red) or ∆L7/L12 (black) ribosomes. Buffer controls are shown in salmon 
and grey, respectively. Traces shown are the average of four to five technical replicates.  
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Figure 6 RF3-induced subunit rotation destabilizes RF1 binding. (a) Cryo-EM map of SSU (light 
blue) and RF1 (orange) from state III compared with SSU (dark blue) and RF1 (red) from state IV. 
(b) Isolated cryo-EM electron densities (grey mesh) with molecular models for RF1 from state III 
(orange) and state IV (red) shown at the same contour level based on comparison with the SSU 
density. (c) Domain 2/4 of RF1 from state III (sIII:RF1, orange) is rotated by 6° and shifted by 4 Å 
compared to RF1 from state IV (sIV:RF1, red). (d,e) Contacts (arrowed) between RF1 (orange) and 
P/P-tRNA (green) are lost upon formation of the hybrid P/E-tRNA (light blue). Amino acids of RF1 
that contact P/P-tRNA are shown as spheres. (e) Zoom of (d) showing the presence or absence of 
RF1 contacts with the ASL of P/P- or P/E-tRNA, respectively. 
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Figure 7 Model for RF3-mediated dissociation of RF1 from the ribosome. (a) Binding of decoding 
release factors, such as RF1 (orange) to the non-rotated termination state ribosome, leads to release 
of the nascent polypeptide chain (NC) from the P-site tRNA (green). Binding of RF1 to the ribosome 
is facilitated by interaction of L7/L12 CTD (purple) with domain 1 of RF1. (b) RF3 (cyan) in the 
GTP conformation binds to the ribosome–RF1 complex. RF3 binding induces a slight rotation of the 
SSU that promotes formation of the partially rotated P-site tRNA conformation (Pint-tRNA). (c) 
Additional SSU rotation and head swivel stabilizes domain I of RF1 and induces a closed 
conformation of L11 (Fig. 5b,c). (d) Further SSU rotation leads to destabilization of RF1, promoting 
its dissociation from the ribosome, as well as accommodation of RF3 on the LSU in close proximity 
to the sarcin-ricin loop (SRL), thus facilitating hydrolysis of GTP to GDP and dissociation of RF3-
GDP from the ribosome. (e) The rotated ribosome with a P/E-tRNA is recognized by the ribosome 
recycling factor (RRF) and EF-G, which recycle the post-termination complex for the next round of 
translation. 
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Table 1 Cryo-EM data collection, refinement and validation statistics. 
 State I 
(EMD 
xxxx, 
PDB xxxx) 
State II 
(EMD 
xxxx, 
PDB xxxx) 
State III 
(EMD 
xxxx, 
PDB xxxx) 
State IV 
(EMD 
xxxx, 
PDB xxxx) 
RF3-70S 
(EMD 
xxxx, 
PDB xxxx) 
Data collection      
Microscope FEI Titan 
Krios 
FEI Titan 
Krios 
FEI Titan 
Krios 
FEI Titan 
Krios 
FEI Titan 
Krios 
Camera Falcon II Falcon II Falcon II Falcon II Falcon II 
Magnification 131,951 131,951 131,951 131,951 131,951 
Voltage (kV) 300 300 300 300 300 
Electron dose (e-/ Å2) 45.9 45.9 45.9 45.9 45.9 
Defocus range (µm) -0.8 to -1.6 -0.8 to -1.6 -0.8 to -1.6 -0.8 to -1.6 -0.8 to -1.6 
Pixel size (Å) 1.061 1.061 1.061 1.061 1.061 
Initial particles (no.) 525,595 525,595 525,595 525,595 525,595 
Final particles (no.) 47,512 49,415 54,142 46,814 30,535 
      
Model composition      
Non-hydrogen atoms 151,484 151,394 151,873 151,479 147,677 
Protein residues 6670 6643 6742 6643 6396 
RNA bases 4638 4638 4637 4642 4554 
      
Refinement      
Resolution (Å) 3.81 3.85 3.93 3.93 4.44 
Mask CC  0.808 0.823 0.819 0.822 0.790 
Volume CC  0.798 0.813 0.810 0.812 0.775 
Map-sharpening B factor (Å2) 
Average B factor (Å2) 
-125.34 
187.9 
-125.88 
204.3 
-129.42 
221.6 
-126.26 
206.0                     
-134.81 
354.1 
R.m.s. deviations      
    Bond lengths (Å) 0.005 0.004 0.004 0.005 0.008 
    Bond angles (°) 0.93 0.88 0.86 0.88 0.87 
      
Validation      
MolProbity score* 1.83 (100th) 1.84 (100th) 1.80 (100th) 1.89 (100th) 1.79 (100th) 
Clashscore** 5.92 (100th) 5.95 (100th) 5.51 (100th) 6.90 (100th) 5.24 (100th) 
Poor rotamers (%) 0.20% 0.24% 0.20% 0.17% 0.27% 
      
Ramachandran plot      
Favored (%) 91.39% 91.22% 91.47% 91.32% 91.14% 
Allowed (%) 8.17% 8.37% 8.09% 8.25% 8.40% 
Disallowed (%) 0.44% 0.41% 0.44% 0.43% 0.46% 
*(3.25Å – 4.05Å)  
**(3Å – 9999Å) 
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SUPPLEMENTARY FIGURES 
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Supplementary Figure 1 Processing of the cryo-EM data of 70S-tRNA-RF1-RF3 complexes. (a) 
Sorting scheme of the cryo-EM data of in vitro reconstituted complexes prepared in the absence of 
API. From a total of 45,363 particles, 6,249 non-aligning particles were discarded after 2D 
classification. The remaining 39,114 particles were subjected to 3D classification and sorted into 8 
different classes. The classes comprise two populations containing only P/P-tRNA, two populations 
containing P/P-tRNA and RF1, two populations harbouring P/E-tRNA and RF3, one population 
containing P/E-tRNA, RF1 and RF3, as well as a minor population of 50S subunits. (b-g) Processing 
of 70S-tRNA-RF1-RF3 complexes that were prepared in the presence of API. (b) From an initial 
703,379 particles, 177,784 non-aligning particles were discarded during 2D classification, yielding 
525,595 ribosomal particles. An initial 3D classification was performed sorting the particles into 8 
distinct classes, four major populations (states I-IV) containing RF1 and RF3, minor populations 
containing RF3 only (RF3-70S), vacant 50S subunits or conformational heterogeneous 70S 
ribosomes. States I to IV were subjected to another round of 3D classification. Moreover, focussed 
classification was employed to improve density for RF3 in states I-IV. The most stable (sub-)classes 
were 3D-refined using undecimated particles. (c-g) Fourier Shell Correlation (FSC0.143; orange) with 
the resolution at FSC=0.143 indicated with a dashed line as well as FSCaverage (blue) and self and 
cross-validated correlations FSCwork (red) and FSCtest (green), respectively, shown for (c) state I, (d) 
state II, (e) state III, (f) state IV and (g) RF3-70S complex.  
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Supplementary Figure 2 Local resolution and molecular models for States I-IV and RF3-70S 
complex. (a) Overview (with schematics shown in first row) and (b) transverse section of the cryo-
EM maps of the RF3-70S complex and states I-IV colored according to local resolution. Cryo-EM 
map density for ligands colored according to (c) local resolution, or (d) with fitted molecular models 
(displayed as ribbons) and transparent densities for RF3 (cyan), RF1 and tRNA (green).  
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Supplementary Figure 3 Interactions at the peptidyltransferase center in states I-IV. (a-e) The cryo-
EM electron density (grey mesh) for API (salmon) bound within the ribosomal tunnel of (a) the RF1-
API-70S complex26 and (b-e) states I-IV. The relative position of the (a) P/P-site tRNA (green) and 
(b-e) Pint-tRNA are shown with A76 of the CCA-end labelled as well as and Gln235 of the GGQ 
motif of RF1. (f-i) The cryo-EM electron density (grey mesh) for the (f) P/P-site tRNA (salmon) in 
the RF1-API-70S complex26 and (g-i) the Pint-tRNA (green) in state I with relative position of (g) 
canonical P/P-tRNA (salmon), (h-i) Pint-RNA (green) with (h) one or (i) two nucleotide shift in the 
interaction of the CCA-end with the P-loop. Red dashes in (i) indicate steric clashes between A76 
and G2252, whereas red line indicates suboptimal distance for basepairing between C74 and C2254. 
(j-k) The cryo-EM electron density (grey mesh) for the (j) P/P-site tRNA (salmon) in the RF1-API-
70S complex26 and (k,l) cryo-EM electron density (grey mesh) for State I with (k) superimposition 
of a canonical P/P-site tRNA (salmon) and (l) the Pint-tRNA with one nucleotide shift, showing the 
location of nucleotide A73.  
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Supplementary Figure 4 Interaction of the G-domain of RF3 with the ribosome. (a) Superimposition 
of RF3 (different shades of green) from states I-IV, relative to the sarcin-ricin loop (SRL, grey) and 
ribosomal protein L6 (red) of the LSU. (b) Same view as (a) but with alignment of three different 
states of EF-Tu (PDB ID 5UYK; 5UYL; 5UYM)40. (c-f) Superimposition of RF3 from state IV with 
(c) IF2, EF-Tu and EF-G together, or separately with (d) IF2 (lime, PDB ID 3JCN)69, (e) EF-Tu 
(brown, PDB 5UYM)40 and (f) EF-G (salmon, PDB 3JA1)70. In (c), the axis of rotation that aligns 
the G-domains of RF3 to the G-domain of the other translational GTPases is shown.  
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Supplementary Figure 5 Interaction of the switch I loop with large ribosomal subunit. (a) The 
ordered switch I loop (teal) of RF3 in state I is shown with the electron density (grey mesh) and 
relative to the SRL (grey) and ribosomal proteins L14 (tan) and L19 (green). (b-f) same view as (a) 
but with aligned structures showing disordered switch I loop in (B) RF3-GDP crystal structure (PDB 
ID 2H5E)17 and (c) RF3-70S complex with P/E-site tRNA (PDB ID 4V8O)28 and ordered switch I 
loop (teal) in (d) RF3-70S complex without tRNA (PDB ID 4V89)29, (e-f) RF3 crystal structure in 
complex with (e) ppGpp (PDB ID 3VR1)18 and (f) GDP (PDB ID 3VQT)18. In (a-f), the switch II 
loop (slate) is shown highlighted and in (b-f) the conformation of the switch I loop from (a) is shown 
in transparent grey for reference. (g-h) Cryo-EM electron density (grey mesh, filtered to 7 Å) for the 
CTD of L7/L12 (purple) interacting with domain 1 (d1) of RF1 (orange) and ribosomal protein L11 
(light blue) in (g) state III and (h) the RF1-API-70S complex26.  
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Supplementary Table 1 Rotational analysis of the 30S ribosomal subunit. 
Complex Head swivel (°) Body/platform rotation (°) 
State I 1.1 0.8 
State II 1.6 1.7 
State III 1.6 5.5 
State IV 3.6 9.6 
RF3-70S complex 5.7* 8.2 
4v6r (A-tRNA + P-tRNA) 4.6 8.8 
4v9d (P-tRNA only) -1.2 1.1 
4v9d (P/E-tRNA; RRF) 2.6 9.9 
4v89 (RF3) 13.6 9.1 
4v8o (P/E-tRNA; RF3) 3.6 10.1 
5LZF (P/E-tRNA**) 3.2 10.4 
*average head swivel; **fMetSec-tRNASec 
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SUPPLEMENTARY VIDEO LEGENDS 
 
Supplementary Video 1 Comparison of movements between state I to IV and RF3-70S. (a-d) The 
structures of state I-IV and the RF3-70S complex shown with view (a) into the factor binding site, 
(b) from above with transparent SSU and LSU, and (c-d) interface views of the (c) LSU and (d) SSU. 
The SSU (yellow), LSU (grey), RF1 (orange), tRNA (green) and RF3 (cyan) are shown as surface 
representations. 
 
Supplementary Video 2 Comparison of RF3-70S complex with RF3-70S crystal structures. (a) The 
RF3-70S X-ray crystallography structures without tRNA (PDB ID 4V89)29 and with hybrid P/E-site 
tRNA (PDB ID 4V8O)28. (b-c) The RF3-70S complex compared with the RF3-70S X-ray 
crystallography structures (b) without tRNA (PDB ID 4V89)29 and (c) with hybrid P/E-site tRNA 
(PDB ID 4V8O)28.  
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ABSTRACT
Ribosomes are the protein synthesizing machines
of the cell. Recent advances in cryo-EM have led
to the determination of structures from a variety of
species, including bacterial 70S and eukaryotic 80S
ribosomes as well as mitoribosomes from eukaryotic
mitochondria, however, to date high resolution struc-
tures of plastid 70S ribosomes have been lacking.
Here we present a cryo-EM structure of the spinach
chloroplast 70S ribosome, with an average resolu-
tion of 5.4 Å for the small 30S subunit and 3.6 Å for
the large 50S ribosomal subunit. The structure re-
veals the location of the plastid-specific ribosomal
proteins (RPs) PSRP1, PSRP4, PSRP5 and PSRP6
as well as the numerous plastid-specific extensions
of the RPs. We discover many features by which the
plastid-specific extensions stabilize the ribosome via
establishing additional interactions with surround-
ing ribosomal RNA and RPs. Moreover, we identify a
large conglomerate of plastid-specific protein mass
adjacent to the tunnel exit site that could facilitate
interaction of the chloroplast ribosome with the thy-
lakoid membrane and the protein-targeting machin-
ery. Comparing the Escherichia coli 70S ribosome
with that of the spinach chloroplast ribosome pro-
vides detailed insight into the co-evolution of RP and
rRNA.
INTRODUCTION
Chloroplasts are organelles found in plant and algal cells,
which are responsible for carrying out photosynthesis. The
origin of chloroplasts is thought to result from an endosym-
biotic event where an early eukaryotic cell engulfed a pho-
tosynthetic cyanobacterium (1). As such chloroplasts pos-
sess their own genome, as well as the transcription and
translation machinery to convert the genetic information
into polypeptides or proteins (2,3). Chloroplast ribosomes,
or chlororibosomes, are very specialized since they are
only involved in synthesizing the limited number of pro-
teins encoded in the chloroplast genome (2,3). For exam-
ple, the complete genome sequence of the Spinacea oler-
acea (spinach) chloroplast contains 146 genes encoding pro-
tein products and structural RNAs (4). The majority of
the chloroplast-encoded proteins are targeted to the chloro-
plast thylakoid membranes and encompass components of
the adenosine triphosphate (ATP) synthase, cytochrome
b/f and photosystem I and II complexes (4). In addition,
chlororibosomes translate NADH dehydrogenase, the large
subunit (LSU) of RuBisCO, RNA polymerase subunits and
a distinct subset of ribosomal proteins (RPs), 12 from the
small subunit (SSU) and 8 from the LSU. Other proteins
essential for chloroplast function are nuclear encoded and
must therefore be imported into the chloroplast. This in-
cludes the remaining 32 chloroplast RPs (cpRPs), which
bear N-terminal chloroplast-targeting sequences that are
cleaved off upon import (5,6).
Sequence comparisons indicate that the components
of the chloroplast translational machinery are similar to
those of eubacteria, especially cyanobacteria, but also ! -
proteobacteria, such as Escherichia coli. The chloroplast
16S rRNA (cp16S) of the SSU contains 1491 nucleotides
(nts) and is therefore only slightly smaller than the E. coli
16S rRNA (Ec16S), which has 1542 nts. The E. coli LSU
contains 2 rRNAs, the 5S (120 nts) and 23S (2904 nts)
rRNAs, totaling to 3024 nts. While the chloroplast LSU
comprises 3 rRNAs, 5S (121 nts), 4.8S (103 nts) and 23S
(2810 nts) rRNAs, the total length of 3034 nts is only slightly
larger (10 nts) than in E. coli. Similarly, chlororibosomes
contain a total of 52 cpRPs (25 in the SSU and 33 in the
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LSU) and with the exception of L25 and L30, have or-
thologs in E. coli (5,6). However, the cpRPs are generally
larger than their E. coli counterparts, predominantly due
to N- and C-terminal extensions (NTEs and CTEs) (5,6).
Proteomic studies also identified six non-orthologous pro-
teins, termed ‘plastid-specific RPs’ (or PSRPs) (5–7). Four
PSRPs (PSRP1-4) were found to be associated with the SSU
and two (PSRP5 and PSRP6) with the LSU (5–7). A cryo-
EM reconstruction of the spinach chlororibosome at 9.4 Å
provided first insights into the localization of the PSRPs
and cpRP extensions (8), however, higher resolution is re-
quired to accurately assign and describe the interactions of
the PSRPs and cpRP extensions within the chlororibosome.
Here we present a cryo-EM structure of the spinach
chlororibosome, with an average resolution of 5.4 Å for the
SSU and 3.6 Å for the LSU, revealing the binding site of
the PSRP1, PSRP4, PSRP5 and PSRP6 as well as the con-
formation of numerous cpRP extensions. The structure il-
lustrates how cpRP extensions and PSRPs wind their way
through the core of the chlororibosome establishing interac-
tions with neighboring rRNA and RPs. In many cases, the
cpRP extensions interact with RNA or protein features that
are specific to the chlororibosome, thus providing insight
into their co-evolution. We also identify a large conglomer-
ate of cpRP mass adjacent to the tunnel exit site that we sug-
gest facilitates interaction of the chlororibosome with the
thylakoid membrane and the protein-targeting machinery.
MATERIALS AND METHODS
Isolation of chloroplast 70S ribosomes
Chloroplast ribosome isolation was performed as described
previously (9). Briefly, 6 kg of spinach leaves were de-
veined and washed thoroughly. The leaves were homoge-
nized (2l/kg of leaves) using 0.7 M Sorbitol in buffer A
(10 mM Tris–HCl pH 7.6, 50 mM KCl, 10 mM MgOAc,
7 mM "-mercaptoethanol). The homogenate was filtered
through several layers of cheesecloth and one layer of Mir-
acloth (Calbiochem) before centrifugation at 1200 × g for
15 min. The pellet was resuspended in 0.4 M Sorbitol in
buffer A and re-centrifuged at 1200 × g for 15 min. The
washed chloroplast pellet was resuspended in buffer A sup-
plemented with 2 % (v/v) Triton-X100 and incubated on ice
for 30 min. The lysed suspension was clarified by centrifu-
gation at 26 000 × g for 30 min before isolation of crude
ribosomes by centrifugation at 50 000 × g for 24 h through
a 1M sucrose (in buffer B: buffer A with 10% glycerol). The
greenish pellet was washed and then resuspended in buffer
B with gentle agitation. The crude ribosomes were clarified
by centrifugation at 26 000 × g for 15 min before being ei-
ther snap frozen at −80◦C. Alternatively, the clarified super-
natant was applied directly onto a 10–30% sucrose gradient
(in buffer B) in order to obtain tight-coupled chloroplast
70S ribosomes.
Negative-stain electron microscopy
Ribosomal particles were diluted in buffer A to a final con-
centration of 5 A260/ml. One drop of each sample was de-
posited on a carbon-coated grid. After 30 s, grids were
washed with distilled water and then stained with 2% aque-
ous uranyl acetate for 15 s. The remaining liquid was re-
moved by touching the grid with filter paper. Micrographs
were taken using a Morgagni transmission electron micro-
scope (FEI), 80 kV, wide angle 8K CCD at direct magnifi-
cations of 110K.
Cryo-electron microscopy and single particle reconstruction
A total of 5 A260/ml chloroplast ribosome sample was
applied to 2 nm pre-coated Quantifoil R3/3 holey car-
bon supported grids and vitrified using a Vitrobot Mark
IV (FEI, Eindhoven). Data collection was performed us-
ing an FEI Titan Krios transmission electron microscope
equipped with a Falcon II direct electron detector (FEI,
Eindhoven), using a pixel size of 1.061 Å and an underfocus
range of 1.0–2.3 #m resulting in 2031 micrographs. Each
micrograph was recorded as a series of 7 frames (3.9 e−/Å2
pre-exposure; 5.2 e−/Å2 dose per frame). All seven frames
(accumulated dose of 40.3 e−/Å2) were motion-corrected
using the Unblur program (10) and power-spectra, defo-
cus values, astigmatism and estimation of micrograph reso-
lution were determined using CTFFIND4 (11). Five hun-
dred and forty-five micrographs showing Thon rings be-
yond 3.2 Å resolution were manually inspected further for
good areas and power-spectra quality. Three times deci-
mated data were pre-processed using the SPIDER software
package (12), in combination with an automated workflow
as described previously (13). After initial, automated par-
ticle selection based on the program SIGNATURE (14),
initial alignment was performed with 56 475 particles us-
ing E. coli LSU as a reference structure (15). The dataset
could be sorted into 37 626 (66.6%) ribosomal particles and
18 849 (33.3%) non-aligning particles using an incremen-
tal K-means-like method of unsupervised 3D sorting (16)
(Supplementary Figure S2). Undecimated ribosomal par-
ticles were again initially aligned against an E. coli LSU
and subsequently refined using FREALIGN (17). Since the
SSU of the chlororibosome was flexible, focused alignment
and refinement was performed by applying masks either on
the SSU or LSU. Due to inherent flexibility, the SSU of the
chlororibosome could be refined to an average resolution
of 5.4 Å (0.143 FSC) and a local resolution extending to
5.0 Å for the core, whereas the LSU of the chlororibosome
could be refined to an average resolution of 3.6 Å (0.143
FSC) and a local resolution extending to <3.5 Å for the
core. The local resolution of the final maps was computed
using ResMap (18) (Supplementary Figure S2). The final
maps were sharpened by dividing the maps by the modula-
tion transfer function of the detector and by applying an au-
tomatically determined negative B-factor (−86 for the LSU
and −130 for the SSU) to the maps using RELION (19).
Molecular modeling and map-docking procedures
The molecular model of the chloroplast LSU was based on
the E. coli-70S-EF-Tu structure (20). The 23S rRNA sec-
ondary structure was initially generated by manual align-
ment of the chloroplast 23S rRNA sequence and the sec-
ondary structure map (21) to the E. coli 23S secondary
structure map, which shows high structural similarity. The
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16S, 5S and 4.8S rRNA sequences of the chloroplast ri-
bosome were aligned accordingly. The resulting rRNA ho-
mology models were rigid-body fitted into the respective
chloroplast EM-map using Chimera (22). Subsequently, the
models were manually adjusted and refined using Coot
(23). E. coli-based (20) homology models of the cpRPs
were built using SwissModel (24) and HHPred (25) and
rigid-body fitted into the map. cpRP-specific extensions
were modeled in Coot (23). PSRP5 and PSRP6 were mod-
eled de novo, using secondary structure predictions gener-
ated by PsiPred (26) as a reference. The complete atomic
model of the chloroplast LSU was subsequently refined us-
ing phenix.real space refine (27) with secondary structure
restraints calculated by PHENIX. In order to reduce the
clashscore, the model was additionally refined in reciprocal
space using REFMAC (28) in EM mode. Cross-validation
against overfitting was performed as described elsewhere
(29,30). The statistics of the refined model were obtained
using MolProbity (31).
Figure preparation
All figures showing electron densities and atomic mod-
els were generated using UCSF Chimera (22) and PyMol
Molecular Graphics Systems (version 1.8 Schrödinger).
RESULTS AND DISCUSSION
Cryo-EM structure of the chloroplast 70S ribosome
Chloroplast 70S ribosomes were isolated from S. oleracea
(spinach) leaves as described previously (8,9) and subjected
to single particle cryo-EM analysis. The cryo-EM data was
collected on a Titan Krios transmission electron micro-
scope with a Falcon II direct electron detector. From a total
of 56,475 ribosomal particles, in silico sorting revealed ex-
treme flexibility of the SSU with respect to the LSU (Sup-
plementary Figure S1). To overcome this conformational
heterogeneity, focused alignment was performed indepen-
dently for each ribosomal subunit using FREALIGN (17).
Subsequent refinement yielded cryo-EM reconstructions of
the chloroplast SSU and LSU (Figure 1A–D), with an aver-
age resolution of 5.4 Å and 3.6 Å, respectively (Supplemen-
tary Figure S2 and Table S1).
Analysis of the chloroplast SSU
The resolution of the SSU allowed a homology model of the
spinach chloroplast SSU to be rigid body fitted based on the
high sequence similarity between the E. coli and S. oleracea
rRNA and RPs (8). As already noted (8), the major differ-
ence with respect to the 16S rRNA is the shortening of he-
lices h6, h10 and h17 in the chlororibosome rRNA, leading
to a truncated spur (Figure 1A and B) when compared to
the E. coli SSU. In the previous chlororibosome cryo-EM
structure, additional protein density was observed, which
was tentatively assigned to PSRP2 and PSRP3, and pro-
posed to compensate for the truncated spur rRNA (8).
At higher resolution, this extra spur density was not well-
resolved (Figure 1A and B), however, filtering at lower reso-
lution indeed revealed extra density within this region (Sup-
plementary Figure S3). The mass of the extra spur density
could not account fully for either PSRP2 or PSRP3, sug-
gesting that if one of these PSRPs is bound there it is highly
flexible.
As mentioned, the S. oleracea cpRPs are larger than their
respective E. coli counterparts due to the presence of NTEs
and/or CTEs (6). To ascertain the location of the cpRP ex-
tensions, homology models for the S. oleracea cpRPs were
generated based on E. coli templates (20,32), which were
then fitted to the cryo-EM map of the chloroplast SSU (Fig-
ure 1A and B). In many cases, additional density continuous
with the N- or C-termini of the cpRPs could be identified,
consistent with the presence of predicted S. oleracea cpRP-
extensions that are absent in the respective E. coli RPs (Fig-
ure 1A and B). For example, density was observed for the
NTE of cpS5, which is 86 aa longer than E. coli S5 (EcS5)
(6). In addition, density for the NTEs of cpS9, cpS10 and
cpS21 and the CTEs of cpS16 and cpS18 were observed, as
well as a rearrangement of the N-terminus of cpS4. The ex-
tensions of the cpRPs are located exclusively on the back
or cytosolic side of the SSU, but nevertheless encroach on
two functional regions related to the path of the mRNA.
Specifically, the CTE of cpS18 and the NTE of cpS21 are
located at the platform region in vicinity of where the Shine-
Dalgarno helix forms between the 5′ end of the mRNA and
the 3′ end of the 16S rRNA (Supplementary Figure S3). The
N-terminus of cpS4, and particularly the NTE of cpS5, sur-
round the mRNA entry channel (Figure 1A and B; Sup-
plementary Figure S3). Curiously, we also observed extra
density in this region that does not originate from any of
the neighboring cpRP extensions. The extra density con-
nects the head and body of the 30S subunit, namely, bridg-
ing the tip of helix h16 in the body with cpS3 of the head.
This connection is often referred to as the ‘latch’ because it
has been observed to open and close during translation ini-
tiation (33,34). Mass spectrometry analysis did not detect
additional non-orthologous proteins on the spinach chloro-
plast SSU (5–7), therefore, the additional density may actu-
ally be derived from part of PSRP2 or PSRP3, but we can-
not exclude that it is derived from unrelated proteins.
Finally, we identified two additional densities that we as-
signed to PSRP1 and PSRP4 (Supplementary Figure S4A
and B). In agreement with the previous localization (8), we
allocated the density within the head of the SSU to PSRP4
(Figure 1A and B) based on its similarity in sequence and
binding position with Thx, a small RP identified in the Ther-
mus thermophilus SSU (35). Similarly, we assigned the addi-
tional density located within the decoding site on the inter-
subunit side of the SSU to the N-terminal domain (NTD) of
PSRP1, as reported previously (8,36). Sequence alignments
indicated that PSRP1 is not a bone fide cpRP but rather
a homolog of a long form hibernation-promoting factor,
which is responsible for 100S formation (70S dimerization)
(37). The NTD of PSRP1 is homologous with YfiA and
the short form HPF, both of which have also been shown
to bind analogously to the SSU of bacterial 70S ribosomes
(38,39), overlapping the binding site of the mRNA and tR-
NAs in the A- and P-sites (Supplementary Figure S4C and
D). No density was observed for the C-terminal domain of
PSRP1, which has been shown to be responsible for 100S
formation in some bacteria (40,41).
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Figure 1. Cryo-EM structure of the chloroplast SSU and LSU. (A–D) Cryo-EM map (transparent gray) of the spinach chloroplast (A and B) SSU and
(C and D) LSU, illustrating the additional density for cpRPs (green) and extra density assigned to PSRPs (blue) and the ribosome recycling factor (RRF).
The molecular model for the SSU and LSU includes rRNA (gray) and cpRPs (yellow).
Molecular model for the chloroplast LSU
Consistent with the local resolution calculations (Supple-
mentary Figure S2), the electron density was particularly
well resolved within the core of the LSU, whereas the pe-
riphery of the subunit was less defined. We were able to
generate molecular models for 28 of the 33 cpRPs present
in the chlororibosome (Figure 2A–C; Supplementary Ta-
ble S2). cpRPs L1, L10, L11, L7/L12 and L31 were not
modeled due to poor density. The density for cpL5, cpL6
and cpL18 allowed only a rigid body fit of a homology
model based on EcL5 and EcL6, and only the NTD of cpL9
was included in the final model. As observed previously (8),
density was not observed for L25 and L30, consistent with
the absence of genes encoding these cpRPs in plant and
chloroplast genomes (4). We could also model domain I of
the chloroplast ribosome recycling factor (cpRRF) (Supple-
mentary Figure S4), which was bound analogously to that
reported previously on the chlororibosome at lower resolu-
tion (8) as well as on bacterial ribosomes (42,43). Together
with cpEF-G, cpRRF has been demonstrated to dissociate
PSRP1 from the chlororibosome (36). In addition, molec-
ular models are presented for the complete 5S and 2843
(97.6%) of the 2913 nucleotides that comprise the 4.8S and
23S rRNAs (Figure 3A and B; Supplementary Figure S5).
Features of the chloroplast LSU rRNAs
Unlike the mammalian mitoribosome where a tRNA
molecule substitutes for the lack of a 5S rRNA (44,45), the
chlororibosome contains a 5S rRNA (Figure 3A and B)
that is highly similar in sequence and structure to the bacte-
rial 5S rRNA. As mentioned, the chloroplast 23S rRNA is
present in the chlororibosome as two pieces, a 5′ fragment
representing H1-H97 of domains I-VI (hereafter referred to
as cp23S rRNA) and a 3′ fragment comprising H99-H101
of domain VII (termed 4.8S rRNA) (Figure 3A and Supple-
mentary Figure S5). This results in the loss of H98 (!16 nts)
that links domains VI and VII within the E. coli 23S (Ec23S)
rRNA (Figure 3C). Together with reductions in helices H9
(!14 nts), H45, (!6 nts), H63 (!27 nts) (Figure 3A and
B), the cp23S rRNA has a total of 75 nts missing relative to
the Ec23S rRNA. While the reductions lead to a shortening
in the length of H9 and H45 (Figure 3D and E), the effect
on H98 and H63 results in the complete absence of these
helices in the chlororibosome (Figure 3C and F). Never-
theless, the combined length of the chloroplast LSU rRNA
(3034 nts) is similar to that for E. coli (3024 nts) because
the four rRNA reductions in the cp23S rRNA are compen-
sated by five rRNA additions (8). This includes additional
nucleotides within H15 (+30 nts), H38 (+20 nts), H58 (+23
nts) and H68 (+4 nts) of the cp23S rRNA, as well as +8
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Figure 2. Molecular model for the chloroplast LSU. (A–C) Three overviews of the chloroplast LSU with rRNA (gray ribbons) and modeled cpRPs and
PSRPs shown with a spacefill representation and colored and labeled individually.
Figure 3. Location of rRNA insertions and deletions in the chlororibo-
some. (A and B) Two overviews of the chloroplast LSU with 4.8S (teal),
5S (purple) and 23S (cyan) rRNA, highlighting insertions (green) on the
cp23S and deletions (red) relative to Ec23S. (C–F) Examples of deletions
in the cp23S (cyan) relative to the Ec23S (gray) include deletion of (C) 16
nts in H98, (D) 14 nts in H9, (E) 6 nts in H45 and (F) 27 nts in H63. (G and
H) Examples of additions in the cp23S (cyan) relative to the Ec23S (gray)
include insertion of (G) 30 nts in H15 and (H) 4 nts in H68.
nt insertion in the linker connecting H100 and H101 of the
4.8S rRNA (Figure 3A and B). The insertions within H15
(Figure 3G) and H68 (Figure 3H) are base-paired and well
resolved in the model, whereas the density for the non-base-
paired insertions within H38 and the H100–H101 linker are
poorly defined and therefore not included in the final model.
Localization of cpRPs and extensions
In contrast to the SSU cpRPs, the LSU cpRPs are sig-
nificantly longer than their E. coli counterparts due to
the presence of NTEs and/or CTEs (5). As expected, ad-
ditional density continuous with the N- or C-termini of
the LSU cpRPs was observed (Figure 1C and D), allow-
ing 283 amino acids of the cpRP extensions to be mod-
eled (Figure 4A; Supplementary Table S2). In particular,
cpRPs L13, L15, L21, L22, L24, L27, L29 and L34 have
long NTEs and/or CTEs (Figure 4A). In addition, cpL33
has a "-hairpin with an internal expansion of 13 aa com-
pared to EcL33 (Figure 4A). There are four major excep-
tions of cpRPs (L2, L17, L19 and L23) that have signifi-
cant deletions (>2 aa) compared to their E. coli counter-
parts. In the chlororibosome, cpL17 is C-terminally trun-
cated by 11 aa, although only 4 aa of these are observed in
the E. coli 70S ribosome structures (20,32). The N-terminus
of cpL2 is shorter than EcL2 by only 6 aa, yet we observed
no density for the first 25 aa (Figure 4B). Similarly, the
CTE of cpL19 is not only 4 aa shorter than EcL19, but
the last 11 aa also adopt a distinct conformation (Figure
4B). Lastly, the "-hairpin of EcL23 that reaches into the
tunnel lumen in the E. coli ribosome (20,32) is significantly
shorter in the chlororibosome (Figure 4B), reminiscent of
the archaeal/eukaryotic L23 homologs (46,47). However,
unlike archaeal/eukaryotic ribosomes that compensate for
the truncated L23 with the presence of aeL38 (46,47), the
equivalent space remains vacant in the chlororibosome.
Binding sites of PSRP5 and PSRP6 on the LSU
Subsequent to modeling of the LSU rRNAs as well as all the
cpRPs and cpRP extensions, we noticed that two unmod-
eled regions of electron density were present in the cryo-EM
map, which we assigned to PSRP5 and PSRP6 (Figure 1C
and D). Due to their buried location within the chlororibo-
some, the electron density was well resolved (Figure 5A and
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Figure 4. Molecular models indicating cpRP extensions and deletions. (A) Structures of cpRPs showing the core region equivalent to the respective EcRPs
(gold) with N-terminal extensions (NTEs), C-terminal extensions (CTEs) or the internal expansion (ITE) highlighted (green). The numbers indicate the
modeled residues with the total expansion length indicated in parentheses. (B) Structures of cpRPs (gold) compared with the respective EcRPs (blue)
highlighting amino acid deletions (in parentheses) in cpRPs relative to EcRPs.
Figure 5. Localization of PSRP5 and PSRP6 on the chlororibosome. (A and B) Cryo-EM electron density (mesh) with molecular models for (A) PSRP5
and (B) PSRP6. (C and D) Cryo-EM electron density for (C) PSRP5 and (D) PSRP6 colored according to local resolution. (E and F) Molecular models
showing secondary structure for (E) PSRP5 and (F) PSRP6. (G) Binding site of PSRP5 (gold) on the LSU (cyan). (H and I) Interaction between PSRP5
(gold) and H58 and H60 of the cp23S rRNA (cyan), with (I) comparison of different conformation of H58 from the Ec23S rRNA (gray). (J) Binding site
of PSRP6 (gold) on the LSU (cyan). (K and L) Interaction between the N-terminus of PSRP6 (gold) and H40, H42 and H89 of the cp23S rRNA (cyan),
and (L) the C-terminus of PSRP6 (gold) with the cpL21 (green).
B), in agreement with local resolution calculations (Figure
5C and D), enabling unambiguous models for both PSRP5
and PSRP6 to be generated (Figure 5E and F; Supplemen-
tary Figure S4). Consistent with secondary structure pre-
dictions, PSRP5 consists of a short C-terminal $-helix con-
nected by a linker to a long central $-helix (Figure 5E). The
binding site of PSRP5 is located at the base of the LSU di-
rectly under the L1 stalk, with the N-terminus extending to-
ward the intersubunit interface (Figure 5G). We note that 38
aa are missing from the N-terminus in our model, presum-
ably due to flexibility outside of the ribosome. The surface
of the buried regions of PSRP5 is highly positively charged
(Supplementary Figure S4F and G), as would be expected
from the surrounding negatively charged rRNA environ-
ment. The short C-terminal $-helix of PSRP5 inserts into
the minor groove of H60, whereas the central $-helix es-
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tablishes interactions with H58 (Figure 5H). The specificity
of PSRP5 for the chlororibosome may be due to the in-
teraction with H58, since there are significant differences
in both the sequence and structural conformation of H58
when comparing with the E. coli 70S ribosome (Figure 5I).
We note that the position of PSRP5 was mis-assigned in the
previous structure of S. oleracea chloroplast 70S ribosome
(8), probably due to the small size of the protein and the
limited resolution of the reconstruction.
PSRP6 adopts a very extended conformation (Figure 5F)
that winds its way through the ribosome (Figure 5J–L).
The N-terminal half of PSRP6 is predominantly positively
charged (Supplementary Figure S4I–K), consistent with
the extensive interaction with the negatively charged rRNA
(Figure 5K). The N-terminus of PSRP6 interacts with the
minor grooves of H89, H40 and H42 as it winds its way out
of the ribosomal core (Figure 5K). The two short central $-
helices of PSRP6 are positioned within the minor grooves
of H40 and H42 and are separated by a linker region that
passes near to the 5S rRNA (Figure 5K). The C-terminal
half of PSRP6 is less charged (Supplementary Figure S4I),
consistent with an interaction with the globular domain of
cpL21, rather than with rRNA. The C-terminus of PSRP6
donates a "-strand to augment the "-sheet of cpL21 (Figure
5L) before extending into the solvent where the C-terminal
22 aa are not visualised. The conservation of this region be-
tween S. oleracea chloroplast and E. coli 70S ribosomes sug-
gests that PSRP6 could in principal bind analogously to the
E. coli 70S ribosome.
cpRP extensions and rRNA stabilization
Generally, the NTE and CTE of cpRPs contain posi-
tively charged amino acids that establish additional interac-
tions with the surrounding rRNA, predominantly with the
phosphate-oxygens of the backbone. For example, the 10 aa
CTE of cpL34 interacts with the loop of helix H8 of the 23S
rRNA and forms a potential hydrogen bond from Lys148
with the backbone of U1638 within H51 (Figure 6A). In
many cases, the cpRP extensions interact with the minor
groove of rRNA helices. Such an interaction is illustrated by
the 25 aa CTE of cpL15, which inserts into the minor groove
of a helix formed from the loops of H22 and H88 (Figure
6B). Lys243 comes within hydrogen bonding distance of the
ribose of A427 and Tyr241 stacks upon A213 that makes an
A-minor interaction within the H22/H88 helix (Figure 6B).
Similarly, the 18 aa NTE of cpL24 that penetrates deeper
into the ribosomal core, approaches the minor groove of an
rRNA helix formed from the loops of H6 and H7, before
the N-terminus emerges within the tunnel lumen (see later).
We also observed that the cpRP extensions often rein-
force interactions with rRNA elements that are already con-
tacted by the core of the cpRP, as illustrated by cpRPs L35
and L13 (Figure 6C and D). Arg140 in the core of cpL35
contacts the phosphate-oxygen of G966 in H38, an inter-
action also observed for EcL35 (Figure 6C). This contact
is reinforced in the chlororibosome by a potential hydrogen
bond from Arg157 within the 7 aa CTE of cpL35 to the
backbone of C966 within H38 (Figure 6C). Similarly, the
interaction from Arg126 in the core of cpL13 with A1170
in H41 is reinforced in the chlororibosome by an additional
hydrogen bond from Arg245 within the NTE of cpL13 to
the backbone of A1170 within H41 (Figure 6D).
Three of the cpRP extensions contain $-helical secondary
structure, namely within the NTE of cpL13 and the CTEs
of cpL15 and cpL27 (Figure 4A). The $-helix within the
CTE of cpL15 interacts with H68, which as mentioned is
extended in the chlororibosome compared to the E. coli
70S (Figure 3H). In the chlororibosome, the NTE of cpL13
forms an $-helix that interacts with the junction where the
5′ end of the 4.8S rRNA meets the 3′ end of the cp23S rRNA
(Figure 6E). Comparison with the E. coli 70S ribosome re-
vealed that the N-terminal $-helix of cpL13 occupies the
position of H10 of the Ec23S rRNA (Figure 6F), which
is absent in the chlororibosome (Figure 6E). The $-helix
within the CTE of cpL27 appears to stabilize a three-way
junction formed by the insertion of 20 nts within H38 of
the cp23S rRNA (Figure 6G), which is lacking in the Ec23S
rRNA (Figure 6H). The site of insertion in H38 in the cp23S
rRNA correlates with the position of expansion segment 12
(ES12L) in eukaryotic 80S ribosomes (47,48). In the E. coli
ribosome, EcL30 contacts H38 in the vicinity of the inser-
tion site (Figure 6H). Such an L30-H38 interaction would
not be possible in the chlororibosome due to the presence of
the additional rRNA helix in H38, thus providing a possible
explanation as to why L30 is missing in plant chloroplasts.
Intertwining of cpRP extensions at the tunnel exit
A number of differences with the E. coli 70S ribosome were
evident when examining the back or cytosolic side of the
LSU of the chlororibosome, in particular, the region sur-
rounding the tunnel exit site. As mentioned, the "-hairpin of
cpL23 is shorter than EcL23 leading to an enlarged luminal
space near the exit site of the chlororibosome (Figure 7A–
C). In contrast, the opposite side of the tunnel from cpL23
has extra mass due to the presence of the NTE of cpL24 that
penetrates into the ribosomal core from the surface located
globular domain (Figure 7B). The 27 aa CTE of cpL29 in-
tertwines with the NTE of cpL23 (Figure 7B), which to-
gether occupy the space where 23S rRNA helix H10 is sit-
uated in the E. coli 70S ribosome (Figure 7C). Comparison
with the binding site of E. coli SRP on the ribosome (49,50),
suggests that the CTE of cpL29 could play a role in recruit-
ment cpSRP54 to the chlororibosome (Figure 7D).
By far the largest conglomerate of cpRP extensions is lo-
cated at the back of the LSU adjacent to the tunnel exit
site (Figure 7E). This conglomerate comprises the 45 aa (of
52 aa) NTE of cpL13, 22 aa (of 67 aa) from the NTE of
cpL21 and 37 aa (of 60 aa) CTE of cpL22, which reach
out from the respective globular domains to form multiple
protein–protein interactions with each other (Figure 7F).
The high flexibility of the extensions, and the poor quality
of the density at the periphery of the ribosome, enabled only
the backbone of the protein extensions to be traced. More-
over, the N-terminal 45 aa of the NTE of cpL21 could not
be modeled, although density was observed at lower thresh-
olds suggesting that these residues establish additional in-
teractions with the CTE of cpL22. Collectively, these cpRP
extensions expand the area of the LSU and could facilitate
interaction with the thylakoid membrane (Figure 7E).
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Figure 6. Interaction of cpRP extensions with rRNA. (A–D) Examples of interaction of cpRP extensions (gold) with cp23S rRNA (cyan) include the
(A) CTE of cpL34 with H51, (B) CTE of cpL15 with H22/H88, (C) CTE of cpL35 with H38 and (D) NTE of cpL13 with H41. (E) Interaction of NTE
of cpL13 (gold) with the 3′ end of the cp23S (cyan) and the 5′ end of the 4.8S (pink) in the chlororibosome, superimposed with the (F) Escherichia coli
70S ribosome showing that H10 of the Ec23S (gray) overlaps with the NTE of cpL13 (gold). (G) Interaction of CTE of cpL27 (gold) with the three-way
junction of H38 (cyan) of the chlororibosome, whereas in the (H) E. coli 70S ribosome, EcL27 (green) has no extension and H38 (gray) is bound by EcL30
(red).
Figure 7. Interaction of cpRP extensions with rRNA. (A) View onto the tunnel exit site of the chloroplast LSU with rRNA (cyan) and highlighting cpRPs
L23 (orange), L29 (purple), L24 (tan), L22 (green), L13 (blue) and L21 (yellow). (B) Zoom of (A) highlighting the NTE of cpL24 and cpL23, and the
CTE of cpL29 as well as the shorter "-hairpin of cpL23. (C) Equivalent view of (B) but for Escherichia coli 70S ribosome, highlighting the absence of
EcL24-NTE and the presence of the "-hairpin of EcL23 in the tunnel lumen, as well as H10 of Ec23S rRNA. (D) Superimposition of EcSRP (blue) on
chlororibosome illustrating overlap with the CTE of cpL29. (E) Chloroplast LSU, colored as in (A), illustrating additional cpRP protein mass that expands
the potential surface area of the LSU and facilitates its possible interaction with the thylakoid membrane (TM). (F) Zoom of boxed region in (E) without
rRNA to illustrate the contribution of the cpRP extensions (NTE/CTE) of L21 (yellow), L13 (blue) and L22 (green) to the thylakoid membrane interaction
surface.
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CONCLUSION
Here we present a near-complete molecular model for
the spinach chloroplast LSU, revealing the location of
rRNA insertions and deletions, cpRP extensions as well
as the binding site of two plastid-specific RPs, PSRP5 and
PSRP6. Prior to submission, a cryo-EM structure of the
spinach chloroplast 50S subunit was reported by Ahmed
and coworkers (51). Generally, the results appear to be in
good agreement with our structure, although a careful com-
parison cannot be undertaken as the cryo-EM map and
model were not yet available at the time of submission, nor
during the review process. In general, the differences of the
chlororibosome with respect to the eubacterial E. coli 70S
ribosome are localized to peripheral regions of the ribo-
some and not within core functional regions that would be
expected to influence translational activity, such as the sub-
unit interface, peptidyl-transferase center or translation fac-
tor binding site. One major exception is related to the ribo-
somal tunnel through which the nascent polypeptide chain
passes as it is synthesized. In the chlororibosome, we ob-
served that the lower region of the tunnel differs from bac-
teria due to a shorter "-hairpin of cpL23 and the additional
presence of the NTE of cpL24. Formation of $-helical sec-
ondary structure within nascent polypeptides chains has
been observed in this region of the ribosomal tunnel (52).
Structural changes within this region of the chlororibosome
may facilitate targeting and insertion of transmembrane-
containing proteins into the thylakoid membrane. In this
respect, we also note that the CTE of cpL29 could play a
role in recruitment of cpSRP54 to the chlororibosome. Un-
like bacterial SRPs, the cpSRP lacks the 4.5S RNA (termed,
SRP RNA) and comprises only the SRP54 protein, and
therefore the CTE of cpL29 may contribute to stabilization
of SRP54 interaction with the chlororibosome. Finally, we
observed a large conglomerate of cpRP extensions that ex-
pand the surface area at the back of the LSU. We suggest
that this may facilitate interaction of the chlororibosome
directly with the thylakoid membrane and/or membrane-
bound components of the targeting machinery, and thereby
increase the efficiency of membrane protein insertion. As
mentioned, the majority of the chloroplast-encoded pro-
teins is targeted to the thylakoid membranes, including
components of the ATP synthase, cytochrome b/f and es-
pecially photosystem I and II complexes (4).
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SUPPLEMENTARY FIGURES 
 
 
Figure S1: In silico sorting and refinement of the chloroplast SSU and LSU. (A) 
In silico sorting was performed using SPIDER (2), starting with an initial 56,475 
particles that yielded after removal of non-aligning particles (18,849), a dataset of 
37,626 ribosomal particles. (B) Subsequently, focused alignment and refinement of 
the SSU and LSU was performed in FREALIGN (3). 
 
 
Figure S2: Resolution of the cryo-EM reconstruction of the chloroplast SSU 
and LSU. (A,B) Fourier-shell correlation curve (FSC) of the refined final map of the 
chloroplast (A) SSU and (B) LSU, indicating the average resolution is 5.4 Å and 
3.6 Å, respectively. (C) Fit of models to maps. FSC curves calculated between the 
refined model and the final map (blue), with the self- and cross-validated correlations 
in orange and black, respectively. Information beyond 3.6 Å was not used during 
refinement and preserved for validation. (D) Overview and (E) transverse section 
through the chloroplast LSU colored according to the local resolution as calculated 
using ResMap (1). 
 
Figure S3: Localization of extra density on the SSU. (A) Overview of the back of 
the cryo-EM map (grey) of the chloroplast SSU with molecular model (rRNA, grey; 
RPs, yellow), and with (B) zoom onto the spur region, showing extra density (blue). 
(C) Overview of the back of the cryo-EM map (grey) of the chloroplast SSU from 
Sharma and coworkers (4) with molecular model (rRNA, grey; RPs, yellow), and with 
(D) zoom onto the spur region, showing additional density that was assigned to 
PSRP2/3. (E) Overview and (F) zoom onto the back of the cryo-EM map (grey) of 
the chloroplast SSU with molecular model (rRNA, grey; RPs, yellow), with cpRP 
densities (green) and unassigned extra density (blue) shown relative to the position 
of mRNA (yellow; superimposed from PDB ID 3I8G (5)). (G) Overview and (H) zoom 
onto the platform of the cryo-EM map (grey) of the chloroplast SSU with molecular 
model (rRNA, grey; RPs, yellow) and cpRP densities (green) shown relative to the 
position of SD-aSD helix (yellow/red; superimposed from PDB ID 3I8G (5)). 
 
Figure S4: Localization of PSRPs on the chlororibosome. (A,B) Cryo-EM 
electron density (grey mesh) for (A) PSRP4 and (B) PSRP1. (C,D) Superimposition 
of the binding site of PSRP1 (blue) on the chlororibosome relative to (C) E. coli HPF 
(orange) bound to the Thermus thermophilus 70S ribosome (PDB ID 4V8H, (6))!and 
(D) mRNA (yellow) and A-site (pink), P-site (green) and E-site (cyan) tRNAs (PDB ID 
3I8G, (5)). (E) Cryo-EM electron density (grey mesh) for domain I of the cpRRF 
(blue, cpRRF-DI). (F-H) Molecular model for PSRP5 shown as (F) surface charge 
(blue, positive) and (G) with electron density (grey mesh) and (H) zoom of the boxed 
region in (G). (I-K) Molecular model for PSRP6 shown as (I) surface charge (blue, 
positive, white neutral, red, negative) and (J) with electron density (grey mesh) and 
(K) zoom of the boxed region in (J). 
 
Figure S5: Modelled nucleotides of the chloroplast 4.8S and 23S rRNAs. (A) 
Secondary structure of the 5’ portion of the cp23S rRNA, with nucleotides highlighted 
in red that were not modelled. The secondary structure diagram was taken from the 
Comparative RNA Web (CRW) Site (www.rna.ccbb.utexas.edu) (7). 
!
Figure S5: Modelled nucleotides of the chloroplast 4.8S and 23S rRNAs. (B) 
Secondary structure of the 3’ portion of the cp23S rRNA and 4.8S rRNA, with 
nucleotides highlighted in red that were not modelled. The secondary structure 
diagram was taken from the Comparative RNA Web (CRW) Site 
(www.rna.ccbb.utexas.edu) (7). 
SUPPLEMENTARY TABLES 
Supplementary Table S1. Data collection and refinement statistics 
Data Collection and Refinement Cp50S 
Particles  37,636!
Pixel size (Å) 1.061!
Defocus range (µm)  )1.0)2.3!
Voltage (kV) 300!
Electron dose (e-/Å-2) 40.3!
Map sharpening B factor (Å2) )84.98!
Resolution (Å, 0.143 FSC) 3.6!
FSCAverage 0.88!
Model Composition !
Protein residues 3,392!
RNA bases 2,963!
Validation (proteins) !
Poor rotamers (%) 7.11!
Ramachandran outliers (%) 2.94!
Ramachandran favored (%) 85.51!
Bad backbone bonds (%) 0.04!
Bad backbone angles 0.01!
MolProbity score 2.48!(99th!percentile)!
Validation (nucleic acids) !
Correct sugar puckers (%) 96.39!
Good backbone conformations (%) 69.83!
Bad bonds (%) 0.01!
Bad angles 0.21!
Clash score, all atoms 3.96!(100th!percentile)!
 
Supplementary Table S2 Modeled proteins of the chloroplast LSU  
Protein( UniProtKB( (((((((((Preprotein( (((((Mature(Length( (((Modeled(Residues(
uL01c! Q9LE95! !!!!!!1)352! 73)352! !
uL02c! P06509! ! 2)272! 26)271!
uL03c! A0A0K9QEC7! !!!!!!1)305! 85)305! 85)303!
uL04c! O49937! !!!!!!1)293! 51)293! 56)260!
uL05c! P82192! ! 1)220! 16)194!
uL06c! A0A0K9R4N9! !!!!!!1)220! 39)220! 40)217!
bL09c! A0A0K9RQ91! !!!!!!1)196! 42)196! 43)87!
uL10c! A0A0K9R3N5! !!!!!!1)232! 53)232! !
uL11c! P31164! !!!!!!1)224! 67)224! !
bL12c! P02398! !!!!!!1)189! 57)189! !
uL13c! P12629! !!!!!!1)250! 48)250! 55)250!
uL14c! P09596! ! 1)121! 1)120!
uL15c! A0A0K9QHT0! !!!!!!1)271! 61)271! 78)259!
uL16c! P17353! ! 1)135! 1)135!
bL17c! A0A0K9RLJ4! !!!!!!1)126! 11)126! 11)126!
uL18c! A0A0K9QQ60! !!!!!!1)166! 45)166! 49)166!
bL19c! P82413! !!!!!!1)233! 78)233! 117)230!
bL20c! P28803! ! 2)128! 2)117!
bL21c! P24613! !!!!!!1)256! 56)256! 101)234!
uL22c! P09594! ! 2)199! 25)176!
uL23c! Q9LWB5! !!!!!!1)198! 77)198! 104)194!
uL24c! P27683! !!!!!!1)191! 47)191! 47)175!
bL27c! A0A0K9R4I2! !!!!!!1)194! 57)194! 59)166!
bL28c! A0A0K9RD02! !!!!!!1)148! 72)148! 72)146!
uL29c! A0A0K9R7W8! !!!!!!1)168! 59)168! 59)152!
bL31c! A0A0K9R0R6! !!!!!!1)130! 37)130! !
bL32c! P28804! !!!!!!1)57! 2)57! 2)43!
bL33c! P28805! ! 1)66! 6)65!
bL34c! P82244! !!!!!!1)152! 92)152! 92)152!
bL35c! P23326! !!!!!!1)159! 87)159! 90)159!
bL36c! P12230! ! 1)37! 1)37!
PSRP5! P27684! !!!!!!1)142! 59)142! 97)142!
PSRP6! P82411! !!!!!!1)116! 48)116! 48)94!
RRF! P82231! ! 1)271! 89)114;191)271!
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Antimicrobial peptides form a diverse group of molecules that are 
produced as part of the innate immune response of all multicellular 
organisms1. Among these, PrAMPs have garnered considerable atten-
tion as a possible means of countering the rapid increase in bacterial 
resistance to classical antibiotics2,3. Unlike many peptides that kill 
bacteria by disrupting their cell membrane, PrAMPs are transported 
into the cytoplasm by specialized transporters, such as SbmA in Gram-
negative bacteria4,5, where they inhibit specific intracellular targets. 
Given that such transport mechanisms are absent in mammalian cells, 
and only limited interactions with intracellular eukaryotic proteins 
have been detected, PrAMPs are generally considered to be nontoxic6 
and therefore an attractive alternative to existing antimicrobials. 
Interestingly, some PrAMPs can cross the blood-brain barrier to selec-
tively target brain cells, thus further highlighting their potential for the 
treatment of cerebral infections or for brain-specific drug delivery7.
Initial efforts to locate bacterial targets for PrAMPs led to the iden-
tification of the heat-shock protein DnaK as the prime candidate for 
inhibition8. Short proline-rich peptides (of 18–20 amino acids (aa)) 
such as oncocin, drosocin, pyrrhocoricin or apidaecin were previously 
shown to bind to this bacterial chaperone in a stereospecific manner, 
thus leading to the development of improved PrAMP derivatives with 
increased affinity for DnaK9–12. However, subsequent studies into the 
antimicrobial properties of PrAMPs13 have suggested that these pep-
tides are likely to use additional modes of action to inhibit growth. For 
example, a C-terminally truncated version of the apidaecin 1b peptide 
results in a loss of antimicrobial activity but no observable decrease 
in DnaK binding or cellular uptake13. Similarly, oncocin (Onc72 and 
Onc112) and apidaecin (Api88 and Api137) derivatives were found 
to inhibit the growth of a dnaK-deletion strain as efficiently as that of 
the dnaK-containing parental strain14. Further investigation revealed 
that these PrAMPs have an additional target within the bacterial cell, 
namely the ribosome14. Although such PrAMPs have been shown 
to bind to the ribosome and inhibit translation14, the mechanism by 
which they inhibit translation has so far not been determined.
Here, we set out to address this issue by obtaining a 3.1-Å- 
resolution X-ray crystallography structure of the Thermus ther-
mophilus 70S ribosome (Tth70S) in complex with a peptidyl (P)-site– 
bound deacylated tRNAiMet and Onc112, a representative of the 
oncocin family of PrAMPs produced by the milkweed bug (Oncopeltus 
fasciatus)15. The structure reveals that the N-terminal residues 1–12 
of Onc112 bind to the upper region of the ribosomal exit tunnel, 
overlapping the binding site for the CCA end of an aminoacyl (A)-site 
tRNA at the peptidyl transferase center. Consistently with this, 
we showed biochemically that Onc112 allows translation to initiate 
but destabilizes the initiation complex and thus prevents subse-
quent entry of affected ribosomes into the translation-elongation 
phase. Moreover, we demonstrated that although truncation of the 
C-terminal portion of Onc112 is dispensable for ribosome binding, 
it is essential for antimicrobial activity. We believe that these findings 
will provide an excellent basis for the design of improved antibacterial 
compounds, either peptidic or peptidomimetic, that inhibit transla-
tion by targeting the ribosomal exit tunnel.
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The proline-rich antimicrobial peptide Onc112 inhibits 
translation by blocking and destabilizing the initiation 
complex
A Carolin Seefeldt1,2,6, Fabian Nguyen3,6, Stéphanie Antunes1,4,6, Natacha Pérébaskine1,2, Michael Graf3,  
Stefan Arenz3, K Kishore Inampudi1,2, Céline Douat1,4, Gilles Guichard1,4, Daniel N Wilson3,5 & C Axel Innis1,2
The increasing prevalence of multidrug-resistant pathogenic bacteria is making current antibiotics obsolete. Proline-rich 
antimicrobial peptides (PrAMPs) display potent activity against Gram-negative bacteria and thus represent an avenue for 
antibiotic development. PrAMPs from the oncocin family interact with the ribosome to inhibit translation, but their mode 
of action has remained unclear. Here we have determined a structure of the Onc112 peptide in complex with the Thermus 
thermophilus 70S ribosome at a resolution of 3.1 Å by X-ray crystallography. The Onc112 peptide binds within the ribosomal  
exit tunnel and extends toward the peptidyl transferase center, where it overlaps with the binding site for an aminoacyl-tRNA.  
We show biochemically that the binding of Onc112 blocks and destabilizes the initiation complex, thus preventing entry into  
the elongation phase. Our findings provide a basis for the future development of this class of potent antimicrobial agents.
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RESULTS
Onc112 binds in a reverse orientation within the exit tunnel
We obtained the structure herein referred to as Tth70S–Onc112 by 
soaking the 19-aa Onc112 peptide (VDKPPYLPRPRPPRrIYNr-NH2, 
in which r denotes d-arginine) into crystals of Tth70S ribosomes 
in complex with a P-site–bound deacylated tRNAiMet and a short 
mRNA (Table 1). Using a minimally biased Fo − Fc map calculated 
after refinement of a model comprising Tth70S ribosomes, tRNAiMet 
and mRNA but lacking Onc112, we could see clear density that could 
be attributed to the N-terminal two-thirds of the Onc112 peptide 
(Fig. 1). Interestingly, the peptide is bound inside the tunnel with 
a reversed orientation relative to the growing polypeptide chain 
during protein synthesis, i.e., with its N terminus located near the 
peptidyl transferase center and its C terminus extending into the 
exit tunnel toward the constriction formed by ribosomal proteins 
L4 and L22. Despite the reversed orientation, the location of the 
Onc112 peptide overlaps to varying extents with the path of nascent 
polypeptide chains that have been visualized within the ribosomal 
tunnel16–18 (Supplementary Fig. 1). The conformation of Onc112 
bound to the ribosome is extended, in a manner similar to but distinct 
from that observed previously for oncocin in complex with DnaK10 
(Supplementary Fig. 2). Our CD studies suggest that, in solution, 
the Onc112 peptide adopts an essentially random conformation, 
with short stretches of poly(Pro)II helix, specifically, 6% A-helix, 
54% random coil, 30% PPII and 6% B-sheet (Supplementary Fig. 3).
Interaction between Onc112 and 23S rRNA of the exit tunnel
Comparison of the Tth70S–Onc112 structure with that of a Tth70S 
ribosome featuring tRNAiMet bound to the P site19 reveals that several 
nucleotides of the 23S rRNA undergo a conformational change upon 
binding of Onc112 to the ribosome (Fig. 2a). U2506 shifts to occupy 
a position similar to that observed upon binding of aminoacyl-tRNA 
to the A site of the ribosome20,21. In the presence of Onc112, 
U2585, which is very flexible in many crystal structures, adopts a 
defined position similar to that modeled in the structure of a vacant 
Escherichia coli 70S ribosome22. In addition, A2062 shifts to provide 
space for Onc112, adopting a similar conformation to that observed 
previously in the presence of the ErmBL nascent chain23. Thus, 
binding of Onc112 to the ribosome is accompanied by an induced 
fit involving several 23S rRNA nucleotides that are generally known 
for their dynamic behavior within the peptidyl transferase center and 
ribosomal tunnel.
Electron density for the Onc112 peptide was strongest for residues 
Val1–Pro8 and became weaker after Pro10, thus making it difficult to 
model the peptide beyond Pro12 (Fig. 1). We observed three sets of 
interactions between the N-terminal 10 aa of Onc112 and nucleotides 
of the 23S rRNA (Fig. 2b). The first set involves aa 1–3 of Onc112 and 
encompasses eight potential hydrogen-bond interactions (Fig. 2b,c). 
Val1 of Onc112 can form three hydrogen bonds with nucleotides of 
the 23S rRNA; two via its A-amine to the N3 atom of C2573 and the 
O3` atom of C2507; and one via its carbonyl oxygen to the N4 atom 
of C2573. Three additional hydrogen bonds are possible between 
the side chain carboxylic acid of Asp2 and the N1 and N2 atoms of 
G2553 or the 2`-OH of C2507. The positively charged side chain of 
Lys3 extends into a negatively charged cavity, displacing a hydrated 
magnesium ion that is present at this site in other Tth70S ribosome 
structures20, and it interacts with the backbone phosphates of A2453 
(Fig. 2c) and U2493 (not shown). Substitution of Val1, Asp2 and 
especially Lys3 by alanine in Onc72 leads to a loss of antimicrobial 
activity10, whereas, as expected, a D2E mutant of Onc112 retained 
both in vitro and in vivo activity (Supplementary Fig. 4). The K3A 
substitution in Onc72 reduced its ribosome binding affinity by a 
factor of 4.3 and lowered the half-maximal inhibitory concentration 
(IC50) for in vitro translation more than 18-fold14.
The second set of interactions involves the side chains of Tyr6 and 
Leu7 of Onc112 (Fig. 2b,d). The aromatic side chain of Tyr6 estab-
lishes a P-stacking interaction with C2452 of the 23S rRNA (Fig. 2d). 
In addition, the side chain hydroxyl of Tyr6 hydrogen-bonds with an 
undetermined ion that is coordinated by the backbone phosphate 
of U2506 and the O2 atoms of C2452 and U2504. The hydrophobic 
cavity occupied by the Tyr6 side chain also accommodates the side 
chain of Leu7 of Onc112, which packs against the phenol moiety of 
Tyr6, whereas the backbone of Leu7 forms two hydrogen bonds with 
U2506 (Fig. 2b,d). The compact hydrophobic core formed by Tyr6 
and Leu7 is likely to be key in anchoring the Onc112 peptide to the 
tunnel because mutagenesis experiments have shown that alanine 
substitution of either residue in Onc72 reduces the ribosome binding 
affinity by a factor of 7 and results in a complete loss of inhibitory 
activity on translation in vitro14. In contrast, mutation of Leu7 in 
Onc112 to cyclohexylalanine, which would preserve the hydrophobic 
environment, resulted in retention of inhibitory activity on transla-
tion in vitro but unexpectedly led to a loss of antimicrobial activity 
(Supplementary Fig. 4).
Additional interactions with the ribosome encompass the PRPRP 
motif of Onc112 (Fig. 2b) and include a P-stacking interaction 
between the guanidino group of Arg9 of Onc112 and the base of 
C2610 (Fig. 2e). Although substitution of Arg11 with alanine in 
Onc72 also reduces the ribosome binding affinity and inhibitory 
properties of the peptide14, we observed very little density for the 
side chain of this residue, thus suggesting that it could be important 
for the overall electrostatic properties of the peptide rather than for 
a defined interaction with the ribosome (Fig. 1). The high conserva-
tion of the 23S rRNA nucleotides that comprise the ribosome-binding 
site of Onc112 is consistent with the broad spectrum of antimicrobial 
Table 1 Data collection and refinement statistics
Tth70S–Onc112a
Data collection
Space group P212121
Cell dimensions
 a, b, c (Å) 209.30, 452.29, 624.12
 A, B, G (°) 90.0, 90.0, 90.0
Resolution (Å) 50 (3.1)
Rmerge 25.5% (166.4%)
I / SI 5.47 (0.95)
Completeness (%) 99.1 (98.8)
Redundancy 3.8 (3.6)
Refinement
Resolution (Å) 3.1
No. reflections 3,999,403
Rwork / Rfree 23.08 / 27.13
No. atoms
 Protein / RNA 91,758 / 195,737
 Ligand/ion 2,333
B factors
 Protein / RNA 64.81 / 63.15
 Ligand/ion 51.31
r.m.s. deviations
 Bond lengths (Å) 0.015
 Bond angles (°) 0.809
aStructure determined from a single crystal.
A R T I C L E S
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activity displayed by this and related PrAMPs against a range of 
Gram-negative bacteria10,24.
Onc112 allows translation to initiate but blocks elongation
Comparison of the Tth70S–Onc112 structure with that of the 
Tth70S ribosome in the preattack state of peptide-bond formation20 
indicated that the binding of Onc112 to the ribosome would prevent 
accommodation of the CCA end of an incoming aminoacyl-tRNA 
via steric occlusion of the ribosomal A site at the peptidyl transferase 
center (Fig. 3a). Indeed, Asp2 of Onc112 directly interacts with 
G2553, a residue located within helix H92 of the 23S rRNA, termed 
the A loop, that normally stabilizes the A site tRNA at the peptidyl 
transferase center via Watson-Crick base-pairing with nucleotide C75 
of its CCA end.
In order to determine the step of translation that Onc112 inhibits, 
we performed cell-free protein synthesis and monitored the loca-
tion of the ribosomes on the mRNA (Fig. 3b and Supplementary 
Data Set 1), by using toe-printing assays25,26. In the absence of 
Onc112 or antibiotic, ribosomes were able to initiate at the AUG 
start codon and translate through the open reading frame, but they 
became trapped on the downstream isoleucine codon because iso-
leucine was omitted from the translation mix. In the presence of the 
antibiotics clindamycin or thiostrepton, ribosomes accumulated at 
the start codon and could not translate down to the isoleucine codon 
because these antibiotics prevent delivery and/or accommodation of 
the first aminoacyl-tRNA directly following the initiation codon27. 
We observed similar results when performing the toe-printing assay 
with increasing concentrations of the Onc112 peptide, namely a loss 
of the band corresponding to ribosomes stalled at the isoleucine 
codon and an increase in the band corresponding to the ribosomes 
accumulating at the start codon. These findings indicate that Onc112 
allows subunit joining and formation of the 70S initiation complex 
but prevents accommodation of the first aminoacyl-tRNA at the 
A site, as suggested by steric overlap between Onc112 and an A-site tRNA 
(Fig. 3a). This contrasts with a bona fide translation-initiation 
inhibitor, such as edeine, which interferes with the stable binding of 
fMet-tRNAiMet to the 30S subunit and thus prevents 70S initiation-
complex formation28, in agreement with the lack of a toe-print band 
at the start codon in the presence of edeine (Fig. 3b).
P-tRNA Asp2
Lys3
Pro4
Pro5
Arg9 Pro8
Arg11
Pro10
Pro12
30S
50S
P
Leu7
Tyr6
Val1
N terminus
C terminus
Figure 1 Onc112-binding site within the exit tunnel of the ribosome. 
Transverse section of the exit tunnel of the Tth70S ribosome showing the 
binding site for the Onc112 peptide (orange). Minimally biased Fo − Fc 
difference map contoured at +3.0S (blue) is observable for the  
first 12 amino acids of Onc112 (VDKPPYLPRPRPPRrIYNr-NH2;  
residues 1–12 are bold and underlined). Initiator tRNAiMet bound at  
the P site is shown in green. Inset shows the view chosen to display the 
Onc112 peptide relative to the complete 70S ribosome.
b
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Figure 2 Interactions between Onc112 and the ribosome.  
(a) Comparison of the conformation of 23S rRNA nucleotides  
(yellow) in the presence of Onc112 (orange) with their  
Onc112-free conformation (blue)19. (b–e) Overview of  
the first 12 aa of Onc112 (b) and interactions of Onc112  
(orange) with 23S rRNA nucleotides (yellow) from the A-site 
CCA-binding pocket (c), A-site crevice (d) and upper ribosomal 
exit tunnel (e), as distinguished by different background colors. 
An uncharacterized ion is shown in gray.
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Onc112 destabilizes the translation-
initiation complex
We noticed that the toe-print bands at the 
start codon in the presence of Onc112 were 
consistently weaker than those observed in the presence of clindamy-
cin or thiostrepton (Fig. 3b and data not shown), thus suggesting that 
Onc112 may also perturb the placement of fMet-tRNAiMet at the P site. 
In the Tth70S–Onc112 structure, the P-site tRNA is uncharged, and its 
terminal A76 residue undergoes a conformational change that posi-
tions it ~3.4 Å away from the Onc112 peptide. In vivo, however, we 
would expect fMet-tRNAiMet to bind to the peptidyl transferase center 
in the same manner as in the Tth70S ribosome preattack complexes20, 
such that the formyl group of the fMet moiety would sterically 
clash with residues Tyr6 and Leu7 of the Onc112 peptide (Fig. 3a). 
Consequently, we used sucrose gradients to monitor disome forma-
tion upon translating a dicistronic ErmBL mRNA in vitro, in order to 
investigate the stability of the translation-initiation complex formed 
in the presence of Onc112 (Fig. 3c–g). As a positive control, we 
performed translation in the presence of the macrolide antibiotic 
erythromycin, which acts synergistically with the ErmBL polypeptide 
chain within the ribosomal tunnel to stall translation at a specific 
site on the mRNA29. Because the mRNA was dicistronic, two stalled 
ribosomes on a single mRNA led to the formation of disomes that 
could be visualized on a sucrose gradient (Fig. 3d), as shown previ-
ously16,23. We observed negligible disome formation in the absence 
of erythromycin because the ribosomes rapidly translated the short 
ORF and were released from the mRNA (Fig. 3e). As expected, thio-
strepton, which allows 70S initiation-complex formation but prevents 
elongation (Fig. 3b), also led to efficient disome formation (Fig. 3f). 
In contrast, the presence of Onc112, even at concentrations as high as 
100 MM, resulted in only a small increase in disomes (Fig. 3g). This 
leads us to suggest that the 70S initiation complexes formed in the 
presence of Onc112 are unstable, presumably because the Onc112 
peptide encroaches onto fMet-tRNAiMet, thus causing it to dissociate 
from the ribosome under the nonequilibrium conditions (centrifuga-
tion and sucrose density) used in the disome assay.
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Figure 3 Onc112 blocks and destabilizes the 
initiation complex. (a) Structural comparison  
of Phe-tRNAPhe (blue) in the A site and  
fMet-tRNAiMet in the P site (green)20 with the 
binding site of Onc112 (orange). (b) Toe-printing 
assay performed in the absence (−) or presence  
of increasing concentrations (1 MM, 10 MM and 
100 MM) of Onc112, 50 MM clindamycin (Cli), 
50 MM edeine (Ede) or 100 MM thiostrepton (Ths). 
Sequencing lanes for C, U, A and G and the 
sequence surrounding the toe-print bands 
(arrows) when ribosomes accumulate at the 
AUG start codon (green, initiation complex) or 
the isoleucine codon (blue, stalled elongation 
complex) are included for reference, as illustrated 
graphically. The uncropped gel image for the  
toe-printing assay is in Supplementary Data Set 1. 
(c–g) Schematic (c) showing the dicistronic 
ErmBL mRNA that was used to monitor disome 
formation with sucrose gradients in the presence (d) 
or absence (e) of 20 MM erythromycin (Ery) or the 
presence of 20 MM thiostrepton (f) or 100 MM 
Onc112 (g). In c, SD denotes the Shine-Dalgarno 
sequence. A, absorbance.
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Figure 4 Characterization of Onc112, its C-terminally truncated derivatives and its membrane transporter in Gram-negative bacteria. (a,b) Effect of 
Onc112 (red) and C-terminally truncated Onc112 derivatives Onc112 $C7 (green) and Onc112 $C9 (purple) on overnight growth of E. coli strain 
BL21(DE3) (a) and the luminescence resulting from the in vitro translation of Fluc (b). (c) Effect of Onc112 on overnight growth of E. coli strain 
BW25113 (blue) or BW25113$sbmA (orange). In a and c, error bars represent mean o s.d. for triplicate experiments, whereas the experiment in b 
was performed in duplicate, with the plotted points representing the mean value. The growth or luminescence measured in the absence of peptide was 
assigned as 100% in all cases. 
np
g
©
 2
01
5 
N
at
ur
e 
A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
474 VOLUME 22 NUMBER 6 JUNE 2015 NATURE STRUCTURAL & MOLECULAR BIOLOGY
A R T I C L E S
Onc112 C terminus is needed for uptake, not ribosome binding
The lack of density for the C terminus of Onc112 (residues 13–19) 
hinted that this region is dispensable for ribosome binding, yet its 
high degree of conservation suggested that it may nevertheless be 
necessary for antimicrobial activity. In order to assess the role of the 
C-terminal region of Onc112, we prepared truncated versions of this 
peptide, Onc112 $C7 and Onc112 $C9, which lacked the last 7 and 
9 aa, respectively. We then determined the half-minimal inhibitory 
concentration (MIC50) for the growth of E. coli strain BL21(DE3) in 
the presence of full-length Onc112 and compared it with those of 
the truncated Onc112 $C7 and Onc112 $C9 derivatives (Fig. 4a). 
As expected, the full-length Onc112 displayed good activity, inhibit-
ing growth with an MIC50 of 10 MM, a value similar to that reported 
previously14. In contrast, truncation of 7 or 9 aa from the C terminus 
of Onc112 led to a complete loss of inhibitory activity, even at con-
centrations above 100 MM (Fig. 4a). To ascertain whether the trun-
cated Onc112 peptides could still bind to the ribosome and inhibit 
translation, we monitored in vitro translation of firefly luciferase 
(Fluc) by measuring luminescence after 60 min of translation in the 
presence of increasing concentrations of either full-length Onc112 
or the truncated Onc112 $C7 and Onc112 $C9 derivatives (Fig. 4b). 
As expected, the full-length peptide displayed excellent activity, inhib-
iting translation of Fluc with an IC50 of 0.8 MM (Fig. 4b), a value 
similar to that reported when the same system was used for well- 
characterized translation inhibitors such as chloramphenicol30. In 
contrast to their lack of antimicrobial activity (Fig. 4a), both truncated 
Onc112 peptides displayed some inhibitory activity with the in vitro– 
translation system (Fig. 4b), albeit with a reduced efficiency relative 
to that of full-length Onc112. Specifically, the Onc112 $C7 peptide 
consisting of residues 1–12 of Onc112 had an IC50 of 5 MM, which was 
only six times greater than that of full-length Onc112, a result consist-
ent with our structure-based prediction that these residues comprise 
the major ribosome binding determinants. In contrast, the Onc112 
$C9 peptide consisting of aa 1–10 of Onc112 had an IC50 of 80 MM, 
which was 16 times greater than that of Onc112 $C7 and two orders 
of magnitude greater than that of full-length Onc112. These results 
illustrate the contribution of Arg11 to efficient ribosome binding and 
translation inhibition, as reported previously14.
Figure 5 Mechanism of action and overlap  
of Onc112 with antibiotics that target  
the large subunit of the ribosome. (a) Model  
for the mechanism of action of Onc112.  
(1) Onc112 binds within the exit tunnel  
of the ribosome with a reverse orientation  
relative to a nascent polypeptide chain.  
(2) Onc112 allows formation of a  
translation-initiation complex but  
prevents accommodation of the  
aminoacyl-tRNA (aa-tRNA) at the  
A site of the peptidyl transferase  
center. (3) The initiation complex  
is destabilized, thus leading to dissociation  
of the fMet-tRNAiMet from the P site.  
Although full-length Onc112 can  
efficiently penetrate the bacterial  
cell membrane by using the SbmA  
transporter (4), C-terminal truncation  
of Onc112 reduces its antimicrobial  
activity (5), presumably owing to  
impaired uptake. (b) Relative  
binding position of Onc112 (orange) on the ribosome, compared with those of well-characterized translation inhibitors chloramphenicol (purple)32,33, 
clindamycin (green)33, tiamulin (yellow)34 and erythromycin (blue)32,33 as well as an A site–bound Phe-tRNAPhe (ref. 20).
Although the inner-membrane protein SbmA has been shown to be 
responsible for the uptake of the eukaryotic PrAMPs Bac7 and PR39 
(refs. 4,5), the only insect PrAMP tested so far was apidaecin Ib4. 
In order to assess the role of SbmA in the uptake of Onc112, we compared 
the growth of an E. coli strain lacking the sbmA gene ($sbmA) with the 
parental strain BW25113 in the presence of increasing concentrations of 
Onc112 (Fig. 4c). As expected, the full-length Onc112 displayed excel-
lent activity against the susceptible SbmA-containing parental strain, 
inhibiting growth with an MIC50 of 8 MM (Fig. 4c), a value similar 
to that observed with the BL21(DE3) strain (Fig. 4a). In contrast, the 
$sbmA strain displayed increased resistance to Onc112, such that even 
with 100 MM Onc112, growth was reduced by only 20% (Fig. 4c). These 
findings indicate that SbmA is indeed necessary for the uptake of 
Onc112 into Gram-negative bacteria, such as E. coli, and provide fur-
ther support for the proposition that the SbmA transporter is involved 
in the mechanism of action of the entire group of the PrAMPs4.
DISCUSSION
From our structural and biochemical data, we propose a model to 
explain the mechanism by which PrAMPs such as oncocin inhibit 
translation (Fig. 5a). We have shown that the binding of Onc112 to 
the ribosomal exit tunnel allows formation of the 70S initiation com-
plex but prevents accommodation of the aminoacyl-tRNA into the 
A site (Fig. 5a, steps 1 and 2). Additionally, we propose that Onc112 
destabilizes the postinitiation complex by inducing dissociation of 
fMet-tRNAiMet from the P site (Fig. 5a, step 3). Finally, our data also 
suggest that positively charged residues distributed along the entire 
length of the Onc112 sequence are necessary for ensuring the efficient 
SbmA-mediated uptake of Onc112 into the cell, whereas residues 
from the N-terminal moiety of Onc112 are responsible for targeting 
this peptide to the ribosome (Fig. 5a, steps 4 and 5). We believe that 
this mechanism of action is likely to be the same for other PrAMPs, 
such as drosocin, pyrrhocoricin and apidaecin, which share many of 
the residues of Onc112 that are important for its ribosome binding 
and antimicrobial function.
The binding site for Onc112 within the ribosomal exit tunnel 
overlaps with the binding sites for a majority of the antibiotics 
that target the large subunit of the ribosome (Fig. 5b), such as the 
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chloramphenicols, pleuromutilins (for example, tiamulin) and lincosa-
mides (for example, clindamycin), which inhibit peptide-bond forma-
tion by preventing the correct positioning of the tRNA substrates, as 
well as the macrolides (for example, erythromycin), which abort trans-
lation by interfering with the movement of the nascent polypeptide 
chain through the ribosomal exit tunnel27. Given the substantial spa-
tial overlap that exists between the binding sites for these antibiotics 
and the regions of the tunnel that interact with Onc112 (Fig. 5b) 
and presumably with several other PrAMPs, it appears likely that 
such antimicrobial peptides represent a vast, untapped resource for 
the development of new therapeutics. Several strategies have been 
pursued to design improved or entirely new antimicrobials that target 
the exit tunnel of the ribosome31. One approach consists of modi-
fying existing antibiotics to create semisynthetic compounds that 
possess enhanced antimicrobial properties, including better affinity 
for mutated or modified ribosomes, the ability to evade drug modi-
fication or degradation pathways, increased solubility, improved 
uptake and reduced efflux. Other strategies involve designing chi-
meric antibiotics from drugs with adjacent binding sites (for example, 
macrolide-chloramphenicol or linezolid-sparsomycin) or developing 
entirely new scaffolds, as exemplified by the oxazolidinone linezolid. 
The ability to produce new scaffolds based on peptides, such as 
Onc112, that display potent activity against a diverse range of Gram-
negative bacteria represents an exciting avenue for the development 
of future antimicrobials.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Coordinates and structure factors have been depos-
ited in the Protein Data Bank under accession code 4ZER.
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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ONLINE METHODS
Peptide synthesis. Commercially available reagents were used throughout 
without purification. N,N-dimethylformamide (DMF, peptide synthesis– 
quality grade) was purchased from Carlo Erba, and piperidine and trifluoroacetic 
acid (TFA) were purchased from Alfa Aesar. Rink amide PS resin was purchased 
from PolyPeptide Laboratories. N,N`-diisopropylcarbodiimide (DIC), Oxyma 
and all standard N-Fmoc–protected l and d amino acids were purchased from Iris 
Biotech. N-Fmoc-cyclohexylalanine-OH (Fmoc-Cha-OH) was purchased from 
PolyPeptide laboratories. RP-HPLC–quality acetonitrile (CH3CN, Sigma-Aldrich) 
and MilliQ water were used for RP-HPLC analyses and purification. Analytical 
RP-HPLC analyses were performed on a Dionex U3000SD with a Macherey-
Nagel Nucleodur column (4.6 × 100 mm, 3 Mm) at a flow rate of 1 ml min−1 
at 50 °C. The mobile phase was composed of 0.1% (v/v) TFA-H2O (solvent A) 
and 0.1% TFA-CH3CN (solvent B). Purification was performed on a Gilson 
GX-281 with a Macherey-Nagel Nucleodur VP250/21 100–5 C18ec column 
(21 × 250 mm, 5 Mm) at a flow rate of 20 mL min−1. The solid-phase syntheses 
of peptides were conducted on an automated Liberty Blue System synthesizer 
(CEM MWaves S.A.S.). 1H NMR spectra were recorded on a DPX-400 NMR 
spectrometer (Bruker Biospin) with a vertical 9.4T narrow-bore/ultrashield 
magnet operating at 400 MHz for 1H observation by means of a 5-mm direct 
QNP 1H/13C/31P/19F probe with gradient capabilities (Supplementary Fig. 5). 
ESI-MS analyses were carried out on a Thermo Exactive from the Mass 
Spectrometry Laboratory at the European Institute of Chemistry and Biology 
(UMS 3033–IECB), Pessac, France (Supplementary Fig. 5).
All peptides were synthesized on Rink Amide PS resin (0.79 mmol/g) with 
a five-fold excess of reagents for the coupling step (0.2 M N-Fmoc–amino acid 
solution (in DMF) with 0.5 M DIC (in DMF) and 1.0 M Oxyma (in DMF)). 
Coupling of N-Fmoc–protected l- and d-arginine-OH was performed twice at 
25 °C without microwaves for 1,500 s. Other amino acid couplings were 
performed first at 90 °C, 170 W, 115 s then at 90 °C, 30 W, 110 s. Fmoc removal 
was performed with a solution of 20% piperidine in DMF at 75 °C with 155 W 
for 15 s then 90 °C, 35 W, 50 s. After completion of the synthesis, the pep-
tide resin was washed three times with DCM. Cleavage was performed by 
treatment with 5 mL of a freshly prepared TFA/TIS/H20 solution for 240 min 
at room temperature. The resin was then filtered off, and the TFA solution was 
concentrated under reduced pressure. The crude products were precipitated as 
TFA salts in the presence of Et2O and purified with the appropriate gradient 
(10–30% of B in 20 min) by semipreparative RP-HPLC. The compounds were 
freeze dried, and TFA was exchanged with HCl by two repetitive freeze-drying 
cycles in 0.1 N HCl solution35.
The list of peptides prepared for this study and details concerning their 
synthesis is as follows: 
Onc112. H-Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg- 
(d-Arg)-Ile-Tyr-Asn-(d-Arg)-NH2 (2,389.85 g mol−1). Synthesis of Onc112 (0.1-
mmol scale): 24 mg (10% yield); RP HPLC tR 4.11 min (gradient 10–50% of B 
in 10 min); ESI HRMS (m/z): found 1,195.70 [M + 2H]2+, 797.47 [M +3 H]3+, 
598.35 [M + 4H]4+, and 478.88 [M + 5H]5+.
Onc112 $C7. H-Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-NH2 
(1,433.73 g mol−1). Synthesis of Onc112 $C7 (0.15-mmol scale): 79.4 mg (37% 
yield); RP HPLC tR 3.54 min (gradient 10–50% of B in 10 min); ESI HRMS (m/z): 
[M + H]+ calcd for C67H108H20O15, 1,433.83758 found 1,433.84017, with 717.42 
[M + 2H]2+ and 478.61 [M + 3H]3+.
Onc112 $C9. H-Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-NH2  
(1,180.42 g mol−1). Synthesis of Onc112 $C9. (0.1-mmol scale): 22.6 mg 
(19% yield); RP HPLC tR 4.78 min (gradient 10–50% of B in 10 min); ESI HRMS 
(m/z): [M + H]+ calcd for C56H89H15O13, 1,180.63370 found 1,180.68368, with 
[M + 2H]2+ 590.84 and [M + 3H]3+ 394.23.
Onc112 D2E. H-Val-Glu-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-
Arg-(d-Arg)-Ile-Tyr-Asn-(d-Arg)-NH2 (2,403.88 g mol−1). Synthesis of Onc112 
D2E (0.05-mmol scale): 11.6 mg (10% yield); RP HPLC tR 5.75 min (gradient 
10–50% of B in 10 min); ESI HRMS (m/z): found 1316.70 [M + 2H]2+, 840.14 
[M + 3H]3+ and 601.86 [M + 4H]4+.
Onc112 L7Cha. H-Val-Asp-Lys-Pro-Pro-Tyr-Cha-Pro-Arg-Pro-Arg-Pro-Pro-
Arg-(d-Arg)-Ile-Tyr-Asn-(d-Arg)-NH2 (2,429.92 g mol−1). Synthesis of Onc112 
L7Cha (0.05-mmol scale): 6.9 mg (6% yield); RP HPLC tR 5.28 min (gradient 
10–50% of B in 10 min); ESI HRMS (m/z): found 1,252.18 [M + 2H]2+, 822.80 
[M + 3H]3+ and 608.36 [M + 4H]4+.
CD spectroscopy. CD spectra of peptides were recorded on a J-815 Jasco 
spectropolarimeter (Jasco France). Data are expressed in terms of total molar 
ellipticity in deg cm2 dmol−1. CD spectra for the Onc112 peptide were acquired 
at four different concentrations in phosphate buffer (pH 7.6, 10 mM) between 
180 and 280 nm with a rectangular quartz cell with a path length of 1 mm (Hellma 
110-QS 1 mm) averaging over two runs. Secondary-structure proportion was 
estimated from the CD spectra with the deconvolution program CDFriend 
(S. Buchoux (Unité de Génie Enzymatique et Cellulaire, UMR 6022 CNRS-
Université de Picardie Jules Verne) and E. Dufourc (Université de Bordeaux, 
CNRS, Institut Polytechnique de Bordeaux, UMR 5248 Institut de Chimie 
et Biologie des Membranes et des Nano-objets (CBMN); available upon request), 
unpublished). This program uses standard curves obtained for each canonical 
structure (A-helix, B-sheet, helix-polyproline type II and random coil) with LiKj 
(alternated hydrophobic leucine and hydrophilic/charged lysine residues) pep-
tides of known length, secondary structure and CD spectra. The program imple-
ments a simulated annealing algorithm to get the best combination of A-helix, 
B-sheet, helix-II and random coil that exhibits the lowest normalized r.m.s. devia-
tion with respect to the experimental spectrum36–38. The algorithm yielded the 
following assessment for the Onc112 peptide: 54% random coil, 30% helix-PPII, 
6% A-helix and 6% B-sheet content.
Purification of T. thermophilus 70S ribosomes. Tth70S ribosomes were purified 
as described previously39 and resuspended in buffer containing 5 mM 
HEPES-KOH, pH 7.5, 50 mM KCl, 10 mM NH4Cl, and 10 mM Mg(CH3COO)2 
to yield a final concentration of 26–32 mg/mL. For storage, Tth70S ribosomes 
were flash frozen in liquid nitrogen and kept at −80 °C.
Preparation of mRNA and tRNAiMet. Synthetic mRNA with the sequence 
5`-GGC AAG GAG GUA AAA AUG CGU UUU CGU-3` was obtained from 
Eurogentec. This mRNA contains a Shine-Dalgarno sequence and an AUG start 
codon followed by several additional codons. E. coli tRNAiMet was overexpressed 
in E. coli HB101 cells and purified as described previously40.
Complex formation. A ternary complex containing Tth70S ribosomes, mRNA 
and deacylated tRNAiMet was formed by mixing of 5 MM Tth70S ribosomes with 
10 MM mRNA and incubating at 55 °C for 10 min. For the next step, 20 MM 
tRNAiMet was added, and the mixture was incubated at 37 °C for 10 min. Before 
the complexes for crystallization were used, the sample was incubated at room 
temperature for at least 15 min. All complexes were centrifuged briefly before 
use for crystallization. The final buffer conditions were 5 mM HEPES-KOH, 
pH 7.6, 50 mM KCl, 10 mM NH4Cl and 10 mM Mg(CH3COO)2.
Crystallization. Published conditions were used as a starting point for screen-
ing crystallization conditions by vapor diffusion in sitting-drop trays at 20 °C 
(refs. 20,39). Crystallization drops consisted of 3 Ml of ternary complex and 3–4 Ml 
of reservoir solution containing 100 mM Tris-HCl, pH 7.6, 2.9% (v/v) PEG 20000, 
7–10% (v/v) MPD and 175 mM arginine. Crystals appeared within 2–3 d and 
grew to ~1,000 × 100 × 100 Mm within 7–8 d. For cryoprotection, the concen-
tration of MPD was increased in a stepwise manner to yield a final concentra-
tion of 40% (v/v). The ionic composition during cryoprotection was 100 mM 
Tris-HCl, pH 7.6, 2.9% (v/v) PEG 20000, 50 mM KCl, 10 mM NH4Cl and 10 mM 
Mg(CH3COO)2. Tth70S–Onc112 complexes were obtained by soaking 10–20 MM 
of Onc112 dissolved in the final cryoprotection solution overnight at 20 °C. 
Crystals were then flash frozen in a nitrogen cryostream at 80 K for subsequent 
data collection.
Data collection and processing. Diffraction data were collected at beamline 
ID29 of the European Synchrotron Radiation Facility (ESRF) in Grenoble, France. 
A complete data set was obtained by merging 0.1° oscillation data collected at 
100 K with a wavelength of 0.97625 Å from multiple regions of the same crystal. 
Initial data processing, including integration and scaling, were performed with 
XDS41. All of the data collected could be indexed in the P212121 space group, 
with unit-cell dimensions around 210 Å × 450 Å × 625 Å and an asymmetric 
unit containing two copies of the Tth70S ribosome.
Model building and refinement. Initial phases were obtained by molecular 
replacement performed with Phaser42. The search model was obtained from 
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a high-resolution structure of the Tth70S ribosome (PDB 4Y4O). Restrained 
crystallographic refinement was carried out with Phenix43 and consisted of a 
single cycle of rigid-body refinement followed by multiple cycles of positional 
and individual B-factor refinement. Rigid bodies comprised four domains from 
the small 30S subunit (head, body, spur and helix h44) and three domains from 
the large 50S subunit (body, L1 stalk and the C terminus of ribosomal protein 
L9). Noncrystallographic symmetry restraints between the two copies of the 
Tth70S ribosome in the asymmetric unit were also applied during refinement. 
After confirming that a single tRNA was bound to the P site and that additional 
density corresponding to the Onc112 peptide was visible inside the exit tunnel 
in a minimally biased Fo − Fc map, a model for Onc112 was built with Rapper44 
and Coot45. The models for the tRNA and mRNA were obtained from a high-
resolution structure of the Tth70S ribosome preattack complex (PDB 1VY4). 
Further refinement and model validation were carried out in Phenix and on the 
MolProbity server46, respectively. In the final model, 0.65% of protein residues 
were classified as Ramachandran outliers, and 94.38% had favorable backbone 
conformations.
In vitro–translation assay. The inhibition of firefly luciferase (Fluc) synthesis 
by Onc112 was assessed with an E. coli lysate–based transcription-translation 
coupled assay (RTS100, 5Prime) as described previously for other translational 
inhibitors30. Briefly, 6-ML reactions, with or without Onc112/antibiotic were 
mixed according to the manufacturer’s description and incubated for 1 h at 30 °C 
with shaking (1,000 r.p.m.). 1 ML of each reaction was stopped with 7 ML kan-
amycin (50 Mg/Ml) and then diluted with 40 ML of luciferase assay substrate 
(Promega) into a white 96-well chimney flat-bottom microtiter plate (Greiner). 
The luminescence was then measured with a Tecan Infinite M1000 plate reader. 
Relative values were determined by defining the luminescence value of the sample 
without inhibitor as 100%.
Growth inhibition assays. Determination of the minimal inhibitory concentration 
(MIC) of Onc112 was performed as described previously for other antibiotics30. 
Specifically, an overnight culture of E. coli strain BL21(DE3) (Invitrogen), 
BW25113 or Keio deletion strain BW25113$sbmA (plate 61, well 10E)47 was 
diluted 1:100 to an OD600 of ~0.02, and 200 ML of the diluted cells was then trans-
ferred into individual wells of a 96-well plate (Sarstedt). Either 10 ML of Onc112, 
Onc112 derivative peptide or water was added to each well. Plates were then incub-
ated overnight in a thermomixer (Eppendorf) at 37 °C/350 r.p.m. The OD600 was 
measured in a Tecan Infinite M1000 plate reader, and the relative growth was 
calculated by defining the growth of samples without antibiotic as 100%.
Toe-printing assay. The position of the ribosome on the mRNA was monitored 
with a toe-printing assay based on an in vitro–coupled transcription-translation 
system with the PURExpress in vitro protein synthesis kit (NEB)26. Briefly, each 
translation reaction consisted of 1 ML solution A, 0.5 ML $isoleucine + tryptophan 
amino acid mixture, 0.5 ML tRNA mixture, 1.5 ML solution B, 1 ML (0.5 pmol) 
hns40aa template: (5`-ATTAATACGACTCACTATAGGGATATAAGGAGGA
AAACATATGAGCGAAGCACTTAAAATTCTGAACAACATCCGTACTC
TTCGTGCGCAGGCAAGAGAATGTACACTTGAAACGCTGGAAGAAAT
GCTGGAAAAATTAGAAGTTGTTGTTAACGAACGTTGGATTTTGTAA 
GTGATAGAATTCTATCGTTAATAAGCAAAATTCATTATAACC-3`, with 
start codon ATG, catch isoleucine codon ATT and stop codon TAA in bold, 
the hns40aa ORF underlined and primer-binding sites in italics) and 0.5 ML 
additional agents (nuclease-free water, Onc112 or antibiotics). Translation was 
performed in the absence of isoleucine at 37 °C for 15 min at 500 r.p.m. in 1.5-mL 
reaction tubes. Ile-tRNA aminoacylation was further prevented by the use of the 
Ile-tRNA synthetase inhibitor mupirocin. After translation, 2 pmol Alexa647-
labeled NV-1 toe-print primer (5`-GGTTATAATGAATTTTGCTTATTAAC-3`) 
was added to each reaction and incubated at 37 °C without shaking for 5 min. 
Reverse transcription was performed with 0.5 ML of AMV RT (NEB), 0.1 ML 
dNTP mix (10 mM) and 0.4 ML Pure System Buffer and incubated at 37 °C for 
20 min. Reverse transcription was quenched and RNA degraded by addition 
of 1 ML 10 M NaOH and incubation for at least 15 min at 37 °C and then was 
neutralized with 0.82 ML of 12 M HCl. 20 ML toe-print resuspension buffer and 
200 ML PN1 buffer were added to each reaction before treatment with a QIAquick 
Nucleotide Removal Kit (Qiagen). The Alexa647-labeled DNA was then eluted 
from the QIAquick columns with 80 ML of nuclease-free water. A vacuum 
concentrator was used to vaporize the solvent, and the Alexa647-labeled DNA 
was then dissolved into 3.5 ML of formamide dye. The samples were heated to 
95 °C for 5 min before being applied onto a 6% polyacrylamide (19:1) sequencing 
gel containing 7 M urea. Gel electrophoresis was performed at 40 W and 2,000 V 
for 2 h. The GE Typhoon FLA9500 imaging system was subsequently used to 
scan the polyacrylamide gel.
Disome formation assay. The disome formation assay was performed as 
described previously16,23. Briefly, in vitro translation of the 2xermBL construct 
was performed with the Rapid Translation System RTS 100 E. coli HY Kit (Roche). 
Translations were carried out for 1 h at 30 °C and then analyzed on 10–55% 
sucrose-density gradients (in a buffer containing 50 mM HEPES-KOH, pH 7.4, 
100 mM KOAc, 25 mM Mg(OAc)2 and 6 mM B-mercaptoethanol) by centrifuga-
tion at 154,693g (SW-40 Ti, Beckman Coulter) for 2.5 h at 4 °C.
Figure preparation. Figures showing electron density and atomic models were 
generated with PyMOL (http://www.pymol.org/).
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Supplementary Figure 1 
Overlap of Onc112 with nascent polypeptide chains in the ribosome exit tunnel. 
Comparison of the binding position of Onc112 (orange) with (a) ErmCL (green), (b) TnaC (blue) and Sec61E (red) nascent chains. In 
(a)-(c), the CCA-end of the P-tRNA is shown in white and in (b) the two tryptophan molecules are in cyan. 
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Supplementary Figure 2 
Comparison of Tth70S–Onc112 with the DnaK–oncocin complex. 
The conformation of residues Lys3–Pro10 of the Oncocin peptide O2 (cyan, VDKPPYLPRPRPPROIYNO–NH2, where O represents 
ornithine) in complex with DnaK (white surface representation) was compared with residues Val1–Pro12 of Onc112 (orange) from the
ribosome-bound Onc112 structure. 
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Supplementary Figure 3 
Conformation of the Onc112 peptide in solution. 
Far-UV circular dichroism (CD) spectra of the Onc112 peptide at concentrations ranging from 20 to 200 PM. 
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Supplementary Figure 4 
Inhibitory activity of Onc112 peptide derivatives. 
(a-b) Effect of Onc112 (red) and Onc112 derivatives Onc112–L7Cha (blue) and Onc112–D2E (olive) on (a) the overnight growth of 
E. coli strain BL21(DE3) and (b) the luminescence resulting from the in vitro translation of firefly luciferase (Fluc). In (a), the error bars 
represent the standard deviation (s.d.) from the mean for a triplicate experiment (n=3). In (b), the experiment was performed in 
duplicate (n=2). The growth or luminescence measured in the absence of peptide was assigned as 100%. 
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Supplementary Figure 5 
Validation of Onc112 and derivatives. 
(a) Electrospray ionization high resolution mass spectrometry (ESI-HRMS) and reverse phase (RP) high performance liquid
chromatography (HPLC), and (b) 1H nuclear magnetic resonance (NMR) spectra of the Onc112 peptide. (c-f) ESI-HRMS and RP HPLC 
of the (c) Onc112–'C9, (d) Onc112–'C7, (e) Onc112–L7Cha and (f) Onc112–D2E peptides. 
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ABSTRACT
Proline-rich antimicrobial peptides (PrAMPs) pro-
duced as part of the innate immune response of
animals, insects and plants represent a vast, un-
tapped resource for the treatment of multidrug-
resistant bacterial infections. PrAMPs such as on-
cocin or bactenecin-7 (Bac7) interact with the bac-
terial ribosome to inhibit translation, but their sup-
posed specificity as inhibitors of bacterial rather than
mammalian protein synthesis remains unclear, de-
spite being key to developing drugs with low toxic-
ity. Here, we present crystal structures of the Ther-
mus thermophilus 70S ribosome in complex with the
first 16 residues of mammalian Bac7, as well as the
insect-derived PrAMPs metalnikowin I and pyrrho-
coricin. The structures reveal that the mammalian
Bac7 interacts with a similar region of the ribosome
as insect-derived PrAMPs. Consistently, Bac7 and
the oncocin derivative Onc112 compete effectively
with antibiotics, such as erythromycin, which target
the ribosomal exit tunnel. Moreover, we demonstrate
that Bac7 allows initiation complex formation but
prevents entry into the elongation phase of trans-
lation, and show that it inhibits translation on both
mammalian and bacterial ribosomes, explaining why
this peptide needs to be stored as an inactive pro-
peptide. These findings highlight the need to con-
sider the specificity of PrAMP derivatives for the bac-
terial ribosome in future drug development efforts.
INTRODUCTION
Antimicrobial peptides (AMPs) represent a large and di-
verse group of molecules that form part of the innate im-
mune response of a variety of invertebrate, plant and ani-
mal species (1). While many AMPs kill bacteria by disrupt-
ing the bacterial cell membrane, there is growing evidence
that some AMPs have intracellular targets (1). Members
of one such class of non-membranolytic peptides are re-
ferred to as proline-rich AMPs (PrAMPs) and are present
in the hemolymph of several species of insects and crus-
taceans, as well as in the neutrophils of many mammals
(2). PrAMPs exhibit potent antimicrobial activity against
a broad range of bacteria, especially Gram-negative, and
are therefore considered as potential lead candidates for
the development of therapeutic antimicrobial agents (3).
Well-characterized insect PrAMPs include the apidaecins
produced by bees (Apis melifera) and wasps (Apis Vesp-
idae), pyrrhocoricin from firebugs (Pyrrhocoris apterus),
drosocins from fruit flies (Drosophila), metalnikowins from
the green shield bug (Palomena prasina) and the milkweed
bug (Oncopeltus fasciatus) oncocins (2,4,5). PrAMPs are
synthesized as inactive precursors, which undergo prote-
olysis to release the active peptide. In contrast to the ac-
tive insect peptides, which are generally <21 amino acids in
length, the active mammalian mature forms tend to be much
longer; for example, the porcine PR-39 is 39 residues long,
whereas the bovine bactenecin-7 (Bac7), which is also found
in sheep and goats, is 60 residues long (2). Nevertheless, C-
terminally truncated versions of the mammalian PrAMPs
retain antimicrobial activity (6–9) and exhibit high sequence
similarity with the insect PrAMPs. Indeed, the Bac7(1–16)
and Bac7(1–35) derivatives corresponding to the first 16 and
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35 residues of Bac7, respectively, display similar, if not im-
proved, antimicrobial activities compared to the full-length
processed Bac7 peptide (6,10,11). For instance, Bac7(1–35)
reduces mortality from Salmonella typhimurium in a mouse
model of infection (12) as well as in a rat model for septic
shock (13).
The insect-derived PrAMPs apidaecin and oncocin, as
well as the mammalian Bac7, penetrate the bacterial cell
membrane mainly via the SbmA transporter present in
many Gram-negative bacteria (10,14). Early studies iden-
tified interactions between both insect and mammalian
PrAMPs and DnaK, suggesting that this molecular chap-
erone was the common intracellular target (2,15). However,
subsequent studies questioned the relevance of this inter-
action by demonstrating that these PrAMPs also display
an equally potent antimicrobial activity against bacterial
strains lacking the dnaK gene (16–18). Instead, apidaecin,
oncocin and Bac7 were shown to bind to the ribosome and
inhibit translation (17,19). Subsequent crystal structures of
the oncocin derivative Onc112 in complex with the bacterial
70S ribosome revealed that this peptide binds with a reverse
orientation in the ribosomal tunnel and blocks binding of
the aminoacyl-tRNA to the A-site (20,21). However, there
are no crystal structures to date of a mammalian PrAMP in
complex with the ribosome.
Here we present 2.8–2.9 Å resolution X-ray struc-
tures of the Thermus thermophilus 70S (Tth70S) ribosome
in complex with either the mammalian Bac7 derivative
Bac7(1–16) or the insect-derived PrAMPs metalnikowin I
or pyrrhocoricin. The structures reveal that Bac7(1–16),
metalnikowin I and pyrrhocoricin bind within the ribo-
somal tunnel with a reverse orientation compared to a
nascent polypeptide chain, as observed previously for on-
cocin (20,21). In contrast to the insect PrAMPs oncocin,
metalnikowin I and pyrrhocoricin, the mammalian Bac7(1–
16) utilizes multiple arginine side chains to establish stack-
ing interactions with exposed nucleotide bases of the rRNA,
and we show that its unique N-terminal RIRR motif is crit-
ical for inhibiting translation. Like oncocin, metalnikowin
I and pyrrhocoricin, the binding site of Bac7 overlaps with
that of the A-tRNA, consistent with our biochemical stud-
ies indicating that Bac7(1–16) allows 70S initiation complex
formation, but prevents subsequent rounds of translation
elongation. Furthermore, we demonstrate that Bac7(1–35)
displays activity in a mammalian in vitro translation system,
providing a possible explanation for why Bac7 is produced
as a pre-pro-peptide that is targeted to large granules and
phagosomes, thus avoiding direct contact between the ac-
tive peptide and the mammalian ribosome.
MATERIALS AND METHODS
Peptide synthesis and purification
The Bac7 N-terminal fragments Bac7(1–16; RRIR-
PRPPRLPRPRPR), Bac7(1–35; RRIRPRPPRL-
PRPRPRPLPFPRPGPRPIPRPLPFP) and Bac7(5–35;
PRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP) were
synthesized on solid phase and purified by reversed-phase
HPLC as described previously (22). Their concentra-
tions were determined as reported previously (4). All
peptides, with a purity of at least 95%, were stored in
milliQ water at −80◦C until use. The Onc112 peptide
was obtained from an earlier study (21). Metalnikowin I
(VDKPDYRPRPRPPNM) and pyrrhocoricin (VDKG-
SYLPRPTPPRPIYNRN) were synthesized to 97.5 and
98.1% purity by NovoPro Bioscience (China).
Purification of T. thermophilus 70S ribosomes
Tth70S ribosomes were purified as described earlier (23)
and resuspended in buffer containing 5 mM HEPES-
KOH, pH 7.5, 50 mM KCl, 10 mM NH4Cl and 10
mM Mg(CH3COO)2 to yield a final concentration of ∼ 30
mg/ml. Tth70S ribosomes were flash frozen in liquid nitro-
gen and kept at −80◦C for storage.
Preparation of mRNA, tRNAiMet and YfiA
Synthetic mRNA containing a Shine-Dalgarno sequence
and an AUG start codon followed by a phenylalanine codon
(5′-GGC AAG GAG GUA AAA AUG UUC UAA -3′) was
purchased from Eurogentec. Escherichia coli tRNAiMet was
overexpressed in E. coli HB101 cells and purified as de-
scribed previously (24). YfiA was overexpressed in BL21
Star cells and purified as described previously (25).
Complex formation
A quaternary complex containing Tth70S ribosomes,
mRNA, deacylated tRNAiMet and Bac7(1–16) peptide was
prepared by mixing of 5 !M Tth70S ribosomes with 10 !M
mRNA and 50 !M Bac7(1–16), and incubating at 55◦C for
10 min. After addition of 20 !M tRNAiMet, the mixture
was incubated at 37◦C for 10 min. The sample was then in-
cubated at room temperature for at least 15 min and cen-
trifuged briefly prior to use. Ternary complexes containing
50 !M metalnikowin I or pyrrhocoricin, 5 !M Tth70S ri-
bosomes and 50 !M YfiA were formed by incubation for 30
min at room temperature. The final buffer conditions were
5 mM HEPES-KOH, pH 7.6, 50 mM KCl, 10 mM NH4Cl
and 10 mM Mg(CH3COO)2.
Crystallization
Published conditions were used as a starting point for
screening crystallization conditions by vapour diffusion in
sitting-drop trays at 20◦C (23,26). Crystallization drops
consisted of 3 !l of quaternary or ternary complexes and
3–4 !l of reservoir solution containing 100 mM Tris–HCl,
pH 7.6, 2.9% (v/v) PEG 20,000, 7–10% (v/v) 2-methyl-
2,4-petanediol (MPD) and 175 mM arginine. Crystals ap-
peared within 2–3 days and grew to ∼ 1000 × 100 × 100
!m within 7–8 days. For cryoprotection, the concentration
of MPD was increased in a stepwise manner to yield a fi-
nal concentration of 40% (v/v). The ionic composition dur-
ing cryoprotection was 100 mM Tris–HCl, pH 7.6, 2.9%
(v/v) PEG 20,000, 50 mM KCl, 10 mM NH4Cl and 10 mM
Mg(CH3COO)2. Crystals were flash frozen in a nitrogen
cryostream at 80 K for subsequent data collection.
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Data collection and processing
Diffraction data for Bac7(1–16) were collected at
PROXIMA-2A, a beamline at the SOLEIL synchrotron
(Saclay, France) equipped with an ADSC Q315 detec-
tor. A complete dataset was obtained by merging 0.25◦
oscillation data collected at 100 K with a wavelength
of 0.98011 Å from multiple regions of the same crystal.
Diffraction data for metalnikowin I and pyrrhocoricin
were collected at PROXIMA-1, a beamline at the SOLEIL
synchrotron equipped with a DECTRIS PILATUS 6M
detector. Complete datasets were obtained by merging
0.1◦ oscillation data collected at 100 K with a wavelength
of 0.97857 Å from multiple regions of the crystal. Initial
data processing, including integration and scaling, was
performed with X-ray Detector Software (XDS) (27). The
data could be indexed in the P212121 space group, with
unit-cell dimensions approximating 210 × 450 × 625 Å and
an asymmetric unit containing two copies of the Tth70S
ribosome.
Model building and refinement
Initial phases were obtained by molecular replacement per-
formed with Phaser (28). The search model was obtained
from a high-resolution structure of the Tth70S ribosome
(PDB ID: 4Y4O) (29) where the RNA backbone had been
further improved with the ERRASER-Phenix pipeline (30),
using the deposited structure factors. Restrained crystallo-
graphic refinement was carried out with Phenix (31) and
consisted of a single cycle of rigid-body refinement followed
by multiple cycles of positional and individual B-factor re-
finement. Rigid bodies comprised four domains from the
small 30S subunit (head, body, spur and helix h44) and three
domains from the large 50S subunit (body, L1 stalk and the
C terminus of ribosomal protein L9). Non-crystallographic
symmetry restraints between the two copies of the Tth70S
ribosome in the asymmetric unit were also applied during
refinement. After confirming that a single tRNA was bound
to the P site or that YfiA was present at the decoding center,
and that additional density corresponding to the PrAMPs
was visible within the exit tunnel in a minimally biased FO–
FC map, models of the corresponding PrAMPs were built in
Coot (32). The models for the tRNA and mRNA were ob-
tained from a high-resolution structure of the Tth70S ribo-
some pre-attack complex (PDB ID: 1VY4). The model for
YfiA was obtained from a high resolution Tth70S ribosome
structure (PDB ID: 4Y4O). Further refinement and model
validation was carried out in Phenix (31) and on the Mol-
Probity server (33), respectively. In the final models, 0.56–
0.95% of protein residues were classified as Ramachandran
outliers, and 92.4–94.3% had favourable backbone confor-
mations (Supplementary Table S1). Coordinates and struc-
ture factors have been deposited in the Protein Data Bank
under accession codes 5F8K (Bac7(1–16)), 5FDU (Metal-
nikowin I) and 5FDV (Pyrrhocoricin).
In vitro translation assays
Escherichia coli lysate-based transcription-translation cou-
pled assay (RTS100, 5Prime) were performed as described
previously for other translational inhibitors (34). Briefly, 6
!l reactions, with or without PrAMP were mixed according
to the manufacturer’s description and incubated for 1 h at
30◦C with shaking (750 rpm). A total of 0.5 !l of each reac-
tion were stopped with 7.5 !l kanamycin (50 !g/!l). The
effect of Bac7(1–35) on eukaryotic translation was deter-
mined using Rabbit Reticulocyte Lysate System (Promega).
A total of 6 !l reactions, with or without Bac7(1–35) were
mixed according to the manufacturer´s description and in-
cubated for 1 h at 30◦C with shaking (300 rpm). A total of
5 !l of each reaction were stopped in 5 !l kanamycin (50
!g/!l). All samples were diluted with 40 !l of Luciferase
assays substrate (Promega) into a white 96-well chimney flat
bottom microtiter plate (Greiner). The luminescence was
then measured using a Tecan Infinite M1000 plate reader.
Relative values were determined by defining the lumines-
cence value of the sample without inhibitor as 100%.
Toe-printing assay
The position of the ribosome on the mRNA was mon-
itored with a toe-printing assay (35) based on an in
vitro–coupled transcription-translation system with the
PURExpress in vitro protein synthesis kit (NEB), as
described previously (21,36). Briefly, each translation
reaction consisted of 1 !l solution A, 0.5 !l !isoleucine
amino acid mixture, 0.5 !l tRNA mixture, 1.5 !l solution
B, 0.5 !l (0.5 pmol) hns37aa template: (5′-ATTAAT
ACGACTCACTATAGGGATATAAGGAGGAAAAC
ATatgAGCGAAGCACTTAAAattCTGAACAACCTGC
GTACTCTTCGTGCGCAGGCAAGACCGCCGCCGC
TTGAAACGCTGGAAGAAATGCTGGAAAAATTA
GAAGTTGTTGTTtaaGTGATAGAATTCTATCGTTA
ATAAGCAAAATTCATTATAAC-3′, with start codon
ATG, catch isoleucine codon ATT and stop codon TAA
in bold, the hns37aa ORF underlined and toe-print
primer binding site in italics) and 0.5 !l additional agents
(nuclease-free water, water dissolved Bac7(1–35) Bac7(1–
16), Bac7(5–35) (1, 10 or 100 !M final concentration)
or antibiotics (100 !M thiostrepton, 50 !M edeine, 50
!M clindamycin final concentration)). Translation was
performed in the absence of isoleucine at 37◦C for 15 min
at 500 rpm in 1.5 ml reaction tubes. After translation,
2 pmol Alexa647-labelled NV-1 toe-print primer (5′-
GGTTATAATGAATTTTGCTTATTAAC-3′) was added
to each reaction. Reverse transcription was performed with
0.5 !l of AMV RT (NEB), 0.1 !l dNTP mix (10 mM)
and 0.4 !l Pure System Buffer and incubated at 37◦C for
20 min. Reverse transcription was quenched and RNA
degraded by addition of 1 !l 10 M NaOH and incubation
for at least 15 min at 37◦C and then was neutralized with
0.82 !l of 12 M HCl. 20 !l toe-print resuspension buffer
and 200 !l PN1 buffer were added to each reaction before
treatment with a QIAquick Nucleotide Removal Kit (Qi-
agen). The Alexa647-labelled DNA was then eluted from
the QIAquick columns with 80 !l of nuclease-free water. A
vacuum concentrator was used to vaporize the solvent and
the Alexa647-labelled DNA was then dissolved into 3.5 !l
of formamide dye. The samples were heated to 95◦C for 5
min before being applied onto a 6% polyacrylamide (19:1)
sequencing gel containing 7 M urea. Gel electrophoresis
was performed at 40 W and 2000 V for 2 h. The GE
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Figure 1. Binding site of Bac7(1–16) on the ribosome and comparison
with Onc112. (A) Overview and closeup view of a cross-section of the
Tth70S ribosomal exit tunnel showing the Bac7(1–16) peptide (RRIR-
PRPPRLPRPRPR) in green and highlighting the three regions of inter-
action with the ribosome: the A-tRNA binding pocket (light pink), the
A-site crevice (light green) and the upper section of the exit tunnel (light
blue). (B) Structural comparison of Bac7(1–16) (green) with Onc112 (or-
ange)(20,21), Met1(1–10) (burgundy) and Pyr(1–16) (cyan), highlighting
the distinct structure of the Bac7 N-terminus (N-term) and the Pyr C-
terminus (C-term).
Typhoon FLA9500 imaging system was subsequently used
to scan the polyacrylamide gel.
Filter binding assay
Filter binding assays were performed as described previ-
ously (34,37). Briefly, 3 pmol of 70S ribosomes purified from
BL21 E. coli strain were exposed to 30 pmol of radiolabelled
[14C]-Erythromycin (Perkin Elmer; 110 dpm/pmol) in pres-
ence of 1x filter binding buffer (10 mM HEPES/KOH
[pH 7.4], 30 mM MgCl2, 150 mM NH4Cl and 6 mM "-
mercaptoethanol) for 15 min at 37◦C. Our controls in-
dicated that approximately 65% of the 70S ribosomes (2
pmol) contained [14C]-Erythromycin previous to the addi-
tion of the different PrAMPs. The PrAMPs were diluted in
nuclease-free water to a concentration of 1 mM, 100 !M
and 10 !M. 2 !l of each PrAMP stock dilution (Onc112,
Bac7(1–35), Bac7(1–16) and Bac7(5–35)) were transferred
to the respective tube resulting in final concentrations of
100, 10 and 1 !M. Reactions were incubated for an addi-
tional 25 min at 37◦C. Afterwards the 20 !l samples were
passed through a HA-type nitrocellulose filter from Milli-
pore (0.45 !m pore size) and the filter subsequently washed
three times with 1 ml 1× filter binding buffer. Scintillation
counting was performed in the presence of Rotiszint R⃝ eco
plus Scintillant. All reactions were performed in duplicate
and results were analysed using GraphPad Prism 5. Error
bars represent the standard deviation from the mean.
Disome formation assay
The disome formation assay was performed as described
previously (38,39). Briefly, in vitro translation of the
2xermBL construct was performed using the Rapid Trans-
lation System RTS 100 E. coli HY Kit (Roche). Transla-
tions were carried-out for 1 h at 30◦C and then analysed
on 10–55% sucrose density gradients (in a buffer contain-
ing 50 mM HEPES-KOH, pH 7.4, 100 mM KOAc, 25 mM
Mg(OAc)2, 6 mM "-mercaptoethanol) by centrifugation at
154 693 × g (SW-40 Ti, Beckman Coulter) for 2.5 h at 4◦C.
RESULTS
The N-terminus of Bac7 adopts a compact conformation
We obtained a structure referred to here as Tth70S-Bac7
from co-crystals of Tth70S ribosomes in complex with dea-
cylated tRNAiMet, a short mRNA and Bac7(1–16) (Sup-
plementary Table S1). In addition, we obtained two addi-
tional structures, Tth70S-MetI and Tth70S-Pyr, from co-
crystals of Tth70S ribosomes in complex with YfiA and
either metalnikowin I or pyrrhocoricin, respectively (Sup-
plementary Table S1). The quality of the electron den-
sity in the minimally biased FO–FC difference maps calcu-
lated after refinement of a model comprising Tth70S ribo-
somes and tRNAiMet/mRNA or YfiA, made it possible to
build a model for the entire Bac7(1–16; RRIRPRPPRL-
PRPRPR), the first 10 (of 15; VDKPDYRPRPRPPNM)
residues of metalnikowin I (MetI) and the first 16 (of
20; VDKGSYLPRPTPPRPIYNRN) residues of pyrrho-
coricin (Pyr), as well as to position several neighbouring sol-
vent molecules (Supplementary Figure S1). Like the insect-
derived Onc112 peptide (20,21), MetI, Pyr and Bac7(1–16)
all bind to the ribosomal exit tunnel in a reverse orienta-
tion relative to the nascent polypeptide chain and make ex-
tensive interactions with three distinct regions of the large
50S ribosomal subunit: the A-tRNA binding pocket, the A-
site crevice and the upper section of the nascent polypep-
tide exit tunnel (Figure 1A, B and Supplementary Figure
S1). A nearly identical, extended backbone conformation
is seen for residues 7–13 of Bac7(1–16) and residues 4–10
of Onc112, Met1 and Pyr, with Arg9 of Bac7(1–16) sub-
stituting for Tyr6 of Onc112, Met1 and Pyr (Figure 1B).
The structural similarity however does not extend to the N-
terminus of Bac7(1–16), where the first six residues adopt a
structure that deviates substantially from that of the shorter
N-terminus of the insert-derived PrAMPs. Indeed, arginine
residues within this region are arranged such that the side
chain of Arg6 is sandwiched between the side chains of Arg2
and Arg4 to form a compact, positively charged structure
(Figure 1A and B). The binding site of Bac7(1–16) sug-
gests that the additional C-terminal residues of Bac7(1–
35) and of the full-length Bac7 (60 residues) would occupy
the entire length of the ribosomal tunnel. Consistently, a
photocrosslinkable derivative of Bac7(1–35) has been cross-
linked to two ribosomal proteins of ∼ 16 and 25 kDa (19),
which we suggest to be L22 and L4, respectively, based on
their size and close proximity to the Bac7(1–16) binding
site (Supplementary Figure S2). Compared to Onc112 and
Met1, additional density for the C-terminal PRPR motif
(residues 13–16) of Pyr is observed extending deeper into
the tunnel (Figure 1 and Supplementary Figure S1). With
the exception of Arg14 for which no density is observed,
the PRPR motif is quite well ordered despite not forming
any obvious direct interactions with the ribosome.
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Bac7 makes extensive interactions with the 50S ribosomal
subunit
As with Onc112 (20,21), binding of Bac7(1–16) to the ribo-
some is accompanied by an induced fit involving 23S rRNA
residues A2062, U2506 and U2585 (Supplementary Figure
S3A; E. coli numbering is used throughout this work for the
23S rRNA), such that the base of this last nucleotide occu-
pies a position that would normally clash with the formyl-
methionyl moiety of fMet-tRNAiMet bound to the P-site of
an initiation complex (Supplementary Figure S3B). Three
modes of interaction are observed between Bac7(1–16) and
the large 50S ribosomal subunit (Figure 2A–E).
First, the N-terminal region of Bac7(1–16) forms multi-
ple hydrogen bonds and salt bridges with the A-tRNA bind-
ing pocket of the ribosome (Figure 2A and B). In particular,
the compact structure formed by Arg2, Arg4 and Arg6 pro-
vides a positively charged N-terminal anchor that displaces
two magnesium ions from a deep groove lined by 23S rRNA
residues C2452, A2453 and G2454 on one side, and residues
U2493 and G2494 on the other (Figure 2B). This groove dif-
fers from the standard A-form RNA major groove in that
it occurs between two unpaired, antiparallel strands of the
23S rRNA. Consequently, the compact arginine structure
at the N-terminus of Bac7(1–16) is ideally sized and shaped
to fit into this groove and the resulting interaction is likely
to be specific in spite of its simple electrostatic nature. Fur-
ther contacts in this region are likely to increase the speci-
ficity of Bac7(1–16) for the ribosome, such as the two hydro-
gen bonds between the side chain of Arg1 and 23S rRNA
residues U2555 and C2556, and four hydrogen bonds be-
tween the backbone of Bac7(1–16) residues Arg2-Arg4 and
23 rRNA residues U2492, U2493 and C2573 (Figure 2A).
Second, the unusually high arginine (50%) and proline
(37.5%) content of Bac7(1–16) restricts the types of con-
tacts that this peptide can establish with the ribosome. This
results in #-stacking interactions between the side chains of
Arg2, Arg9, Arg12, Arg14 and Arg16 and exposed bases of
23S rRNA residues C2573, C2452/U2504, C2610, C2586
and A2062, respectively. Additional rigidity within the pep-
tide is provided through the packing of Arg1 against Ile3
and Arg9 against Leu10, and through the compact arginine
stack described above (Figure 2C).
Third, numerous possible hydrogen bonds can be estab-
lished between the backbone of Bac7(1–16) and the ribo-
some (Figure 2A, D and E), including many indirect inter-
actions via ordered solvent molecules (Figure 2D and E).
Many of the water-mediated contacts suggested for Tth70S-
Bac7 are likely to occur with oncocin, even though the
lower resolution of the earlier Tth70S-Onc112 structures
precluded the modelling of any water molecules (20,21).
In addition, interactions such as those between 23S rRNA
residue U2506 and the backbone of Bac7(1–16) residues
Arg9 and Leu10 were also proposed to occur between the
Onc112 peptide and the ribosome (20,21).
Bac7 and Onc112 compete with erythromycin for ribosome
binding
The C-terminal residues 12–16 of Bac7(1–16) overlap with
the binding site of the macrolide antibiotic erythromycin
on the bacterial ribosome (40,41), in particular with the re-
gion occupied by the cladinose sugar and part of the lac-
tone ring (Figure 3A). Consistently, we could demonstrate
that Bac7(1–16) and Bac7(1–35) efficiently compete with
the binding of radiolabelled erythromycin to the 70S ribo-
some (Figure 3B). Similarly, Onc112 also efficiently com-
peted with erythromycin (Figure 3B), as expected based
on the similarity in binding mode with the ribosome for
these regions of Onc112 and Bac7 (Figure 1B). In contrast,
Bac7(5–35) was a poor competitor of erythromycin (Fig-
ure 3B), indicating that the highly cationic N-terminus of
Bac7 and its interaction with the A-tRNA binding pocket
(Figure 2B) are important for high affinity binding of Bac7
to the ribosome. Indeed, Bac7 derivatives lacking the first
four N-terminal residues (RRIR), Bac7(5–35) and Bac7(5–
23), exhibit dramatically reduced minimal inhibitory con-
centrations (MIC) against Gram-negative strains, such as E.
coli, as well as Salmonella typhimurium (6). We note, how-
ever, that the internalization of Bac7(5–35) into bacteria is
reduced, indicating that the N-terminal RRIR motif also
plays an important role for cell penetration (11).
Bac7 allows initiation, but prevents translation elongation
Consistent with the erythromycin binding assays and in
agreement with previous results (Figure 4A) (19), we ob-
served that Bac7(1–35) inhibits the production of luciferase
with an IC50 of 1 !M in an E. coli in vitro translation system,
similar to MetI and Pyr (Supplementary Figure S1), as well
as that observed previously for Onc112 (20,21). Bac7(1–16)
was an equally potent inhibitor as Bac7(1–35), consistent
with the similar MICs observed for these two derivatives
(6,10,11). In contrast, Bac7(5–35) inhibited in vitro trans-
lation with an IC50 of 10 !M, i.e. 10-fold higher than ob-
served for Bac7(1–16) or Bac7(1–35), indicating that the re-
duced affinity for the ribosome, together with reduced cellu-
lar uptake (11), results in the higher MIC of the Bac7(5–35)
derivative (6,42).
Next we investigated the mechanism of inhibition by
Bac7 using two in vitro translation assays. First, we com-
pared the effect of Bac7(1–35) and Bac7(5–35) on the stabi-
lization of disomes formed upon the stalling of ribosomes
on a dicistronic mRNA (in this case 2XErmBL mRNA),
as measured by sucrose gradient centrifugation (21,38,39).
In the absence of inhibitor, the majority of ribosomes are
present as 70S monosomes (control in Figure 4B), whereas
the presence of erythromycin leads to translational arrest of
the ribosomes on both cistrons of the 2XErmBL mRNA,
thereby generating the expected disome peaks (Ery in Fig-
ure 4B). Consistent with the in vitro translation assays (Fig-
ure 4A), translation inhibition and thus disome formation
was observed in the presence of 10 !M Bac7(1–35), whereas
even 100 !M of Bac7(5–35) did not produce significant dis-
omes (Figure 4B). These findings suggest that Bac7(1–35)
but not Bac7(5–35) stabilizes an arrested ribosome com-
plex, as observed previously for Onc112 (21).
Second, to monitor the exact site of translation inhibi-
tion of the Bac7 derivatives, we employed a toeprinting as-
say, which uses reverse transcription from the 3′ end of
an mRNA to determine the exact location of the ribo-
somes that are translating it (35). In the absence of in-
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Figure 2. Interactions between Bac7(1–16) and the ribosome. (A) Bac7(1–16) (green) makes extensive contacts with the A-site tRNA binding region of
the ribosome, in particular (B) electrostatic interactions between its N-terminal arginine stack and a deep groove lined by phosphate groups from the 23S
rRNA (B). (C) #-stacking interactions between arginine side chains (green) of Bac7(1–16) and 23S rRNA bases contribute to much of the binding and are
reinforced through further packing against aliphatic side chains (blue). (D and E) Water-mediated contacts between the peptide and the ribosome are also
proposed to occur further down the exit tunnel, in addition to direct hydrogen bonding interactions between the two.
Figure 3. Competition between Bac7 derivatives and erythromycin. (A) Superimposition of the binding site of erythromycin (blue) (40,41) with residues
11–16 of Bac7(1–16) (green). (B) A filter binding assay was used to monitor competition between radiolabelled [14C]-erythromycin and increasing concen-
trations (1–100 !M) of Bac7(1–35) (red), Bac7(1–16) (green), Bac7(5–35) (blue), Onc112 (grey) and cold (non-radioactive) erythromycin (ery, black).
hibitor, ribosomes initiated at the AUG start codon of the
mRNA, translated through the open reading frame and
ultimately became stalled on an isoleucine codon (Figure
4C) due to the omission of isoleucine from the translation
mix. In the presence of thiostrepton or clindamycin, ribo-
somes accumulated at the AUG codon (Figure 4C), since
these antibiotics prevent delivery and/or accommodation
of aminoacyl-tRNA at the A-site directly following initi-
ation (43). Similar results were observed when using the
Bac7(1–35) and Bac7(1–16) derivatives, such that complete
inhibition of translation elongation was observed at a pep-
tide concentration of 10 !M (Figure 4C). These findings
suggest that like Onc112 (21), Bac7 allows subunit joining
and fMet-tRNAiMet binding, but prevents accommodation
of the first aminoacyl-tRNA at the A-site, as suggested by
the overlap in the binding site of Bac7 and the CCA-end of
an A-tRNA (Figure 4D). Curiously, the toeprint for ribo-
somes stalled during initiation became weaker at 100 !M
of Bac7(1–16) and Bac7(1–35) and the signal for the full-
length mRNA became stronger, similar to the effect ob-
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Figure 4. Mechanism of action of Bac7 on the ribosome. (A) Effects of increasing concentrations of Bac7 derivatives Bac7(1–16) (green), Bac7(1–35) (red)
and Bac7(5–35) (blue) on the luminescence resulting from the in vitro translation of firefly luciferase (Fluc) using an Escherichia coli lysate-based system.
The error bars represent the standard deviation from the mean for triplicate experiments and the luminescence is normalized relative to that measured in
the absence of peptide, which was assigned as 100%. (B) Sucrose gradient profiles to monitor disome formation from in vitro translation of the 2XErmBL
mRNA in the absence (control) or presence of 20 !M erythromycin (Ery), 10 !M Bac7(1–35) (red) or 100 !M Bac7(5–35) (blue). (C) Toe-printing assay
performed in the absence (−) or presence of increasing concentrations (1, 10, 100 !M) of Bac7(1–35), Bac7(1–16) or Bac7(5–35), or 100 !M thiostrepton
(Ths), 50 !M edeine (Ede) or 50 !M clindamycin (Cli). Sequencing lanes for C, U, A and G and the sequence surrounding the toe-print bands (arrowed)
when ribosomes accumulate at the AUG start codon (green, initiation complex) or the isoleucine codon (blue, stalled elongation complex) are included for
reference. (D) Structural comparison of Phe-tRNAPhe (slate) in the A-site and fMet-tRNAiMet in the P-site (blue) (26) with the binding site of Bac7(1–16)
(green).
served when the antibiotic edeine was used (Figure 4C).
Edeine prevents 70S initiation complex formation by desta-
bilizing fMet-tRNAiMet binding to the 30S subunit (43).
Thus, Bac7 may have a similar effect when high cytosolic
concentrations are achieved through active uptake into the
cell, possibly due to the presence of non-specific interactions
with the ribosome. In contrast to Bac7(1–16) and Bac7(1–
35), Bac7(5–35) only stabilized the initiation complex at a
much higher concentration (100 !M) (Figure 4C). This is
consistent with a reduced affinity of Bac7(5–35) for the ri-
bosome and reinforces the critical role played by the first
four residues of Bac7 in its inhibitory activity (Figure 1A)
(6,42).
Bac7 inhibits eukaryotic translation in vitro
Bac7(1–35) is internalized by mammalian cells (42,44), yet
no toxicity has been observed, even at concentrations well
above those effective against microbes (12,13,42), raising
the question as to whether Bac7 binds to eukaryotic cytoso-
lic ribosomes. A comparison of the binding site of Bac7(1–
16) on the bacterial 70S ribosome with the equivalent region
of a mammalian 80S ribosome reveals that the rRNA nu-
cleotide sequence is highly conserved. Structurally, the con-
formation of three 25S rRNA nucleotides, C4519 (C2573),
U4452 (U2506) and A3908 (A2602), would be expected to
preclude Bac7(1–16) from binding to the mammalian ri-
bosome (Figure 5A). Nevertheless, these nucleotides are
highly mobile and adopt different conformations depend-
ing on the functional state of the ribosome (26,39,45,46),
suggesting that conformational rearrangements of these nu-
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Figure 5. Specificity of Bac7 for bacterial and eukaryotic ribosomes. (A) Superimposition of Bac7(1–16) (green) onto a mammalian 80S ribosome (PDB ID:
3J7O) (47) on the basis of the 23S and 25S rRNA chains in the corresponding structures, with inset illustrating three rRNA nucleotides whose conformation
differs in the 80S (grey) and Tth70S-Bac7 (yellow) structures. (B) Effect of increasing concentrations of Bac7(1–35) on the luminescence resulting from the
in vitro translation of firefly luciferase (Fluc) using an Escherichia coli lysate-based system (red) or rabbit reticulocyte-based system (black). The error bars
represent the standard deviation from the mean for triplicate experiments and the fluorescence is normalized relative to that measured in the absence of
peptide, which was assigned as 100%. (C) Model for the targeting of proBac7 to large granules and its processing by elastase to yield active Bac7 peptide.
The latter is transported through the bacterial inner membrane by the SbmA transporter and binds within the tunnel of bacterial ribosomes to inhibit
translation.
cleotides could allow Bac7(1–16) binding. Indeed, we ob-
served that increasing concentrations of Bac7(1–35) inhib-
ited in vitro translation using a rabbit reticulocyte system
(Figure 5B). Bac7(1–35) exhibited an IC50 of 2.5 !M, only
2.5-fold higher than that observed in the E. coli in vitro
translation system (Figure 5B). The excellent inhibitory ac-
tivity of Bac7(1–35) on mammalian ribosomes, combined
with its lack of toxicity on mammalian cells (42), would be
consistent with a mechanism of internalization via an endo-
cytotic process (42) to ensure that Bac7 minimizes contact
with the mammalian cytosolic ribosomes.
DISCUSSION
Our finding that Bac7 is active against eukaryotic trans-
lation, together with the current literature, allows us to
present a model that explains how and why the mammalian
cell prevents the active Bac7 peptide from being present in
the cytoplasm (Figure 5C). Bac7 is produced by immature
myeloid cells as a pre-pro-Bac7 precursor that is targeted
to large granules, where it is stored as pro-Bac7 in differ-
entiated neutrophils (48). The inactive proBac7 is cleaved
by elastase, a serine protease that is present in azurophil
granules, either upon (A) fusion with the phagosome, or (B)
exocytosis and release into the extracellular matrix (Figure
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5C) (48,49). The resulting activated Bac7 peptide can then
enter into the bacterial cell through the SbmA transporter
(10), where it subsequently binds to the ribosome to inhibit
translation (Figure 5C) (19). Our structure of the Tth70S–
Bac7 complex reveals specifically how Bac7 interacts with
the bacterial ribosome (Figures 1 and 2) and inhibits trans-
lation by allowing initiation but preventing translation elon-
gation (Figure 3). Although the overall mechanism of ac-
tion of Bac7 is similar to that of insect-derived AMPs like
oncocin (20,21), the high arginine content of Bac7 leads to
a distinct mode of binding to the ribosome, namely through
electrostatic and stacking interactions with the backbone
and bases of 23S rRNA nucleotides, respectively (Figure
2C). It will be interesting to see whether such interactions
are the basis for the translational arrest that has been ob-
served when the ribosome translates a nascent polypeptide
chain bearing positively charged arginine residues (50,51).
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Table S1. X-ray data processing and crystallographic refinement statistics 
 
 Bac7(1-16) MetI Pyr 
PDB code 5F8K 5FDU 5FDV 
Space group P212121 P212121 P212121 
Unit cell dimensions 
a 
b 
c 
α 
β 
γ 
 
209.8 Å 
450.3 Å 
622.2 Å 
90.0° 
90.0° 
90.0° 
 
209.7 Å 
448.1 Å 
623.4 Å 
90.0° 
90.0° 
90.0° 
 
209.9 Å 
450.1 Å 
622.9 Å 
90.0° 
90.0° 
90.0° 
Data processing    
Resolution 50 Å – 2.8 Å 50 Å – 2.9 Å 50 Å – 2.8 Å  
RMerge 51.3% (233.9%) 17.0% (181.0%) 17.8% (229.7%) 
I/σI 5.71 (0.95) 11.61 (1.10) 15.99 (1.29) 
CC 1/2 95.7 (16.1) 99.7 (34.9) 99.9 (41.1) 
Completeness 99.6% (97.6%) 99.6% (99.5%) 100% (100%) 
Redundancy 8.3 (8.1) 6.9 (6.7) 13.8 (13.4) 
Refinement    
Rwork/Rfree 24.8% / 29.2% 18.3% / 23.4% 18.9% / 24.0% 
Bond deviations 0.018 Å 0.030 Å 0.029 Å 
Angle deviations 1.083° 1.976° 1.942° 
Figure of merit 0.80 0.84 0.83 
Ramachandran outliers 0.56% 0.95% 0.87% 
Favorable backbone 94.3% 92.4% 93.3% 
 
 
	
  
 
Figure S1. Minimally biased electron density for (A) the Bac7(1-16) peptide (green) 
and surrounding solvent molecules, as well as the (B) Pyr(1-16) (cyan) and (C) 
MetI(1-10) (burgundy) peptides. The peptides are shown in the same orientation as 
in Figure 1A and solvent molecules are displayed as spheres (red). Continuous 
density for the entire peptide and clear density for the solvent molecules are 
observed in a minimally biased Fo–Fc difference map contoured at +2.0σ (blue mesh). 
(D) Superimposition of the Bac7(1-16), Onc112(1-12) (orange), Pyr(1-16) and MetI(1-
10) peptides. (E) Effects of increasing concentrations of Bac7(1-16) (red), 
Metalnikowin I (green) and Pyrrhocoricin (green) on the luminescence resulting from 
the in vitro translation of firefly luciferase (Fluc) using an E. coli lysate-based system. 
The error bars represent the standard deviation from the mean for triplicate 
experiments and the luminescence is normalized relative to that measured in the 
absence of peptide, which was assigned as 100%. 
  
 
Figure S2. Relative position of the ribosome-bound Bac7(1-16) peptide (green) to 
the ribosomal proteins L4 (red) and L22 (blue) that reach into the lumen of the 
ribosomal tunnel. The proposed path for the full-length Bac7 peptide is shown as a 
dotted green line. 
  
 
Figure S3. (A) Conformational changes in 23S rRNA nucleotides A2062, U2506 and 
U2585 that take place upon binding of Bac7(1-16) to the ribosome. Nucleotides from 
the Tth70S-Bac7 structure are shown in yellow, while nucleotides in the Bac7-free or 
“uninduced” conformation are in blue (1). (B) Clash between the formyl-methionyl 
moiety of a P-site bound fMet-tRNAiMet (blue) and 23S rRNA residue U2585 in its 
Bac7-bound conformation (yellow). Bac7(1-16) is shown as a green Cα-trace in both 
panels. 
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Proline-rich antimicrobial peptides targeting
protein synthesis
Michael Graf, †a Mario Mardirossian,†a Fabian Nguyen,†a A. Carolin Seefeldt,b
Gilles Guichard,c Marco Scocchi,d C. Axel Innis b and Daniel N. Wilson *ae
Covering: up to 2017
The innate immune system employs a broad array of antimicrobial peptides (AMPs) to attack invading
microorganisms. While most AMPs act by permeabilizing the bacterial membrane, specific subclasses of
AMPs have been identified that pass through membranes and inhibit bacterial growth by targeting
fundamental intracellular processes. One such subclass is the proline-rich antimicrobial peptides
(PrAMPs) that bind to the ribosome and interfere with the process of protein synthesis. A diverse range of
PrAMPs have been identified in insects, such as bees, wasps and beetles, and crustaceans, such as crabs,
as well as in mammals, such as cows, sheep, goats and pigs. Mechanistically, the best-characterized
PrAMPs are the insect oncocins, such as Onc112, and bovine bactenecins, such as Bac7. Biochemical
and structural studies have revealed that these PrAMPs bind within the ribosomal exit tunnel with
a reverse orientation compared to a nascent polypeptide chain. The PrAMPs allow initiation but prevent
the transition into the elongation phase of translation. Insight into the interactions of PrAMPs with their
ribosomal target provides the opportunity to further develop these peptides as novel antimicrobial agents.
1 Discovery of PrAMPs
The innate immune system uses a broad range of antimicrobial
peptides (AMP) as the rst line of defense to kill invading
microorganisms. AMPs inhibit the proliferation of bacteria and
therefore can prevent the establishment of an infection. They can
either be induced through pathogen sensing receptors or are
continuously secreted into body uids.1 Based on their nature and
composition they can be divided into amphiphilic peptides, with
two to four b-strands, amphipathic a-helices, loop structures and
extended structures.2 Although most of these ve classes inhibit
bacterial cells by permeabilizing the membrane, the action of
AMPs is not limited to the surface of pathogens.3 Some AMPs have
intracellular targets which affect the metabolism of the invading
organism,4 such as the subclass of Proline-rich Antimicrobial
Peptides (PrAMPs).5–7 PrAMPs belong to the group of cationic
peptides that are enriched in proline residues and are oen
arranged in conserved patterns together with arginine resi-
dues (Fig. 1A and B). PrAMPs appear to be irregularly
dispersed amongst animals, being so far only identied in
some arthropods (insects and crustaceans) and mammals
(Fig. 1A). The discovery of the rst PrAMP started with api-
daecin in the late 1980s.8 Casteels and coworkers injected
a sub-lethal dose of Escherichia coli cells into the body cavity of
adult bees and subsequently monitored the appearance of
AMPs by HPLC.8 This led to the identication of three active
forms of apidaecin which were further characterized with
respect to their molecular mass and amino acid sequence.8
The discovery of apidaecins was quickly followed by the
identication of other insect and mammalian PrAMPs. Insect
PrAMPs include abaecin from the honey bee Apis mellifera,9
drosocin from the fruit y Drosophila melanogaster,10 pyr-
rhocoricin from the rebeetle Pyrrhocoris apterus,11
metalnikowin-1 from the green shield bug Palomena prasina12
and oncocin from the milkweed bug Oncopeltus fasciatus13,14
(Fig. 1A). In crustaceans, the PrAMP Arasin 1 has been isolated
from the spider crab Hyas araneus19 as well as a PrAMP with
similarity to Bac7 from the shore crab Carcinus maenas.20 Two
distinct mammalian PrAMPs have been identied in ruminant
species, such as cows (e.g. Bos taurus),15 sheep (e.g. Ovis
aries)16,17 and goats (e.g. Capra hircus) (Fig. 1A).16,17 These
PrAMPs were named bactenecin 5 and 7 (Bac5 and Bac7) due
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to the molecular weight of the mature peptides being 5 and 7
kDa, respectively.15 In pigs the corresponding PrAMP homolog
to Bac7 has been called PR-39 due to its length of 39 amino
acids.18 Additional bactenecin-like PrAMPs, such as Bac4,
Bac6.5 and Bac11, were identied in the sheep genome,16 but
remain to be characterized.
2 Synthesis of PrAMPs
The synthesis of AMPs, including PrAMPs, occurs mainly in
response to invading bacteria.1 While most of the PrAMPs
characterized to date are synthesized by the ribosome as inac-
tive precursors, interestingly, their paths of activation differ
signicantly between species.
Mammalian Bac5/Bac7 peptides are produced, as other non-
proline-rich mammalian AMPs, by immature myeloid cells as
pre-pro-peptide precursors (Fig. 2A). The Bac5 and Bac7 pre-pro-
peptides comprise a 29 aa pre-signal followed by a 101 aa pro-
region. Bac5/Bac7 are targeted to large granules, where the
targeting signals are cleaved upon import to yield pro-peptides
in differentiated neutrophils.21 When the immune system
recognizes invading bacteria, the maturation of pro-Bacs is
triggered by secretion and mixing of the contents of large and
azurophil granules.22 The inactive pro-Bacs are then cleaved by
elastase, a serine protease that is present in azurophils, either
upon (i) fusion with the phagosome, or (ii) exocytosis and
release into the extracellular matrix (Fig. 2A).22,23 The mature
Bac5 (43 aa) and Bac7 (60 aa) peptides can then pass through
the bacterial cell membrane via the SbmA transporter (see next
section), where they can subsequently interact with their
intracellular target (Fig. 2A).24,25 Similarly, cDNA analysis
showed that the pig PR-39 is synthesized as a 172 aa pre-pro-PR-
39 peptide, which is comprised of a 29 aa signal sequence, a 101
aa pro-region and a 42 aa N-terminal PR-39-containing region.
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The last 3 aa are removed post-translationally to generate the 39
aa active PR-39 peptide.26
PrAMPs have been found in many insect species. In Drosophila
melanogaster one gene encoding the PrAMP drosocin has been
identied.27 The gene encodes a 21 aa N-terminal signal sequence
(pre-sequence), the 19 aa PrAMP and a 24 aa inactivating pro-
sequence that lies behind the PrAMP.10 In contrast, some
PrAMPs are synthesized asmultiple copy peptides encoded within
a single ORF, conferring the advantage of a fast signal ampli-
cation in response to a bacterial infection (Fig. 2B).28 Examples
include the PrAMPs riptocin [Genebank AB842297.1] and api-
daecin.28 Themultiple copy product of apidaecin contains a single
pre-signal sequence of 16 or 19 aa followed by a pro-fragment of
13–16 aa in length (Fig. 2B).28 The mature 18 aa long apidaecin
peptide sequence follows in multiple copies containing different
isoforms (Fig. 2B).28,29 In Apis mellifera individual apidaecin
peptide sequences are separated by an inactivating RR-EAEPEAEP
spacer sequence (Fig. 2B).28 Upon activation amino-, endo- and
carboxypeptidases process the linker and liberate the multiple
copies of mature apidaecin (Fig. 2A and B). Strikingly, apidaecin is
not just encoded as multiple copies within one gene, it is also
encoded in several genes containing different isoforms.28,29 In the
Asian honey bee Apis cerana, multiple genes encoding four
different apidaecin isoforms are evident.29 Each gene contains
a single pre-pro-region that is followed by a variable number of 84
nt repeats containing a linker sequence, a RR or CR dipeptide and
a mature isoform of apidaecin.29
3 Membrane permeability and uptake
of PrAMPs
The majority of AMPs act by damaging bacterial membranes
and causing thereby metabolite efflux and cell destruction.
However, PrAMPs primarily kill bacteria using a non-lytic
mechanism i.e. without signicantly affecting membrane
integrity. The rst indications for this mode of action came
from studies on apidaecin and PR-39, both of which were shown
to inhibit bacterial growth without causing cell lysis.5,30 More-
over, it was shown that apidaecin was internalized by bacteria,
indicating that such PrAMPs do not lyse microorganisms but
rather kill them from within by inhibiting important metabolic
pathways.6 By contrast, previous investigations indicated that
Bac7 permeabilizes the envelope of Gram-negative bacteria
Fig. 1 Sequence alignments of PrAMPs. (A) Sequences of naturally occurring and synthetic PrAMPs derived from arthropods (insects and
crustaceans, blue) and mammals (green). The central PrAMPs were aligned first based on ribosome-bound structures of Onc112, Pyr, Met and
Bac7 and then on sequence similarity. Similar and identical residues are shown in grey and black, respectively. The O-glycosylation (Thr11) of
drosocin indicated (red) and position 11 of oncocin is unknown and indicated with an “X”. The number of amino acids (aa) comprising the mature
peptide is also indicated for each PrAMP. (B) Sequence conservation of the core residues I to XIII of the natural PrAMPs listed in the central region
of (A) between oncocin and PR-39 is shown using a WebLogo62 representation.
704 | Nat. Prod. Rep., 2017, 34, 702–711 This journal is © The Royal Society of Chemistry 2017
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under restrictive conditions, with a higher permeabilizing
activity correlating with longer and more hydrophobic
peptides.31 This contradiction was resolved when a dual mode
of action was demonstrated for shorter fragments of Bac7, such
as Bac7(1-35), against Enterobacteriaceae.32 The lytic mode of
action was relegated to a secondary effect of this molecule,
observable only in the presence of high peptide concentrations
(starting from 16 mM), much above the bacteriostatic and
bactericidal levels (0.5 mM and 1 mM respectively).32
The non-lytic mode of action of PrAMPs implies the presence
of one or more transporters for cellular uptake into bacteria.
The principal “Trojan horse” exploited by insect and mamma-
lian PrAMPs was shown to be the inner membrane protein
SbmA.24 The SbmA transporter is also involved in uptake of the
microcins B17,33 J25,34 and of the non-ribosomal peptide anti-
biotic bleomycin.35 SbmA transports PrAMPs inside the bacte-
rial cytosol exploiting the electrochemical proton gradient
across the inner membrane36 and is the major transporter
responsible for their uptake.24 The physiological role of SbmA
still remains unclear, but this protein can be found in phylo-
genetically distant species of Gram-negative bacteria (Fig. 2C).37
Evidence for SbmA homologs can be found amongst Gamma-
proteobacteria, in particular, the Enterobacteriaceae (e.g. E. coli,
S. dysenteriae, S. enterica, and Klebsiella pneumoniae) and Pseu-
domonadales (A. baumannii), but also amongst Alpha-proteo-
bacteria such as Rhizobiales (e.g. S. meliloti, A. tumefaciens and B.
abortus), Beta-proteobacteria (e.g. Neisseria meningitis), and
Epsilon-proteobacteria (Campylobacter spp.) (Fig. 2C). The
deletion of the sbmA gene in bacteria did not fully confer
resistance towards PrAMPs, but signicantly reduced their
sensitivity.24 This is likely due to a decrease but not abolishment
of peptide internalization in bacteria in the absence of SbmA (or
presence of non-functional SbmA),24 indicating that SbmA is not
the only transporter for uptake of PrAMPs. Indeed, a second
transport mechanism for PrAMP uptake was recently discov-
ered, namely, the inner membrane protein MdtM.38 MdtM is an
efflux pump that extrudes antibiotics from the bacterial
cytosol.39,40 Simultaneous deletions of MdtM and SbmA in E. coli
further decreased the susceptibility of bacteria to some PrAMPs,
but not to all of them.38 For PrAMPs with a dual mode of action,
such as Bac7 or the synthetic A3-APO, the lytic mode of action
becomes dominant at high concentrations, thus obliterating
the advantage that the deletion mutants have over wild-type
bacteria.38
Interestingly, there is a link between the presence of trans-
porters for PrAMPs in the membrane of a bacterial species and
the mode of action of the PrAMP towards a specic microor-
ganism. For example, Pseudomonas aeruginosa does not have
SbmA, therefore PrAMPs cannot easily reach the cytosol to
inhibit bacterial growth by targeting specic intracellular
pathways. The antimicrobial effect of Bac7 fragments is indeed
lower on Pseudomonas sp. if compared with other bacterial
species in which an sbmA gene is present.41 Similarly, insect
PrAMPs are also less active toward P. aeruginosa strains, and
studies optimizing apidaecins with improved antimicrobial
activity toward this pathogen, ended up selecting for derivatives
Fig. 2 Synthesis of PrAMPs. (A) Mammalian PrAMPs are synthesized as pre-pro-sequences and targeted to large granules. The PrAMPs are
activated upon bacterial infection by fusion of pro-PrAMP containing large granules with the elastase-containing azurophil granules and either
the plasmamembrane or the phagosome. Elastase activates the mature PrAMP by removal of the pro-sequence. The activated PrAMP is
transported via SbmA (or to a lesser extent MdtM) into the bacterial cell. (B) Schematic (left) illustrating the activation of insect PrAMPs synthesized
as multiple copies within one open reading frame. Liberation of the mature peptide involves the processing of a pre-pro-AMP by amino-,
carboxy- and endoproteases. An example for a pre-pro form (right) of apidaecin type 73 fragment from Apis mellifera, which contains several
isoforms of mature apidaecin. Putative cleavage sites are highlighted with arrows. (C) Phylogenic tree showing distribution of SbmA (orange)
across Eubacteria. Bacterial groups that have some members carrying SbmA have been highlighted in orange. The iTOL software was used to
draw the tree.37
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with more membranolytic capabilities.42 However, if the exog-
enous E. coli SbmA is expressed in P. aeruginosa PA01, an
increase in internalization and antimicrobial activity was
observed.43 On the other hand, the PrAMP becomes less per-
meabilizing toward the bacterial cell. SbmA seems therefore to
drain Bac7 from the membrane, keeping the local concentra-
tion lower and thereby as a consequence reducing membrane
damage by the PrAMP.43
4 Intracellular targets of PrAMPs
Despite the identication of several PrAMPs, the exact target of
these peptides remained elusive for a long time and in the
beginning it was even unclear whether PrAMPs were lytic, like
most other AMPs, or whether they utilize a completely different
mode of action. Five years aer the initial discovery of apidae-
cin, permeabilization assays suggested that the PrAMP apidae-
cin utilizes a non-lytic mechanism5 and inhibits bacteria by
targeting intracellular components.6 In vivo metabolic labeling
assays monitoring the incorporation of radioactive methionine
indicated that protein synthesis may be the intracellular target
of apidaecin,6 however, these ndings were initially not inves-
tigated further. The second target suggested for PrAMP inter-
action were the chaperones of the Hsp70 family.44 In co-
immunoprecipitation assays the DnaK chaperone was shown
to co-purify with PrAMPs, such as drosocin, pyrrhocoricin,
apidaecin 1a44 and Bac7(1-35).45 Subsequent structural studies
visualized the interactions of PrAMPs with DnaK and revealed
that PrAMPs bind within the same pocket as natural DnaK
substrates.46–48 The hypothesis that DnaK is the primary target
for PrAMP action was challenged when studies reported that
DnaK-decient strains still remained susceptible to Bac7(1-35)
treatment.45 Subsequently, similar results were also obtained
for the insect PrAMPs oncocin and apidaecin.49 Thus, the
interaction of PrAMPs with DnaK appeared to be a secondary
effect, suggesting the existence of another intracellular target
for PrAMP action.
To identify the physiological target of PrAMPs, synthetic
derivatives of the insect PrAMP oncocin and apidaecin were
biotin-labeled and used to “sh” for interactors within bacterial
extracts.49 This led to the identication of ribosomal proteins,
suggesting that ribosomes may be the major target of PrAMPs.49
Consistently, oncocins and apidaecins derivatives were shown
to bind to E. coli 70S ribosomes and inhibit E. coli protein
synthesis using in vitro transcription/translation assays.49 A
second independent study reached the same conclusion,
demonstrating that the mammalian PrAMP Bac7 co-
sedimented with bacterial ribosomes, inhibited in vitro
transcription/translation reactions using bacterial lysates and
blocked protein synthesis in living bacteria.25 Recently, api-
daecin was proposed to have a distinct mechanism of action
compared to other insect PrAMPs, such as oncocin, namely, by
interfering with the assembly of the large ribosomal subunit.50
However, it remains to be determined whether this is a direct
effect on assembly or an indirect effect resulting from inhibition
of translation. Nevertheless, competition assays with other
translation inhibitors indicate that the apidaecin binding site
on the ribosome may differ somewhat from that of oncocin.50 A
distinct mechanism of action for apidaecins compared to
oncocins is also supported by differences in the importance of
their C- and N-terminal residues, respectively,6,41,49,51 as dis-
cussed in the following section.
5 Structure activity relationships of
PrAMPs
The antimicrobial potency of PrAMPs is most effective against
Gram-negative bacteria, especially Enterobacteriaceae such as E.
coli, whereas Gram-positive bacteria are generally less susceptible
to PrAMPs, presumably due to the absence of specic trans-
porters, such as SbmA.7 Given the potential of native PrAMPs for
development as antibacterial compounds against Gram-negative
bacteria, efforts have been made to identify which residues are
crucial or dispensable for their inhibitory activity. The best-
characterized PrAMP derivatives are those related to the insect
oncocins and apidaecins, as well as the bovine Bac7.
The original sequencing analysis of oncocin did not reveal
the nature of the residue at position 11 (see Fig. 1A),13 yet further
mutagenesis studies indicated that the antimicrobial efficiency
of oncocin derivatives strongly depends on this position.14 For
example, oncocin derivatives containing Pro11 or Thr11 dis-
played signicantly worse MICs (128 mg mL!1) against E. coli
compared to derivatives with Arg11 (8 mg mL!1). Subsequent
removal of Asn18 and addition of an amino group to the C-
terminus, coupled with the additional replacement of both
Arg15 and Arg19 with either D-arginine or L-ornithine, led to the
development of Onc112 and Onc72 derivatives, respectively,
both of which displayed increased serum stability without loss
in antimicrobial activity against E. coli and Micrococcus luteus
strains.14,52 Onc72 showed moderate activity against different E.
coli strains with MICs ranging from 18–44 mg mL!1, whereas
Onc112 was more active against E. coli in diluted tryptic broth
media with MICs of 2.5–6.8 mg mL!1.53 Alanine-scanning
mutagenesis of oncocin revealed that replacement of Tyr6 or
Leu7 with Ala led to a 32-fold increase of MIC against E. coli,48
whereas these mutations had little effect on the MIC against P.
aeruginosa.54 Onc112 and Onc72 both display potent inhibitory
activity in E. coli in vitro translation systems.49 While Onc112
derivatives lacking the last seven C-terminal residues
(Onc112D7) retained some translation inhibition activity,
truncation of an additional two residues (Onc112D9) led to
complete loss of activity.55 Both derivatives were unable to
inhibit the growth of E. coli BL21(DE3) in undiluted LB medium
at concentrations up to 383 mg mL!1, while full-length Onc112
inhibited the growth at 60 mg mL!1 indicating that the very C-
terminus of oncocin is more important for cellular uptake
than for ribosome binding and inhibition.55 An oncocin deriv-
ative lacking the rst two N-terminal residues (Onc112DVD) had
reduced capacity to inhibit bacterial growth in vivo and protein
synthesis in vitro,51 illustrating the signicance of N-terminal
residues for activity.
Given the increased length (60 aa) of Bac7 compared to
insect PrAMPs (<20 aa), structure-activity studies on Bac7 have
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so far focussed mainly on analyzing activity of truncated Bac7
derivatives, rather than specic amino acid substitutions.41
These studies demonstrated that the rst 35 N-terminal resi-
dues of Bac7 are necessary and sufficient to inhibit bacterial
growth with the same efficacy as the full-length native peptide.
Bac7(1-35) was shown to display excellent activity (MIC# 8.4 mg
mL!1) against a range of clinically relevant Gram-negative
pathogens, such as E. coli, A. baumannii, K. pneumoniae and
Salmonella enterica.41 The Bac7 peptide can be further shortened
to encompass only the rst 16 N-terminal residues (Bac7(1-16)),
sacricing only partially its antimicrobial potency, whereas
further truncation of even one amino acid (Bac7(1-15)) leads to
a complete loss of antimicrobial activity.41 The loss of activity of
Bac7(1-15) results from impaired transport into the cytosol,
indicating that Bac7(1-16) is the shortest Bac7 PrAMP that is
efficiently taken up by bacterial cells.56 Unlike the C-terminal
truncations, removal of the two N-terminal arginine residues
of Bac7(1-23) increases the MIC by 8-fold56 and truncation of the
rst four N-terminal residues basically inactivated Bac7(1-35).41
Thus, only the rst 16 amino acids of the full 60 of the native
Bac7 are crucial for its killing activity. Similarly, N-terminally
truncated Bac7(5-35) was shown to have reduced inhibitory
activity compared to both Bac7(1-16) and Bac7(1-35) when
analyzed using E. coli in vitro translation assays.57 This indicates
that the rst 16 amino acids of Bac7 are necessary to inhibit
bacterial growth, and are also necessary to efficiently block
protein synthesis.
The rst insights into which apidaecin residues are critical
for its inhibitory activity came from a comparative analysis of
natural apidaecin-type peptides from a diverse range of
insects.58 Comparison of these peptides revealed a conserved
core containing the sequence R/KPxxxPxxPRPPHPRI/L. Devia-
tions from the C-terminal consensus severely reduced the
antimicrobial activity of apidaecins, for example, an exchange
of penultimate Arg by Ala in hornet apidaecin resulted in an
2500-fold increase inMIC (from 0.01 mgmL!1 for the wildtype to
25 mg mL!1).6 In contrast, substitutions within the middle or N-
terminal part of hornet apidaecin produced milder effects.6 The
promising MIC values made apidaecin a potential candidate for
the development of new antimicrobial agents, however, api-
daecin displayed low stability in mouse serum.59 In order to
improve serum stability, the honey bee apidaecin 1b was
modied with an N-terminal tetramethylguanidino-L-ornithine
group instead of a glycine, yielding the apidaecin derivative
Api137.59 In addition to increased serum stability, Api137 also
exhibited a slightly improved MIC against E. coli strains.59 In
accordance with previous studies,6 the C-terminal of Api137 was
shown to be crucial for activity in vivo.49 In the absence of the
last C-terminal Leu18 residue, the MIC of Api137 increased by
16-fold (from 4 mg mL!1 to 66 mg mL!1),49 whereas removal of
the last two residues (Arg17-Leu18), increased the MIC towards
E. coli"140-fold (to 578 mgmL!1). By contrast, mutations within
the N-terminal region, for example the Arg4Ala mutation, did
not signicantly alter the MIC.49 Thus, unlike oncocin and Bac7
where the N-terminal terminus is critical for antimicrobial
activity and the C-terminus is to a large extent dispensable, it is
the C-terminus of apidaecins that is important for activity
whereas the N-terminus appears to be less critical.
6 Interaction of PrAMPs with the 70S
ribosome
The reports that PrAMPs bind to ribosomes and inhibit protein
synthesis25,49 prompted two independent studies to determine
structures of the oncocin derivative Onc112 in complex with the
bacterial 70S ribosome.55,60 Subsequently, structures were also
reported for the insect PrAMPs pyrrhocoricin (Pyr) and
metalnikowin-1 (Met) as well as mammalian Bac7 bound to the
ribosome.51,57 These structures revealed that these PrAMPs all
interact with the large (50S) subunit of the ribosome, speci-
cally, binding within the ribosomal exit tunnel (Fig. 3A and B).
The binding site of the PrAMPs was visualized within the upper
region of the exit tunnel, adjacent to the binding site of a pep-
tidyl-tRNA and overlaps with the path of the nascent poly-
peptide through the tunnel (Fig. 3C).
Within the tunnel, the PrAMPs adopt an elongated confor-
mation, predominantly consisting of random coil interspersed
with stretches of trans-polyproline helices (type II). The PrAMPs
bind with an opposite orientation compared to a nascent
polypeptide chain (for example MifM), namely, with the N-
terminus located at the tunnel entry and the C-terminus
extending deeper into the tunnel (Fig. 3C). For each of the
insect PrAMPs, the C-terminal residues (4 aa, 5 aa and 6 aa of
Pyr, Met and Onc112, respectively) were not visualized in the
structure (Fig. 3B), suggesting that they are not crucial for
stabilizing the interaction with the ribosome.51,55,57,60 Similarly,
while all 16 residues of Bac7(1-16) were observed,57 only 19
residues of Bac7(1-35) were visible with the C-terminal 16 resi-
dues being disordered. Consistently, the native Bac7 is 60 aa
long however the C-terminus of Bac7 is less crucial for activity
and C-terminal truncated derivatives of native Bac7, such as
Bac7(1-16), have been shown to retain activity.41
PrAMP interaction with the 70S ribosome is facilitated by
a multitude of hydrogen bonds and stacking interactions
(Fig. 3D–F).51,55,57,60 The majority of hydrogen bonds are formed
between the peptide backbone of PrAMP with the nucleobases
of the 23S rRNA. The high content of trans-proline residues
within PrAMPs seems to be important for maintaining the
elongated structure that maximizes the interaction of the
peptide backbone with the surrounding rRNA. For insect
PrAMPs, such as Onc112, Pyr and Met, additional hydrogen
bond interactions are established by amino acid sidechains
within the N-terminus of the PrAMP, specically, Asp2 (D2)
interacts with the nucleobase of G2553 and Lys3 (K3) with the
phosphate-oxygen rRNA of A2453 (Fig. 3D). Two conserved
stacking interactions are observed for the insect PrAMPs
Onc112, Pyr and Met, namely, Arg9 (R9) stacks upon 23S rRNA
nucleotide C2610 whereas Tyr6 is stacked between C2452 and
the neighboring Leu7/Asp7 sidechain of the PrAMP.51,55,57,60
These stacking interactions are likely to be important, since
exchange of Arg9 by Ala leads to a loss of activity when tested in
P. aeruginosa,54 and substitutions of Tyr6 or Leu7 with Ala in
This journal is © The Royal Society of Chemistry 2017 Nat. Prod. Rep., 2017, 34, 702–711 | 707
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oncocin reduce the inhibitory activity in E. coli by 32-fold.48
Mutations within the ribosomal tunnel, namely, A2503C or
A2059C, increased resistance against Onc112 by about 4-fold,
and the double mutation by more than 15-fold.51 While neither
of these rRNA nucleotides directly contacts Onc112, both resi-
dues interact with A2062, which in turn forms stacking inter-
action with the peptide (Fig. 3E).51 In addition to revealing the
importance of A2062 for Onc112 activity, the mutagenesis data
establishes the ribosome as the immediate cellular target of
Onc112 and probably other PrAMPs.51
Compared to insect PrAMPs, the mammalian Bac7(1-16)
contains many more arginine residues. In fact, half (8) of the
16 residues are arginines, which establish multiple hydrogen
bonding and stacking interactions with the 23S rRNA (Fig. 3F).
The two stacking interactions observed in the insect PrAMPs
from Tyr6 and Arg9 have equivalents in Bac7(1-16), namely,
Arg9 in Bac7(1-16), which occupies the position of Tyr6, and
Arg12, which aligns with Arg9 of insect PrAMPs within the
conserved core PRP motif (Fig. 1A and B). This centrally
conserved core region is the most structurally conserved region
Fig. 3 Binding site of PrAMP within the ribosomal exit tunnel. (A) Overview showing the binding site of pyrrhocoricin (Pyr, salmon) within the exit
tunnel of the 50S subunit (grey) with P-site tRNA (green). (B) Superimposition of mammalian Bac7(1-16) (light blue) and insect derived PrAMPs
Onc112 (cyan), metalnikowin-1 (Met, yellow) and Pyr (salmon), with the conserved PRP motif highlighted. (C) Binding position of Pyr (salmon)
relative to the MifM polypeptide chain (dark blue). (D–F) Interactions of (D) insect Pyr (salmon), (E) Onc112 (cyan) and (F) mammalian Bac7(1-16)
with nucleotides situated within the polypeptide exit tunnel. Hydrogen bonds are indicated as dashed yellow lines and stacking interactions with
arrows.
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between PrAMPs, with diverse conformations being observed
for the N- and C-terminally anking regions of the various
PrAMPs. Bac7(1-16) establishes another three stacking interac-
tions involving the sidechains of Arg2, Arg14 and Arg16 with 23S
rRNA nucleotides C2573, C2586 and A2062, respectively
(Fig. 3F).51,57 The N-terminus of Bac7(1-16) is particularly
arginine-rich, comprising Arg1, Arg2, Arg4 and Arg6, which
generate a positively charged compacted structure that anchors
the N-terminus of the PrAMP to the negatively charged cle
created by the surrounding rRNA. Truncations of four N-
terminal residues of Bac7(1-35) inactivated the PrAMP indi-
cating that these interactions are also likely to be critical for
Bac7 activity.41
7 Mechanism of action of PrAMPs
The outcome of initiation of translation is the presence of the
initiator fMet-tRNA interacting with the AUG start codon of the
mRNA located within the P-site of the ribosome (Fig. 4A).
Translation elongation ensues with the delivery of an amino-
acylated tRNA (aa-tRNA) to the ribosomal A-site of the ribosome
by the elongation factor EF-Tu (Fig. 4B). Correct recognition of
the codon of the mRNA by the anticodon of the aa-tRNA leads to
dissociation of EF-Tu from the ribosome and accommodation
of the aa-tRNA on the large subunit (Fig. 4C). The binding
position of PrAMPs, such as Onc112 and Bac7(1-35), on the
ribosome indicates that they would allow delivery of the aa-
tRNA by EF-Tu to the ribosome, but would prevent accommo-
dation of the aa-tRNA on the large subunit (Fig. 4D). Specically,
overlapping the structure of an accommodated aa-tRNA shows
a steric clash between the aminoacylated CCA-end of the A-tRNA
and the N-terminal residues of these PrAMPs (Fig. 4E and
F).51,55,57,60 Bac7 shows the largest extension into the A-site,
surpassing Onc112, Pyr (Fig. 4E) and Met by four amino acids
at the N-terminus (Fig. 4F).51,57 This is consistent with the loss of
activity of Onc112 derivatives lacking the rst two N-terminal
residues and the reduced activity and binding affinity of N-
terminal truncated Bac7 derivatives.51,57 In contrast, the N-
terminus of the PrAMPs does not signicantly overlap with
the binding position of the P-tRNA, which is in agreement with
biochemical assays demonstrating that these PrAMPs allow
binding of the initiator tRNA at the P-site during translation
initiation but prevent the transition from initiation into the
elongation cycle to occur.51,55,57 Presumably, once ribosomes are
translating, they are immune to the effects of PrAMPs, such as
oncocin, since the binding position of PrAMPs within the
ribosomal exit tunnel is likely to be incompatible with the
presence of a nascent polypeptide chain (Fig. 3C). Thus, PrAMPs
are likely to bind to ribosomes following termination of trans-
lation when the polypeptide chain has been released from the
ribosome. Additionally, PrAMPs could bind during the late
stages of ribosome biogenesis when the binding pocket has
formed on the large ribosomal particle.
8 Outlook
A structural understanding of how different PrAMPs interact
with components of the ribosome provides further insight into
which residues of the PrAMPs as well as which interactions are
critical for their inhibitory activity. Importantly, the structures
also reveal which regions of the PrAMPs are less important and
can be further modied to increase stability and solubility as
well as establish additional interactions with the ribosome to
increase the binding affinity. This latter point may become
important since the binding site of PrAMPs overlaps with many
known translation inhibitors, such as chloramphenicol, clin-
damycin and erythromycin (Fig. 4G).55,60,61 Therefore, it will be
important to assess cross-resistance between such antibiotics
and PrAMPs, especially since initial reports reveal some ribo-
somal mutations that confer erythromycin resistance also
Fig. 4 Inhibition of protein synthesis by PrAMPs. (A–C) Canonical translation in absence of protein synthesis inhibitors, showing (A) translation
initiation with initiator P-tRNA (green) bound to the ribosomal P-site. (B) Delivery of aa-tRNA by EF-Tu to the A-site, followed by (C) tRNA
accommodation into the A-site on the large subunit and subsequent departure of EF-Tu. (D) In the presence of PrAMPs, such as oncocin, aa-
tRNA delivery can occur however the aa-tRNA accommodation is blocked. (E and F) Superimposition of (E) insect Pyr (salmon) and (F)
mammalian Bac7(1-16) with accommodated aa-tRNA (bright orange). (G) Superimposition of antibiotics chloramphenicol (Cam; yellow), clin-
damycin (Cln; slate) and erythromycin (Ery; cyan) with the binding position of the insect PrAMP Pyr (salmon).
This journal is © The Royal Society of Chemistry 2017 Nat. Prod. Rep., 2017, 34, 702–711 | 709
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reduce PrAMP inhibition.51 PrAMPs, such as Bac7, also bind to
and inhibit translation on eukaryotic ribosomes, albeit less
efficiently than on bacterial ribosomes,57 thus raising issues of
toxicity. Fortunately, it seems that most PrAMPs do not pene-
trate eukaryotic membranes, however, maintaining the non-
lytic mechanism of the PrAMPs during optimization will be
critical to avoid disrupting the eukaryotic cell membranes. One
major concern for development of PrAMPs as an antimicrobial
is the ease with which resistance arises in bacteria viamutation
of the SbmA transporter. Whether these resistant strains can be
overcome by the next generation PrAMPs remains to be seen.
Lastly, it is unclear as to the full scope of PrAMPs across
different species and, in particular, as to the conservation in
terms of mechanism of action. Initial indications suggest that
PrAMPs such as drosocin and apidaecin may differ from those
of well-characterized PrAMPs such as oncocin and Bac7.
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The release of the polypeptide from the ribosome is an essential step 
of protein synthesis. When the translating ribosome reaches the end 
of an open reading frame (ORF), it carries the completed protein 
chain attached to the P-site tRNA and has a stop codon in the A site. 
In bacteria, termination requires the action of three release factors, 
RF1, RF2 and RF3. RF1 or RF2 recognize the stop codon in the A 
site of the small (30S) subunit while their conserved GGQ motif is 
placed in the active site of the peptidyl transferase center (PTC) of the 
large (50S) subunit where it facilitates the hydrolysis of the peptidyl-
tRNA ester bond, releasing the completed protein (reviewed in ref. 1). 
Because the number of ribosomes in the cell greatly exceeds the 
number of RF1 and RF2 molecules2,3, continuous translation relies 
upon the rapid turnover of these factors in order to serve the needs of 
all the cellular ribosomes. RF3 is a GTPase that facilitates recycling of 
RF1 and RF2 subsequent to polypeptide release4,5. Finally, the ribos-
ome-recycling factor together with the elongation factor G dislodges 
the ribosome from the mRNA and splits it into subunits6. Inhibition 
of any of these reactions should reduce fitness and viability of the 
bacterial cell. Strikingly, in spite of the complexity and importance 
of translation termination, no specific inhibitors of this key step in 
protein synthesis have so far been identified.
Antimicrobial peptides constitute an important component of the 
innate immune defense system of multicellular organisms against bacte-
rial infection7. While many antibacterial peptides lyse cells by disrupting 
their membrane, a specific class of nonlytic peptides, called proline-
rich antimicrobial peptides (PrAMPs), act upon the intracellular target, 
the ribosome8–13. Several investigated PrAMPs, such as oncocin 112 
(Onc112) and others, whose sizes range from 15 to 20 amino acids, bind 
to the nascent peptide exit tunnel of the ribosome and, by encroaching 
upon the A site of the PTC, prevent binding of aminoacyl-tRNA10–13. 
This mode of action results in the arrest of the ribosome at the mRNA 
start codon before the first peptide bond can be formed10–13.
Among PrAMPs, the 18–20-amino-acid long antimicrobial peptides 
called apidaecins, which are produced by bees, hornets and wasps, remain 
outliers. Compared to other PrAMPs, they compete with a different sub-
set of ribosomal antibiotics for binding14. Furthermore, whereas Onc112 
and other PrAMPs readily inhibit protein synthesis in vivo and in vitro, 
apidaecins efficiently interfere with protein synthesis in living cells but 
are poor inhibitors of in vitro translation14–16. We sought to understand 
the mechanism of action of apidaecins using Api137 (Fig. 1a), an 18-
amino-acid derivative of the natural apidaecin 1b, which was optimized 
to have improved antibacterial properties and serum stability17.
RESULTS
Api137 arrests translation at the stop codon of mRNAs
To identify the stage of translation inhibited by Api137, we used in 
vitro toeprinting analysis, which determines the location of stalled 
ribosomes on mRNA18. In contrast to Onc112, which arrests transla-
tion at the start codon12,13 (Fig. 1a), Api137 arrested translation when 
the stop codon entered the A site of the ribosome (Fig. 1b). Similar 
stalling at the stop codon was obtained with other tested mRNAs 
when translation was carried out in the presence of Api137 or the 
unmodified natural apidaecin 1a (Supplementary Fig. 1). These 
results show that Api137, unlike other ribosome-targeting PrAMPs 
or any other known antibiotic, has the unique ability to specifically 
arrest the terminating ribosome.
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An antimicrobial peptide that inhibits translation by 
trapping release factors on the ribosome
Tanja Florin1,5, Cristina Maracci2,5, Michael Graf3,5  , Prajwal Karki2  , Dorota Klepacki1, Otto Berninghausen3,  
Roland Beckmann3, Nora Vázquez-Laslop1  , Daniel N Wilson3,4  , Marina V Rodnina2  & Alexander S Mankin1  
Many antibiotics stop bacterial growth by inhibiting different steps of protein synthesis. However, no specific inhibitors of 
translation termination are known. Proline-rich antimicrobial peptides, a component of the antibacterial defense system of 
multicellular organisms, interfere with bacterial growth by inhibiting translation. Here we show that Api137, a derivative 
of the insect-produced antimicrobial peptide apidaecin, arrests terminating ribosomes using a unique mechanism of action. 
Api137 binds to the Escherichia coli ribosome and traps release factor (RF) RF1 or RF2  subsequent to the release of the nascent 
polypeptide chain. A high-resolution cryo-EM structure of the ribosome complexed with RF1 and Api137 reveals the molecular 
interactions that lead to RF trapping. Api137-mediated depletion of the cellular pool of free release factors causes the majority of 
ribosomes to stall at stop codons before polypeptide release, thereby resulting in a global shutdown of translation termination.
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Mutations in RF1, RF2  and the ribosome confer resistance to 
Api137
In order to identify the components of the translation apparatus that 
are involved in the mechanism of Api137 action, we carried out an 
unbiased selection of spontaneous Api137-resistant mutants in two 
E. coli strains. We isolated three types of mutants. The resistance in the 
first type of mutant was caused by nonsense mutations in the sbmA 
gene (Supplementary Fig. 2a) encoding the transporter responsible 
for importing PrAMPs into the cell19.
Resistant mutants of the second type carried mutations in the prfA or 
prfB genes encoding RF1 and RF2, respectively. RF1 and RF2 recognize 
the stop codon of the mRNA and facilitate hydrolysis of the peptidyl- 
tRNA ester bond, releasing the completed protein (reviewed in ref. 1). 
Mutants isolated using E. coli strain SQ110 carried a mutation in the prfA 
gene, which resulted in the replacement of Asp241 of the encoded RF1 
with a glycine residue (Supplementary Fig. 2). The Api137-resistant 
mutant isolated with the E. coli strain BL21 had mutations in the prfB 
gene, resulting in substitutions R262C or Q280L in RF2 (Supplementary 
Fig. 2). The difference in the results obtained using these two strains 
probably reflects the fact that SQ110, as a derivative of the K12 strain, 
carries an alteration in the prfB gene that results in the replacement of 
Ala246 of RF2 with a threonine20 (Supplementary Fig. 2d). This muta-
tion affects the properties of RF2 (ref. 21) and could conceivably alter 
the interactions of the K12-type RF2 with Api137. The RF1 and RF2 
mutations found in Api137-resistant strains are located in proximity 
to the catalytically important GGQ motif (Supplementary Fig. 2b,c), 
suggesting that Api137 interferes with the function of RF1 and RF2.
The third type of Api137-resistant mutants had a mutation in the 
gene rplP encoding ribosomal protein uL16 (Supplementary Fig. 2). 
Subsequent testing of other ribosomal-protein mutants showed 
that mutations in the proteins uL22 and uL4, which are located in 
the nascent peptide exit tunnel, also increased resistance to Api137 
(Supplementary Fig. 2). In agreement with this observation, mutations 
of nearby 23S rRNA nucleotides A2059 and A2503 rendered cells resist-
ant to Api137 (Supplementary Fig. 2). Consistently, Api137 did not 
induce pronounced arrest of the A2059C or A2503G mutant ribosomes 
at the stop codons in vitro (Fig. 1c). Taken together, these results indi-
cate that Api137 interferes with translation termination by influencing 
functional interactions between RF1 or RF2 and the ribosome.
Api137 inhibits turnover of RF1 and RF2
To understand the mode of inhibition of translation termination by 
Api137, we used a fully reconstituted in vitro translation system. We 
prepared a model termination complex corresponding to the state of 
the ribosome before hydrolysis of peptidyl-tRNA (prehydrolysis com-
plex, PreHC)4,22 (Fig. 2a). Mixing the PreHC with RF1 or RF2 results 
in the hydrolysis of the ester bond linking fMet to the P-site tRNA, 
emulating the polypeptide-release reaction. At a high concentration 
of RF1 or RF2, when recycling of the factors was not required for the 
reaction to progress to completion, rapid and complete hydrolysis of 
peptidyl-tRNA was observed even in the presence of high Api137 con-
centrations (Fig. 2b), suggesting that Api137 does not inhibit peptidyl-
tRNA hydrolysis. In contrast, at limiting concentrations of RF1 or RF2, 
when multiple rounds of binding and dissociation of the factors from 
PreHC were needed to achieve termination on all PreHCs, the reaction 
was dramatically inhibited in the presence of as little as 1 MM Api137 
(Fig. 2c). This result suggested that Api137 either competes with the 
RFs for binding to the PreHC or traps the RFs in the posthydrolysis 
(PostHC) complex, abolishing recycling of the factor.
To distinguish between these scenarios, we directly examined the 
effect of Api137 on RF1 binding or dissociation using a fluorescent 
derivative of fMet-tRNAfMet (PreHCFlu) and a quencher-dye-labeled 
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Figure 1 Api137 stalls ribosomes at the termination step of translation. (a) Amino acid sequences of PrAMPs Api137 and Onc112. gu, N,N,N`,N`-
tetramethylguanidino; OH, hydroxyl; O, L-ornithine; r = D-arginine. (b,c) In vitro toeprinting analysis comparing the Onc112- or Api137-mediated 
(labeled Onc and Api, respectively) translation arrest on model mRNA templates derived from the yrbA (b) or ermCL (c) genes. Positions of the toeprint 
bands (indicated by arrowheads on the gene sequence) are 16–17 nt downstream from the first nucleotide of the P-site codon. The P- and A-site 
codons of the stalled ribosomes are indicated by brackets. Toeprints in c were produced by wild-type ribosomes (WT) or by ribosomes with mutations in 
specific rRNA nucleotides (Supplementary Fig. 2a). Gray arrowheads indicate toeprint bands in b and c generated by Onc112-arrested ribosomes at the 
initiation codon; white arrowheads indicate bands from ribosomes arrested by Api137 at termination. The similar intensities of the PrAMP-independent 
toeprint bands marked with a black arrowhead in c shows that WT and mutant ribosomes translate with comparable efficiencies. Sequencing reactions 
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RF1 (RF1Qsy) and following changes in fluorescence resonance energy 
transfer (Fig. 2d). Though Api137 did not affect binding of RF1 
(Fig. 2e), it entirely blocked RF1 dissociation (Fig. 2f), demonstrating 
that Api137 prevents turnover of RF1 and RF2 by trapping them on 
the ribosome. When similar experiments were carried out with the 
Api137-resistant mutant of RF1 (Supplementary Fig. 2a), Api137 was 
unable to abolish RF1 dissociation (Supplementary Fig. 3a), indicat-
ing that the mutation allowed RF1 to escape Api137-mediated trapping 
in the PostHC complex. Similarly, the RF2 A246T mutation endemic 
in the K12 E. coli strain and located in the vicinity of the selected 
Api137-resistance mutations (Supplementary Fig. 2d) showed 
considerably increased tolerance of Api137 inhibition compared 
to the unaltered RF2 (Supplementary Fig. 3b). Collectively, these 
results showed that Api137 traps RF1 and RF2 on the ribosome after 
the release of the nascent protein, abolishes RF turnover and prevents 
disassembly of the termination complex and recycling of the ribosome 
for new rounds of translation.
Interactions of Api137 with the ribosome and RF1 illuminate 
molecular mechanisms of RF trapping
To obtain insights into the molecular mechanism of RF trapping, we 
determined a cryo-EM structure of Api137 bound to a terminating 
ribosome (Fig. 3). The ribosome–nascent chain complex bearing a 
UAG stop codon in the A site was prepared by translating in vitro the 
model ermCL ORF in the presence of Api137 and then purified and 
subjected to cryo-EM analysis. In silico sorting of the cryo-EM data 
revealed a major subpopulation of ribosomes bearing a tRNA in the P 
site and RF1 bound in the A site (Supplementary Fig. 4 and Table 1). 
A final cryo-EM reconstruction with an average resolution of 3.4 Å 
enabled the generation of a molecular model for the entire complex 
(Fig. 3a). In the Api137-stalled complex, the conformation of RF1 
is similar to that observed previously in the PostHC during canoni-
cal termination23,24 (Supplementary Fig. 5a–c). Consistent with our 
kinetics data, the P-site tRNA is deacylated, showing that RF1 has cat-
alyzed hydrolysis of the polypeptide chain in the presence of Api137. 
A distinct electron density observed within the ribosomal exit tunnel 
could be unambiguously assigned to residues 5–18 of Api137 bound 
in an extended conformation (Fig. 3b and Supplementary Fig. 4g,h). 
The orientation of Api137 within the tunnel matches that of a nascent 
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Figure 2 Api137 allows peptide hydrolysis but inhibits turnover of RF1 
and RF2. (a) Schematics of the peptidyl-tRNA hydrolysis experiments. 
PreHC carrying f[3H]Met-tRNAfMet is reacted with RF1 (shown) or RF2, 
and the release of f[3H]Met is measured. (b) Time courses of peptide 
hydrolysis in PreHC in the presence of excess RF1 without (black) or 
with the indicated concentrations of Api137 (colored traces). (c) Time 
courses of peptide hydrolysis in PreHC by RF1 (black) and RF2 (red) 
under turnover conditions in the absence (open circles) or presence 
(closed circles) of 1 MM Api137. RF3-GTP was present in all reactions. 
Control experiments (blue) lacked RF1 and RF2 in the absence (open 
circles) or presence (closed circles) of Api137. 100% corresponds to ten 
cycles of RF binding, catalysis and dissociation. Error bars represent the 
range of two independent replicates. (d) Schematics of the RF1-binding 
experiments. PreHC carries fluorescein-labeled fMet-tRNAfMet (PreHCFlu) 
and RF1 carries fluorescence quencher dye (RF1Qsy). (e) Time courses 
of binding of RF1Qsy to PreHCFlu in the absence (red) or presence (blue) 
of Api137. Gray trace, no RF1. The fluorescence traces represent the 
average of five to seven technical replicates. a.u., arbitrary units.  
(f) Time course of RF1 dissociation. RF1Qsy was incubated with PreHCFlu 
to generate PostHCFlu and then mixed with a ten-fold excess of unlabeled 
RF1 and RF3-GTP in the absence (gray) or in the presence (black) 
of Api137. The traces represent the average of up to seven technical 
replicates. Details in Online Methods. 
Table 1 Cryo-EM data collection, refinement and validation statistics
RF1–API (EMD 3730, PDB 5O2R)
Data collection
 Microscope FEI Titan Krios
 Camera Falcon II
 Magnification 129,151
 Voltage (kV) 300
 Electron dose (e−/Å2) 28
 Defocus range (Mm) −0.7 to −2.5
 Pixel size (Å) 1.084
 Initial particles (no.) 116,212
 Final particles (no.) 36,826
Model composition
 Nonhydrogen atoms 147,985
 Protein residues 6,205
 RNA residues 4,643
Refinement
 Resolution (Å) 3.4
 Map CC (around atoms) 0.78
 Map CC (whole unit cell) 0.76
 Map-sharpening B factor (Å2) −73.07
 Average B factor (Å2) 52.5
R.m.s. deviations
 Bond lengths (Å) 0.0110
 Bond angles (°) 1.30
Validation
 MolProbity score 1.99
 Clashscore 7.00
 Poor rotamers (%) 1.01
Ramachandran plot
 Favored (%) 87.90
 Allowed (%) 11.58
 Disallowed (%) 0.52
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peptide (Supplementary Fig. 5d) but is opposite from that observed 
for other investigated PrAMPs10–13 (Supplementary Fig. 5e). The C-
terminal Arg17 and Leu18, which are critical for the activity of Api137 
(ref. 16), are positioned close to the PTC (Fig. 4a). However, in contrast 
to other PrAMPs that encroach upon the PTC A site, Api137 is posi-
tioned entirely within the exit tunnel, allowing it to bind when the A 
site is occupied by RF1 or RF2 (Supplementary Fig. 5e).
Api137 makes multiple interactions with the exit tunnel, including 
stacking and van der Waals interactions with the 23S rRNA nucle-
otides (Fig. 3d,e) and a potential hydrogen bond with the ribosomal 
protein uL4 (Fig. 3f), clarifying how rRNA and ribosomal protein 
mutations could confer resistance (Supplementary Figs. 2 and 6).
The interactions of the central and N-terminal segments of Api137 
with the tunnel elements help to place the functionally critical 
C-terminal amino acids of Api137 in the vicinity of the GGQ motif 
of RF1 in the PTC (Fig. 4a–c). The side chain of the penultimate 
residue Arg17 of Api137 is fixed in place by hydrogen bonding with 
the 2` hydroxyl of the G2505 ribose and the O2 of the C2452 base 
(Fig. 4b). This network of hydrogen bonds with the nucleotides of 
the 23S rRNA positions Arg17 for interaction with RF1. The Gln235 
side chain carbonyl of RF1 is within hydrogen bond distance from 
the terminal nitrogen of the Arg17 guanidinium group (Fig. 4b). The 
contact between the Arg17 side chain and RF1 is likely to be critical, 
because mutations of the penultimate residue of Api137 decrease the 
affinity of the PrAMP for the ribosome and reduce its inhibitory activ-
ity16. Additionally, the backbone carboxyl of Arg17 of Api137 is also 
within hydrogen bond distance of the Gln235 side chain amine of RF1 
(Fig. 4b). Interaction between Api137 and RF1 not only helps to trap 
the RF on the ribosome but also stabilizes binding of Api137 itself. 
RNA probing experiments showed that in the absence of RF1, Api137 
only minimally shielded A2058, A2059 and A2062 from modification, 
whereas the PrAMP readily protected these nucleotides when RF1 was 
present (Fig. 4d). The C-terminal hydroxyl of Api137 is within hydro-
gen bond distance from the ribose hydroxyls of A76 of the deacylated 
P-site tRNA (Fig. 4c). These interactions could further contribute to 
RF1 or RF2 trapping by preventing the ribosome from undergoing 
the RF3-stimulated transition into the rotated state required for RF1 
or RF2 dissociation5,25.
The results of the structural analysis not only corroborate the find-
ings of biochemical and genetic experiments but also illuminate the 
possible molecular mechanism of trapping RF1 and RF2 on the ter-
minating ribosome after the release of the nascent peptide.
Api137-mediated RF depletion inhibits nascent peptide release
The number of ribosomes in the bacterial (E. coli) cell exceeds the number 
of RF2 and RF1 molecules by ~25-fold and ~200-fold, respectively2,3. 
Api137-mediated trapping of RF1 or RF2 on a relatively small number 
of ribosomes should lead to a rapid depletion of the RFs. As a conse-
quence, there would be no RF1 or RF2 available to facilitate the peptide 
release when the remaining translating ribosomes reach a stop 
codon. Therefore, although Api137 arrests the ribosome in a posthy-
drolysis state, in the cells treated with Api137, most of the ribosomes 
should stall at stop codons in a prehydrolysis state carrying an intact 
peptidyl-tRNA.
We first tested this hypothesis in a cell-free translation system using 
the TnaC stalling peptide as a model. At high tryptophan concentrations 
(5 mM), the RF2-mediated release of TnaC peptide is impeded, lead-
ing to a well-documented accumulation of TnaC–tRNA26 (Fig. 5a). 
By contrast, at low concentrations of tryptophan (0.3 mM), the TnaC 
peptide is rapidly released at the RF2-specific UGA stop codon. 
Strikingly, when Api137 was present, TnaC–tRNA also accumulated 
at low tryptophan concentrations. A similar result was obtained with 
the tnaC template carrying an RF1-specific UAG stop codon (Fig. 5a). 
These results demonstrated that as a consequence of RF1 or RF2 deple-
tion due to Api137-mediated trapping on a fraction of ribosomes, 
the majority of ribosomes are unable to release the TnaC peptide. 
Consistent with this conclusion, the Api137-induced accumulation of 
TnaC–tRNA was largely rescued by supplementing the reaction with 
a five-fold molar excess of RF1 over the ribosomes (Fig. 5b).
When the translating ribosome reaches a stop codon, the occa-
sional binding of a near-cognate aminoacyl-tRNA instead of the RFs 
may promote a stop codon readthrough event. The Api137-induced 
depletion of the pools of free RF1 and RF2 is expected to bias this 
competition in favor of aminoacyl-tRNA binding. Indeed, Api137 
dramatically increased the readthrough frequency in a reporter E. coli 
strain carrying a mutant lacZ allele with a premature UAG stop codon 
(Fig. 5c). Notably, the efficiency of Api137-induced readthrough was 
considerably higher than that induced by the miscoding antibiotic 
streptomycin (Fig. 5c). These results confirm that while Api137 traps 
RF1 and RF2 on the ribosome after the nascent protein release, the 
main downstream effect of Api137 action is the arrest of the ribos-
omes in the prehydrolysis state (Fig. 5d,e).
DISCUSSION
Our biochemical, genetic and structural data reveal Api137 as the first 
known inhibitor that is specific for translation termination. Though 
several inhibitors can potentially interfere with polypeptide release27,28, 
these antibiotics also target other steps of protein synthesis; in these 
cases, inhibition of termination is just a collateral effect of the antibiotic 
binding to the ribosomal centers critical for various ribosomal activities. 
In contrast, Api137 does not inhibit initiation or elongation of translation 
but specifically arrests the ribosome at the stop codons. Api137 achieves 
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Figure 3 Binding of Api137 to the terminating ribosome and its interactions with the exit tunnel. (a) Transverse section of the 50S subunit (gray) showing 
the binding site of Api137 (salmon) on the 70S ribosome (30S subunit in yellow) within the polypeptide exit tunnel relative to RF1 (orange) and the  
P-site tRNA (green). (b) Cryo-EM density (mesh) and molecular model (salmon) for residues 5–18 of Api137. (c) Placement of Api137 in the exit tunnel 
relative to RF1, P-site tRNA and ribosomal proteins uL4 and uL22. (d–f) Enlargement of boxed regions from b showing interactions of Api137 with 
components of the exit tunnel, including (d,e) nucleotides of the 23S rRNA (gray) and (f) ribosomal protein uL4. In e, sphere representation is used to 
approximate van der Waals interactions, and in f, a dashed yellow line indicates a hydrogen bond.
©
 2
01
7 
N
at
ur
e 
A
m
er
ic
a,
 In
c.
, p
ar
t o
f S
pr
in
ge
r 
N
at
ur
e.
 A
ll 
ri
gh
ts
 r
es
er
ve
d.
756 VOLUME 24 NUMBER 9 SEPTEMBER 2017 NATURE STRUCTURAL & MOLECULAR BIOLOGY
A R T I C L E S
its inhibitory action in two related but functionally distinct ways. The 
primary effect of Api137 is to trap RF1 and RF2 on the ribosomes after 
the release of the nascent peptide (Fig. 5d). This leads to depletion of 
the free RF pool and, as a result, the majority of cellular ribosomes 
are arrested at the stop codons in the prehydrolysis state (Fig. 5e). 
The arrested ribosome may additionally block other ribosomes on the 
same ORF from completing translation. Thus, treatment of cells with 
Api137 results in the formation of two populations of ribosomes stalled 
at the stop codons: a small fraction is arrested in a posthydrolysis state, 
whereas the majority carries unhydrolyzed peptidyl-tRNA.
Although Api137 belongs to the broad group of ribosome-targeting 
PrAMPs, its mode of binding is fundamentally different from those of 
the previously studied derivatives of oncocin, bactenecin, pyrrhocor-
icin and metalnikowin10–14. Whereas the binding sites of all PrAMPs 
overlap, the orientation of Api137 is opposite to that observed for 
other PrAMPs. Furthermore, the N termini of other PrAMPs encroach 
upon the A site of the PTC, completely blocking it and hindering bind-
ing of any A-site substrates10–13, whereas Api137 binds entirely within 
the exit tunnel. Therefore, the binding of RF1 or RF2 to the A site is 
incompatible with the placement of oncocin and similar PrAMPs, 
whereas Api137 actually requires RF1 or RF2 for efficient binding.
Due to the spatial constraints of the tunnel, direct binding of Api137 
promoted by its interactions with RF1 or RF2 is likely to occur only 
after the peptidyl-tRNA ester bond has been hydrolyzed and the newly 
synthesized protein has vacated the ribosome. Therefore, apidaecins 
have a rather narrow time window to exert their inhibitory action: 
namely, after the departure of the newly made protein but before RF1 
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Figure 4 Inhibitory action of Api137 is mediated by its interactions with 
RF1 and P-site tRNA. (a) Position of Api137 (salmon) relative to RF1 
(orange) and P-site tRNA (green). The boxed regions are enlarged in b and c. 
(b) Interactions of Api137 with RF1. Arg17 of Api137 is coordinated  
by bonding with 23S rRNA nucleotides C2452, G2505 and U2506 (gray) 
to form direct contacts with Gln235 of the GGQ motif of RF1 (orange).  
(c) The C-terminal hydroxyl of Leu18 of Api137 interacts with the ribose of 
A76 of deacylated P-site tRNA (green). (d) Dimethylsulfate (DMS) probing 
of Api137 interaction with PostHC 23S rRNA in the absence or presence 
of RF1. The gel is representative of two independent experiments.
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Figure 5 Api137 induces accumulation of peptidyl-tRNA and stop 
codon readthrough. (a) Gel electrophoresis analysis of the [35S]-labeled 
products of the in vitro translation of the tnaC gene with its original UGA 
stop codon (lanes 1–6) or with the UAG stop codon (lanes 7–9), in the 
absence or presence of Api137. Lane 1, control reaction without mRNA. 
Lane 2 (M, marker) shows RNase-sensitive TnaC–tRNA accumulated 
at high concentration of tryptophan (Trp). Lanes 5 and 8 show Api137-
induced accumulation of TnaC–tRNA at low concentration of tryptophan. 
The bands corresponding to TnaC–tRNA and the released TnaC peptide 
are indicated with filled and open arrowheads, respectively. The gel 
is representative of five independent biological replicates. (b) Excess 
of RF1 rescues Api137-induced accumulation of peptidyl-tRNA. Cell-
free translation with a low tryptophan concentration was carried out in 
standard conditions (lanes 1 and 3) or with five-fold molar excess of RF1 
over the ribosomes (lane 2). The gel is representative of two independent 
biological replicates. (c) Expression of the chromosomal mutant lacZ 
with a premature stop codon, mediated by stop codon readthrough 
stimulated by the miscoding antibiotic streptomycin (Str) or by Api137. 
The central circles indicate where droplets of Str or Api137 were placed 
on a lawn of E. coli cells grown on an LB-agar plate supplemented with 
ampicillin, IPTG and X-Gal. This plate represents one of three independent 
experiments. (d,e) The dual mode of Api137 action. (d) Api137 binds 
to the ribosome after RF1 or RF2 catalyzes the release of the complete 
protein and traps RF1 or RF2, thereby preventing their turnover. (e) Trapping 
of RF1 or RF2 depletes their available pool, causing the stalling of most of 
the ribosomes at the stop codons, unable to release the nascent proteins.
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or RF2 dissociation. Within this window, Api137 has to traverse the 
entire length of the exit tunnel to reach its binding site close to the 
PTC where it can establish interactions with the RF. Thus, Api137-
dependent trapping of RF1 and RF2 is probably a fairly rare event in 
the context of the global cellular translation. However, the resulting 
complex is long lived (Fig. 2d), and the majority of RF1 and RF2 
molecules will eventually be sequestered.
Recycling of RF1 and RF2 in the cell is facilitated by RF3, but RF3 
does not prevent trapping of RF1 or RF2 by Api137 in vitro (Fig. 2f). 
Nevertheless, minimal inhibitory concentration (MIC) testing shows 
that cells lacking RF3 are eight times more sensitive to Api137 than 
those expressing RF3 (Supplementary Table 1). This suggests that 
RF3 can partly mitigate the Api137 effect, probably by speeding up 
RF1 or RF2 dissociation before Api137 binding or by stimulating the 
dissociation of the already trapped factors.
Because of its unique mechanism of action, Api137 and its analogs 
could serve as important tools for research and medicine. Api137 
could have an application in synthetic biology in which interference 
with peptide release at engineered stop codons could stimulate the 
incorporation of noncanonical amino acids via stop codon sup-
pression29. The use of Api137 for medicine could go far beyond its 
known antibacterial action. Many human genetic disorders are caused 
by nonsense mutations. Although enabling premature stop codon 
readthrough by using translation-error-inducing compounds is one 
of the promising strategies, the decrease in translational accuracy 
makes such drugs highly toxic30. The ability of Api137 to dramati-
cally stimulate readthrough by interfering with the function of RFs 
provides new avenues for exploring this approach31, and our high- 
resolution structure of Api137 complexed with the bacterial ribosome 
can serve as a starting point for the rational design of specific inhibi-
tors of eukaryotic translation termination.
METHODS
Methods, including statements of data availability and any associated 
accession codes and references, are available in the online version of 
the paper.
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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ONLINE METHODS
Peptides and oligonucleotides. Api137 was synthesized by NovoPro 
Biosciences Inc. Onc112 was synthesized by GenScript. The ‘start-stop’ mRNA 
(Supplementary Table 2) was purchased from IBA GmbH. The 2XermCL_S10_
UAG construct was synthesized by Eurofins. DNA oligonucleotides were synthe-
sized by Integrated DNA Technologies.
Generation of templates for in vitro translation and toeprinting. The DNA 
templates for toeprinting (Supplementary Table 2) were generated by PCR using 
AccuPrime DNA Polymerase (Thermo Fisher Scientific) and primers listed in 
Supplementary Table 3. The synthetic template yrbA-fs15 was prepared using 
three overlapping primers (T7-IR-AUG, IR-yrbA-fs15-RF1 and posT-NV1) in a 
single PCR reaction. The ermCL template was created by PCR amplification of the 
gene from the plasmid pERMCT7-M32 using primers T7 and ermCL-UAG. The 
complete sequences of the templates are shown in Supplementary Table 2.
Toeprinting reactions were carried out in 5 Ml of PURExpress transcrip-
tion–translation system (New England Biolabs) as previously described32,33. The 
reverse transcription on the ermCL template was carried out using the primer 
ermCL-TP-term. The final concentrations of Api137 and Onc112 in the reactions 
were 50 MM; the PrAMPs were added as stock solutions in water.
Selection of Api137-resistant mutants. The first round of selection of Api137-
resistant mutants was performed with the E. coli strain SQ110, derived from the 
K12 strain (Supplementary Table 4). An overnight culture grown in LB medium 
was diluted 100-fold into fresh medium containing a subinhibitory concentration 
of Api137 (10 MM). After 24 h of growth at 37 °C, the culture was diluted 100-fold 
into 1 ml fresh LB medium containing 50 MM Api137. The culture was passaged 
one more time at 100 MM Api137 (eight-fold MIC). The dilutions of cell culture 
were plated on LB agar. After overnight incubation, the sbmA gene was PCR 
amplified from 20 individual colonies using primers SbmA-seq-fwd and SbmA-
seq-rev and sequenced. All but one clone had mutations in the sbmA gene. The 
Api137-resistant clone with the WT sbmA sequence (clone SQ110 ApiR21 in 
Supplementary Table 4) was grown in liquid culture; genomic DNA was isolated 
and prepared for sequencing using a Nextera XT kit (Illumina). Sequencing was 
performed on an Illumina NextSeq500 instrument (paired-end, 2 × 150 base 
reads) at the DNA Services facility at UIC. After mapping the reads to the genome 
of the strain SQ110 (ref. 34), the single mutation A722G in the prfA gene was 
identified. The presence of the mutation was verified by PCR amplification of 
the prfA gene using primers PrfA-seq-fwd and PrfA-seq-rev from the parent and 
mutant strains and sequencing.
E. coli strain BL21(DE3) (Supplementary Table 4) was used in the second 
selection experiment. In order to avoid selection of sbmA mutants, before selec-
tion cells were transformed with the multicopy plasmid pZA-SbmA encoding the 
functional SbmA transporter. The pZA-SbmA plasmid was prepared by amplify-
ing the E. coli sbmA gene using primers SbmA-seq-fwd and SbmA-EcoRI-rev, cut-
ting the PCR product with restriction enzymes NdeI and EcoRI and ligating the 
resulting DNA fragment into the pZA plasmid35 cut with the same enzymes. For 
selection of Api137-resistant mutants, the overnight culture of BL21(DE3)/pZA-
SbmA cells was diluted 1:100 in LB medium containing ampicillin (100 Mg/ml) 
and 0.1 MM IPTG and grown at 37 °C until reaching A600 of 0.5. 2 ml (approxi-
mately 109 cells) was plated on LB agar supplemented with 100 Mg/ml ampicillin, 
0.1 MM IPTG and 12 MM (four-fold MIC) Api137. After overnight incubation at 
37 °C, ten colonies appeared. The prfA, prfB and prfC genes were PCR amplified 
using primer pairs PrfA-seq-fwd with PrfA-seq-rev, PrfB-seq-fwd and PrfB-seq-
rev, or PrfC-seq-fwd with PrfC-seq-rev, respectively, and sequenced. Five clones 
had mutations in the prfB gene: three had the C784T and two had the A839T 
mutation. The genome of one of the remaining five clones was sequenced and 
revealed the presence of the G241A mutation in the rplP gene encoding ribosomal 
protein uL16. The presence of this mutation in this and four remaining clones 
was verified by PCR amplification of the rplP gene using primers RplP-seq-fwd 
and RplP-seq-rev and sequencing.
The MICs of Api137 for the parental strains and selected resistant mutants 
were determined by microbroth dilution technique in 96-well plates. Specifically, 
exponentially growing cells were diluted to the final density A600 = 0.002, 100 Ml 
of the culture were placed in the wells, and after the addition of Api137, plates 
were incubated overnight at 37 °C. The minimal Api137 concentration preventing 
appearance of the visible cell density was recoded as the MIC.
Preparation of PreHC for fast kinetics experiments. All experiments were 
performed in buffer A (50 mM Tris-HCl, pH 7.5, 70 mM MgCl2, 30 mM KCl, 
7 mM MgCl2) at 37 °C unless stated otherwise. Ribosomes from the E. coli strain 
MRE600, E. coli initiation factors IF1, IF2 and IF3, f[3H]Met-tRNAfMet and its 
fluorescein-labeled version f[3H]Met-tRNAfMet(Flu) were prepared as described36,37. 
PreHC was assembled on the synthetic ‘start-stop’ mRNA (Supplementary 
Table 2) and purified through sucrose cushion as described38. The extent of 
f[3H]Met-tRNAfMet binding was better than 95% as determined by nitrocellulose-
filter binding. The pellets of PreHC were resuspended in buffer A, flash frozen in 
liquid nitrogen, and stored at −80 °C.
Single-cysteine mutants RF1 S167C, RF1 S167C D241G and the K12-type RF2 
A246T variant were generated by site-directed mutagenesis of the corresponding 
plasmids. C-terminally 6×His-tagged RF1 and RF2 were purified and in vitro 
methylated by PrmC according to the published protocol22. RF3 was purified 
as described38.
Peptide hydrolysis assay. f[3H]Met-tRNAfMet hydrolysis was monitored under 
single-round conditions, by mixing [3H]PreHC (0.1 MM), preincubated with 
0–100 MM Api137, with RF1 (1 MM) in a quench-flow apparatus at 37 °C. 
Reactions were quenched with a 10% trichloroacetic acid (TCA) solution in 50% 
ethanol. The extent of hydrolysis was assessed by means of liquid scintillation 
counting of the supernatants after centrifugation for 30 min at 16,000 × g at 4 °C. 
To measure peptide release under multiturnover conditions, [3H]PreHC (0.1 MM) 
was preincubated with RF3 (0.1 MM), GTP (1 mM), pyruvate kinase (0.1 mg/ml), 
and phosphoenol pyruvate (3 mM) for 15 min at 37 °C. The concentration of 
Api137, when present, was 1 MM. Time courses were started by addition of RF1 
or RF2 (10 nM), and after quenching the reactions with a 10% TCA solution in 
50% ethanol, the samples were processed as described above.
Preparation of quencher-labeled RF1Qsy. Prior to labeling, RF1s containing a 
single cysteine was incubated for 30 min at room temperature with a ten-fold 
molar excess of Tris(2-carboxyethyl)phosphine (TCEP, Sigma). The quencher 
dye QSY9 (Thermo Fisher) was dissolved in DMSO and added to the RF1 solu-
tion at a ten-fold molar excess. The labeling reaction was incubated for 1 h 
at room temperature with vigorous shaking and stopped by the addition of 2 
mM DTT. The excess dye was removed by gel filtration on a PD10 column (GE 
Healthcare), and protein purity was checked by means of SDS-PAGE. The extent 
of RF1 labeling (as analyzed by absorbance) was greater than 80%.
Measuring kinetics of RF1 binding and dissociation. Rapid kinetics meas-
urements were performed on an SX-20MV stopped-flow apparatus (Applied 
Photophysics, Leatherhead, UK). Experiments were performed by rapidly mixing 
equal volumes (60 Ml) of f[3H]Met-tRNAfMet(Flu)-carrying PreHC (0.05 MM), 
preincubated with Api137, for 2 min at room temperature and RF1Qsy (0.15 MM) 
at 37 °C. Fluorescein was excited at 470 nm and fluorescence emission was moni-
tored after passing a KV500 filter (Schott). Time courses were evaluated by fitting 
using exponential functions by GraphPad Prism software. Dissociation rates (koff) 
were determined by chase experiments. PreHCflu (0.05 MM) was preincubated 
with 0.15 MM RF1Qsy to generate PostHCflu in the absence or presence of 1 MM 
Api137. PreHC was then rapidly mixed with a ten-fold excess of unlabeled RF1 
and RF3-GTP (1 mM); pyruvate kinase (0.1 mg/ml) and phosphoenol pyruvate 
(3 mM) were present in both syringes. The increase of fluorescence upon dis-
sociation of RF1Qsy was monitored as described above.
Chemical probing of Api137 interaction with the ribosome. PostHC was pre-
pared by incubating 70S ribosomes (9 MM) with tRNAfMet (18 MM) and start-stop 
mRNA (18 MM) at 37 °C for 30 min in buffer A containing 20 mM MgCl2. PostHC 
(0.2 MM) was incubated in 50 Ml of reaction buffer B (250 mM K-Borate, 50 mM 
MgCl2, 500 mM NH4Cl) with RF1 (1 MM) and/or Api137 (50 MM) at 37 °C for 
10 min. Modification with dimethylsulfate (Sigma-Aldrich) and quenching were 
carried out at 37 °C for 10 min as described39. rRNA was isolated using phenol 
extraction, and the distribution of modifications was analyzed by primer exten-
sion using primers L2667 and L2180.
Cell-free translation and analysis of peptidyl-tRNA accumulation. To prepare 
the templates for translation in the E. coli S30 Extract System for Linear Templates 
(Promega), the tnaC gene was first amplified by PCR from genomic DNA of E. coli 
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MG1655 using primer Ptrc-tnaC-2 in combination with either tnaC-UGA-rev or 
tnaC-UAG-rev. These PCR fragments were cloned into the SmaI site of pUC18, 
and the tnaC template was reamplified with primers Ptrc-eCLi and rev-44.
The transcription–translation reactions were carried out in a total volume of 
5 Ml. The reactions contained 0.5 pmol of the tnaC DNA template, 2 MCi [35S]L-
methionine (specific activity 1,175 Ci/mmol, MP Biomedicals). When needed, 
the reactions were supplemented with 50 MM of Api137, 5 mM tryptophan or 
3.7 MM of purified RF1. The reactions were incubated at 37 °C for 30 min and 
then, when needed, split into two aliquots, one of which was treated for 5 min 
at 37 °C with 0.5 Mg RNase A (Sigma-Aldrich). The translation products were 
precipitated with four volumes of cold acetone and resolved in 16.5% Tris-Tricine 
gels that preserve the integrity of peptidyl-tRNA40. Gels were dried, exposed to 
the phosphoimager screen and scanned on a Typhoon scanner (GE).
In vivo suppression of premature stop codon. The E. coli strain with a premature 
stop codon in the lacZ gene was generated by subjecting the SQ171-$tolC strain 
(Supplementary Table 4) to chemical mutagenesis and selecting lacZ-deficient 
mutants. For this procedure, an overnight culture of SQ171-$tolC was diluted 
1:200 into fresh LB medium supplemented with kanamycin (30 Mg/ml), grown at 
37 °C until reaching A600 of 0.1, then exposed to 0.1% of ethyl methanesulfonate 
for 1 h. Cells were washed twice with LB medium and plated at high density 
on LB agar supplemented with kanamycin (50 Mg/ml), X-gal (40 Mg/ml), and 
IPTG (0.3 mM). White colonies were selected and restreaked on fresh kanamycin 
(50 Mg/ml), X-gal (40 Mg/ml), and IPTG (0.3 mM) LB-agar plates. The presence 
of mutations was detected by PCR amplification of the lacZ gene and sequencing. 
The clone designated SQ171-tolC/W3 (Supplementary Table 4) contained the 
C2035T mutation, which changed Gln679 of the encoded B-galactosidase to a 
UAG stop codon.
To test the stop codon suppressing activity of Api137, SQ171-$tolC/W3 cells 
were grown in LB medium supplemented with 50 Mg/ml of kanamycin. Upon 
reaching A600 of 1.0, 0.5 ml were mixed with 3.5 mL of LB agar (0.6%) kept at 
50 °C and poured on an LB-agar plate containing kanamycin (50 Mg/ml), IPTG 
(0.2 mM) and X-gal (80 Mg/ml). After solidification of the soft agar, 1 Ml of a 
50 mg/ml solution of streptomycin (100 Mg) or 1 Ml of a 2 mM solution of Api137 
(4.6 Mg) were spotted on top of the cell lawn. The plate was incubated overnight 
at 37 °C. Stop codon readthrough activity was revealed by a blue halo around 
the spotted antibiotic.
Purification of RF1 for cryo-electron microscopy. N-terminally 6×His-tagged 
E. coli RF1 was overexpressed in BL21 E. coli cells grown at 37 °C from overnight 
culture in LB medium and in the presence of 100 Mg/mL ampicillin. Protein 
expression was induced at A600 of 0.4 by adding IPTG to a final concentration 
of 1 mM. RF1 was expressed from pET28-plasmid kindly provided by R. Green 
(John Hopkins University). After 1 h of expression, cells were lysed using a micro-
fluidizer. The cell lysate was cleared by centrifugation in a SS34 rotor (Sorval) at 
4 °C and 44,100 × g for 30 min. Purification of His-tagged RF1 was done with 
Protino Ni-NTA agarose beads (Macherey-Nagel). The final eluate was applied 
onto a Superdex HiLoad S75 16/600 column (GE Healthcare) to yield the final 
concentrated protein in gel filtration buffer (50 mM HEPES pH 7.4, 50 mM KCl, 
100 mM NaCl, 2% glycerol and 5 mM 2-mercaptoethanol).
Sample preparation for cryo-electron microscopy. ErmCL_S10_UAG-SRCs 
(stalled ribosome complexes) were generated following the same disome purifica-
tion procedure as previously described41,42. The 2XermCL_S10_UAG template 
was based on the 2XermCL_disome construct described previously41 except that 
the Ser10 codon was replaced by a UAG stop codon (Supplementary Table 2).
In vitro translation of the 2XermCL_S10_UAG template was performed using 
the Rapid Translation System RTS100 E. coli HY Kit (5PRIME) in the presence of 
50 MM Api137. Disomes were isolated using sucrose density gradients (10–55% 
sucrose in buffer A, containing 50 mM HEPES-KOH, pH 7.4, 100 mM KOAc, 
25 mM Mg(OAc)2, 6 mM 2-mercaptoethanol, 20 MM Api137 and one Complete 
EDTA-free Protease Inhibitor cocktail (Roche)) as previously described41,42. The 
final purified complex was reincubated with a 2.5-fold excess of RF1 and 50 MM 
Api137 for 15 min at 37 °C.
Cryo-electron microscopy and single-particle reconstruction. A total of 5 
A260/ml Api137–RF1 complex was applied to 2 nm precoated Quantifoil R3/3 
holey carbon supported grids and vitrified using a Vitrobot Mark IV (FEI, 
Eindhoven). Data collection was performed using an FEI Titan Krios transmis-
sion electron microscope equipped with a Falcon II direct electron detector with 
a Falcon III chip (FEI, Eindhoven) at 300 kV using a pixel size of 1.084 Å and a 
defocus range of 0.7–2.5 Mm. The data collection yielded a total number of 5,132 
micrographs. Each micrograph was recorded as a series of ten frames (2.5 e−/Å2 
dose per frame). All frames (accumulated dose of 28 e−/Å2) were aligned using 
the Motion correction software43, and power spectra, defocus values, astigma-
tism and estimation of micrograph resolution were determined by CTFFIND4 
(ref. 44). Micrographs showing Thon rings beyond 3.2-Å resolution were fur-
ther manually inspected for good areas and power-spectra quality. Automatic 
particle picking was performed using SIGNATURE45, and single particles were 
processed using the FREALIGN Software package46. Initial alignment was 
performed with 116,212 particles using the E. coli 70S ribosome as a reference 
structure. Subsequently, particles were subjected to 3D classification resulting 
in six classes with a maximum resolution extending to <3.4 Å (0.143 FSC) for 
class 1 (Supplementary Fig. 4a–c). 3D classification and initial alignment was 
performed using 3-times-decimated data. The local resolution of the final maps 
was computed using ResMap47 (Supplementary Fig. 4e–g). The final maps were 
sharpened by dividing the maps by the modulation transfer function of the detec-
tor and by applying an automatically determined negative B factor to the maps 
using RELION48.
Molecular modeling and map-docking procedures. The molecular model of 
the 70S ribosome was based on E. coli-70S-EF-Tu structure49. RF1 was modeled 
based on the previously reported RF1 structure (PDB 5J3C)24. The Ile-tRNA 
model was generated based on the previously described P-site tRNA50. The mod-
els were initially adjusted and refined using Coot51. Api137 was modeled de novo 
into the map using Coot. The complete atomic model of the E. coli ribosome 
was refined using phenix.real_space_refine52 with secondary structure restraints 
calculated by PHENIX52. Cross-validation against overfitting (Supplementary 
Fig. 4d) was performed as described elsewhere53. The statistics of the refined 
model were obtained using MolProbity54 and are presented in Table 1.
Figure preparation. Figures showing electron densities and atomic models were 
generated using either UCSF Chimera55 or PyMol Molecular Graphic Systems 
(version 1.8, Schrödinger).
A Life Sciences Reporting Summary for this article is available.
Data availability. The cryo-EM density map of the Api137-RF1-ribosome com-
plex has been deposited in the Electron Microscopy Data Bank under acces-
sion code EMD 3730. The corresponding molecular model has been deposited 
in the Protein Data Bank under accession code PDB 5O2R. Source data for 
Figure 2b,c,e,f and Supplementary Figure 3 are available online. All other data 
are available from the corresponding author upon reasonable request.
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Supplementary Figure 1 
Api137-induced ribosome stalling at the end of the ORFs 
Toeprinting analysis of translation arrest in the synthetic ORF RST2 (left) and the natural ORF ermBL (right) mediated by PrAMPs. The 
toeprint bands corresponding to the ribosomes arrested by Api137 or the natural apidaecin 1a (Api1a) at the stop codon of the ORF are 
indicated with orange arrowheads; the bands representing the ribosome arrested by Onc112 at the start codon are marked with blue 
arrowheads. Sequencing lanes are shown. The nucleotides corresponding to the toeprint bands are indicated in the gene sequence on 
the side of the gels; orange brackets indicate codons positioned in the P- and A- sites of the Api-stalled ribosome; blue brackets 
indicate codons in the P- and A- sites of the Onc112-stalled ribosome. The gels are representatives of two independent experiments. 
Nature Structural & Molecular Biology: doi:10.1038/nsmb.3439
 
 
 
 
Supplementary Figure 2 
Api137-resistance mutations. 
a, Effect of the newly-isolated (marked by asterisks) or tested mutations on sensitivity of E. coli cells to Api137. The RF1 mutation is 
highlighted in orange; RF2 mutations, teal; rRNA mutations. grey; uL16, brown; uL4, blue; uL22, purple. Each MIC was determined in at 
least two independent experiments. b-d, Location of resistance mutations within the context of the terminating ribosome. b, Transverse 
section of the 50S ribosomal subunit (grey) of the 70S ribosome (30S subunit, yellow) showing the location of ribosomal proteins uL4, 
uL16, uL22 or 23S rRNA nucleotides (grey) whose mutations confer resistance to Api137. The region enlarged in (c) is boxed. c-d, 
Location of Api137 resistance mutations (spheres) in 23S rRNA (grey), ribosomal proteins uL4 (blue), uL16 (brown) and uL22 (purple), 
as well as (c) RF1 (orange) or (d) RF2 (teal). The GGQ motif of RF1 and RF2 is colored red in (c) and (d). 
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Supplementary Figure 3 
Mutations allow faster dissociation of RF1 and RF2 from the PostHC. 
a, Dissociation of RF1(D241G) from the PostHC in the presence of Api137. RF1(D241G)Qsy was incubated with PreHCFlu (0.05 µM) to 
generate PostHCFlu and then mixed with a 10-fold excess of unlabeled RF1 and RF3·GTP in the absence (grey) or in the presence 
(black) of Api137 (1 µM). The traces represent the average of up to eight technical replicates. No dissociation of wt RF1 in the presence 
of Api137 was observed under the same experimental conditions (Fig. 2f). b, Peptide hydrolysis by K12 strain-specific RF2(Ala246Thr) 
at turnover conditions in the absence (open circles) or in the presence (closed circles) of Api137 (1 µM). In the presence of Api137, the 
peptide hydrolysis reaction proceeds faster when it is catalyzed by the K12 strain RF2, compared to the B strain RF2 (Fig. 2c). 
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Supplementary Figure 4 
In silico sorting and resolution of the Api-RF1-70S complex. 
a, In silico sorting was performed with the FreAlign 9.11 software package (as described in Grigorieff, N., J. Struct. Biol. 157, 117-125 
(2007)). Initial alignment of 116,212 particles was followed by 3D classification, resulting in six different classes. Class 1 (38,203 
particles) was further refined, yielding a (b) final reconstruction consisting of 36,826 particles, with (c) an average resolution of 3.4 Å 
(based on the Fourier shell correlation (FSC) curve at FSC 0.143). d, Validation of the fit of molecular models to cryo-EM map for the 
Api137-RF1-70S complex. FSC curves calculated between the refined model and the final map (blue), with the self- and cross-validated 
correlations in orange and black, respectively. Information beyond 3.4 Å was not used during refinement and preserved for validation. 
(e) Side view and (f) transverse section of the cryo-EM map of Api137-RF1-70S complex colored according to local resolution as shown 
previously (Kucukelbir, A., Sigworth, F. J. & Tagare, H. D., Nat. Methods 11, 63-65 (2014)). g-h, Cryo-EM density for Api137 (g) colored 
according to local resolution and (h) shown as grey mesh with molecular model for residues 5-18. 
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Supplementary Figure 5 
Features of the Api137-RF1-70S complex. 
a, RF1 (orange), deacylated P-site tRNA (green) and Api137 (salmon) in the Api137-RF1-70S complex. The position of RF1 during 
canonical termination is shown in blue (PDBID 5J30; Pierson, W. E. et al., Cell Rep. 17, 11-18 (2016)). Boxed regions are zoomed in 
the panels (b) and (c). b, Interaction of the PAT motif of RF1 (orange) with the UAG stop codon of the mRNA (cyan) in the Api137-RF1-
70S complex. c, A2602 of the 23S rRNA is in the rotated conformation as observed in previous RF1-70S structures (Korostelev, A. et 
al., EMBO J. 29, 2577-2585 (2010); Pierson, W. E. et al., Cell Rep. 17, 11-18 (2016); Laurberg, M. et al., Nature 454, 852-857 (2008); 
Svidritskiy, E. & Korostelev, A. A., Structure 23, 2155-2161 (2015)). Conformation of A2602 (grey) in Api137-RF1-70S complex 
compared to A2602 (blue) during canonical termination (PDBID 5J30; Pierson, W. E. et al., Cell Rep. 17, 11-18 (2016)) and A2602 
(slate) from the pre-attack state (PDBID 1VY4; Polikanov, Y. S., Steitz, T. A. & Innis, C. A., Nat. Struct. Mol. Biol. 21, 787-793 (2014)). 
Api137 (salmon) and P-site tRNA (green) are shown for reference. d, e, The binding position of Api137 (salmon) relative to the (d) MifM 
nascent chain (dark green; Sohmen, D. et al., Nat. Commun. 6, 6941 (2015)) or (e) antimicrobial peptide Onc112 (slate; Seefeldt, A. C. 
et al., Nat. Struct. Mol. Biol. 22, 470-475 (2015)). In (d) and (e) the orientations of the peptides are indicated. 
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Supplementary Figure 6 
Mutations that increase resistance to Api137 
(a-c) Location of residues in (a) RF1 (orange) and (b, c) RF2 (teal) that increase resistance to Api137 when mutated. Site of mutations 
are shown in stick and surface representation and glutamines of the GGQ motif (Gln235 in RF1 and Gln252 in RF2) are shown as 
sticks for reference. (d-f) Location of Api137 resistance mutations in ribosomal proteins. (d) Lys63 in uL4 (blue) interacts with 23S rRNA 
residues G2061 and G2444. (e) Deletion of 82MKR84 (outside of the figure boundaries) in uL22 (purple) confers resistance to Api137 
presumably by changing the geometry of the uL22 exit tunnel loop and disrupting Api137 interaction with neighboring 23S rRNA 
nucleotides (grey), such as A751. (f) The mutation of Arg81 in uL16 (brown) may relieve Api137-mediated RF1 and RF2 trapping by 
indirectly destabilizing interactions of deacylated tRNA with the P-site mediated by G2251 of the 23S rRNA. 
 
Nature Structural & Molecular Biology: doi:10.1038/nsmb.3439
Supplementary Table 1. Deletion of the RF3-encoding prfC gene affects minimal 
inhibitory concentration (MIC) of Api137 
 
E. coli strain MIC [µM] 
wild type (BW25113) a) 6.25 
∆xylA b) 6.25 
∆prfC c) 0.75 
 
a) Parental E. coli K-type strain 
b) The xylA::kan strain, where an unrelated gene was inactivated, was used as an additional 
negative control 
c) The prfC::kan strain  
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Supplementary Table 2: DNA & RNA templates 
Promoter – blue, ORF – red, annealing site for toeprinting primer – purple, annealing site for 
oligonucleotide for RNase H treatment of disomes – green. Start codons of the ORFs are shown 
in bold, stop codons are underlined. 
Name DNA Sequence (5’ – 3’) 
yrbA-fs TAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAACATATGAT
ATACCCCTGCGGAGTGGGCGCGCGATCGCAAACTGAACGGCTTTAG
GCCGACCTCGACAGTTGGATTCACGTGCTGAATCCTGATGCGATGTC
GAGTTAATAAGCAAAATTCATTATAACC 
ermCL-UAG TTAATACGACTCACTATAGGGAATTGTGAGCGGATAACAATTGCTAGT
CTTAAGTTTTATAAGGAGGAAAAAATATGGGCATTTTTAGTATTTTTGT
AATCAGCACAGTTCATTATCAACCAAACAAAAAATAGGTGGTTATAATG
AATCGTTAATAAGCAAAATTCATTATAACCAAATTAAAGAGGGTTATAA 
RST2 TAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAACATATGTA
TTGGGTAACCTCACGTCAGCCGAATATGCTGAAAATCCATGGCTTCGA
AGACTGCGCCTAATAATAATAAAAAAAGTGATAGAATTCTATCGTTAAT
AAGCAAAATTCATTATAACC 
ermBL TAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAAAATATGTT
GGTATTCCAAATGCGTAATGTAGATAAAACATCTACTATTTAAGTGATA
GAATTCTATCGTTAATAAGCAAAATTCATTATAACC 
Start-Stop GGCAAGGAGGUAAAUAAUGUAAACGAUU 
tnaC-UAG ACATGGATTCTTGACAATTAATCATCGGCTCGTATAATGTGTGGAAGTT
TTATAAGGAGGAAAACATATGAATATCTTACATATATGTGTGACCTCAA
AATGGTTCAATATTGACAACAAAATTGTCGATCACCGCCCTTAG 
tnaC-UGA ACATGGATTCTTGACAATTAATCATCGGCTCGTATAATGTGTGGAAGTT
TTATAAGGAGGAAAACATATGAATATCTTACATATATGTGTGACCTCAA
AATGGTTCAATATTGACAACAAAATTGTCGATCACCGCCCTTGA 
2XermCL_S10_
UAG 
UAAUACGACUCACUAUAGGGAGUUUUAUAAGGAGGAAAAAAUAUGG
GCAUUUUUAGUAUUUUUGUAAUCUAGACAGUUCAUUAUCAACCAAA
CAAAAAAUAAAGUUUUAUAAGGAGGAAAAAAUAUGGGCAUUUUUAGU
AUUUUUGUAAUCUAGACAGUUCAUUAUCAACCAAACAAAAAAUAA 
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Supplementary Table 3: DNA primers used in this study 
 
  
Name Sequence 
T7-IR-AUG TAATACGACTCACTATAGGGCTTAAGTATAAGGAGGAAAACATATG 
IR-yrbA-fs15-
RF1 
GTATAAGGAGGAAAACATATGATATACCCCTGCGGAGTGGGCGCGCGAT 
CGCAAACTGAACGGCTTTAGGCCGACCTCGACAGTTGGAT 
posT-NV1 GGTTATAATGAATTTTGCTTATTAACTCGACATCGCATCAGGATTCAGCAC 
GTGAATCCAACTGTCGAGGTCG 
T7 TAATACGACTCACTATAGGG 
ermCL-UAG TTATAACCCTCTTTAATTTGGTTATAATGAATTTTGCTTATTAACGATTCAT 
TATAACCACCTATT  
ermCL-TP-term TTATAACCCTCTTTAATTTGGTT 
SbmA-seq-fwd CATTTGGCTGACGCTTTGTA 
SbmA-seq-rev TACTACACCCCGCTAAAACC 
SbmA-EcoRI-
rev 
TGACGCGCGGAATTCCTTCT 
PrfA-seq-fwd CTGAATATTCTGCGCGACAG 
PrfA-seq-rev CAGGATTTCAGCATCACGC 
PrfB-seq-fwd GCTCTTATCACCGCATTTTG 
PrfB-seq-rev GTTCATTGTTAAGATCGACTACC 
PrfC-seq-fwd GAAGGTAAGCTGGATATGCTG 
PrfC-seq-rev GCTTCTGATAACGTAGCCAG 
rplP-seq-fwd CGTTAAAGTGTGGATCTTCAAAGG 
rplP-seq-rev CACTTGCTTCAACAGGTGAG 
L2667 GGTCCTCTCGTACTAGGAGCAG 
L2180 GGGTGGTATTTCAAGGTCGG 
Ptrc-tnaC ACATGGATTCTTGACAATTAATCATCGGCTCGTATAATGTGTGGA 
AGTTTTATAAGGAGGAAAACATATG 
tnaC-UAG-rev GCAAACTAAGGGCGGTGATCGAC 
tnaC-UGA-rev GCAAATCAAGGGCGGTGATCGAC 
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Supplementary Table 4: Bacterial strains used in this study 
 
E. coli strain Type Source 
SQ171 K-strain; F-, Δ(rrsH-aspU)794(::FRT), λ-, Δ(rrfG-
rrsG)791(::FRT), Δ(rrfF-rrsD)793(::FRT), rph-1, 
Δ(rrsC-trpT)795(::FRT), Δ(rrsA-rrfA)792(::FRT), 
Δ(rrsB-rrfB)790(::FRT), Δ(rrsE-rrfE)789(::FRT), 
ptRNA67, pKK3535 
Quan, S. et al., G3 5, 
2555-2557 (2015) 
SQ110 K-strain, F-, Δ(rrsH-aspU)794(::FRT), λ-, Δ(rrfG-
rrsG)791(::FRT), Δ(rrfF-rrsD)793(::FRT), rph-1, 
Δ(rrsC-trpT)795(::FRT), Δ(rrsA-rrfA)792(::FRT), 
Δ(rrsB-rrfB)790(::FRT), ptRNA67 
Quan, S. et al., G3 5, 
2555-2557 (2015) 
SQ110 ApiR2  derived from SQ110, sbmA(C752A) this study 
SQ110 ApiR21  derived from SQ110, prfA(A722G) this study 
BL21 (DE3) B-strain; F-, lon-11, Δ(ompT-nfrA)885, Δ(galM-
ybhJ)884, λDE3 [lacI, lacUV5-T7 gene 1, ind1, 
sam7, nin5], Δ46, [mal+]K-12(λS), hsdS10 
Wood, W.B., J Mol Biol 
16, 118-133 (1966); 
Studier, F.W. & Moffatt, 
B.A., J Mol Biol 189, 113-
30 (1986) 
BL21 ApiR10 derived from BL21 (DE3), rplP(G241A), pZa-SbmA this study 
BL21 ApiR11 derived from BL21 (DE3), prfB(C784T), pZa-SbmA this study 
BL21 ApiR12 derived from BL21 (DE3), prfB(A839T), pZa-SbmA this study 
AB301 K-strain; Hfr(PO21), relA1, spoT1, metB1 Bouck, N. & Adelberg, 
E.A., J Bacteriol 102, 
688-701 (1970) 
N281 K-strain; Hfr(PO21), relA1, rplV281, spoT1, metB1 Wittmann, H.G. et al., Mol 
Gen Genet 127, 175-89. 
(1973); Chittum, H.S. & 
Champney, W.S., J 
Bacteriol 176, 6192-8 
(1994). 
N282 K-strain; Hfr(PO21), relA1, rplD282, spoT1, metB1 Wittmann, H.G. et al., Mol 
Gen Genet 127, 175-89. 
(1973); Chittum, H.S. & 
Champney, W.S., J 
Bacteriol 176, 6192-8 
(1994). 
SQ171-∆tolC derived from SQ171; ∆tolC, pCSacB Kannan, K., Vázquez-
Laslop, N. & Mankin, 
A.S., Cell 151, 508-520 
(2012) 
SQ171-
∆tolC/W3 
derived from SQ171-∆tolC, lacZ(C2035T) pCSacB this study 
BW25113 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-
1, Δ(rhaD-rhaB)568, hsdR514 
Baba, T. et al., Mol Syst 
Biol 2, 2006 0008 (2006) 
BW25113 ∆xylA 
(JW3537) 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-
, ΔxylA748::kan, rph-1, Δ(rhaD-rhaB)568, hsdR514 
Baba, T. et al., Mol Syst 
Biol 2, 2006 0008 (2006) 
BW25113 ∆prfC 
(JW5873) 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-
1, Δ(rhaD-rhaB)568, hsdR514, ΔprfC770::kan 
Baba, T. et al., Mol Syst 
Biol 2, 2006 0008 (2006) 
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